Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,Carcinoma in situ of breast,A1BG,Alpha-1B-glycoprotein,11662,77,1.41 [0.41-4.82],0.5819152802616441
Chapter II Neoplasms,Carcinoma in situ of breast,AAMDC,Mth938 domain-containing protein,11330,75,0.81 [0.53-1.23],0.311944682630863
Chapter II Neoplasms,Carcinoma in situ of breast,AARSD1,Alanyl-tRNA editing protein Aarsd1,13380,89,0.88 [0.63-1.24],0.4759130733519776
Chapter II Neoplasms,Carcinoma in situ of breast,ABCA2,ATP-binding cassette sub-family A member 2,11293,74,0.72 [0.38-1.37],0.3217444848960993
Chapter II Neoplasms,Carcinoma in situ of breast,ABHD14B,Protein ABHD14B,13312,89,0.82 [0.59-1.13],0.2201288593326531
Chapter II Neoplasms,Carcinoma in situ of breast,ABL1,Tyrosine-protein kinase ABL1,13380,89,0.63 [0.47-0.86],0.0031950503089769
Chapter II Neoplasms,Carcinoma in situ of breast,ABO,Histo-blood group ABO system transferase,11650,75,0.93 [0.80-1.08],0.326789540162903
Chapter II Neoplasms,Carcinoma in situ of breast,ABRAXAS2,BRISC complex subunit Abraxas 2,11293,74,0.78 [0.55-1.11],0.1713806159398224
Chapter II Neoplasms,Carcinoma in situ of breast,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",13139,87,0.93 [0.74-1.18],0.574162894531924
Chapter II Neoplasms,Carcinoma in situ of breast,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",11399,77,0.79 [0.54-1.16],0.2274078712409191
Chapter II Neoplasms,Carcinoma in situ of breast,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",11652,74,0.84 [0.65-1.09],0.1786441940550134
Chapter II Neoplasms,Carcinoma in situ of breast,ACAN,Aggrecan core protein,13336,90,0.82 [0.43-1.58],0.5518657477105584
Chapter II Neoplasms,Carcinoma in situ of breast,ACE,Angiotensin-converting enzyme,11650,75,0.55 [0.23-1.30],0.1727662953828622
Chapter II Neoplasms,Carcinoma in situ of breast,ACE2,Angiotensin-converting enzyme 2,13220,88,0.74 [0.47-1.19],0.2161186957443059
Chapter II Neoplasms,Carcinoma in situ of breast,ACHE,Acetylcholinesterase,11384,76,0.67 [0.33-1.39],0.2837674347584155
Chapter II Neoplasms,Carcinoma in situ of breast,ACOT13,Acyl-coenzyme A thioesterase 13,11587,77,0.84 [0.69-1.01],0.0707265329484674
Chapter II Neoplasms,Carcinoma in situ of breast,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,13452,90,0.91 [0.61-1.34],0.628107987559462
Chapter II Neoplasms,Carcinoma in situ of breast,ACP1,Low molecular weight phosphotyrosine protein phosphatase,11319,73,0.68 [0.40-1.17],0.1659739688354972
Chapter II Neoplasms,Carcinoma in situ of breast,ACP5,Tartrate-resistant acid phosphatase type 5,13495,87,1.09 [0.61-1.96],0.7732809491188919
Chapter II Neoplasms,Carcinoma in situ of breast,ACP6,Lysophosphatidic acid phosphatase type 6,13550,87,1.05 [0.78-1.40],0.7593958475549696
Chapter II Neoplasms,Carcinoma in situ of breast,ACRBP,Acrosin-binding protein,11571,75,0.82 [0.45-1.51],0.5213095846105471
Chapter II Neoplasms,Carcinoma in situ of breast,ACRV1,Acrosomal protein SP-10,11319,73,0.91 [0.48-1.71],0.7582082194037199
Chapter II Neoplasms,Carcinoma in situ of breast,ACSL1,Long-chain-fatty-acid--CoA ligase 1,11293,74,0.98 [0.53-1.80],0.952191496601834
Chapter II Neoplasms,Carcinoma in situ of breast,ACTA2,"Actin, aortic smooth muscle",13220,88,0.79 [0.48-1.28],0.3304417646747347
Chapter II Neoplasms,Carcinoma in situ of breast,ACTN2,Alpha-actinin-2,11293,74,0.76 [0.48-1.20],0.2420447530105693
Chapter II Neoplasms,Carcinoma in situ of breast,ACTN4,Alpha-actinin-4,13187,89,0.92 [0.49-1.71],0.787271543288733
Chapter II Neoplasms,Carcinoma in situ of breast,ACVRL1,Serine/threonine-protein kinase receptor R3,13342,90,1.04 [0.45-2.37],0.9345801208640782
Chapter II Neoplasms,Carcinoma in situ of breast,ACY1,Aminoacylase-1,13452,90,0.90 [0.65-1.24],0.531052388323221
Chapter II Neoplasms,Carcinoma in situ of breast,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,11293,74,0.83 [0.55-1.24],0.3618874949463473
Chapter II Neoplasms,Carcinoma in situ of breast,ACYP1,Acylphosphatase-1,11335,76,0.71 [0.50-0.99],0.0435684924087699
Chapter II Neoplasms,Carcinoma in situ of breast,ADA,Adenosine deaminase,13604,89,0.68 [0.38-1.18],0.1707486947637359
Chapter II Neoplasms,Carcinoma in situ of breast,ADA2,Adenosine deaminase 2,13329,86,0.90 [0.56-1.43],0.6439061339036641
Chapter II Neoplasms,Carcinoma in situ of breast,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,11319,73,0.97 [0.51-1.84],0.9313555394094012
Chapter II Neoplasms,Carcinoma in situ of breast,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,13220,88,0.57 [0.30-1.06],0.0759819961723209
Chapter II Neoplasms,Carcinoma in situ of breast,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,13363,90,0.62 [0.36-1.06],0.0815216785226107
Chapter II Neoplasms,Carcinoma in situ of breast,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,13604,89,0.92 [0.55-1.56],0.7689017141065663
Chapter II Neoplasms,Carcinoma in situ of breast,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,13557,89,1.01 [0.51-2.00],0.9743998434524576
Chapter II Neoplasms,Carcinoma in situ of breast,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,11587,77,1.07 [0.51-2.21],0.8641729421758368
Chapter II Neoplasms,Carcinoma in situ of breast,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,11319,73,0.55 [0.25-1.19],0.1312545485019024
Chapter II Neoplasms,Carcinoma in situ of breast,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,13609,89,0.97 [0.43-2.23],0.9520041478581892
Chapter II Neoplasms,Carcinoma in situ of breast,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,13380,89,1.01 [0.67-1.52],0.9798010854710248
Chapter II Neoplasms,Carcinoma in situ of breast,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,13220,88,0.81 [0.41-1.60],0.5351439240026803
Chapter II Neoplasms,Carcinoma in situ of breast,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,11319,73,0.91 [0.48-1.72],0.7770249395309491
Chapter II Neoplasms,Carcinoma in situ of breast,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,13480,90,1.17 [0.78-1.76],0.4528445874371559
Chapter II Neoplasms,Carcinoma in situ of breast,ADAMTSL2,ADAMTS-like protein 2,11632,77,0.72 [0.34-1.51],0.3848198357787746
Chapter II Neoplasms,Carcinoma in situ of breast,ADAMTSL4,ADAMTS-like protein 4,11330,75,0.78 [0.30-2.02],0.6069050866246296
Chapter II Neoplasms,Carcinoma in situ of breast,ADAMTSL5,ADAMTS-like protein 5,11652,74,0.82 [0.47-1.44],0.4944153459836334
Chapter II Neoplasms,Carcinoma in situ of breast,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,13139,87,1.08 [0.68-1.72],0.7556920121208377
Chapter II Neoplasms,Carcinoma in situ of breast,ADD1,Alpha-adducin,11384,76,0.79 [0.58-1.09],0.157987442357768
Chapter II Neoplasms,Carcinoma in situ of breast,ADGRB3,Adhesion G protein-coupled receptor B3,13342,90,1.60 [0.92-2.80],0.0972926328447931
Chapter II Neoplasms,Carcinoma in situ of breast,ADGRD1,Adhesion G-protein coupled receptor D1,11384,76,0.79 [0.43-1.48],0.4654954661708634
Chapter II Neoplasms,Carcinoma in situ of breast,ADGRE1,Adhesion G protein-coupled receptor E1,11587,77,1.25 [0.85-1.85],0.2527008187541423
Chapter II Neoplasms,Carcinoma in situ of breast,ADGRE2,Adhesion G protein-coupled receptor E2,13507,91,0.93 [0.48-1.82],0.8424803446872187
Chapter II Neoplasms,Carcinoma in situ of breast,ADGRE5,Adhesion G protein-coupled receptor E5,13531,87,0.77 [0.40-1.49],0.4404685860559045
Chapter II Neoplasms,Carcinoma in situ of breast,ADGRF5,Adhesion G protein-coupled receptor F5,11652,74,0.80 [0.39-1.68],0.5604257724382893
Chapter II Neoplasms,Carcinoma in situ of breast,ADGRG1,Adhesion G-protein coupled receptor G1,13380,89,0.53 [0.31-0.91],0.0207453263607984
Chapter II Neoplasms,Carcinoma in situ of breast,ADGRG2,Adhesion G-protein coupled receptor G2,13452,90,1.22 [0.61-2.44],0.5817141334927829
Chapter II Neoplasms,Carcinoma in situ of breast,ADGRV1,Adhesion G-protein coupled receptor V1,11311,73,0.66 [0.44-0.99],0.0464980135754955
Chapter II Neoplasms,Carcinoma in situ of breast,ADH1B,All-trans-retinol dehydrogenase,11384,76,1.02 [0.76-1.37],0.9133323067055664
Chapter II Neoplasms,Carcinoma in situ of breast,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,13220,88,0.85 [0.67-1.07],0.1645101492285914
Chapter II Neoplasms,Carcinoma in situ of breast,ADIPOQ,Adiponectin,11662,77,1.28 [0.91-1.78],0.1516686566167468
Chapter II Neoplasms,Carcinoma in situ of breast,ADM,Pro-adrenomedullin,13571,87,1.00 [0.50-2.01],0.9889260277942148
Chapter II Neoplasms,Carcinoma in situ of breast,ADRA2A,Alpha-2A adrenergic receptor,11293,74,0.97 [0.71-1.32],0.8358081923784693
Chapter II Neoplasms,Carcinoma in situ of breast,AFAP1,Actin filament-associated protein 1,11384,76,0.80 [0.61-1.05],0.1120268044848007
Chapter II Neoplasms,Carcinoma in situ of breast,AFM,Afamin,11662,77,1.50 [0.46-4.87],0.4995566989889966
Chapter II Neoplasms,Carcinoma in situ of breast,AFP,Alpha-fetoprotein,13327,90,0.96 [0.73-1.25],0.7419948058119088
Chapter II Neoplasms,Carcinoma in situ of breast,AGBL2,Cytosolic carboxypeptidase 2,11311,73,0.95 [0.75-1.19],0.6417404633297552
Chapter II Neoplasms,Carcinoma in situ of breast,AGER,Advanced glycosylation end product-specific receptor,13418,90,0.96 [0.60-1.53],0.8682471601505479
Chapter II Neoplasms,Carcinoma in situ of breast,AGR2,Anterior gradient protein 2 homolog,12988,82,0.93 [0.77-1.13],0.4484628448665403
Chapter II Neoplasms,Carcinoma in situ of breast,AGR3,Anterior gradient protein 3,13120,87,0.92 [0.66-1.29],0.6213688000887283
Chapter II Neoplasms,Carcinoma in situ of breast,AGRN,Agrin,13507,91,1.00 [0.55-1.80],0.9983056005343526
Chapter II Neoplasms,Carcinoma in situ of breast,AGRP,Agouti-related protein,13604,89,0.87 [0.62-1.21],0.4071607554836901
Chapter II Neoplasms,Carcinoma in situ of breast,AGT,Angiotensinogen,11650,75,0.60 [0.21-1.71],0.3390195995888254
Chapter II Neoplasms,Carcinoma in situ of breast,AGXT,Serine--pyruvate aminotransferase,13452,90,1.07 [0.85-1.35],0.5754030708420742
Chapter II Neoplasms,Carcinoma in situ of breast,AHCY,Adenosylhomocysteinase,13452,90,0.76 [0.58-1.01],0.0583031374315253
Chapter II Neoplasms,Carcinoma in situ of breast,AHNAK,Neuroblast differentiation-associated protein AHNAK,11330,75,0.94 [0.46-1.92],0.8562786967058301
Chapter II Neoplasms,Carcinoma in situ of breast,AHNAK2,Protein AHNAK2,11330,75,0.91 [0.41-2.00],0.8073689159330486
Chapter II Neoplasms,Carcinoma in situ of breast,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,11571,75,0.39 [0.24-0.63],0.0001315032928191
Chapter II Neoplasms,Carcinoma in situ of breast,AHSG,Alpha-2-HS-glycoprotein,11650,75,0.94 [0.42-2.12],0.8787475822887446
Chapter II Neoplasms,Carcinoma in situ of breast,AHSP,Alpha-hemoglobin-stabilizing protein,13428,89,1.10 [0.90-1.35],0.3647122559785427
Chapter II Neoplasms,Carcinoma in situ of breast,AIDA,"Axin interactor, dorsalization-associated protein",11312,75,0.91 [0.68-1.21],0.4986768317603171
Chapter II Neoplasms,Carcinoma in situ of breast,AIF1,Allograft inflammatory factor 1,13139,87,1.01 [0.70-1.46],0.9390856733445976
Chapter II Neoplasms,Carcinoma in situ of breast,AIF1L,Allograft inflammatory factor 1-like,11330,75,0.81 [0.52-1.26],0.3438017904609426
Chapter II Neoplasms,Carcinoma in situ of breast,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",13350,89,0.80 [0.66-0.96],0.0198732667826401
Chapter II Neoplasms,Carcinoma in situ of breast,AK1,Adenylate kinase isoenzyme 1,13452,90,0.93 [0.70-1.24],0.6165332631471532
Chapter II Neoplasms,Carcinoma in situ of breast,AK2,"Adenylate kinase 2, mitochondrial",11617,76,0.79 [0.64-0.97],0.0251579383178324
Chapter II Neoplasms,Carcinoma in situ of breast,AKAP12,A-kinase anchor protein 12,11384,76,1.31 [0.54-3.21],0.5514152604626115
Chapter II Neoplasms,Carcinoma in situ of breast,AKR1B1,Aldo-keto reductase family 1 member B1,13139,87,0.89 [0.69-1.14],0.3555104696286337
Chapter II Neoplasms,Carcinoma in situ of breast,AKR1B10,Aldo-keto reductase family 1 member B10,11312,75,0.89 [0.60-1.33],0.5812258805466997
Chapter II Neoplasms,Carcinoma in situ of breast,AKR1C4,Aldo-keto reductase family 1 member C4,13220,88,1.17 [0.87-1.58],0.2902183675170098
Chapter II Neoplasms,Carcinoma in situ of breast,AKR7L,Aflatoxin B1 aldehyde reductase member 4,11319,73,0.91 [0.65-1.26],0.563691657425339
Chapter II Neoplasms,Carcinoma in situ of breast,AKT1S1,Proline-rich AKT1 substrate 1,13108,85,0.71 [0.53-0.95],0.0227505069890296
Chapter II Neoplasms,Carcinoma in situ of breast,AKT2,RAC-beta serine/threonine-protein kinase,11634,76,0.83 [0.70-0.98],0.0305057656180815
Chapter II Neoplasms,Carcinoma in situ of breast,AKT3,RAC-gamma serine/threonine-protein kinase,13072,87,0.78 [0.56-1.09],0.1477594307289944
Chapter II Neoplasms,Carcinoma in situ of breast,ALCAM,CD166 antigen,13609,89,0.86 [0.32-2.28],0.7551043443145602
Chapter II Neoplasms,Carcinoma in situ of breast,ALDH1A1,Retinal dehydrogenase 1,13449,89,0.96 [0.68-1.37],0.8410370428228033
Chapter II Neoplasms,Carcinoma in situ of breast,ALDH2,"Aldehyde dehydrogenase, mitochondrial",11571,75,0.83 [0.51-1.37],0.4715608448679704
Chapter II Neoplasms,Carcinoma in situ of breast,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",13418,87,1.20 [0.93-1.56],0.1638799209861512
Chapter II Neoplasms,Carcinoma in situ of breast,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",11634,76,0.97 [0.61-1.55],0.9077372649131362
Chapter II Neoplasms,Carcinoma in situ of breast,ALMS1,Alstrom syndrome protein 1,11399,77,0.90 [0.54-1.49],0.6731100830747678
Chapter II Neoplasms,Carcinoma in situ of breast,ALPI,Intestinal-type alkaline phosphatase,11319,73,0.88 [0.73-1.06],0.1872225286429066
Chapter II Neoplasms,Carcinoma in situ of breast,ALPP,"Alkaline phosphatase, placental type",13380,89,0.92 [0.76-1.12],0.4153410529419243
Chapter II Neoplasms,Carcinoma in situ of breast,AMBN,Ameloblastin,13187,89,0.58 [0.26-1.30],0.1845407744884115
Chapter II Neoplasms,Carcinoma in situ of breast,AMBP,Protein AMBP,13555,86,1.38 [0.51-3.71],0.5287373622572767
Chapter II Neoplasms,Carcinoma in situ of breast,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,11632,77,1.03 [0.44-2.42],0.9523659618536808
Chapter II Neoplasms,Carcinoma in situ of breast,AMFR,E3 ubiquitin-protein ligase AMFR,13108,85,1.12 [0.86-1.46],0.3904729990052056
Chapter II Neoplasms,Carcinoma in situ of breast,AMIGO1,Amphoterin-induced protein 1,11312,75,1.08 [0.73-1.60],0.7115613557241385
Chapter II Neoplasms,Carcinoma in situ of breast,AMIGO2,Amphoterin-induced protein 2,13380,89,0.52 [0.23-1.20],0.124337433856949
Chapter II Neoplasms,Carcinoma in situ of breast,AMN,Protein amnionless,13187,89,1.05 [0.72-1.54],0.8071567802110414
Chapter II Neoplasms,Carcinoma in situ of breast,AMOT,Angiomotin,11384,76,0.76 [0.45-1.29],0.3086494608144742
Chapter II Neoplasms,Carcinoma in situ of breast,AMOTL2,Angiomotin-like protein 2,11545,75,0.52 [0.28-0.95],0.0323981732716244
Chapter II Neoplasms,Carcinoma in situ of breast,AMPD3,AMP deaminase 3,11617,76,1.07 [0.80-1.43],0.6542373489719855
Chapter II Neoplasms,Carcinoma in situ of breast,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,10916,66,0.60 [0.35-1.02],0.059976532701943
Chapter II Neoplasms,Carcinoma in situ of breast,AMY2A,Pancreatic alpha-amylase,12934,85,0.76 [0.50-1.15],0.1979852428551403
Chapter II Neoplasms,Carcinoma in situ of breast,AMY2B,Alpha-amylase 2B,12524,81,0.75 [0.49-1.15],0.1925507751093669
Chapter II Neoplasms,Carcinoma in situ of breast,ANG,Angiogenin,13370,87,1.59 [0.99-2.57],0.0572959676246368
Chapter II Neoplasms,Carcinoma in situ of breast,ANGPT1,Angiopoietin-1,13406,91,0.89 [0.72-1.09],0.2593277622790424
Chapter II Neoplasms,Carcinoma in situ of breast,ANGPT2,Angiopoietin-2,13571,87,0.77 [0.47-1.26],0.2967946703362602
Chapter II Neoplasms,Carcinoma in situ of breast,ANGPTL1,Angiopoietin-related protein 1,13267,90,0.70 [0.37-1.32],0.2691695517250735
Chapter II Neoplasms,Carcinoma in situ of breast,ANGPTL2,Angiopoietin-related protein 2,13469,91,1.09 [0.68-1.74],0.7280076245732399
Chapter II Neoplasms,Carcinoma in situ of breast,ANGPTL3,Angiopoietin-related protein 3,13420,89,1.16 [0.69-1.95],0.5843731482126765
Chapter II Neoplasms,Carcinoma in situ of breast,ANGPTL4,Angiopoietin-related protein 4,13486,91,1.08 [0.73-1.60],0.7047162261098776
Chapter II Neoplasms,Carcinoma in situ of breast,ANGPTL7,Angiopoietin-related protein 7,13571,87,0.69 [0.41-1.16],0.1589189200465958
Chapter II Neoplasms,Carcinoma in situ of breast,ANK2,Ankyrin-2,11293,74,1.00 [0.73-1.37],0.9879670925032584
Chapter II Neoplasms,Carcinoma in situ of breast,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,11319,73,0.69 [0.51-0.92],0.0119640552333143
Chapter II Neoplasms,Carcinoma in situ of breast,ANKRA2,Ankyrin repeat family A protein 2,11230,75,0.98 [0.65-1.46],0.903673789002626
Chapter II Neoplasms,Carcinoma in situ of breast,ANKRD54,Ankyrin repeat domain-containing protein 54,13139,87,0.99 [0.71-1.37],0.9431464766586044
Chapter II Neoplasms,Carcinoma in situ of breast,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,11330,75,0.90 [0.51-1.59],0.7179642511259992
Chapter II Neoplasms,Carcinoma in situ of breast,ANPEP,Aminopeptidase N,13428,89,1.71 [0.94-3.12],0.0793891133746471
Chapter II Neoplasms,Carcinoma in situ of breast,ANXA1,Annexin A1,11305,76,1.44 [0.97-2.12],0.0675196295006846
Chapter II Neoplasms,Carcinoma in situ of breast,ANXA10,Annexin A10,13108,85,0.84 [0.64-1.09],0.1904891877269534
Chapter II Neoplasms,Carcinoma in situ of breast,ANXA11,Annexin A11,13416,87,0.86 [0.66-1.13],0.2906125350412423
Chapter II Neoplasms,Carcinoma in situ of breast,ANXA2,Annexin A2,11157,75,0.95 [0.68-1.31],0.7387007521595361
Chapter II Neoplasms,Carcinoma in situ of breast,ANXA3,Annexin A3,13557,89,0.82 [0.63-1.07],0.1460427094531378
Chapter II Neoplasms,Carcinoma in situ of breast,ANXA4,Annexin A4,13379,90,0.83 [0.64-1.08],0.1705803714700252
Chapter II Neoplasms,Carcinoma in situ of breast,ANXA5,Annexin A5,13070,85,0.92 [0.49-1.74],0.8059780409931991
Chapter II Neoplasms,Carcinoma in situ of breast,AOC1,Amiloride-sensitive amine oxidase [copper-containing],13187,89,1.03 [0.74-1.42],0.8795909928108605
Chapter II Neoplasms,Carcinoma in situ of breast,AOC3,Membrane primary amine oxidase,13459,89,1.60 [0.86-2.95],0.1345946804220071
Chapter II Neoplasms,Carcinoma in situ of breast,AP1G2,AP-1 complex subunit gamma-like 2,11571,75,0.69 [0.51-0.92],0.0122694338730614
Chapter II Neoplasms,Carcinoma in situ of breast,AP2B1,AP-2 complex subunit beta,11312,75,0.60 [0.35-1.02],0.0575296954180443
Chapter II Neoplasms,Carcinoma in situ of breast,AP3B1,AP-3 complex subunit beta-1,11587,77,0.77 [0.57-1.03],0.0794492083222052
Chapter II Neoplasms,Carcinoma in situ of breast,AP3S2,AP-3 complex subunit sigma-2,11617,76,0.61 [0.36-1.03],0.0632130560572176
Chapter II Neoplasms,Carcinoma in situ of breast,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,13380,89,1.11 [0.76-1.64],0.5826468761357413
Chapter II Neoplasms,Carcinoma in situ of breast,APCS,Serum amyloid P-component,11562,76,1.80 [0.98-3.30],0.0596818809746584
Chapter II Neoplasms,Carcinoma in situ of breast,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,13531,87,0.97 [0.71-1.34],0.8589738036875019
Chapter II Neoplasms,Carcinoma in situ of breast,APLP1,Amyloid-like protein 1,13452,90,1.00 [0.69-1.43],0.9837043336151248
Chapter II Neoplasms,Carcinoma in situ of breast,APOA1,Apolipoprotein A-I,11662,77,1.09 [0.52-2.28],0.8196058139235342
Chapter II Neoplasms,Carcinoma in situ of breast,APOA2,Apolipoprotein A-II,11650,75,1.23 [0.77-1.97],0.3788913607761576
Chapter II Neoplasms,Carcinoma in situ of breast,APOA4,Apolipoprotein A-IV,11662,77,1.07 [0.60-1.88],0.8249860931980708
Chapter II Neoplasms,Carcinoma in situ of breast,APOB,Apolipoprotein B-100,11650,75,0.61 [0.24-1.55],0.2970881633360268
Chapter II Neoplasms,Carcinoma in situ of breast,APOBR,Apolipoprotein B receptor,11330,75,1.02 [0.61-1.72],0.9356430818274456
Chapter II Neoplasms,Carcinoma in situ of breast,APOC1,Apolipoprotein C-I,11636,77,1.16 [0.67-2.02],0.5981427600572085
Chapter II Neoplasms,Carcinoma in situ of breast,APOD,Apolipoprotein D,11102,74,1.10 [0.70-1.72],0.6859260678247079
Chapter II Neoplasms,Carcinoma in situ of breast,APOE,Apolipoprotein E,11662,77,0.78 [0.53-1.15],0.2056621466317534
Chapter II Neoplasms,Carcinoma in situ of breast,APOF,Apolipoprotein F,11650,75,1.26 [0.52-3.01],0.6105684175765997
Chapter II Neoplasms,Carcinoma in situ of breast,APOH,Beta-2-glycoprotein 1,13449,89,1.35 [0.83-2.22],0.2311935224935098
Chapter II Neoplasms,Carcinoma in situ of breast,APOL1,Apolipoprotein L1,11650,75,0.95 [0.68-1.32],0.7408477293396089
Chapter II Neoplasms,Carcinoma in situ of breast,APOM,Apolipoprotein M,13441,89,1.85 [0.92-3.73],0.0861053673845434
Chapter II Neoplasms,Carcinoma in situ of breast,APP,Amyloid-beta precursor protein,13423,89,0.84 [0.63-1.11],0.2254271001659735
Chapter II Neoplasms,Carcinoma in situ of breast,APPL2,DCC-interacting protein 13-beta,11384,76,0.80 [0.66-0.97],0.0233186842392548
Chapter II Neoplasms,Carcinoma in situ of breast,APRT,Adenine phosphoribosyltransferase,13345,90,0.72 [0.50-1.04],0.0783013144194407
Chapter II Neoplasms,Carcinoma in situ of breast,ARAF,Serine/threonine-protein kinase A-Raf,11399,77,0.70 [0.49-1.01],0.0555099443580974
Chapter II Neoplasms,Carcinoma in situ of breast,AREG,Amphiregulin,13380,89,1.07 [0.74-1.54],0.7144327183949599
Chapter II Neoplasms,Carcinoma in situ of breast,ARF6,ADP-ribosylation factor 6,11587,77,0.85 [0.70-1.04],0.1141948519419275
Chapter II Neoplasms,Carcinoma in situ of breast,ARFIP1,Arfaptin-1,11634,76,0.80 [0.58-1.11],0.1819793269741677
Chapter II Neoplasms,Carcinoma in situ of breast,ARG1,Arginase-1,13393,87,1.27 [0.90-1.79],0.179647356327472
Chapter II Neoplasms,Carcinoma in situ of breast,ARG2,"Arginase-2, mitochondrial",11571,75,1.25 [0.83-1.89],0.2757635411392031
Chapter II Neoplasms,Carcinoma in situ of breast,ARHGAP1,Rho GTPase-activating protein 1,13139,87,0.70 [0.47-1.06],0.0920307133090078
Chapter II Neoplasms,Carcinoma in situ of breast,ARHGAP25,Rho GTPase-activating protein 25,13139,87,1.01 [0.74-1.37],0.9711823496227356
Chapter II Neoplasms,Carcinoma in situ of breast,ARHGAP30,Rho GTPase-activating protein 30,11399,77,0.79 [0.41-1.51],0.4714799785154677
Chapter II Neoplasms,Carcinoma in situ of breast,ARHGAP45,Rho GTPase-activating protein 45,11384,76,0.80 [0.61-1.05],0.1014966000428706
Chapter II Neoplasms,Carcinoma in situ of breast,ARHGAP5,Rho GTPase-activating protein 5,11230,75,0.77 [0.55-1.09],0.143963952365024
Chapter II Neoplasms,Carcinoma in situ of breast,ARHGEF1,Rho guanine nucleotide exchange factor 1,11617,76,0.81 [0.64-1.03],0.0889308645366055
Chapter II Neoplasms,Carcinoma in situ of breast,ARHGEF10,Rho guanine nucleotide exchange factor 10,11634,76,0.75 [0.59-0.96],0.0241543333603645
Chapter II Neoplasms,Carcinoma in situ of breast,ARHGEF12,Rho guanine nucleotide exchange factor 12,13434,87,0.85 [0.71-1.02],0.088294111988155
Chapter II Neoplasms,Carcinoma in situ of breast,ARHGEF5,Rho guanine nucleotide exchange factor 5,11311,73,1.07 [0.81-1.43],0.6194276709163545
Chapter II Neoplasms,Carcinoma in situ of breast,ARID3A,AT-rich interactive domain-containing protein 3A,11311,73,0.97 [0.55-1.70],0.9174383043231504
Chapter II Neoplasms,Carcinoma in situ of breast,ARID4B,AT-rich interactive domain-containing protein 4B,13108,85,1.07 [0.69-1.64],0.7694538509219728
Chapter II Neoplasms,Carcinoma in situ of breast,ARL13B,ADP-ribosylation factor-like protein 13B,11293,74,0.75 [0.53-1.07],0.1145452746175241
Chapter II Neoplasms,Carcinoma in situ of breast,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,11293,74,0.60 [0.34-1.07],0.0844331587799824
Chapter II Neoplasms,Carcinoma in situ of breast,ARMCX2,Armadillo repeat-containing X-linked protein 2,11311,73,1.05 [0.76-1.44],0.7867918960171628
Chapter II Neoplasms,Carcinoma in situ of breast,ARNT,Aryl hydrocarbon receptor nuclear translocator,13187,89,0.43 [0.24-0.80],0.0072718842009539
Chapter II Neoplasms,Carcinoma in situ of breast,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,11293,74,1.06 [0.72-1.57],0.7561671972829808
Chapter II Neoplasms,Carcinoma in situ of breast,ARSA,Arylsulfatase A,13449,89,0.65 [0.42-1.02],0.0610856751792302
Chapter II Neoplasms,Carcinoma in situ of breast,ARSB,Arylsulfatase B,13380,89,0.84 [0.59-1.19],0.3250477311578625
Chapter II Neoplasms,Carcinoma in situ of breast,ART3,Ecto-ADP-ribosyltransferase 3,13459,89,0.93 [0.51-1.67],0.7951032730222136
Chapter II Neoplasms,Carcinoma in situ of breast,ART5,Ecto-ADP-ribosyltransferase 5,11311,73,0.56 [0.33-0.96],0.0365924055387556
Chapter II Neoplasms,Carcinoma in situ of breast,ARTN,Artemin,13187,89,0.96 [0.63-1.45],0.8382584218475673
Chapter II Neoplasms,Carcinoma in situ of breast,ASAH1,Acid ceramidase,11537,77,0.75 [0.45-1.23],0.2489554697034889
Chapter II Neoplasms,Carcinoma in situ of breast,ASAH2,Neutral ceramidase,13363,90,1.16 [0.80-1.68],0.4304694649345765
Chapter II Neoplasms,Carcinoma in situ of breast,ASGR1,Asialoglycoprotein receptor 1,13363,90,0.85 [0.44-1.64],0.6275570798041779
Chapter II Neoplasms,Carcinoma in situ of breast,ASGR2,Asialoglycoprotein receptor 2,11650,75,1.50 [0.64-3.52],0.352134554197841
Chapter II Neoplasms,Carcinoma in situ of breast,ASPN,Asporin,11652,74,1.11 [0.49-2.53],0.8027740347432369
Chapter II Neoplasms,Carcinoma in situ of breast,ASPSCR1,Tether containing UBX domain for GLUT4,11634,76,0.68 [0.49-0.94],0.0204072940249555
Chapter II Neoplasms,Carcinoma in situ of breast,ASRGL1,Isoaspartyl peptidase/L-asparaginase,11330,75,0.88 [0.70-1.09],0.2386681725557644
Chapter II Neoplasms,Carcinoma in situ of breast,ASS1,Argininosuccinate synthase,11293,74,0.96 [0.73-1.27],0.7914356961079351
Chapter II Neoplasms,Carcinoma in situ of breast,ATF2,Cyclic AMP-dependent transcription factor ATF-2,13108,85,0.82 [0.58-1.16],0.2715408942694928
Chapter II Neoplasms,Carcinoma in situ of breast,ATF4,Cyclic AMP-dependent transcription factor ATF-4,11230,75,0.34 [0.16-0.69],0.0031548300028913
Chapter II Neoplasms,Carcinoma in situ of breast,ATG16L1,Autophagy-related protein 16-1,11587,77,0.79 [0.61-1.03],0.0771162371489425
Chapter II Neoplasms,Carcinoma in situ of breast,ATG4A,Cysteine protease ATG4A,13139,87,0.68 [0.49-0.96],0.0286624168280373
Chapter II Neoplasms,Carcinoma in situ of breast,ATOX1,Copper transport protein ATOX1,13480,90,0.74 [0.58-0.95],0.0181474953848847
Chapter II Neoplasms,Carcinoma in situ of breast,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,11293,74,0.89 [0.54-1.47],0.6466759316886166
Chapter II Neoplasms,Carcinoma in situ of breast,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,11293,74,0.60 [0.28-1.30],0.1969634331522455
Chapter II Neoplasms,Carcinoma in situ of breast,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,11293,74,1.24 [0.78-1.96],0.3635387043215544
Chapter II Neoplasms,Carcinoma in situ of breast,ATP1B4,Protein ATP1B4,11230,75,0.44 [0.23-0.83],0.0118807191755275
Chapter II Neoplasms,Carcinoma in situ of breast,ATP2B4,Plasma membrane calcium-transporting ATPase 4,11293,74,1.09 [0.79-1.49],0.5987370272987621
Chapter II Neoplasms,Carcinoma in situ of breast,ATP5F1D,"ATP synthase subunit delta, mitochondrial",11293,74,1.12 [0.79-1.60],0.5203179775251394
Chapter II Neoplasms,Carcinoma in situ of breast,ATP5IF1,"ATPase inhibitor, mitochondrial",13507,91,0.85 [0.72-1.00],0.0555637152457906
Chapter II Neoplasms,Carcinoma in situ of breast,ATP5PO,"ATP synthase subunit O, mitochondrial",13108,85,0.79 [0.49-1.27],0.3325409635576383
Chapter II Neoplasms,Carcinoma in situ of breast,ATP6AP2,Renin receptor,13139,87,0.94 [0.60-1.50],0.8084980672290312
Chapter II Neoplasms,Carcinoma in situ of breast,ATP6V1D,V-type proton ATPase subunit D,13380,89,0.42 [0.19-0.91],0.0281739275382673
Chapter II Neoplasms,Carcinoma in situ of breast,ATP6V1F,V-type proton ATPase subunit F,13079,85,0.90 [0.67-1.22],0.499085955748512
Chapter II Neoplasms,Carcinoma in situ of breast,ATP6V1G1,V-type proton ATPase subunit G 1,11330,75,0.74 [0.54-1.02],0.0632334111100128
Chapter II Neoplasms,Carcinoma in situ of breast,ATP6V1G2,V-type proton ATPase subunit G 2,11293,74,0.95 [0.75-1.19],0.6548956929452223
Chapter II Neoplasms,Carcinoma in situ of breast,ATRAID,All-trans retinoic acid-induced differentiation factor,11587,77,1.06 [0.55-2.03],0.8592501985097234
Chapter II Neoplasms,Carcinoma in situ of breast,ATRN,"Attractin, Isoform 2",11662,77,3.25 [0.88-12.08],0.0779519404052826
Chapter II Neoplasms,Carcinoma in situ of breast,ATXN10,Ataxin-10,13108,85,0.79 [0.61-1.03],0.084448311065294
Chapter II Neoplasms,Carcinoma in situ of breast,ATXN2,Ataxin-2,11311,73,0.99 [0.81-1.20],0.9155654449860654
Chapter II Neoplasms,Carcinoma in situ of breast,ATXN2L,Ataxin-2-like protein,11634,76,0.74 [0.45-1.23],0.2508592884408706
Chapter II Neoplasms,Carcinoma in situ of breast,ATXN3,Ataxin-3,11617,76,0.84 [0.59-1.20],0.345600506230348
Chapter II Neoplasms,Carcinoma in situ of breast,AXIN1,Axin-1,13434,87,0.78 [0.64-0.96],0.0176038923860674
Chapter II Neoplasms,Carcinoma in situ of breast,AXL,Tyrosine-protein kinase receptor UFO,13459,89,1.17 [0.59-2.31],0.6511098324359608
Chapter II Neoplasms,Carcinoma in situ of breast,AZI2,5-azacytidine-induced protein 2,11634,76,0.78 [0.52-1.19],0.2497942425352599
Chapter II Neoplasms,Carcinoma in situ of breast,AZU1,Azurocidin,13014,84,1.26 [1.02-1.54],0.0292207784039036
Chapter II Neoplasms,Carcinoma in situ of breast,B2M,Beta-2-microglobulin,11662,77,1.17 [0.68-2.02],0.5701109630678546
Chapter II Neoplasms,Carcinoma in situ of breast,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,11293,74,0.46 [0.15-1.45],0.183044622046395
Chapter II Neoplasms,Carcinoma in situ of breast,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",11330,75,0.52 [0.29-0.93],0.028786030151525
Chapter II Neoplasms,Carcinoma in situ of breast,B4GALT1,"Beta-1,4-galactosyltransferase 1",13507,91,0.82 [0.41-1.64],0.5680492654830323
Chapter II Neoplasms,Carcinoma in situ of breast,B4GAT1,"Beta-1,4-glucuronyltransferase 1",13449,89,0.66 [0.30-1.44],0.2981558068006203
Chapter II Neoplasms,Carcinoma in situ of breast,BABAM1,BRISC and BRCA1-A complex member 1,11319,73,0.50 [0.21-1.21],0.1263557964520256
Chapter II Neoplasms,Carcinoma in situ of breast,BACH1,Transcription regulator protein BACH1,13434,87,0.83 [0.63-1.09],0.1740178952344275
Chapter II Neoplasms,Carcinoma in situ of breast,BAG3,BAG family molecular chaperone regulator 3,13342,90,0.89 [0.56-1.40],0.6103527182161641
Chapter II Neoplasms,Carcinoma in situ of breast,BAG4,BAG family molecular chaperone regulator 4,11319,73,0.79 [0.49-1.29],0.3474753296774838
Chapter II Neoplasms,Carcinoma in situ of breast,BAG6,Large proline-rich protein BAG6,13220,88,0.62 [0.36-1.07],0.0866764650111889
Chapter II Neoplasms,Carcinoma in situ of breast,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,13139,87,0.89 [0.65-1.24],0.4989802469107542
Chapter II Neoplasms,Carcinoma in situ of breast,BAMBI,BMP and activin membrane-bound inhibitor homolog,13139,87,0.47 [0.24-0.94],0.032213421817408
Chapter II Neoplasms,Carcinoma in situ of breast,BANK1,B-cell scaffold protein with ankyrin repeats,13434,87,0.88 [0.74-1.05],0.1717796182035642
Chapter II Neoplasms,Carcinoma in situ of breast,BAP18,Chromatin complexes subunit BAP18,11617,76,1.21 [0.93-1.58],0.1617369235507562
Chapter II Neoplasms,Carcinoma in situ of breast,BATF,Basic leucine zipper transcriptional factor ATF-like,11312,75,0.95 [0.72-1.25],0.7168248202650245
Chapter II Neoplasms,Carcinoma in situ of breast,BAX,Apoptosis regulator BAX,13089,85,0.86 [0.69-1.07],0.1737133970514717
Chapter II Neoplasms,Carcinoma in situ of breast,BCAM,Basal cell adhesion molecule,13449,89,0.51 [0.23-1.16],0.1093503109587201
Chapter II Neoplasms,Carcinoma in situ of breast,BCAN,Brevican core protein,13363,90,0.86 [0.49-1.52],0.6068388212972142
Chapter II Neoplasms,Carcinoma in situ of breast,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",11652,74,0.51 [0.23-1.14],0.1009065196338178
Chapter II Neoplasms,Carcinoma in situ of breast,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",11311,73,0.83 [0.52-1.31],0.41948291612771
Chapter II Neoplasms,Carcinoma in situ of breast,BCHE,Cholinesterase,11421,74,3.35 [1.49-7.53],0.003414603005164
Chapter II Neoplasms,Carcinoma in situ of breast,BCL2,Apoptosis regulator Bcl-2,11587,77,1.43 [1.09-1.87],0.0106154173272114
Chapter II Neoplasms,Carcinoma in situ of breast,BCL2L1,Bcl-2-like protein 1,11617,76,0.76 [0.61-0.95],0.0161487319525697
Chapter II Neoplasms,Carcinoma in situ of breast,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",13434,87,0.97 [0.65-1.45],0.8715411294208855
Chapter II Neoplasms,Carcinoma in situ of breast,BCL2L15,Bcl-2-like protein 15,11319,73,1.09 [0.75-1.57],0.6552642885663653
Chapter II Neoplasms,Carcinoma in situ of breast,BCL7A,B-cell CLL/lymphoma 7 protein family member A,11230,75,0.71 [0.47-1.08],0.1057731718279334
Chapter II Neoplasms,Carcinoma in situ of breast,BCL7B,B-cell CLL/lymphoma 7 protein family member B,11571,75,1.19 [0.79-1.79],0.4108034698181345
Chapter II Neoplasms,Carcinoma in situ of breast,BCR,Breakpoint cluster region protein,13434,87,0.86 [0.69-1.06],0.1519351207729874
Chapter II Neoplasms,Carcinoma in situ of breast,BDNF,Brain-derived neurotrophic factor,11632,77,0.88 [0.69-1.14],0.3378388319380588
Chapter II Neoplasms,Carcinoma in situ of breast,BECN1,Beclin-1,11330,75,0.74 [0.50-1.08],0.1181928201084109
Chapter II Neoplasms,Carcinoma in situ of breast,BEX3,Protein BEX3,11230,75,0.90 [0.55-1.48],0.6808932461084248
Chapter II Neoplasms,Carcinoma in situ of breast,BGLAP,Osteocalcin,11632,77,0.94 [0.75-1.20],0.6354167697763433
Chapter II Neoplasms,Carcinoma in situ of breast,BGN,Biglycan,13121,86,1.06 [0.91-1.24],0.4514978051096083
Chapter II Neoplasms,Carcinoma in situ of breast,BHLHE40,Class E basic helix-loop-helix protein 40,11311,73,0.89 [0.64-1.25],0.5112825513108075
Chapter II Neoplasms,Carcinoma in situ of breast,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,11293,74,0.69 [0.30-1.61],0.3935326119199247
Chapter II Neoplasms,Carcinoma in situ of breast,BID,BH3-interacting domain death agonist,13434,87,0.69 [0.52-0.94],0.0164896342496515
Chapter II Neoplasms,Carcinoma in situ of breast,BIN2,Bridging integrator 2,13449,89,0.79 [0.64-0.98],0.0296763727457456
Chapter II Neoplasms,Carcinoma in situ of breast,BIRC2,Baculoviral IAP repeat-containing protein 2,13139,87,0.76 [0.56-1.04],0.0885618102623648
Chapter II Neoplasms,Carcinoma in situ of breast,BLMH,Bleomycin hydrolase,13609,89,0.57 [0.33-0.98],0.0421375505112347
Chapter II Neoplasms,Carcinoma in situ of breast,BLNK,B-cell linker protein,11319,73,0.57 [0.29-1.14],0.110319053118027
Chapter II Neoplasms,Carcinoma in situ of breast,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,11311,73,0.82 [0.58-1.16],0.2603123533998375
Chapter II Neoplasms,Carcinoma in situ of breast,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,11617,76,0.52 [0.28-0.96],0.0373622891889057
Chapter II Neoplasms,Carcinoma in situ of breast,BLVRB,Flavin reductase,13449,89,1.14 [0.88-1.48],0.3134224522295637
Chapter II Neoplasms,Carcinoma in situ of breast,BMP10,Bone morphogenetic protein 10,11384,76,1.07 [0.49-2.33],0.8685783988416486
Chapter II Neoplasms,Carcinoma in situ of breast,BMP4,Bone morphogenetic protein 4,13342,90,0.81 [0.53-1.24],0.3266852910225177
Chapter II Neoplasms,Carcinoma in situ of breast,BMP6,Bone morphogenetic protein 6,13193,86,0.75 [0.49-1.13],0.1707711600075491
Chapter II Neoplasms,Carcinoma in situ of breast,BMPER,BMP-binding endothelial regulator protein,11384,76,1.70 [0.71-4.07],0.2317116124161099
Chapter II Neoplasms,Carcinoma in situ of breast,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,11652,74,0.62 [0.31-1.22],0.1650077032323772
Chapter II Neoplasms,Carcinoma in situ of breast,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,11319,73,0.68 [0.39-1.17],0.1638169353843749
Chapter II Neoplasms,Carcinoma in situ of breast,BOC,Brother of CDO,13220,88,0.73 [0.33-1.62],0.4425114403856758
Chapter II Neoplasms,Carcinoma in situ of breast,BOLA1,BolA-like protein 1,11311,73,0.80 [0.52-1.24],0.3196715408783532
Chapter II Neoplasms,Carcinoma in situ of breast,BOLA2_BOLA2B,BolA-like protein 2,11330,75,0.80 [0.54-1.18],0.2660554354615255
Chapter II Neoplasms,Carcinoma in situ of breast,BPIFA2,BPI fold-containing family A member 2,10927,74,0.88 [0.71-1.09],0.2508892808449645
Chapter II Neoplasms,Carcinoma in situ of breast,BPIFB1,BPI fold-containing family B member 1,13426,86,0.85 [0.63-1.16],0.3069964979774015
Chapter II Neoplasms,Carcinoma in situ of breast,BPIFB2,BPI fold-containing family B member 2,11633,74,0.97 [0.68-1.38],0.8796309670746806
Chapter II Neoplasms,Carcinoma in situ of breast,BRAP,BRCA1-associated protein,11494,75,0.86 [0.70-1.05],0.1363289601159583
Chapter II Neoplasms,Carcinoma in situ of breast,BRD1,Bromodomain-containing protein 1,11399,77,0.99 [0.49-2.00],0.974621012163981
Chapter II Neoplasms,Carcinoma in situ of breast,BRD2,Bromodomain-containing protein 2,11311,73,0.65 [0.30-1.41],0.2767201564892307
Chapter II Neoplasms,Carcinoma in situ of breast,BRD3,Bromodomain-containing protein 3,11293,74,0.87 [0.52-1.43],0.5766886716120518
Chapter II Neoplasms,Carcinoma in situ of breast,BRDT,Bromodomain testis-specific protein,11293,74,0.64 [0.34-1.21],0.17440672784235
Chapter II Neoplasms,Carcinoma in situ of breast,BRK1,Protein BRICK1,13108,85,0.94 [0.60-1.45],0.7727990867210656
Chapter II Neoplasms,Carcinoma in situ of breast,BRME1,Break repair meiotic recombinase recruitment factor 1,11311,73,0.71 [0.38-1.31],0.2731419736523697
Chapter II Neoplasms,Carcinoma in situ of breast,BRSK2,Serine/threonine-protein kinase BRSK2,11634,76,0.50 [0.26-0.95],0.0346513522690788
Chapter II Neoplasms,Carcinoma in situ of breast,BSG,Basigin,13577,88,0.74 [0.28-1.94],0.5426623945675698
Chapter II Neoplasms,Carcinoma in situ of breast,BSND,Barttin,11230,75,0.33 [0.15-0.74],0.0069470072261408
Chapter II Neoplasms,Carcinoma in situ of breast,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,13577,89,0.79 [0.58-1.09],0.1550003551506319
Chapter II Neoplasms,Carcinoma in situ of breast,BST2,Bone marrow stromal antigen 2,13577,89,0.90 [0.62-1.31],0.5769702344913996
Chapter II Neoplasms,Carcinoma in situ of breast,BTC,Probetacellulin,13139,87,0.87 [0.66-1.14],0.3135830170676961
Chapter II Neoplasms,Carcinoma in situ of breast,BTD,Biotinidase,11662,77,3.98 [1.37-11.58],0.0113153092406967
Chapter II Neoplasms,Carcinoma in situ of breast,BTLA,B- and T-lymphocyte attenuator,11230,75,0.79 [0.57-1.10],0.1651326130437659
Chapter II Neoplasms,Carcinoma in situ of breast,BTN1A1,Butyrophilin subfamily 1 member A1,11551,75,0.90 [0.52-1.57],0.7130426129675865
Chapter II Neoplasms,Carcinoma in situ of breast,BTN2A1,Butyrophilin subfamily 2 member A1,13507,91,0.81 [0.38-1.72],0.5836489918976733
Chapter II Neoplasms,Carcinoma in situ of breast,BTN3A2,Butyrophilin subfamily 3 member A2,13434,87,0.69 [0.42-1.14],0.1507425232394766
Chapter II Neoplasms,Carcinoma in situ of breast,BTNL10,Butyrophilin-like protein 10,11230,75,0.89 [0.48-1.63],0.6981727916674281
Chapter II Neoplasms,Carcinoma in situ of breast,C19orf12,Protein C19orf12,13108,85,0.87 [0.62-1.24],0.4458855243226887
Chapter II Neoplasms,Carcinoma in situ of breast,C1GALT1C1,C1GALT1-specific chaperone 1,11293,74,0.54 [0.25-1.16],0.1165375114070758
Chapter II Neoplasms,Carcinoma in situ of breast,C1QA,Complement C1q subcomponent subunit A,13530,88,0.61 [0.27-1.36],0.2252568445476563
Chapter II Neoplasms,Carcinoma in situ of breast,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",11634,76,0.97 [0.69-1.37],0.8629215108770356
Chapter II Neoplasms,Carcinoma in situ of breast,C1QL2,Complement C1q-like protein 2,11319,73,0.96 [0.56-1.63],0.8801029124778273
Chapter II Neoplasms,Carcinoma in situ of breast,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,13459,89,1.39 [0.91-2.11],0.125369139972804
Chapter II Neoplasms,Carcinoma in situ of breast,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,11384,76,1.68 [0.94-3.03],0.0820951792278901
Chapter II Neoplasms,Carcinoma in situ of breast,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,11634,76,0.96 [0.49-1.89],0.902288349629666
Chapter II Neoplasms,Carcinoma in situ of breast,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,11359,76,1.14 [0.72-1.82],0.575689315977452
Chapter II Neoplasms,Carcinoma in situ of breast,C1R,Complement C1r subcomponent,11662,77,1.42 [0.58-3.49],0.4475059747543745
Chapter II Neoplasms,Carcinoma in situ of breast,C1RL,Complement C1r subcomponent-like protein,11642,77,1.32 [0.42-4.09],0.6352154210629231
Chapter II Neoplasms,Carcinoma in situ of breast,C1S,Complement C1s subcomponent,11662,77,1.33 [0.48-3.74],0.5834637619185516
Chapter II Neoplasms,Carcinoma in situ of breast,C2,Complement C2,13441,89,1.36 [0.58-3.20],0.4810988847444664
Chapter II Neoplasms,Carcinoma in situ of breast,C2CD2L,Phospholipid transfer protein C2CD2L,13079,85,0.79 [0.50-1.26],0.3235492153010456
Chapter II Neoplasms,Carcinoma in situ of breast,C2orf69,UPF0565 protein C2orf69,11312,75,0.77 [0.50-1.21],0.2570029361955038
Chapter II Neoplasms,Carcinoma in situ of breast,C3,Complement C3,11066,72,0.61 [0.34-1.10],0.1035045173964779
Chapter II Neoplasms,Carcinoma in situ of breast,C4BPB,C4b-binding protein beta chain,13480,90,1.08 [0.69-1.70],0.7234004139780421
Chapter II Neoplasms,Carcinoma in situ of breast,C5,Complement C5,11662,77,0.93 [0.23-3.72],0.919804932850494
Chapter II Neoplasms,Carcinoma in situ of breast,C7,Complement component C7,11391,75,0.73 [0.36-1.45],0.3682516523927361
Chapter II Neoplasms,Carcinoma in situ of breast,C7orf50,Uncharacterized protein C7orf50,11617,76,1.19 [0.55-2.58],0.6631485667524142
Chapter II Neoplasms,Carcinoma in situ of breast,C8B,Complement component C8 beta chain,11662,77,0.91 [0.45-1.82],0.791650397870107
Chapter II Neoplasms,Carcinoma in situ of breast,C9,Complement component C9,11650,75,1.06 [0.66-1.69],0.8113078540598081
Chapter II Neoplasms,Carcinoma in situ of breast,C9orf40,Uncharacterized protein C9orf40,11587,77,1.10 [0.86-1.42],0.4386615464884846
Chapter II Neoplasms,Carcinoma in situ of breast,CA1,Carbonic anhydrase 1,13101,83,1.18 [0.87-1.59],0.2820251548795984
Chapter II Neoplasms,Carcinoma in situ of breast,CA11,Carbonic anhydrase-related protein 11,13139,87,0.71 [0.34-1.48],0.3614945955647611
Chapter II Neoplasms,Carcinoma in situ of breast,CA12,Carbonic anhydrase 12,13380,89,1.36 [0.79-2.32],0.2678266404784663
Chapter II Neoplasms,Carcinoma in situ of breast,CA13,Carbonic anhydrase 13,13291,87,0.82 [0.69-0.98],0.0287970590358036
Chapter II Neoplasms,Carcinoma in situ of breast,CA14,Carbonic anhydrase 14,13571,87,1.37 [0.79-2.39],0.2662820732304964
Chapter II Neoplasms,Carcinoma in situ of breast,CA2,Carbonic anhydrase 2,13407,89,1.08 [0.84-1.39],0.566673048576125
Chapter II Neoplasms,Carcinoma in situ of breast,CA3,Carbonic anhydrase 3,13584,88,1.07 [0.80-1.43],0.6430715233479531
Chapter II Neoplasms,Carcinoma in situ of breast,CA4,Carbonic anhydrase 4,13609,89,0.60 [0.27-1.35],0.2199387024120409
Chapter II Neoplasms,Carcinoma in situ of breast,CA5A,"Carbonic anhydrase 5A, mitochondrial",13220,88,1.03 [0.84-1.27],0.7721956068045734
Chapter II Neoplasms,Carcinoma in situ of breast,CA6,Carbonic anhydrase 6,13411,88,1.42 [1.05-1.92],0.0211174424875295
Chapter II Neoplasms,Carcinoma in situ of breast,CA7,Carbonic anhydrase 7,11399,77,1.00 [0.53-1.91],0.992593527266214
Chapter II Neoplasms,Carcinoma in situ of breast,CA8,Carbonic anhydrase-related protein,11319,73,0.64 [0.23-1.82],0.4044531963805788
Chapter II Neoplasms,Carcinoma in situ of breast,CA9,Carbonic anhydrase 9,13571,87,1.06 [0.68-1.64],0.8045578959590151
Chapter II Neoplasms,Carcinoma in situ of breast,CABP2,Calcium-binding protein 2,11312,75,0.91 [0.64-1.28],0.5839470434190308
Chapter II Neoplasms,Carcinoma in situ of breast,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,11311,73,0.71 [0.33-1.52],0.3733112155280687
Chapter II Neoplasms,Carcinoma in situ of breast,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,11293,74,1.15 [0.85-1.57],0.3625436601062954
Chapter II Neoplasms,Carcinoma in situ of breast,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,11311,73,0.99 [0.68-1.44],0.9525254282897084
Chapter II Neoplasms,Carcinoma in situ of breast,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,11634,76,0.75 [0.58-0.97],0.0298163857239627
Chapter II Neoplasms,Carcinoma in situ of breast,CACYBP,Calcyclin-binding protein,11355,76,0.82 [0.66-1.01],0.0591416332150536
Chapter II Neoplasms,Carcinoma in situ of breast,CADPS,Calcium-dependent secretion activator 1,11312,75,0.46 [0.23-0.92],0.0293831326427043
Chapter II Neoplasms,Carcinoma in situ of breast,CALB1,Calbindin,13380,89,1.14 [0.71-1.83],0.5818793377341622
Chapter II Neoplasms,Carcinoma in situ of breast,CALB2,Calretinin,13108,85,0.72 [0.37-1.40],0.3338257914655067
Chapter II Neoplasms,Carcinoma in situ of breast,CALCA,Calcitonin,13334,90,1.04 [0.74-1.46],0.8137057808378101
Chapter II Neoplasms,Carcinoma in situ of breast,CALCB,Calcitonin gene-related peptide 2,11617,76,1.06 [0.61-1.83],0.8342339929989819
Chapter II Neoplasms,Carcinoma in situ of breast,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,13530,87,0.83 [0.69-0.99],0.0415856773244172
Chapter II Neoplasms,Carcinoma in situ of breast,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,11330,75,0.80 [0.60-1.08],0.1467804430154305
Chapter II Neoplasms,Carcinoma in situ of breast,CALY,Neuron-specific vesicular protein calcyon,11293,74,0.63 [0.31-1.29],0.2103905186393257
Chapter II Neoplasms,Carcinoma in situ of breast,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,13139,87,0.47 [0.29-0.76],0.0021696962498259
Chapter II Neoplasms,Carcinoma in situ of breast,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,11312,75,0.66 [0.41-1.06],0.0860321645242771
Chapter II Neoplasms,Carcinoma in situ of breast,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,11634,76,0.78 [0.63-0.96],0.0180708934021928
Chapter II Neoplasms,Carcinoma in situ of breast,CANT1,Soluble calcium-activated nucleotidase 1,13420,90,0.95 [0.38-2.40],0.9192855348698072
Chapter II Neoplasms,Carcinoma in situ of breast,CAPG,Macrophage-capping protein,13364,86,1.32 [0.97-1.80],0.0749876567099397
Chapter II Neoplasms,Carcinoma in situ of breast,CAPN3,Calpain-3,11571,75,0.92 [0.49-1.72],0.7944359411635107
Chapter II Neoplasms,Carcinoma in situ of breast,CAPS,Calcyphosin,11617,76,0.88 [0.65-1.19],0.4146751066013422
Chapter II Neoplasms,Carcinoma in situ of breast,CARHSP1,Calcium-regulated heat-stable protein 1,13108,85,0.96 [0.67-1.38],0.8159623474227423
Chapter II Neoplasms,Carcinoma in situ of breast,CASC3,Protein CASC3,11312,75,0.70 [0.40-1.25],0.2293476737491623
Chapter II Neoplasms,Carcinoma in situ of breast,CASP1,Caspase-1,13108,85,1.10 [0.83-1.45],0.5137901908904792
Chapter II Neoplasms,Carcinoma in situ of breast,CASP10,Caspase-10,13108,85,0.90 [0.70-1.17],0.4497587023228195
Chapter II Neoplasms,Carcinoma in situ of breast,CASP2,Caspase-2,13434,87,0.84 [0.63-1.12],0.2271469213286906
Chapter II Neoplasms,Carcinoma in situ of breast,CASP3,Caspase-3,13609,89,0.81 [0.66-1.00],0.0483888401984145
Chapter II Neoplasms,Carcinoma in situ of breast,CASP4,Caspase-4,11399,77,0.97 [0.85-1.11],0.6668476652576405
Chapter II Neoplasms,Carcinoma in situ of breast,CASP7,Caspase-7,11617,76,0.79 [0.61-1.03],0.0771382090911175
Chapter II Neoplasms,Carcinoma in situ of breast,CASP8,Caspase-8,13534,86,0.89 [0.66-1.21],0.4614544568770738
Chapter II Neoplasms,Carcinoma in situ of breast,CASP9,Caspase-9,11319,73,0.82 [0.56-1.19],0.2889029484029756
Chapter II Neoplasms,Carcinoma in situ of breast,CASQ2,Calsequestrin-2,11293,74,1.16 [0.79-1.69],0.4529007893675997
Chapter II Neoplasms,Carcinoma in situ of breast,CAT,Catalase,11464,75,1.07 [0.72-1.58],0.7371619334413779
Chapter II Neoplasms,Carcinoma in situ of breast,CBLIF,Cobalamin binding intrinsic factor,13434,90,1.25 [0.95-1.65],0.1049312213919862
Chapter II Neoplasms,Carcinoma in situ of breast,CBLN1,Cerebellin-1,11311,73,0.85 [0.65-1.12],0.2459751582308942
Chapter II Neoplasms,Carcinoma in situ of breast,CBLN4,Cerebellin-4,13571,87,1.31 [0.73-2.36],0.3692479795336465
Chapter II Neoplasms,Carcinoma in situ of breast,CBS,Cystathionine beta-synthase,11330,75,1.16 [0.77-1.74],0.4830380623832095
Chapter II Neoplasms,Carcinoma in situ of breast,CBX2,Chromobox protein homolog 2,11293,74,0.92 [0.51-1.63],0.764671932188733
Chapter II Neoplasms,Carcinoma in situ of breast,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,13363,90,0.74 [0.57-0.97],0.0292547965366403
Chapter II Neoplasms,Carcinoma in situ of breast,CCAR2,Cell cycle and apoptosis regulator protein 2,11617,76,0.90 [0.59-1.39],0.6458329631811838
Chapter II Neoplasms,Carcinoma in situ of breast,CCDC134,Coiled-coil domain-containing protein 134,11571,75,0.54 [0.33-0.88],0.0134830591122932
Chapter II Neoplasms,Carcinoma in situ of breast,CCDC28A,Coiled-coil domain-containing protein 28A,11312,75,0.87 [0.41-1.85],0.716740589880988
Chapter II Neoplasms,Carcinoma in situ of breast,CCDC50,Coiled-coil domain-containing protein 50,11634,76,0.83 [0.60-1.14],0.2545019551840767
Chapter II Neoplasms,Carcinoma in situ of breast,CCDC80,Coiled-coil domain-containing protein 80,13452,90,0.80 [0.45-1.41],0.4345547931361545
Chapter II Neoplasms,Carcinoma in situ of breast,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,11330,75,0.77 [0.53-1.13],0.1864881213076601
Chapter II Neoplasms,Carcinoma in situ of breast,CCL11,Eotaxin,13604,89,0.77 [0.47-1.25],0.290620938107186
Chapter II Neoplasms,Carcinoma in situ of breast,CCL13,C-C motif chemokine 13,13583,89,0.76 [0.58-1.00],0.0536513927633385
Chapter II Neoplasms,Carcinoma in situ of breast,CCL14,C-C motif chemokine 14,13370,87,1.10 [0.68-1.78],0.6854301856337726
Chapter II Neoplasms,Carcinoma in situ of breast,CCL15,C-C motif chemokine 15,13609,89,0.99 [0.64-1.52],0.9605238418307566
Chapter II Neoplasms,Carcinoma in situ of breast,CCL16,C-C motif chemokine 16,13609,89,0.91 [0.65-1.28],0.5973363365858635
Chapter II Neoplasms,Carcinoma in situ of breast,CCL17,C-C motif chemokine 17,13420,88,0.81 [0.66-1.00],0.0514191303437124
Chapter II Neoplasms,Carcinoma in situ of breast,CCL18,C-C motif chemokine 18,13218,84,0.84 [0.63-1.14],0.2634551098974877
Chapter II Neoplasms,Carcinoma in situ of breast,CCL19,C-C motif chemokine 19,13577,89,0.98 [0.84-1.14],0.7470266781356244
Chapter II Neoplasms,Carcinoma in situ of breast,CCL2,C-C motif chemokine 2,13342,90,0.95 [0.67-1.36],0.7868268135460862
Chapter II Neoplasms,Carcinoma in situ of breast,CCL20,C-C motif chemokine 20,13604,89,1.10 [0.91-1.35],0.3197603991211151
Chapter II Neoplasms,Carcinoma in situ of breast,CCL21,C-C motif chemokine 21,13507,91,0.86 [0.53-1.38],0.5310282645898425
Chapter II Neoplasms,Carcinoma in situ of breast,CCL22,C-C motif chemokine 22,13296,88,0.70 [0.48-1.03],0.0701220790624886
Chapter II Neoplasms,Carcinoma in situ of breast,CCL23,C-C motif chemokine 23,13507,91,0.82 [0.52-1.29],0.3862863182605798
Chapter II Neoplasms,Carcinoma in situ of breast,CCL24,C-C motif chemokine 24,13486,91,0.99 [0.79-1.23],0.901534240540908
Chapter II Neoplasms,Carcinoma in situ of breast,CCL25,C-C motif chemokine 25,13604,89,0.92 [0.63-1.33],0.6497317918730415
Chapter II Neoplasms,Carcinoma in situ of breast,CCL26,C-C motif chemokine 26,13434,87,0.80 [0.63-1.01],0.0655215758605051
Chapter II Neoplasms,Carcinoma in situ of breast,CCL27,C-C motif chemokine 27,13452,90,0.81 [0.60-1.09],0.161987647555756
Chapter II Neoplasms,Carcinoma in situ of breast,CCL28,C-C motif chemokine 28,13394,87,0.96 [0.69-1.32],0.7863035697090648
Chapter II Neoplasms,Carcinoma in situ of breast,CCL3,C-C motif chemokine 3,13434,87,0.76 [0.51-1.14],0.1899004678651282
Chapter II Neoplasms,Carcinoma in situ of breast,CCL4,C-C motif chemokine 4,13457,89,0.67 [0.47-0.96],0.0296653762677623
Chapter II Neoplasms,Carcinoma in situ of breast,CCL5,C-C motif chemokine 5,13459,89,0.81 [0.67-0.97],0.0213217514879855
Chapter II Neoplasms,Carcinoma in situ of breast,CCL7,C-C motif chemokine 7,13434,87,0.73 [0.50-1.05],0.0889195270603773
Chapter II Neoplasms,Carcinoma in situ of breast,CCL8,C-C motif chemokine 8,13555,86,1.00 [0.73-1.36],0.9854689022666148
Chapter II Neoplasms,Carcinoma in situ of breast,CCN1,CCN family member 1,13361,88,0.79 [0.63-1.00],0.0478086381039726
Chapter II Neoplasms,Carcinoma in situ of breast,CCN2,CCN family member 2,13450,91,0.79 [0.57-1.08],0.1386111539774631
Chapter II Neoplasms,Carcinoma in situ of breast,CCN3,CCN family member 3,13592,89,1.04 [0.58-1.87],0.8899902768635162
Chapter II Neoplasms,Carcinoma in situ of breast,CCN4,CCN family member 4,13571,87,1.07 [0.68-1.67],0.7765598673573285
Chapter II Neoplasms,Carcinoma in situ of breast,CCN5,CCN family member 5,13449,89,1.05 [0.65-1.68],0.8500171254475513
Chapter II Neoplasms,Carcinoma in situ of breast,CCND2,G1/S-specific cyclin-D2,11399,77,1.30 [0.72-2.35],0.3874610145319618
Chapter II Neoplasms,Carcinoma in situ of breast,CCNE1,G1/S-specific cyclin-E1,11319,73,1.02 [0.82-1.26],0.8825919252213824
Chapter II Neoplasms,Carcinoma in situ of breast,CCS,Copper chaperone for superoxide dismutase,13363,90,0.95 [0.65-1.39],0.7874950869009388
Chapter II Neoplasms,Carcinoma in situ of breast,CCT5,T-complex protein 1 subunit epsilon,13139,87,0.52 [0.32-0.86],0.010012809973793
Chapter II Neoplasms,Carcinoma in situ of breast,CD101,Immunoglobulin superfamily member 2,11587,77,1.05 [0.62-1.76],0.8647901406862557
Chapter II Neoplasms,Carcinoma in situ of breast,CD109,CD109 antigen,13449,89,0.69 [0.40-1.19],0.1818042982245527
Chapter II Neoplasms,Carcinoma in situ of breast,CD14,Monocyte differentiation antigen CD14,13109,86,1.19 [0.76-1.87],0.4543010055498345
Chapter II Neoplasms,Carcinoma in situ of breast,CD160,CD160 antigen,13604,89,0.80 [0.52-1.22],0.3000083194875276
Chapter II Neoplasms,Carcinoma in situ of breast,CD163,Scavenger receptor cysteine-rich type 1 protein M130,13459,89,0.75 [0.48-1.17],0.2082581280805817
Chapter II Neoplasms,Carcinoma in situ of breast,CD164,Sialomucin core protein 24,13449,89,1.05 [0.52-2.13],0.895867492962194
Chapter II Neoplasms,Carcinoma in situ of breast,CD164L2,CD164 sialomucin-like 2 protein,11312,75,0.57 [0.30-1.10],0.0956091464701549
Chapter II Neoplasms,Carcinoma in situ of breast,CD177,CD177 antigen,13429,89,1.14 [0.97-1.33],0.1239818634291515
Chapter II Neoplasms,Carcinoma in situ of breast,CD1C,T-cell surface glycoprotein CD1c,13480,90,1.35 [0.59-3.06],0.4746565234624251
Chapter II Neoplasms,Carcinoma in situ of breast,CD2,T-cell surface antigen CD2,11293,74,0.62 [0.30-1.28],0.197556445740876
Chapter II Neoplasms,Carcinoma in situ of breast,CD200,OX-2 membrane glycoprotein,13434,87,0.93 [0.44-1.97],0.8394083384135672
Chapter II Neoplasms,Carcinoma in situ of breast,CD200R1,Cell surface glycoprotein CD200 receptor 1,13397,86,0.88 [0.50-1.54],0.6532532863907423
Chapter II Neoplasms,Carcinoma in situ of breast,CD207,C-type lectin domain family 4 member K,13168,89,0.71 [0.43-1.17],0.1784891619465611
Chapter II Neoplasms,Carcinoma in situ of breast,CD209,CD209 antigen,13466,85,0.94 [0.57-1.54],0.8012539327834722
Chapter II Neoplasms,Carcinoma in situ of breast,CD22,B-cell receptor CD22,13604,89,0.59 [0.37-0.95],0.031350785918735
Chapter II Neoplasms,Carcinoma in situ of breast,CD226,CD226 antigen,11319,73,0.70 [0.41-1.22],0.2095814848532469
Chapter II Neoplasms,Carcinoma in situ of breast,CD244,Natural killer cell receptor 2B4,13604,89,0.68 [0.34-1.38],0.2860296685223007
Chapter II Neoplasms,Carcinoma in situ of breast,CD248,Endosialin,11632,77,0.80 [0.46-1.39],0.4349665079359601
Chapter II Neoplasms,Carcinoma in situ of breast,CD27,CD27 antigen,13480,90,0.97 [0.59-1.60],0.9143698278693976
Chapter II Neoplasms,Carcinoma in situ of breast,CD274,Programmed cell death 1 ligand 1,13363,90,1.00 [0.57-1.73],0.9890139809262324
Chapter II Neoplasms,Carcinoma in situ of breast,CD276,CD276 antigen,13445,90,1.15 [0.68-1.94],0.6141692303579533
Chapter II Neoplasms,Carcinoma in situ of breast,CD28,T-cell-specific surface glycoprotein CD28,13139,87,0.73 [0.41-1.28],0.2663332134232244
Chapter II Neoplasms,Carcinoma in situ of breast,CD2AP,CD2-associated protein,13452,90,0.76 [0.56-1.03],0.0794439502934917
Chapter II Neoplasms,Carcinoma in situ of breast,CD300A,CMRF35-like molecule 8,11384,76,0.74 [0.34-1.61],0.4509845257866768
Chapter II Neoplasms,Carcinoma in situ of breast,CD300C,CMRF35-like molecule 6,13577,89,1.05 [0.60-1.84],0.8634777227867847
Chapter II Neoplasms,Carcinoma in situ of breast,CD300E,CMRF35-like molecule 2,13527,87,0.99 [0.60-1.64],0.9835647694497376
Chapter II Neoplasms,Carcinoma in situ of breast,CD300LF,CMRF35-like molecule 1,13571,87,1.02 [0.75-1.40],0.8944668677692335
Chapter II Neoplasms,Carcinoma in situ of breast,CD300LG,CMRF35-like molecule 9,13449,89,1.04 [0.63-1.73],0.8674579751886694
Chapter II Neoplasms,Carcinoma in situ of breast,CD302,CD302 antigen,13380,89,1.05 [0.54-2.04],0.87734130147282
Chapter II Neoplasms,Carcinoma in situ of breast,CD33,Myeloid cell surface antigen CD33,13480,90,0.91 [0.73-1.14],0.4273718416812752
Chapter II Neoplasms,Carcinoma in situ of breast,CD34,Hematopoietic progenitor cell antigen CD34,13519,89,0.94 [0.43-2.04],0.8686129989004402
Chapter II Neoplasms,Carcinoma in situ of breast,CD36,Platelet glycoprotein 4,11319,73,0.79 [0.47-1.32],0.36208217135384
Chapter II Neoplasms,Carcinoma in situ of breast,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,13380,89,0.73 [0.39-1.39],0.3395442891554522
Chapter II Neoplasms,Carcinoma in situ of breast,CD3D,T-cell surface glycoprotein CD3 delta chain,11311,73,0.65 [0.30-1.41],0.2812287293520195
Chapter II Neoplasms,Carcinoma in situ of breast,CD3E,T-cell surface glycoprotein CD3 epsilon chain,11399,77,1.36 [0.87-2.11],0.1754747702083887
Chapter II Neoplasms,Carcinoma in situ of breast,CD3G,T-cell surface glycoprotein CD3 gamma chain,11319,73,0.97 [0.75-1.25],0.8053057055657119
Chapter II Neoplasms,Carcinoma in situ of breast,CD4,T-cell surface glycoprotein CD4,13410,87,0.60 [0.30-1.22],0.1564347115014859
Chapter II Neoplasms,Carcinoma in situ of breast,CD40,Tumor necrosis factor receptor superfamily member 5,13436,89,0.70 [0.47-1.04],0.0801079596616158
Chapter II Neoplasms,Carcinoma in situ of breast,CD40LG,CD40 ligand,13604,89,0.83 [0.65-1.05],0.1189746115572582
Chapter II Neoplasms,Carcinoma in situ of breast,CD46,Membrane cofactor protein,13316,86,1.15 [0.59-2.22],0.6816632483805969
Chapter II Neoplasms,Carcinoma in situ of breast,CD48,CD48 antigen,13486,91,0.81 [0.42-1.54],0.5194339363646108
Chapter II Neoplasms,Carcinoma in situ of breast,CD5,T-cell surface glycoprotein CD5,13555,86,0.88 [0.48-1.60],0.6725198308402431
Chapter II Neoplasms,Carcinoma in situ of breast,CD55,Complement decay-accelerating factor,12942,81,1.27 [0.62-2.60],0.522038438836421
Chapter II Neoplasms,Carcinoma in situ of breast,CD58,Lymphocyte function-associated antigen 3,13417,90,0.91 [0.31-2.63],0.8604484112340847
Chapter II Neoplasms,Carcinoma in situ of breast,CD59,CD59 glycoprotein,12927,84,0.69 [0.26-1.89],0.4756629573512713
Chapter II Neoplasms,Carcinoma in situ of breast,CD5L,CD5 antigen-like,11596,77,0.83 [0.51-1.33],0.4394126391110343
Chapter II Neoplasms,Carcinoma in situ of breast,CD6,T-cell differentiation antigen CD6,13577,88,0.80 [0.57-1.14],0.2168000993821299
Chapter II Neoplasms,Carcinoma in situ of breast,CD63,CD63 antigen,13342,90,0.96 [0.68-1.37],0.8288498597346579
Chapter II Neoplasms,Carcinoma in situ of breast,CD69,Early activation antigen CD69,13381,88,0.81 [0.66-1.00],0.0454689462564146
Chapter II Neoplasms,Carcinoma in situ of breast,CD7,T-cell antigen CD7,11299,73,0.81 [0.47-1.40],0.4446488760313316
Chapter II Neoplasms,Carcinoma in situ of breast,CD70,CD70 antigen,13434,87,1.12 [0.71-1.78],0.6214678689730333
Chapter II Neoplasms,Carcinoma in situ of breast,CD72,B-cell differentiation antigen CD72,11384,76,0.81 [0.47-1.41],0.4566130796891238
Chapter II Neoplasms,Carcinoma in situ of breast,CD74,HLA class II histocompatibility antigen gamma chain,13577,89,0.90 [0.51-1.56],0.6965010534463556
Chapter II Neoplasms,Carcinoma in situ of breast,CD79B,B-cell antigen receptor complex-associated protein beta chain,13604,89,0.75 [0.47-1.20],0.2290856029597812
Chapter II Neoplasms,Carcinoma in situ of breast,CD80,T-lymphocyte activation antigen CD80,11652,74,0.79 [0.40-1.54],0.4846170711708401
Chapter II Neoplasms,Carcinoma in situ of breast,CD82,CD82 antigen,11399,77,0.57 [0.29-1.13],0.105914919293868
Chapter II Neoplasms,Carcinoma in situ of breast,CD83,CD83 antigen,13434,87,0.81 [0.44-1.48],0.4889208231254669
Chapter II Neoplasms,Carcinoma in situ of breast,CD84,SLAM family member 5,13434,87,0.68 [0.37-1.25],0.2124456797525042
Chapter II Neoplasms,Carcinoma in situ of breast,CD86,T-lymphocyte activation antigen CD86,11587,77,0.97 [0.46-2.04],0.9372923006292077
Chapter II Neoplasms,Carcinoma in situ of breast,CD8A,T-cell surface glycoprotein CD8 alpha chain,13577,89,1.32 [0.91-1.94],0.1460468992737981
Chapter II Neoplasms,Carcinoma in situ of breast,CD93,Complement component C1q receptor,12896,78,1.59 [0.85-2.99],0.1472795816462624
Chapter II Neoplasms,Carcinoma in situ of breast,CD99,CD99 antigen,13449,89,0.78 [0.29-2.10],0.6248513388955257
Chapter II Neoplasms,Carcinoma in situ of breast,CD99L2,CD99 antigen-like protein 2,13449,89,0.77 [0.35-1.71],0.5256082308841237
Chapter II Neoplasms,Carcinoma in situ of breast,CDA,Cytidine deaminase,11631,74,1.57 [1.05-2.35],0.0273950243825189
Chapter II Neoplasms,Carcinoma in situ of breast,CDAN1,Codanin-1,11617,76,0.87 [0.32-2.32],0.7770341566260374
Chapter II Neoplasms,Carcinoma in situ of breast,CDC123,Cell division cycle protein 123 homolog,11230,75,1.18 [0.89-1.56],0.2520385002349292
Chapter II Neoplasms,Carcinoma in situ of breast,CDC25A,M-phase inducer phosphatase 1,11230,75,0.64 [0.35-1.20],0.1664258360350825
Chapter II Neoplasms,Carcinoma in situ of breast,CDC26,Anaphase-promoting complex subunit CDC26,11573,77,0.69 [0.50-0.95],0.0229672564438331
Chapter II Neoplasms,Carcinoma in situ of breast,CDC27,Cell division cycle protein 27 homolog,13139,87,0.60 [0.42-0.86],0.0051309834426775
Chapter II Neoplasms,Carcinoma in situ of breast,CDC37,Hsp90 co-chaperone Cdc37,13480,90,0.79 [0.63-0.99],0.0386206112496846
Chapter II Neoplasms,Carcinoma in situ of breast,CDC42BPB,Serine/threonine-protein kinase MRCK beta,11587,77,0.74 [0.59-0.92],0.0082774158776455
Chapter II Neoplasms,Carcinoma in situ of breast,CDCP1,CUB domain-containing protein 1,13363,90,0.74 [0.48-1.13],0.1614119513465471
Chapter II Neoplasms,Carcinoma in situ of breast,CDH1,Cadherin-1,12945,82,0.98 [0.59-1.61],0.92434103600009
Chapter II Neoplasms,Carcinoma in situ of breast,CDH15,Cadherin-15,13548,89,0.68 [0.41-1.13],0.1332321634915065
Chapter II Neoplasms,Carcinoma in situ of breast,CDH17,Cadherin-17,13452,90,0.73 [0.54-0.98],0.0383126273011834
Chapter II Neoplasms,Carcinoma in situ of breast,CDH2,Cadherin-2,13452,90,1.61 [0.95-2.72],0.0752087218036704
Chapter II Neoplasms,Carcinoma in situ of breast,CDH22,Cadherin-22,11399,77,1.16 [0.57-2.34],0.6870882953333199
Chapter II Neoplasms,Carcinoma in situ of breast,CDH23,Cadherin-23,11617,76,1.10 [0.49-2.46],0.815716194834515
Chapter II Neoplasms,Carcinoma in situ of breast,CDH3,Cadherin-3,13577,89,1.44 [0.86-2.40],0.1641966991985781
Chapter II Neoplasms,Carcinoma in situ of breast,CDH4,Cadherin-4,11311,73,0.99 [0.62-1.58],0.9714990499551428
Chapter II Neoplasms,Carcinoma in situ of breast,CDH5,Cadherin-5,13609,89,0.61 [0.32-1.16],0.1344203352787864
Chapter II Neoplasms,Carcinoma in situ of breast,CDH6,Cadherin-6,13452,90,1.11 [0.68-1.80],0.6839141212229024
Chapter II Neoplasms,Carcinoma in situ of breast,CDHR1,Cadherin-related family member 1,13108,85,1.09 [0.70-1.69],0.7033444025545652
Chapter II Neoplasms,Carcinoma in situ of breast,CDHR2,Cadherin-related family member 2,13380,89,1.02 [0.80-1.30],0.8828016554960391
Chapter II Neoplasms,Carcinoma in situ of breast,CDHR5,Cadherin-related family member 5,13452,90,1.04 [0.64-1.68],0.8820341276701774
Chapter II Neoplasms,Carcinoma in situ of breast,CDK1,Cyclin-dependent kinase 1,11230,75,0.81 [0.45-1.47],0.4934453501471444
Chapter II Neoplasms,Carcinoma in situ of breast,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,11634,76,0.89 [0.61-1.30],0.5378535777123596
Chapter II Neoplasms,Carcinoma in situ of breast,CDKL5,Cyclin-dependent kinase-like 5,11311,73,1.14 [0.78-1.65],0.4966453522593569
Chapter II Neoplasms,Carcinoma in situ of breast,CDKN1A,Cyclin-dependent kinase inhibitor 1,13380,89,0.78 [0.65-0.93],0.0056668779596957
Chapter II Neoplasms,Carcinoma in situ of breast,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,13380,89,0.83 [0.69-1.00],0.0499700451519048
Chapter II Neoplasms,Carcinoma in situ of breast,CDNF,Cerebral dopamine neurotrophic factor,13380,89,0.62 [0.34-1.15],0.1279403178966207
Chapter II Neoplasms,Carcinoma in situ of breast,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,13470,90,1.35 [0.68-2.71],0.393376046672004
Chapter II Neoplasms,Carcinoma in situ of breast,CDSN,Corneodesmosin,13560,89,1.35 [0.87-2.09],0.1800270488793767
Chapter II Neoplasms,Carcinoma in situ of breast,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,13458,90,0.93 [0.44-1.98],0.858233694282876
Chapter II Neoplasms,Carcinoma in situ of breast,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,11587,77,1.20 [0.91-1.57],0.1969987429563357
Chapter II Neoplasms,Carcinoma in situ of breast,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,11399,77,0.98 [0.70-1.35],0.8873607571778689
Chapter II Neoplasms,Carcinoma in situ of breast,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,11587,77,1.10 [0.63-1.91],0.7404607854438578
Chapter II Neoplasms,Carcinoma in situ of breast,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,11399,77,0.97 [0.59-1.59],0.9032475512937226
Chapter II Neoplasms,Carcinoma in situ of breast,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,13434,87,1.01 [0.81-1.26],0.9039130023272032
Chapter II Neoplasms,Carcinoma in situ of breast,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,13139,87,0.99 [0.67-1.47],0.9652707412027036
Chapter II Neoplasms,Carcinoma in situ of breast,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,12939,87,0.73 [0.53-1.02],0.063385145091433
Chapter II Neoplasms,Carcinoma in situ of breast,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,11632,77,0.99 [0.55-1.79],0.9767330471960544
Chapter II Neoplasms,Carcinoma in situ of breast,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,13220,88,1.08 [0.75-1.57],0.6752228512421654
Chapter II Neoplasms,Carcinoma in situ of breast,CEBPA,CCAAT/enhancer-binding protein alpha,11319,73,0.94 [0.53-1.68],0.8465644386470568
Chapter II Neoplasms,Carcinoma in situ of breast,CEBPB,CCAAT/enhancer-binding protein beta,13220,88,1.00 [0.61-1.64],0.9963035849355928
Chapter II Neoplasms,Carcinoma in situ of breast,CELA2A,Chymotrypsin-like elastase family member 2A,11632,77,0.79 [0.54-1.14],0.2078464504155237
Chapter II Neoplasms,Carcinoma in situ of breast,CELA3A,Chymotrypsin-like elastase family member 3A,13587,89,0.84 [0.59-1.18],0.3152271153831627
Chapter II Neoplasms,Carcinoma in situ of breast,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,11384,76,0.58 [0.27-1.28],0.1791030468545053
Chapter II Neoplasms,Carcinoma in situ of breast,CEMIP2,Cell surface hyaluronidase,11319,73,0.72 [0.32-1.60],0.4158739260455518
Chapter II Neoplasms,Carcinoma in situ of breast,CEND1,Cell cycle exit and neuronal differentiation protein 1,11311,73,0.87 [0.57-1.33],0.5232066469872065
Chapter II Neoplasms,Carcinoma in situ of breast,CENPF,Centromere protein F,11399,77,0.95 [0.64-1.41],0.7949520448441267
Chapter II Neoplasms,Carcinoma in situ of breast,CENPJ,Centromere protein J,11399,77,1.08 [0.82-1.42],0.5974123889538652
Chapter II Neoplasms,Carcinoma in situ of breast,CEP112,Centrosomal protein of 112 kDa,11293,74,0.49 [0.24-1.02],0.0572112544338843
Chapter II Neoplasms,Carcinoma in situ of breast,CEP152,Centrosomal protein of 152 kDa,11230,75,0.60 [0.33-1.11],0.1024179053567711
Chapter II Neoplasms,Carcinoma in situ of breast,CEP164,Centrosomal protein of 164 kDa,13187,89,1.06 [0.80-1.40],0.6773152764687665
Chapter II Neoplasms,Carcinoma in situ of breast,CEP170,Centrosomal protein of 170 kDa,11330,75,0.72 [0.53-0.99],0.040218269433948
Chapter II Neoplasms,Carcinoma in situ of breast,CEP20,Centrosomal protein 20,13139,87,0.81 [0.62-1.07],0.1340114926796262
Chapter II Neoplasms,Carcinoma in situ of breast,CEP290,Centrosomal protein of 290 kDa,11399,77,1.06 [0.72-1.57],0.7706672017163855
Chapter II Neoplasms,Carcinoma in situ of breast,CEP350,Centrosome-associated protein 350,11230,75,1.00 [0.56-1.80],0.995918072257883
Chapter II Neoplasms,Carcinoma in situ of breast,CEP43,Centrosomal protein 43,13112,86,0.71 [0.53-0.95],0.0225462704595343
Chapter II Neoplasms,Carcinoma in situ of breast,CEP85,Centrosomal protein of 85 kDa,13139,87,0.61 [0.44-0.85],0.0036661652292086
Chapter II Neoplasms,Carcinoma in situ of breast,CERT,Ceramide transfer protein,13108,85,0.95 [0.70-1.31],0.7738449509540752
Chapter II Neoplasms,Carcinoma in situ of breast,CES1,Liver carboxylesterase 1,13467,89,0.85 [0.66-1.10],0.2251732718510878
Chapter II Neoplasms,Carcinoma in situ of breast,CES2,Cocaine esterase,13380,89,1.03 [0.72-1.46],0.8809915305354298
Chapter II Neoplasms,Carcinoma in situ of breast,CES3,Carboxylesterase 3,13380,89,0.89 [0.66-1.19],0.4240980819845044
Chapter II Neoplasms,Carcinoma in situ of breast,CETN2,Centrin-2,13108,85,0.82 [0.60-1.10],0.1818261648469872
Chapter II Neoplasms,Carcinoma in situ of breast,CETN3,Centrin-3,11587,77,0.77 [0.58-1.02],0.0716584929938658
Chapter II Neoplasms,Carcinoma in situ of breast,CFB,Complement factor B,11435,76,1.84 [0.95-3.56],0.0689981508426157
Chapter II Neoplasms,Carcinoma in situ of breast,CFC1,Cryptic protein,13139,87,0.86 [0.56-1.32],0.4898559592923867
Chapter II Neoplasms,Carcinoma in situ of breast,CFD,Complement factor D,11662,77,1.28 [0.41-4.00],0.6681205075152248
Chapter II Neoplasms,Carcinoma in situ of breast,CFH,Complement factor H,10981,72,2.21 [0.85-5.71],0.1018250311727905
Chapter II Neoplasms,Carcinoma in situ of breast,CFHR2,Complement factor H-related protein 2,11581,77,0.85 [0.59-1.22],0.3673289900486406
Chapter II Neoplasms,Carcinoma in situ of breast,CFHR4,Complement factor H-related protein 4,11645,77,1.12 [0.82-1.52],0.4876451635905769
Chapter II Neoplasms,Carcinoma in situ of breast,CFHR5,Complement factor H-related protein 5,11502,75,1.33 [0.77-2.31],0.3051364157093647
Chapter II Neoplasms,Carcinoma in situ of breast,CFI,Complement factor I,11662,77,1.71 [0.59-4.97],0.3249407401484359
Chapter II Neoplasms,Carcinoma in situ of breast,CFP,Properdin,11662,77,1.25 [0.61-2.58],0.5385731220396437
Chapter II Neoplasms,Carcinoma in situ of breast,CGA,Glycoprotein hormones alpha chain,13449,89,0.98 [0.80-1.19],0.8123444828078037
Chapter II Neoplasms,Carcinoma in situ of breast,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,11650,75,1.03 [0.67-1.59],0.8806867439298264
Chapter II Neoplasms,Carcinoma in situ of breast,CGN,Cingulin,11312,75,0.62 [0.31-1.21],0.1620519586633902
Chapter II Neoplasms,Carcinoma in situ of breast,CGREF1,Cell growth regulator with EF hand domain protein 1,13452,90,0.72 [0.46-1.13],0.1492790526284187
Chapter II Neoplasms,Carcinoma in situ of breast,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,13139,87,0.60 [0.42-0.85],0.0042257526025746
Chapter II Neoplasms,Carcinoma in situ of breast,CHAD,Chondroadherin,11384,76,0.82 [0.54-1.24],0.3432981391469907
Chapter II Neoplasms,Carcinoma in situ of breast,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",11617,76,0.62 [0.33-1.17],0.1396201280253146
Chapter II Neoplasms,Carcinoma in situ of breast,CHCHD6,MICOS complex subunit MIC25,11571,75,1.26 [0.66-2.40],0.487817233101569
Chapter II Neoplasms,Carcinoma in situ of breast,CHEK2,Serine/threonine-protein kinase Chk2,13220,88,1.17 [0.70-1.96],0.5470423122629751
Chapter II Neoplasms,Carcinoma in situ of breast,CHGA,Chromogranin-A,11632,77,1.09 [0.84-1.41],0.5133844329275958
Chapter II Neoplasms,Carcinoma in situ of breast,CHGB,Secretogranin-1,13520,88,0.78 [0.48-1.29],0.3382484718888113
Chapter II Neoplasms,Carcinoma in situ of breast,CHI3L1,Chitinase-3-like protein 1,13090,82,0.81 [0.60-1.08],0.1500717612413849
Chapter II Neoplasms,Carcinoma in situ of breast,CHIT1,Chitotriosidase-1,13493,87,1.03 [0.90-1.18],0.6735134492278897
Chapter II Neoplasms,Carcinoma in situ of breast,CHL1,Neural cell adhesion molecule L1-like protein,13434,87,1.46 [0.84-2.53],0.1748266303861646
Chapter II Neoplasms,Carcinoma in situ of breast,CHM,Rab proteins geranylgeranyltransferase component A 1,11312,75,0.62 [0.42-0.91],0.0158898431721961
Chapter II Neoplasms,Carcinoma in situ of breast,CHMP1A,Charged multivesicular body protein 1a,13363,90,0.79 [0.63-1.00],0.0506928791633477
Chapter II Neoplasms,Carcinoma in situ of breast,CHMP6,Charged multivesicular body protein 6,11652,74,0.68 [0.46-1.02],0.0608649411760969
Chapter II Neoplasms,Carcinoma in situ of breast,CHP1,Calcineurin B homologous protein 1,11311,73,1.01 [0.75-1.36],0.9408006258744498
Chapter II Neoplasms,Carcinoma in situ of breast,CHRDL1,Chordin-like protein 1,13486,91,1.41 [0.76-2.63],0.271866624968158
Chapter II Neoplasms,Carcinoma in situ of breast,CHRDL2,Chordin-like protein 2,13452,90,0.94 [0.70-1.28],0.7120542524921007
Chapter II Neoplasms,Carcinoma in situ of breast,CHRM1,Muscarinic acetylcholine receptor M1,11312,75,0.73 [0.37-1.44],0.3679879179249433
Chapter II Neoplasms,Carcinoma in situ of breast,CIAPIN1,Anamorsin,13480,90,0.76 [0.57-1.02],0.0693409410336636
Chapter II Neoplasms,Carcinoma in situ of breast,CILP,Cartilage intermediate layer protein 1,11632,77,1.11 [0.73-1.68],0.6235269488217976
Chapter II Neoplasms,Carcinoma in situ of breast,CINP,Cyclin-dependent kinase 2-interacting protein,11399,77,0.68 [0.37-1.22],0.1975897814609875
Chapter II Neoplasms,Carcinoma in situ of breast,CIRBP,Cold-inducible RNA-binding protein,11587,77,0.83 [0.66-1.03],0.0961029754663781
Chapter II Neoplasms,Carcinoma in situ of breast,CIT,Citron Rho-interacting kinase,11312,75,0.64 [0.38-1.10],0.1095243150506837
Chapter II Neoplasms,Carcinoma in situ of breast,CKAP4,Cytoskeleton-associated protein 4,13527,86,0.96 [0.44-2.10],0.9271422880436896
Chapter II Neoplasms,Carcinoma in situ of breast,CKB,Creatine kinase B-type,11632,77,1.04 [0.72-1.50],0.8315894237596853
Chapter II Neoplasms,Carcinoma in situ of breast,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",13383,89,1.17 [0.87-1.56],0.292456520572073
Chapter II Neoplasms,Carcinoma in situ of breast,CLASP1,CLIP-associating protein 1,11230,75,0.73 [0.50-1.05],0.092837336708464
Chapter II Neoplasms,Carcinoma in situ of breast,CLC,Galectin-10,13434,90,0.99 [0.75-1.31],0.938460899542355
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC10A,C-type lectin domain family 10 member A,13363,90,1.25 [0.74-2.11],0.4006488804757502
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC11A,C-type lectin domain family 11 member A,13420,89,0.84 [0.56-1.25],0.386142037893603
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC12A,C-type lectin domain family 12 member A,11319,73,0.81 [0.26-2.59],0.7284761371031894
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC14A,C-type lectin domain family 14 member A,13449,89,0.78 [0.42-1.46],0.4371874897351874
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC1A,C-type lectin domain family 1 member A,13220,88,0.77 [0.42-1.41],0.39427638371343
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC1B,C-type lectin domain family 1 member B,13577,89,0.80 [0.66-0.97],0.0265948594966931
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC2L,C-type lectin domain family 2 member L,11312,75,0.85 [0.52-1.38],0.5070743305139922
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC3B,Tetranectin,11387,75,1.51 [0.57-3.96],0.4064739278101525
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC4A,C-type lectin domain family 4 member A,13434,87,1.05 [0.61-1.81],0.8725292339658106
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC4C,C-type lectin domain family 4 member C,13434,87,0.88 [0.58-1.33],0.5468359342476148
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC4D,C-type lectin domain family 4 member D,13434,87,0.97 [0.71-1.33],0.8473930749995374
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC4G,C-type lectin domain family 4 member G,13434,87,0.97 [0.55-1.72],0.9266143460105334
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC4M,C-type lectin domain family 4 member M,11606,77,0.94 [0.60-1.48],0.8037597554871772
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC5A,C-type lectin domain family 5 member A,13402,88,1.44 [0.73-2.85],0.2925948777242559
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC6A,C-type lectin domain family 6 member A,13139,87,0.93 [0.61-1.41],0.7265602816583205
Chapter II Neoplasms,Carcinoma in situ of breast,CLEC7A,C-type lectin domain family 7 member A,13604,89,0.95 [0.69-1.30],0.7360459795755034
Chapter II Neoplasms,Carcinoma in situ of breast,CLGN,Calmegin,11312,75,0.96 [0.58-1.60],0.8724153275813394
Chapter II Neoplasms,Carcinoma in situ of breast,CLIC5,Chloride intracellular channel protein 5,11312,75,0.76 [0.35-1.63],0.4791512854296059
Chapter II Neoplasms,Carcinoma in situ of breast,CLINT1,Clathrin interactor 1,11230,75,1.30 [0.87-1.95],0.2058155570191716
Chapter II Neoplasms,Carcinoma in situ of breast,CLIP2,CAP-Gly domain-containing linker protein 2,13434,87,0.82 [0.70-0.97],0.0174734004574038
Chapter II Neoplasms,Carcinoma in situ of breast,CLMP,CXADR-like membrane protein,13571,87,1.03 [0.39-2.67],0.9583065477302528
Chapter II Neoplasms,Carcinoma in situ of breast,CLNS1A,Methylosome subunit pICln,11312,75,0.57 [0.28-1.16],0.1209561036994198
Chapter II Neoplasms,Carcinoma in situ of breast,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",13334,90,0.94 [0.77-1.14],0.5178301687195519
Chapter II Neoplasms,Carcinoma in situ of breast,CLPS,Colipase,13428,89,0.89 [0.68-1.17],0.4029458705016965
Chapter II Neoplasms,Carcinoma in situ of breast,CLSPN,Claspin,13079,85,0.40 [0.19-0.85],0.0168306177885326
Chapter II Neoplasms,Carcinoma in situ of breast,CLSTN1,Calsyntenin-1,13108,85,1.05 [0.74-1.50],0.7824282904930648
Chapter II Neoplasms,Carcinoma in situ of breast,CLSTN2,Calsyntenin-2,13604,89,1.07 [0.67-1.71],0.7887833968008253
Chapter II Neoplasms,Carcinoma in situ of breast,CLSTN3,Calsyntenin-3,11617,76,1.25 [0.64-2.46],0.509518635256391
Chapter II Neoplasms,Carcinoma in situ of breast,CLTA,Clathrin light chain A,13220,88,0.82 [0.54-1.26],0.3746048095147656
Chapter II Neoplasms,Carcinoma in situ of breast,CLU,Clusterin,11662,77,0.98 [0.52-1.86],0.9553135866148192
Chapter II Neoplasms,Carcinoma in situ of breast,CLUL1,Clusterin-like protein 1,13436,90,0.82 [0.54-1.23],0.3300335935580778
Chapter II Neoplasms,Carcinoma in situ of breast,CMC1,COX assembly mitochondrial protein homolog,11652,74,0.77 [0.60-0.99],0.044611504087112
Chapter II Neoplasms,Carcinoma in situ of breast,CMIP,C-Maf-inducing protein,11571,75,0.75 [0.57-0.99],0.0428940515216514
Chapter II Neoplasms,Carcinoma in situ of breast,CNDP1,Beta-Ala-His dipeptidase,13459,89,1.23 [0.81-1.88],0.3267190529618739
Chapter II Neoplasms,Carcinoma in situ of breast,CNGB3,Cyclic nucleotide-gated cation channel beta-3,11311,73,0.97 [0.64-1.47],0.890397727243335
Chapter II Neoplasms,Carcinoma in situ of breast,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",11306,75,0.77 [0.58-1.03],0.078521960983656
Chapter II Neoplasms,Carcinoma in situ of breast,CNPY2,Protein canopy homolog 2,13220,88,0.86 [0.60-1.22],0.4014844708420297
Chapter II Neoplasms,Carcinoma in situ of breast,CNPY4,Protein canopy homolog 4,13380,89,0.82 [0.64-1.04],0.1047520164627611
Chapter II Neoplasms,Carcinoma in situ of breast,CNST,Consortin,13452,90,0.87 [0.73-1.03],0.116075276876317
Chapter II Neoplasms,Carcinoma in situ of breast,CNTF,Ciliary neurotrophic factor,11311,73,1.11 [0.60-2.06],0.7453436852272574
Chapter II Neoplasms,Carcinoma in situ of breast,CNTN1,Contactin-1,13609,89,1.52 [0.77-3.02],0.226050051177176
Chapter II Neoplasms,Carcinoma in situ of breast,CNTN2,Contactin-2,13571,87,1.04 [0.69-1.58],0.8442578331982992
Chapter II Neoplasms,Carcinoma in situ of breast,CNTN3,Contactin-3,13449,89,1.33 [0.78-2.29],0.2977375898821598
Chapter II Neoplasms,Carcinoma in situ of breast,CNTN4,Contactin-4,13449,89,0.93 [0.43-2.03],0.8562531817574988
Chapter II Neoplasms,Carcinoma in situ of breast,CNTN5,Contactin-5,13482,88,0.83 [0.49-1.40],0.4898748743883101
Chapter II Neoplasms,Carcinoma in situ of breast,CNTNAP2,Contactin-associated protein-like 2,13434,87,0.84 [0.52-1.37],0.4856175013252217
Chapter II Neoplasms,Carcinoma in situ of breast,CNTNAP4,Contactin-associated protein-like 4,11312,75,0.96 [0.76-1.20],0.7075116117097554
Chapter II Neoplasms,Carcinoma in situ of breast,COCH,Cochlin,11652,74,0.78 [0.48-1.27],0.3121141848576124
Chapter II Neoplasms,Carcinoma in situ of breast,COL15A1,Collagen alpha-1(XV) chain,11632,77,2.13 [0.92-4.96],0.078021261412961
Chapter II Neoplasms,Carcinoma in situ of breast,COL18A1,Collagen alpha-1(XVIII) chain,13492,87,1.08 [0.47-2.46],0.8600421006304936
Chapter II Neoplasms,Carcinoma in situ of breast,COL1A1,Collagen alpha-1(I) chain,13609,89,0.78 [0.38-1.60],0.5062771382968109
Chapter II Neoplasms,Carcinoma in situ of breast,COL24A1,Collagen alpha-1(XXIV) chain,11587,77,1.47 [0.97-2.22],0.0707656976928722
Chapter II Neoplasms,Carcinoma in situ of breast,COL28A1,Collagen alpha-1(XXVIII) chain,11312,75,1.00 [0.73-1.36],0.9967792552119786
Chapter II Neoplasms,Carcinoma in situ of breast,COL2A1,Collagen alpha-1(II) chain,11330,75,0.88 [0.67-1.17],0.3823279904909709
Chapter II Neoplasms,Carcinoma in situ of breast,COL3A1,Collagen alpha-1(III) chain,11632,77,0.90 [0.36-2.30],0.833186832531098
Chapter II Neoplasms,Carcinoma in situ of breast,COL4A1,Collagen alpha-1(IV) chain,13452,90,0.72 [0.44-1.16],0.174799887225667
Chapter II Neoplasms,Carcinoma in situ of breast,COL4A4,Collagen alpha-4(IV) chain,11382,77,1.04 [0.68-1.57],0.8666777457088706
Chapter II Neoplasms,Carcinoma in situ of breast,COL5A1,Collagen alpha-1(V) chain,11384,76,0.70 [0.39-1.26],0.2355244520346941
Chapter II Neoplasms,Carcinoma in situ of breast,COL6A3,Collagen alpha-3(VI) chain,13609,89,1.15 [0.64-2.08],0.6357241747887783
Chapter II Neoplasms,Carcinoma in situ of breast,COL9A1,Collagen alpha-1(IX) chain,13434,87,1.28 [0.86-1.90],0.2267319877658197
Chapter II Neoplasms,Carcinoma in situ of breast,COL9A2,Collagen alpha-2(IX) chain,11399,77,1.03 [0.66-1.61],0.8937358782964482
Chapter II Neoplasms,Carcinoma in situ of breast,COLEC12,Collectin-12,13445,90,0.73 [0.34-1.59],0.4267405490816787
Chapter II Neoplasms,Carcinoma in situ of breast,COMMD1,COMM domain-containing protein 1,11330,75,0.79 [0.55-1.14],0.2048765362220954
Chapter II Neoplasms,Carcinoma in situ of breast,COMMD9,COMM domain-containing protein 9,11571,75,0.72 [0.39-1.32],0.288048820582168
Chapter II Neoplasms,Carcinoma in situ of breast,COMP,Cartilage oligomeric matrix protein,13274,85,0.79 [0.44-1.40],0.4166969623361795
Chapter II Neoplasms,Carcinoma in situ of breast,COMT,Catechol O-methyltransferase,13071,85,0.79 [0.63-0.99],0.037824779294187
Chapter II Neoplasms,Carcinoma in situ of breast,COPB2,Coatomer subunit beta',11293,74,0.70 [0.40-1.21],0.2043262475860436
Chapter II Neoplasms,Carcinoma in situ of breast,COPE,Coatomer subunit epsilon,13108,85,0.75 [0.46-1.21],0.2360656788070393
Chapter II Neoplasms,Carcinoma in situ of breast,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",11330,75,1.36 [0.92-2.03],0.1235191934046617
Chapter II Neoplasms,Carcinoma in situ of breast,CORO1A,Coronin-1A,13157,84,0.83 [0.66-1.05],0.1190533537002054
Chapter II Neoplasms,Carcinoma in situ of breast,CORO6,Coronin-6,11311,73,0.67 [0.34-1.33],0.2561387652680549
Chapter II Neoplasms,Carcinoma in situ of breast,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",13380,89,0.83 [0.62-1.09],0.1813314914033179
Chapter II Neoplasms,Carcinoma in situ of breast,COX6B1,Cytochrome c oxidase subunit 6B1,11652,74,0.57 [0.28-1.19],0.1361705569002098
Chapter II Neoplasms,Carcinoma in situ of breast,CPA1,Carboxypeptidase A1,13609,89,0.85 [0.61-1.19],0.3357438533966723
Chapter II Neoplasms,Carcinoma in situ of breast,CPA2,Carboxypeptidase A2,13524,89,0.80 [0.59-1.08],0.1498029298614736
Chapter II Neoplasms,Carcinoma in situ of breast,CPA4,Carboxypeptidase A4,11145,76,1.00 [0.59-1.68],0.996989326735832
Chapter II Neoplasms,Carcinoma in situ of breast,CPB1,Carboxypeptidase B,13609,89,0.83 [0.59-1.17],0.2838670634347682
Chapter II Neoplasms,Carcinoma in situ of breast,CPB2,Carboxypeptidase B2,11636,77,3.35 [1.66-6.75],0.0007407474653413
Chapter II Neoplasms,Carcinoma in situ of breast,CPE,Carboxypeptidase E,13483,86,0.94 [0.58-1.51],0.7896613659533384
Chapter II Neoplasms,Carcinoma in situ of breast,CPLX2,Complexin-2,11230,75,0.59 [0.26-1.30],0.1881097973251473
Chapter II Neoplasms,Carcinoma in situ of breast,CPM,Carboxypeptidase M,13518,88,0.78 [0.46-1.35],0.3776814583378981
Chapter II Neoplasms,Carcinoma in situ of breast,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",11319,73,0.69 [0.30-1.61],0.3958927727247878
Chapter II Neoplasms,Carcinoma in situ of breast,CPPED1,Serine/threonine-protein phosphatase CPPED1,13577,89,1.00 [0.76-1.32],0.993049842546226
Chapter II Neoplasms,Carcinoma in situ of breast,CPQ,Carboxypeptidase Q,11612,77,0.83 [0.49-1.41],0.4928784590458541
Chapter II Neoplasms,Carcinoma in situ of breast,CPTP,Ceramide-1-phosphate transfer protein,11293,74,1.17 [0.72-1.89],0.5243900049357109
Chapter II Neoplasms,Carcinoma in situ of breast,CPVL,Probable serine carboxypeptidase CPVL,13552,87,0.82 [0.53-1.28],0.3929114663054474
Chapter II Neoplasms,Carcinoma in situ of breast,CPXM1,Probable carboxypeptidase X1,13480,90,0.83 [0.63-1.09],0.1864417461452019
Chapter II Neoplasms,Carcinoma in situ of breast,CPXM2,Inactive carboxypeptidase-like protein X2,11652,74,0.99 [0.39-2.50],0.9871167147073184
Chapter II Neoplasms,Carcinoma in situ of breast,CR1,Complement receptor type 1,11599,75,1.10 [0.59-2.06],0.7673634764918554
Chapter II Neoplasms,Carcinoma in situ of breast,CR2,Complement receptor type 2,13459,89,1.11 [0.74-1.67],0.6176002055450733
Chapter II Neoplasms,Carcinoma in situ of breast,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,13139,87,0.84 [0.67-1.07],0.1552205801063261
Chapter II Neoplasms,Carcinoma in situ of breast,CRADD,Death domain-containing protein CRADD,13334,90,0.78 [0.61-0.99],0.0417332592880748
Chapter II Neoplasms,Carcinoma in situ of breast,CREB3,Cyclic AMP-responsive element-binding protein 3,11230,75,0.97 [0.66-1.44],0.8892746295710912
Chapter II Neoplasms,Carcinoma in situ of breast,CREBZF,CREB/ATF bZIP transcription factor,11230,75,0.54 [0.22-1.34],0.1853751131287083
Chapter II Neoplasms,Carcinoma in situ of breast,CREG1,Protein CREG1,13256,86,0.73 [0.42-1.26],0.2576210158336397
Chapter II Neoplasms,Carcinoma in situ of breast,CRELD1,Protein disulfide isomerase CRELD1,11384,76,1.51 [0.85-2.68],0.1617805377616287
Chapter II Neoplasms,Carcinoma in situ of breast,CRELD2,Protein disulfide isomerase CRELD2,13486,91,0.97 [0.68-1.38],0.8461506243067567
Chapter II Neoplasms,Carcinoma in situ of breast,CRH,Corticoliberin,13115,87,0.90 [0.72-1.13],0.3672624494855626
Chapter II Neoplasms,Carcinoma in situ of breast,CRHBP,Corticotropin-releasing factor-binding protein,13445,90,0.89 [0.47-1.69],0.7200097482898931
Chapter II Neoplasms,Carcinoma in situ of breast,CRHR1,Corticotropin-releasing factor receptor 1,13220,88,1.11 [0.84-1.45],0.4669004139983351
Chapter II Neoplasms,Carcinoma in situ of breast,CRIM1,Cysteine-rich motor neuron 1 protein,13507,91,0.59 [0.23-1.51],0.272239397475648
Chapter II Neoplasms,Carcinoma in situ of breast,CRIP2,Cysteine-rich protein 2,13363,90,0.64 [0.37-1.10],0.1077844922130097
Chapter II Neoplasms,Carcinoma in situ of breast,CRISP2,Cysteine-rich secretory protein 2,13571,87,1.17 [0.85-1.62],0.3248597499179942
Chapter II Neoplasms,Carcinoma in situ of breast,CRISP3,Cysteine-rich secretory protein 3,11536,75,1.36 [0.60-3.11],0.4645312980333456
Chapter II Neoplasms,Carcinoma in situ of breast,CRKL,Crk-like protein,13458,91,0.82 [0.69-0.97],0.0231617827664589
Chapter II Neoplasms,Carcinoma in situ of breast,CRLF1,Cytokine receptor-like factor 1,13507,91,1.37 [0.68-2.78],0.3815160889923767
Chapter II Neoplasms,Carcinoma in situ of breast,CRNN,Cornulin,13030,84,0.91 [0.67-1.22],0.518746490148251
Chapter II Neoplasms,Carcinoma in situ of breast,CRTAC1,Cartilage acidic protein 1,13609,89,0.70 [0.38-1.30],0.2559517226454579
Chapter II Neoplasms,Carcinoma in situ of breast,CRTAM,Cytotoxic and regulatory T-cell molecule,13363,90,0.83 [0.56-1.23],0.3551991876271059
Chapter II Neoplasms,Carcinoma in situ of breast,CRTAP,Cartilage-associated protein,11312,75,0.79 [0.47-1.32],0.364588354904917
Chapter II Neoplasms,Carcinoma in situ of breast,CRX,Cone-rod homeobox protein,13220,88,0.86 [0.70-1.07],0.1726671530533783
Chapter II Neoplasms,Carcinoma in situ of breast,CRYBB1,Beta-crystallin B1,11652,74,0.72 [0.51-1.01],0.0588866446990946
Chapter II Neoplasms,Carcinoma in situ of breast,CRYBB2,Beta-crystallin B2,11617,76,0.59 [0.32-1.11],0.1022784506223012
Chapter II Neoplasms,Carcinoma in situ of breast,CRYGD,Gamma-crystallin D,11617,76,0.75 [0.60-0.94],0.0111169823154463
Chapter II Neoplasms,Carcinoma in situ of breast,CRYM,Ketimine reductase mu-crystallin,11311,73,0.69 [0.48-0.98],0.0406605622909846
Chapter II Neoplasms,Carcinoma in situ of breast,CRYZL1,Quinone oxidoreductase-like protein 1,11330,75,0.83 [0.65-1.05],0.1186475080250438
Chapter II Neoplasms,Carcinoma in situ of breast,CSDE1,Cold shock domain-containing protein E1,11293,74,0.89 [0.73-1.10],0.2861005527723785
Chapter II Neoplasms,Carcinoma in situ of breast,CSF1,Macrophage colony-stimulating factor 1,13507,91,0.54 [0.26-1.13],0.1016154713572165
Chapter II Neoplasms,Carcinoma in situ of breast,CSF1R,Macrophage colony-stimulating factor 1 receptor,11650,75,0.82 [0.46-1.48],0.5084621882139738
Chapter II Neoplasms,Carcinoma in situ of breast,CSF2,Granulocyte-macrophage colony-stimulating factor,11293,74,1.33 [0.78-2.28],0.2908541502161663
Chapter II Neoplasms,Carcinoma in situ of breast,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,13363,90,1.23 [0.94-1.62],0.1383261928692915
Chapter II Neoplasms,Carcinoma in situ of breast,CSF2RB,Cytokine receptor common subunit beta,11319,73,0.91 [0.55-1.49],0.6975702487823049
Chapter II Neoplasms,Carcinoma in situ of breast,CSF3,Granulocyte colony-stimulating factor,13187,89,0.65 [0.43-0.96],0.0324971994015099
Chapter II Neoplasms,Carcinoma in situ of breast,CSF3R,Granulocyte colony-stimulating factor receptor,11319,73,0.63 [0.29-1.38],0.2445908389538576
Chapter II Neoplasms,Carcinoma in situ of breast,CSH1,Chorionic somatomammotropin hormone 1,11650,75,0.95 [0.49-1.87],0.8930363159586827
Chapter II Neoplasms,Carcinoma in situ of breast,CSNK1D,Casein kinase I isoform delta,11319,73,0.70 [0.47-1.04],0.0808416037918579
Chapter II Neoplasms,Carcinoma in situ of breast,CSNK2A1,Casein kinase II subunit alpha,11634,76,0.67 [0.41-1.09],0.1076509864168444
Chapter II Neoplasms,Carcinoma in situ of breast,CSPG4,Chondroitin sulfate proteoglycan 4,11632,77,0.77 [0.40-1.48],0.4288469164228923
Chapter II Neoplasms,Carcinoma in situ of breast,CSPG5,Chondroitin sulfate proteoglycan 5,11311,73,0.94 [0.58-1.52],0.7987182728310488
Chapter II Neoplasms,Carcinoma in situ of breast,CSRP3,Cysteine and glycine-rich protein 3,11293,74,1.08 [0.86-1.34],0.5095364448669603
Chapter II Neoplasms,Carcinoma in situ of breast,CST1,Cystatin-SN,10077,69,0.96 [0.76-1.23],0.7596698182480008
Chapter II Neoplasms,Carcinoma in situ of breast,CST3,Cystatin-C,13440,89,1.16 [0.58-2.35],0.670946025639419
Chapter II Neoplasms,Carcinoma in situ of breast,CST5,Cystatin-D,13226,90,1.20 [0.86-1.67],0.2960640372163159
Chapter II Neoplasms,Carcinoma in situ of breast,CST6,Cystatin-M,13107,85,1.18 [0.78-1.78],0.4386956579131814
Chapter II Neoplasms,Carcinoma in situ of breast,CST7,Cystatin-F,13457,89,0.90 [0.72-1.12],0.342120949408667
Chapter II Neoplasms,Carcinoma in situ of breast,CSTB,Cystatin-B,13251,87,0.77 [0.49-1.22],0.2628693255073411
Chapter II Neoplasms,Carcinoma in situ of breast,CTAG1A_CTAG1B,Cancer/testis antigen 1,11373,77,1.21 [0.82-1.78],0.3339437286482761
Chapter II Neoplasms,Carcinoma in situ of breast,CTBS,Di-N-acetylchitobiase,11479,71,0.77 [0.35-1.68],0.5143432117647366
Chapter II Neoplasms,Carcinoma in situ of breast,CTF1,Cardiotrophin-1,13220,88,0.84 [0.67-1.06],0.1449360556638352
Chapter II Neoplasms,Carcinoma in situ of breast,CTHRC1,Collagen triple helix repeat-containing protein 1,11632,77,1.00 [0.45-2.25],0.9931335626714426
Chapter II Neoplasms,Carcinoma in situ of breast,CTLA4,Cytotoxic T-lymphocyte protein 4,11632,77,0.67 [0.32-1.41],0.2937319617715922
Chapter II Neoplasms,Carcinoma in situ of breast,CTNNA1,Catenin alpha-1,11311,73,0.59 [0.26-1.34],0.2059882504596579
Chapter II Neoplasms,Carcinoma in situ of breast,CTRB1,Chymotrypsinogen B,13449,89,0.87 [0.61-1.25],0.4585792687374956
Chapter II Neoplasms,Carcinoma in situ of breast,CTRC,Chymotrypsin-C,13445,89,0.85 [0.63-1.16],0.3086115331323904
Chapter II Neoplasms,Carcinoma in situ of breast,CTRL,Chymotrypsin-like protease CTRL-1,11617,76,0.79 [0.57-1.10],0.1689884197494711
Chapter II Neoplasms,Carcinoma in situ of breast,CTSB,Cathepsin B,13439,87,1.06 [0.75-1.51],0.7363813234005663
Chapter II Neoplasms,Carcinoma in situ of breast,CTSC,Dipeptidyl peptidase 1,13418,91,0.59 [0.37-0.92],0.0201979695513752
Chapter II Neoplasms,Carcinoma in situ of breast,CTSD,Cathepsin D,12489,77,0.77 [0.43-1.38],0.3789084447482016
Chapter II Neoplasms,Carcinoma in situ of breast,CTSE,Cathepsin E,11384,76,1.07 [0.71-1.63],0.7345590081360382
Chapter II Neoplasms,Carcinoma in situ of breast,CTSF,Cathepsin F,13480,90,0.69 [0.44-1.09],0.1154651632332978
Chapter II Neoplasms,Carcinoma in situ of breast,CTSH,Pro-cathepsin H,13181,88,0.93 [0.72-1.21],0.5884333872852827
Chapter II Neoplasms,Carcinoma in situ of breast,CTSL,Cathepsin L1,13452,90,0.66 [0.30-1.48],0.316603954791877
Chapter II Neoplasms,Carcinoma in situ of breast,CTSO,Cathepsin O,13604,89,0.64 [0.34-1.20],0.1611715935021033
Chapter II Neoplasms,Carcinoma in situ of breast,CTSS,Cathepsin S,10614,71,1.03 [0.40-2.66],0.957730388188138
Chapter II Neoplasms,Carcinoma in situ of breast,CTSV,Cathepsin L2,13538,87,1.11 [0.72-1.71],0.6366609468390736
Chapter II Neoplasms,Carcinoma in situ of breast,CTSZ,Cathepsin Z,13401,89,0.88 [0.47-1.62],0.677441655999935
Chapter II Neoplasms,Carcinoma in situ of breast,CUZD1,CUB and zona pellucida-like domain-containing protein 1,11312,75,0.79 [0.40-1.57],0.5024423268178402
Chapter II Neoplasms,Carcinoma in situ of breast,CWC15,Spliceosome-associated protein CWC15 homolog,11523,77,1.14 [0.83-1.55],0.4164813765060335
Chapter II Neoplasms,Carcinoma in situ of breast,CX3CL1,Fractalkine,13363,90,0.96 [0.55-1.68],0.8978483926337066
Chapter II Neoplasms,Carcinoma in situ of breast,CXADR,Coxsackievirus and adenovirus receptor,13434,87,0.70 [0.47-1.05],0.0826864046905943
Chapter II Neoplasms,Carcinoma in situ of breast,CXCL1,Growth-regulated alpha protein,13407,89,0.79 [0.64-0.97],0.0262510455375498
Chapter II Neoplasms,Carcinoma in situ of breast,CXCL10,C-X-C motif chemokine 10,13507,91,0.81 [0.60-1.10],0.1823448475185586
Chapter II Neoplasms,Carcinoma in situ of breast,CXCL11,C-X-C motif chemokine 11,13577,89,0.68 [0.52-0.89],0.0045677849842587
Chapter II Neoplasms,Carcinoma in situ of breast,CXCL12,Stromal cell-derived factor 1,13187,89,0.64 [0.39-1.03],0.0677710770155686
Chapter II Neoplasms,Carcinoma in situ of breast,CXCL13,C-X-C motif chemokine 13,13577,89,1.00 [0.74-1.36],0.9868078284159368
Chapter II Neoplasms,Carcinoma in situ of breast,CXCL14,C-X-C motif chemokine 14,13187,89,0.99 [0.73-1.33],0.942156833620976
Chapter II Neoplasms,Carcinoma in situ of breast,CXCL16,C-X-C motif chemokine 16,13579,87,0.99 [0.44-2.25],0.9886434369912482
Chapter II Neoplasms,Carcinoma in situ of breast,CXCL17,C-X-C motif chemokine 17,13604,89,1.12 [0.71-1.77],0.6318156393161114
Chapter II Neoplasms,Carcinoma in situ of breast,CXCL3,C-X-C motif chemokine 3,13436,89,0.80 [0.67-0.97],0.0227149415538918
Chapter II Neoplasms,Carcinoma in situ of breast,CXCL5,C-X-C motif chemokine 5,13405,90,0.84 [0.71-0.98],0.0294915260918283
Chapter II Neoplasms,Carcinoma in situ of breast,CXCL6,C-X-C motif chemokine 6,13604,89,0.77 [0.61-0.99],0.0407433928825061
Chapter II Neoplasms,Carcinoma in situ of breast,CXCL8,Interleukin-8,13338,87,0.87 [0.64-1.17],0.3583773821777728
Chapter II Neoplasms,Carcinoma in situ of breast,CXCL9,C-X-C motif chemokine 9,13507,91,0.83 [0.61-1.12],0.2189662381362213
Chapter II Neoplasms,Carcinoma in situ of breast,CYB5A,Cytochrome b5,11230,75,1.17 [0.92-1.50],0.2086651574315716
Chapter II Neoplasms,Carcinoma in situ of breast,CYB5R2,NADH-cytochrome b5 reductase 2,11438,77,0.96 [0.65-1.42],0.8275138415095449
Chapter II Neoplasms,Carcinoma in situ of breast,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",11293,74,0.65 [0.45-0.95],0.0260021663523605
Chapter II Neoplasms,Carcinoma in situ of breast,CYTH3,Cytohesin-3,11230,75,1.06 [0.80-1.40],0.7007192111735825
Chapter II Neoplasms,Carcinoma in situ of breast,CYTL1,Cytokine-like protein 1,11632,77,1.31 [0.50-3.42],0.5772086715414902
Chapter II Neoplasms,Carcinoma in situ of breast,DAAM1,Disheveled-associated activator of morphogenesis 1,11384,76,0.73 [0.55-0.96],0.0260468228378607
Chapter II Neoplasms,Carcinoma in situ of breast,DAB2,Disabled homolog 2,13571,87,0.80 [0.68-0.95],0.0093355107950585
Chapter II Neoplasms,Carcinoma in situ of breast,DAG1,Dystroglycan,13507,91,0.68 [0.46-0.99],0.0470678405213673
Chapter II Neoplasms,Carcinoma in situ of breast,DAND5,DAN domain family member 5,11319,73,0.97 [0.65-1.46],0.8950559010933488
Chapter II Neoplasms,Carcinoma in situ of breast,DAPK2,Death-associated protein kinase 2,11319,73,1.20 [0.83-1.73],0.3272553247087777
Chapter II Neoplasms,Carcinoma in situ of breast,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,13434,87,0.92 [0.79-1.07],0.2677263833784408
Chapter II Neoplasms,Carcinoma in situ of breast,DARS1,"Aspartate--tRNA ligase, cytoplasmic",13334,90,0.84 [0.65-1.08],0.1770239371495272
Chapter II Neoplasms,Carcinoma in situ of breast,DBH,Dopamine beta-hydroxylase,11629,75,1.15 [0.91-1.45],0.2432596022051259
Chapter II Neoplasms,Carcinoma in situ of breast,DBI,Acyl-CoA-binding protein,13387,89,0.80 [0.63-1.02],0.0742841231825111
Chapter II Neoplasms,Carcinoma in situ of breast,DBN1,Drebrin,11319,73,0.55 [0.34-0.88],0.0136045888075893
Chapter II Neoplasms,Carcinoma in situ of breast,DBNL,Drebrin-like protein,13507,91,0.80 [0.65-0.97],0.0234809920591962
Chapter II Neoplasms,Carcinoma in situ of breast,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",13480,90,1.20 [0.69-2.07],0.5165086461447801
Chapter II Neoplasms,Carcinoma in situ of breast,DCC,Netrin receptor DCC,11312,75,1.33 [0.57-3.13],0.5070456872833017
Chapter II Neoplasms,Carcinoma in situ of breast,DCDC2C,Doublecortin domain-containing protein 2C,11230,75,0.88 [0.61-1.28],0.5018048930363099
Chapter II Neoplasms,Carcinoma in situ of breast,DCLRE1C,Protein artemis,11230,75,0.38 [0.18-0.81],0.0123946642653902
Chapter II Neoplasms,Carcinoma in situ of breast,DCN,Decorin,13220,88,0.58 [0.24-1.40],0.2224753159562018
Chapter II Neoplasms,Carcinoma in situ of breast,DCTD,Deoxycytidylate deaminase,11384,76,0.80 [0.64-1.01],0.0592198780685823
Chapter II Neoplasms,Carcinoma in situ of breast,DCTN1,Dynactin subunit 1,13571,87,0.74 [0.55-0.99],0.041225526628264
Chapter II Neoplasms,Carcinoma in situ of breast,DCTN2,Dynactin subunit 2,13380,89,0.84 [0.68-1.04],0.1026584531668278
Chapter II Neoplasms,Carcinoma in situ of breast,DCTN6,Dynactin subunit 6,13108,85,0.82 [0.61-1.11],0.2051558466136236
Chapter II Neoplasms,Carcinoma in situ of breast,DCTPP1,dCTP pyrophosphatase 1,13452,90,0.75 [0.42-1.35],0.3389774602568834
Chapter II Neoplasms,Carcinoma in situ of breast,DCUN1D1,DCN1-like protein 1,11311,73,0.95 [0.70-1.29],0.736006921090124
Chapter II Neoplasms,Carcinoma in situ of breast,DCUN1D2,DCN1-like protein 2,11230,75,1.23 [0.99-1.52],0.0619666070972466
Chapter II Neoplasms,Carcinoma in situ of breast,DCXR,L-xylulose reductase,13480,90,0.87 [0.60-1.26],0.4562792852808474
Chapter II Neoplasms,Carcinoma in situ of breast,DDA1,DET1- and DDB1-associated protein 1,11293,74,0.64 [0.33-1.21],0.1672561092278213
Chapter II Neoplasms,Carcinoma in situ of breast,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",13380,89,0.89 [0.58-1.37],0.6082886420078422
Chapter II Neoplasms,Carcinoma in situ of breast,DDC,Aromatic-L-amino-acid decarboxylase,13434,90,0.88 [0.60-1.30],0.5286742937497655
Chapter II Neoplasms,Carcinoma in situ of breast,DDHD2,Phospholipase DDHD2,11634,76,0.71 [0.51-0.99],0.0447718742141304
Chapter II Neoplasms,Carcinoma in situ of breast,DDI2,Protein DDI1 homolog 2,11384,76,1.03 [0.78-1.35],0.8532786024538461
Chapter II Neoplasms,Carcinoma in situ of breast,DDR1,Epithelial discoidin domain-containing receptor 1,13577,89,1.03 [0.45-2.38],0.9439079168101014
Chapter II Neoplasms,Carcinoma in situ of breast,DDT,D-dopachrome decarboxylase,11632,77,0.83 [0.48-1.43],0.5080080038239461
Chapter II Neoplasms,Carcinoma in situ of breast,DDX1,ATP-dependent RNA helicase DDX1,11587,77,1.52 [1.13-2.05],0.0061086948714079
Chapter II Neoplasms,Carcinoma in situ of breast,DDX25,ATP-dependent RNA helicase DDX25,11312,75,0.61 [0.30-1.24],0.1763026749908109
Chapter II Neoplasms,Carcinoma in situ of breast,DDX39A,ATP-dependent RNA helicase DDX39A,11319,73,1.03 [0.37-2.85],0.9584354578172644
Chapter II Neoplasms,Carcinoma in situ of breast,DDX4,Probable ATP-dependent RNA helicase DDX4,11319,73,1.12 [0.78-1.61],0.5498053186762935
Chapter II Neoplasms,Carcinoma in situ of breast,DDX53,Probable ATP-dependent RNA helicase DDX53,11312,75,1.57 [0.88-2.78],0.1239379264245153
Chapter II Neoplasms,Carcinoma in situ of breast,DDX58,Antiviral innate immune response receptor RIG-I,13139,87,0.89 [0.63-1.25],0.4988106418377104
Chapter II Neoplasms,Carcinoma in situ of breast,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",13434,87,0.89 [0.73-1.08],0.2515098780913871
Chapter II Neoplasms,Carcinoma in situ of breast,DEFA1_DEFA1B,Neutrophil defensin 1,13131,80,1.50 [1.10-2.03],0.0093127460735123
Chapter II Neoplasms,Carcinoma in situ of breast,DEFB103A_DEFB103B,Beta-defensin 103,11235,73,1.20 [0.77-1.87],0.4241026118785566
Chapter II Neoplasms,Carcinoma in situ of breast,DEFB104A_DEFB104B,Beta-defensin 104,11311,73,0.89 [0.58-1.36],0.5841211804944079
Chapter II Neoplasms,Carcinoma in situ of breast,DEFB116,Beta-defensin 116,11311,73,0.92 [0.68-1.26],0.6071036603592667
Chapter II Neoplasms,Carcinoma in situ of breast,DEFB118,Beta-defensin 118,11311,73,0.93 [0.61-1.41],0.7265633197660479
Chapter II Neoplasms,Carcinoma in situ of breast,DEFB4A_DEFB4B,Beta-defensin 4A,13250,88,0.95 [0.83-1.08],0.4421476596211792
Chapter II Neoplasms,Carcinoma in situ of breast,DENND2B,DENN domain-containing protein 2B,11293,74,1.04 [0.69-1.56],0.8690109587354613
Chapter II Neoplasms,Carcinoma in situ of breast,DENR,Density-regulated protein,11319,73,0.61 [0.39-0.95],0.0293351509980164
Chapter II Neoplasms,Carcinoma in situ of breast,DFFA,DNA fragmentation factor subunit alpha,13604,89,0.76 [0.57-1.01],0.0619992042154938
Chapter II Neoplasms,Carcinoma in situ of breast,DGCR6,Protein DGCR6,11311,73,0.68 [0.37-1.27],0.2273607941163362
Chapter II Neoplasms,Carcinoma in situ of breast,DGKA,Diacylglycerol kinase alpha,11319,73,0.65 [0.41-1.01],0.0552601463612685
Chapter II Neoplasms,Carcinoma in situ of breast,DGKZ,Diacylglycerol kinase zeta,13187,89,0.70 [0.40-1.22],0.2066546764125359
Chapter II Neoplasms,Carcinoma in situ of breast,DHODH,Dihydroorotate dehydrogenase,11293,74,1.06 [0.68-1.65],0.8027410744660386
Chapter II Neoplasms,Carcinoma in situ of breast,DHPS,Deoxyhypusine synthase,11571,75,1.15 [0.73-1.83],0.545301580781002
Chapter II Neoplasms,Carcinoma in situ of breast,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,11617,76,0.61 [0.36-1.05],0.0767463447225109
Chapter II Neoplasms,Carcinoma in situ of breast,DIABLO,"Diablo homolog, mitochondrial",13402,88,0.83 [0.70-0.99],0.0366267946357196
Chapter II Neoplasms,Carcinoma in situ of breast,DIPK1C,Divergent protein kinase domain 1C,11312,75,0.52 [0.27-0.98],0.0418950559532529
Chapter II Neoplasms,Carcinoma in situ of breast,DIPK2B,Divergent protein kinase domain 2B,11384,76,1.52 [0.71-3.24],0.2836305692522841
Chapter II Neoplasms,Carcinoma in situ of breast,DKK1,Dickkopf-related protein 1,13577,89,0.77 [0.57-1.05],0.1004183381037514
Chapter II Neoplasms,Carcinoma in situ of breast,DKK3,Dickkopf-related protein 3,13609,89,0.72 [0.38-1.38],0.3205455088932128
Chapter II Neoplasms,Carcinoma in situ of breast,DKK4,Dickkopf-related protein 4,13340,90,0.93 [0.61-1.40],0.7236170544080687
Chapter II Neoplasms,Carcinoma in situ of breast,DKKL1,Dickkopf-like protein 1,13380,89,1.09 [0.87-1.36],0.454905383383411
Chapter II Neoplasms,Carcinoma in situ of breast,DLG4,Disks large homolog 4,11617,76,0.72 [0.51-1.00],0.0515604502703387
Chapter II Neoplasms,Carcinoma in situ of breast,DLGAP5,Disks large-associated protein 5,11634,76,0.84 [0.52-1.35],0.4680118336724074
Chapter II Neoplasms,Carcinoma in situ of breast,DLK1,Protein delta homolog 1,13609,89,1.01 [0.71-1.43],0.9758518397264488
Chapter II Neoplasms,Carcinoma in situ of breast,DLL1,Delta-like protein 1,13480,90,1.21 [0.62-2.36],0.5759771516890505
Chapter II Neoplasms,Carcinoma in situ of breast,DLL4,Delta-like protein 4,11330,75,0.93 [0.68-1.28],0.6665905928469151
Chapter II Neoplasms,Carcinoma in situ of breast,DMD,Dystrophin,11330,75,0.64 [0.39-1.07],0.0887361937876491
Chapter II Neoplasms,Carcinoma in situ of breast,DMP1,Dentin matrix acidic phosphoprotein 1,11330,75,1.07 [0.74-1.53],0.7250269451964702
Chapter II Neoplasms,Carcinoma in situ of breast,DNAJA1,DnaJ homolog subfamily A member 1,11230,75,1.02 [0.65-1.61],0.9270300885479246
Chapter II Neoplasms,Carcinoma in situ of breast,DNAJA2,DnaJ homolog subfamily A member 2,13554,87,0.73 [0.59-0.92],0.0074878287815106
Chapter II Neoplasms,Carcinoma in situ of breast,DNAJA4,DnaJ homolog subfamily A member 4,11617,76,1.02 [0.76-1.37],0.8958861952446916
Chapter II Neoplasms,Carcinoma in situ of breast,DNAJB1,DnaJ homolog subfamily B member 1,13380,89,0.81 [0.65-1.00],0.0516414901835335
Chapter II Neoplasms,Carcinoma in situ of breast,DNAJB14,DnaJ homolog subfamily B member 14,11587,77,0.80 [0.57-1.13],0.2118539767529652
Chapter II Neoplasms,Carcinoma in situ of breast,DNAJB2,DnaJ homolog subfamily B member 2,11384,76,0.78 [0.52-1.17],0.2301947820680288
Chapter II Neoplasms,Carcinoma in situ of breast,DNAJB6,DnaJ homolog subfamily B member 6,11267,76,0.76 [0.59-1.00],0.0460750472280685
Chapter II Neoplasms,Carcinoma in situ of breast,DNAJB8,DnaJ homolog subfamily B member 8,13220,88,1.11 [0.82-1.49],0.4968327854501351
Chapter II Neoplasms,Carcinoma in situ of breast,DNAJC21,DnaJ homolog subfamily C member 21,11617,76,0.85 [0.47-1.52],0.578635240214042
Chapter II Neoplasms,Carcinoma in situ of breast,DNAJC6,Putative tyrosine-protein phosphatase auxilin,11330,75,0.75 [0.57-0.99],0.0391478177953241
Chapter II Neoplasms,Carcinoma in situ of breast,DNAJC9,DnaJ homolog subfamily C member 9,11587,77,0.87 [0.66-1.16],0.3390538580908894
Chapter II Neoplasms,Carcinoma in situ of breast,DNER,Delta and Notch-like epidermal growth factor-related receptor,13424,89,0.92 [0.43-1.97],0.8303115916821728
Chapter II Neoplasms,Carcinoma in situ of breast,DNLZ,DNL-type zinc finger protein,11311,73,1.07 [0.86-1.32],0.5559224197164256
Chapter II Neoplasms,Carcinoma in situ of breast,DNM1,Dynamin-1,11587,77,0.84 [0.70-1.01],0.0707894038970495
Chapter II Neoplasms,Carcinoma in situ of breast,DNM3,Dynamin-3,11634,76,0.78 [0.51-1.19],0.2489835030841751
Chapter II Neoplasms,Carcinoma in situ of breast,DNMBP,Dynamin-binding protein,13363,90,0.78 [0.57-1.07],0.1255050137813025
Chapter II Neoplasms,Carcinoma in situ of breast,DNPEP,Aspartyl aminopeptidase,11617,76,0.74 [0.53-1.02],0.0680325479412587
Chapter II Neoplasms,Carcinoma in situ of breast,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,13479,91,0.84 [0.59-1.19],0.3169975770887409
Chapter II Neoplasms,Carcinoma in situ of breast,DOC2B,Double C2-like domain-containing protein beta,11312,75,0.60 [0.28-1.29],0.1881478132944292
Chapter II Neoplasms,Carcinoma in situ of breast,DOCK9,Dedicator of cytokinesis protein 9,11311,73,1.01 [0.84-1.21],0.9437031069625712
Chapter II Neoplasms,Carcinoma in situ of breast,DOK1,Docking protein 1,11617,76,0.84 [0.72-0.98],0.0253883352713096
Chapter II Neoplasms,Carcinoma in situ of breast,DOK2,Docking protein 2,13452,90,0.83 [0.71-0.97],0.0205155678173196
Chapter II Neoplasms,Carcinoma in situ of breast,DPEP1,Dipeptidase 1,13334,90,0.73 [0.51-1.04],0.0837755144249251
Chapter II Neoplasms,Carcinoma in situ of breast,DPEP2,Dipeptidase 2,13380,89,0.78 [0.41-1.52],0.4686981099104286
Chapter II Neoplasms,Carcinoma in situ of breast,DPP10,Inactive dipeptidyl peptidase 10,13434,87,0.50 [0.27-0.92],0.0265686995226548
Chapter II Neoplasms,Carcinoma in situ of breast,DPP4,Dipeptidyl peptidase 4,13140,85,0.97 [0.51-1.87],0.9393367029037089
Chapter II Neoplasms,Carcinoma in situ of breast,DPP6,Dipeptidyl aminopeptidase-like protein 6,13380,89,0.73 [0.41-1.29],0.2745490655289694
Chapter II Neoplasms,Carcinoma in situ of breast,DPP7,Dipeptidyl peptidase 2,13337,90,0.91 [0.66-1.24],0.5485692144912124
Chapter II Neoplasms,Carcinoma in situ of breast,DPT,Dermatopontin,13609,89,0.71 [0.37-1.38],0.3112076451484845
Chapter II Neoplasms,Carcinoma in situ of breast,DPY30,Protein dpy-30 homolog,13531,87,0.89 [0.64-1.23],0.4843647137645812
Chapter II Neoplasms,Carcinoma in situ of breast,DRAXIN,Draxin,13363,90,1.23 [0.79-1.90],0.3613037253795624
Chapter II Neoplasms,Carcinoma in situ of breast,DRG2,Developmentally-regulated GTP-binding protein 2,13380,89,0.57 [0.39-0.81],0.0019371934815781
Chapter II Neoplasms,Carcinoma in situ of breast,DSC2,Desmocollin-2,13302,88,0.88 [0.49-1.58],0.6681741410530915
Chapter II Neoplasms,Carcinoma in situ of breast,DSCAM,Down syndrome cell adhesion molecule,11634,76,0.61 [0.32-1.15],0.1282815605891203
Chapter II Neoplasms,Carcinoma in situ of breast,DSG2,Desmoglein-2,13449,89,1.04 [0.52-2.09],0.9153910332466392
Chapter II Neoplasms,Carcinoma in situ of breast,DSG3,Desmoglein-3,13532,87,0.79 [0.45-1.40],0.4160408389528776
Chapter II Neoplasms,Carcinoma in situ of breast,DSG4,Desmoglein-4,13327,89,0.94 [0.66-1.36],0.7563064613164301
Chapter II Neoplasms,Carcinoma in situ of breast,DTD1,D-aminoacyl-tRNA deacylase 1,11384,76,0.75 [0.59-0.97],0.0291662588953801
Chapter II Neoplasms,Carcinoma in situ of breast,DTNB,Dystrobrevin beta,11557,75,0.61 [0.35-1.05],0.076342402815855
Chapter II Neoplasms,Carcinoma in situ of breast,DTX2,Probable E3 ubiquitin-protein ligase DTX2,11312,75,0.70 [0.47-1.05],0.084469491769153
Chapter II Neoplasms,Carcinoma in situ of breast,DTX3,Probable E3 ubiquitin-protein ligase DTX3,13380,89,0.99 [0.44-2.22],0.9773523633715604
Chapter II Neoplasms,Carcinoma in situ of breast,DTYMK,Thymidylate kinase,11652,74,0.68 [0.50-0.95],0.0214061956392478
Chapter II Neoplasms,Carcinoma in situ of breast,DUOX2,Dual oxidase 2,13220,88,0.92 [0.70-1.22],0.5596912457172845
Chapter II Neoplasms,Carcinoma in situ of breast,DUSP13,Dual specificity protein phosphatase 13 isoform A,11571,75,1.02 [0.59-1.75],0.9436230656491432
Chapter II Neoplasms,Carcinoma in situ of breast,DUSP29,Dual specificity phosphatase 29,11312,75,0.87 [0.60-1.26],0.4630459939231831
Chapter II Neoplasms,Carcinoma in situ of breast,DUSP3,Dual specificity protein phosphatase 3,13108,85,0.87 [0.68-1.11],0.2677528663664074
Chapter II Neoplasms,Carcinoma in situ of breast,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",11587,77,0.87 [0.70-1.08],0.1992869986621985
Chapter II Neoplasms,Carcinoma in situ of breast,DXO,Decapping and exoribonuclease protein,11617,76,0.80 [0.49-1.30],0.3639477936706877
Chapter II Neoplasms,Carcinoma in situ of breast,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,11571,75,0.63 [0.35-1.13],0.1230723802547852
Chapter II Neoplasms,Carcinoma in situ of breast,DYNLT1,Dynein light chain Tctex-type 1,11312,75,1.08 [0.83-1.39],0.5739190801485564
Chapter II Neoplasms,Carcinoma in situ of breast,DYNLT3,Dynein light chain Tctex-type 3,11571,75,0.78 [0.46-1.31],0.3403653596393146
Chapter II Neoplasms,Carcinoma in situ of breast,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,13363,90,0.78 [0.64-0.95],0.0143868611926091
Chapter II Neoplasms,Carcinoma in situ of breast,EBI3_IL27,Interleukin-27,13550,87,0.85 [0.45-1.59],0.6097462617883815
Chapter II Neoplasms,Carcinoma in situ of breast,ECE1,Endothelin-converting enzyme 1,13108,85,0.83 [0.48-1.44],0.5148048935174987
Chapter II Neoplasms,Carcinoma in situ of breast,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",11652,74,0.98 [0.72-1.32],0.8733349621715805
Chapter II Neoplasms,Carcinoma in situ of breast,ECHS1,"Enoyl-CoA hydratase, mitochondrial",11330,75,0.90 [0.72-1.13],0.3743992474609444
Chapter II Neoplasms,Carcinoma in situ of breast,ECI2,Enoyl-CoA delta isomerase 2,11293,74,0.57 [0.37-0.88],0.011685792511077
Chapter II Neoplasms,Carcinoma in situ of breast,ECM1,Extracellular matrix protein 1,11319,76,1.02 [0.55-1.87],0.9582731051964676
Chapter II Neoplasms,Carcinoma in situ of breast,ECSCR,Endothelial cell-specific chemotaxis regulator,11311,73,1.05 [0.69-1.59],0.8350861615402491
Chapter II Neoplasms,Carcinoma in situ of breast,EDA2R,Tumor necrosis factor receptor superfamily member 27,13571,87,1.40 [0.78-2.49],0.2555535630050342
Chapter II Neoplasms,Carcinoma in situ of breast,EDAR,Tumor necrosis factor receptor superfamily member EDAR,13434,87,0.89 [0.73-1.10],0.2875179895610688
Chapter II Neoplasms,Carcinoma in situ of breast,EDDM3B,Epididymal secretory protein E3-beta,11571,75,1.49 [0.99-2.24],0.0551287027599865
Chapter II Neoplasms,Carcinoma in situ of breast,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,11293,74,0.52 [0.25-1.12],0.0962088880105251
Chapter II Neoplasms,Carcinoma in situ of breast,EDF1,Endothelial differentiation-related factor 1,11634,76,0.67 [0.46-0.99],0.0428276340052279
Chapter II Neoplasms,Carcinoma in situ of breast,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,13220,88,1.23 [0.73-2.10],0.4377133292967106
Chapter II Neoplasms,Carcinoma in situ of breast,EDN1,Endothelin-1,11330,75,1.00 [0.46-2.19],0.9935882337523436
Chapter II Neoplasms,Carcinoma in situ of breast,EDNRB,Endothelin receptor type B,11319,73,0.75 [0.42-1.34],0.3373789987730309
Chapter II Neoplasms,Carcinoma in situ of breast,EEF1D,Elongation factor 1-delta,11652,74,0.80 [0.62-1.02],0.077164024419526
Chapter II Neoplasms,Carcinoma in situ of breast,EFCAB14,EF-hand calcium-binding domain-containing protein 14,11587,77,1.16 [0.56-2.43],0.689738029064159
Chapter II Neoplasms,Carcinoma in situ of breast,EFCAB2,Dynein regulatory complex protein 8,11399,77,0.76 [0.40-1.47],0.4208560285883158
Chapter II Neoplasms,Carcinoma in situ of breast,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,13429,87,0.77 [0.41-1.46],0.429967970275437
Chapter II Neoplasms,Carcinoma in situ of breast,EFHD1,EF-hand domain-containing protein D1,11634,76,0.73 [0.37-1.46],0.3730737859729832
Chapter II Neoplasms,Carcinoma in situ of breast,EFNA1,Ephrin-A1,13426,89,0.92 [0.44-1.92],0.817901032464226
Chapter II Neoplasms,Carcinoma in situ of breast,EFNA4,Ephrin-A4,13342,90,0.86 [0.42-1.76],0.6730394675944588
Chapter II Neoplasms,Carcinoma in situ of breast,EFNB2,Ephrin-B2,11312,75,1.10 [0.80-1.52],0.5452647485099478
Chapter II Neoplasms,Carcinoma in situ of breast,EGF,Pro-epidermal growth factor,13419,90,0.86 [0.72-1.03],0.1005158505896477
Chapter II Neoplasms,Carcinoma in situ of breast,EGFL7,Epidermal growth factor-like protein 7,13139,87,0.76 [0.46-1.23],0.2656726809070187
Chapter II Neoplasms,Carcinoma in situ of breast,EGFLAM,Pikachurin,11587,77,0.74 [0.36-1.56],0.4319744255969056
Chapter II Neoplasms,Carcinoma in situ of breast,EGFR,Epidermal growth factor receptor,13609,89,1.01 [0.32-3.22],0.9810243424552252
Chapter II Neoplasms,Carcinoma in situ of breast,EGLN1,Egl nine homolog 1,13434,87,0.95 [0.66-1.37],0.7749268679706556
Chapter II Neoplasms,Carcinoma in situ of breast,EHBP1,EH domain-binding protein 1,11652,74,0.69 [0.50-0.94],0.0197097683070282
Chapter II Neoplasms,Carcinoma in situ of breast,EHD3,EH domain-containing protein 3,11330,75,0.90 [0.74-1.08],0.258542665102129
Chapter II Neoplasms,Carcinoma in situ of breast,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",11617,76,0.87 [0.57-1.35],0.542313442318269
Chapter II Neoplasms,Carcinoma in situ of breast,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",11557,76,0.78 [0.63-0.96],0.0192835740714472
Chapter II Neoplasms,Carcinoma in situ of breast,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,11293,74,0.62 [0.42-0.91],0.0147220960032314
Chapter II Neoplasms,Carcinoma in situ of breast,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,11330,75,0.69 [0.38-1.26],0.2269066456918032
Chapter II Neoplasms,Carcinoma in situ of breast,EIF4B,Eukaryotic translation initiation factor 4B,13363,90,0.68 [0.50-0.92],0.0122446264631781
Chapter II Neoplasms,Carcinoma in situ of breast,EIF4E,Eukaryotic translation initiation factor 4E,11319,73,0.78 [0.60-1.00],0.053677358262691
Chapter II Neoplasms,Carcinoma in situ of breast,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,13452,90,0.87 [0.65-1.16],0.3417433882486845
Chapter II Neoplasms,Carcinoma in situ of breast,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,13604,89,0.80 [0.66-0.96],0.0145888517394427
Chapter II Neoplasms,Carcinoma in situ of breast,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,11634,76,0.81 [0.57-1.14],0.2239766926293681
Chapter II Neoplasms,Carcinoma in situ of breast,EIF5,Eukaryotic translation initiation factor 5,11293,74,0.71 [0.41-1.26],0.2425602929073951
Chapter II Neoplasms,Carcinoma in situ of breast,EIF5A,Eukaryotic translation initiation factor 5A-1,13187,89,0.92 [0.49-1.74],0.7980023060411077
Chapter II Neoplasms,Carcinoma in situ of breast,ELAC1,Zinc phosphodiesterase ELAC protein 1,11634,76,0.76 [0.59-0.97],0.0308187369490341
Chapter II Neoplasms,Carcinoma in situ of breast,ELAVL4,ELAV-like protein 4,11311,73,0.93 [0.71-1.21],0.5807165843504839
Chapter II Neoplasms,Carcinoma in situ of breast,ELN,Elastin,11652,74,0.72 [0.37-1.41],0.3380505303871475
Chapter II Neoplasms,Carcinoma in situ of breast,ELOA,Elongin-A,13380,89,0.94 [0.65-1.36],0.7530904445406708
Chapter II Neoplasms,Carcinoma in situ of breast,ELOB,Elongin-B,11293,74,0.53 [0.27-1.05],0.0686921441721239
Chapter II Neoplasms,Carcinoma in situ of breast,ENAH,Protein enabled homolog,13187,89,0.90 [0.61-1.34],0.6116653880135356
Chapter II Neoplasms,Carcinoma in situ of breast,ENDOU,Poly(U)-specific endoribonuclease,10776,70,1.36 [0.89-2.08],0.1535732620625271
Chapter II Neoplasms,Carcinoma in situ of breast,ENG,Endoglin,13609,89,0.63 [0.21-1.93],0.4216634922313483
Chapter II Neoplasms,Carcinoma in situ of breast,ENO1,Alpha-enolase,13425,89,0.86 [0.68-1.09],0.218143924554882
Chapter II Neoplasms,Carcinoma in situ of breast,ENO2,Gamma-enolase,13577,89,0.74 [0.55-0.99],0.040358618022609
Chapter II Neoplasms,Carcinoma in situ of breast,ENO3,Beta-enolase,11330,75,0.79 [0.51-1.22],0.2930342327744198
Chapter II Neoplasms,Carcinoma in situ of breast,ENOPH1,Enolase-phosphatase E1,11571,75,0.77 [0.50-1.21],0.2583521315021964
Chapter II Neoplasms,Carcinoma in situ of breast,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,11293,74,0.42 [0.18-1.02],0.0559807365768728
Chapter II Neoplasms,Carcinoma in situ of breast,ENPEP,Glutamyl aminopeptidase,11293,74,0.76 [0.41-1.42],0.3906844965690308
Chapter II Neoplasms,Carcinoma in situ of breast,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,13609,89,0.48 [0.25-0.96],0.036913835564011
Chapter II Neoplasms,Carcinoma in situ of breast,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,13507,91,0.89 [0.59-1.33],0.5625437932941401
Chapter II Neoplasms,Carcinoma in situ of breast,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,11330,75,1.53 [0.83-2.81],0.1704148309102262
Chapter II Neoplasms,Carcinoma in situ of breast,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,13059,88,0.99 [0.80-1.23],0.9494377853859464
Chapter II Neoplasms,Carcinoma in situ of breast,ENSA,Alpha-endosulfine,11571,75,0.73 [0.46-1.15],0.1697717855002016
Chapter II Neoplasms,Carcinoma in situ of breast,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,13139,87,0.75 [0.48-1.17],0.2041690708083538
Chapter II Neoplasms,Carcinoma in situ of breast,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,13220,88,0.70 [0.29-1.69],0.4225645515300149
Chapter II Neoplasms,Carcinoma in situ of breast,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,13220,88,0.77 [0.40-1.49],0.4345888288305867
Chapter II Neoplasms,Carcinoma in situ of breast,ENTR1,Endosome-associated-trafficking regulator 1,11330,75,0.96 [0.65-1.42],0.8437276248060592
Chapter II Neoplasms,Carcinoma in situ of breast,EP300,Histone acetyltransferase p300,11319,73,1.26 [0.62-2.55],0.5289589627152278
Chapter II Neoplasms,Carcinoma in situ of breast,EPB41L5,Band 4.1-like protein 5,11312,75,1.06 [0.78-1.45],0.70671233056016
Chapter II Neoplasms,Carcinoma in situ of breast,EPCAM,Epithelial cell adhesion molecule,13448,90,0.78 [0.65-0.95],0.0125503709839261
Chapter II Neoplasms,Carcinoma in situ of breast,EPGN,Epigen,11571,75,0.87 [0.52-1.44],0.5802577737343617
Chapter II Neoplasms,Carcinoma in situ of breast,EPHA1,Ephrin type-A receptor 1,13479,91,1.01 [0.59-1.73],0.9834765043293632
Chapter II Neoplasms,Carcinoma in situ of breast,EPHA10,Ephrin type-A receptor 10,13108,85,1.07 [0.81-1.42],0.6184105021917011
Chapter II Neoplasms,Carcinoma in situ of breast,EPHA2,Ephrin type-A receptor 2,12968,86,0.63 [0.31-1.28],0.2005359331078969
Chapter II Neoplasms,Carcinoma in situ of breast,EPHA4,Ephrin type-A receptor 4,11384,76,0.69 [0.32-1.52],0.3601993008695682
Chapter II Neoplasms,Carcinoma in situ of breast,EPHB4,Ephrin type-B receptor 4,13609,89,1.07 [0.48-2.40],0.8620085048029865
Chapter II Neoplasms,Carcinoma in situ of breast,EPHB6,Ephrin type-B receptor 6,13334,90,0.78 [0.42-1.47],0.4489873327684135
Chapter II Neoplasms,Carcinoma in situ of breast,EPHX2,Bifunctional epoxide hydrolase 2,13220,88,0.91 [0.66-1.26],0.5881696858646202
Chapter II Neoplasms,Carcinoma in situ of breast,EPN1,Epsin-1,11399,77,0.95 [0.56-1.61],0.858795590072273
Chapter II Neoplasms,Carcinoma in situ of breast,EPO,Erythropoietin,13434,87,0.88 [0.68-1.13],0.3195547765249611
Chapter II Neoplasms,Carcinoma in situ of breast,EPPK1,Epiplakin,11330,75,0.92 [0.68-1.24],0.5745009411553332
Chapter II Neoplasms,Carcinoma in situ of breast,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,13552,87,0.90 [0.47-1.72],0.7545181744025903
Chapter II Neoplasms,Carcinoma in situ of breast,ERBB2,Receptor tyrosine-protein kinase erbB-2,13480,90,1.07 [0.50-2.31],0.8594599318925135
Chapter II Neoplasms,Carcinoma in situ of breast,ERBB3,Receptor tyrosine-protein kinase erbB-3,13392,88,0.92 [0.34-2.49],0.8726431193097637
Chapter II Neoplasms,Carcinoma in situ of breast,ERBB4,Receptor tyrosine-protein kinase erbB-4,13480,90,1.41 [0.64-3.09],0.3912350363869616
Chapter II Neoplasms,Carcinoma in situ of breast,ERBIN,Erbin,13380,89,0.78 [0.65-0.93],0.006163229269443
Chapter II Neoplasms,Carcinoma in situ of breast,ERC2,ERC protein 2,11312,75,0.62 [0.41-0.93],0.0210466675690604
Chapter II Neoplasms,Carcinoma in situ of breast,ERCC1,DNA excision repair protein ERCC-1,11230,75,0.49 [0.23-1.06],0.0703600066743647
Chapter II Neoplasms,Carcinoma in situ of breast,EREG,Proepiregulin,13334,90,0.83 [0.65-1.07],0.1530374949836392
Chapter II Neoplasms,Carcinoma in situ of breast,ERI1,3'-5' exoribonuclease 1,11399,77,0.89 [0.46-1.73],0.7323341884637522
Chapter II Neoplasms,Carcinoma in situ of breast,ERMAP,Erythroid membrane-associated protein,11319,73,0.51 [0.31-0.84],0.0078832239522373
Chapter II Neoplasms,Carcinoma in situ of breast,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,11571,75,0.77 [0.43-1.40],0.3900325313372024
Chapter II Neoplasms,Carcinoma in situ of breast,ERP29,Endoplasmic reticulum resident protein 29,11384,76,0.83 [0.69-1.00],0.044739336688835
Chapter II Neoplasms,Carcinoma in situ of breast,ERP44,Endoplasmic reticulum resident protein 44,13361,88,0.68 [0.32-1.42],0.2990505509899763
Chapter II Neoplasms,Carcinoma in situ of breast,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,11293,74,0.61 [0.35-1.09],0.0972739310819218
Chapter II Neoplasms,Carcinoma in situ of breast,ESAM,Endothelial cell-selective adhesion molecule,13609,89,0.56 [0.30-1.05],0.0700069536505741
Chapter II Neoplasms,Carcinoma in situ of breast,ESM1,Endothelial cell-specific molecule 1,13445,90,0.71 [0.40-1.23],0.2225682489555732
Chapter II Neoplasms,Carcinoma in situ of breast,ESPL1,Separin,11230,75,0.89 [0.58-1.37],0.6049007377040001
Chapter II Neoplasms,Carcinoma in situ of breast,ESR1,Estrogen receptor,11319,73,0.92 [0.61-1.36],0.6652297016687877
Chapter II Neoplasms,Carcinoma in situ of breast,ESYT2,Extended synaptotagmin-2,11617,76,0.77 [0.58-1.02],0.0728535216859397
Chapter II Neoplasms,Carcinoma in situ of breast,EVI2B,Protein EVI2B,11230,75,1.06 [0.65-1.75],0.8054521400137051
Chapter II Neoplasms,Carcinoma in situ of breast,EVI5,Ecotropic viral integration site 5 protein homolog,11319,73,0.76 [0.59-0.99],0.0381536174650176
Chapter II Neoplasms,Carcinoma in situ of breast,EVPL,Envoplakin,11399,77,0.75 [0.36-1.56],0.44207208383963
Chapter II Neoplasms,Carcinoma in situ of breast,EXOSC10,Exosome component 10,11293,74,0.71 [0.44-1.15],0.1650340620326537
Chapter II Neoplasms,Carcinoma in situ of breast,EXTL1,Exostosin-like 1,11293,74,0.71 [0.41-1.24],0.2271335432909827
Chapter II Neoplasms,Carcinoma in situ of breast,EZR,Ezrin,13577,89,0.55 [0.25-1.25],0.1537664962812633
Chapter II Neoplasms,Carcinoma in situ of breast,F10,Coagulation factor X,11650,75,0.91 [0.39-2.14],0.8234620287501044
Chapter II Neoplasms,Carcinoma in situ of breast,F11,Coagulation factor XI,11493,76,1.35 [0.87-2.10],0.1797910213214803
Chapter II Neoplasms,Carcinoma in situ of breast,F11R,Junctional adhesion molecule A,13449,89,0.77 [0.55-1.08],0.1237504434072981
Chapter II Neoplasms,Carcinoma in situ of breast,F12,Coagulation factor XII,11662,77,1.07 [0.64-1.80],0.7882446681935107
Chapter II Neoplasms,Carcinoma in situ of breast,F13B,Coagulation factor XIII B chain,11596,77,3.01 [1.37-6.63],0.0062921973303776
Chapter II Neoplasms,Carcinoma in situ of breast,F2,Prothrombin,11662,77,1.69 [0.39-7.36],0.4860312274252761
Chapter II Neoplasms,Carcinoma in situ of breast,F2R,Proteinase-activated receptor 1,13486,91,0.80 [0.58-1.11],0.1789530630571087
Chapter II Neoplasms,Carcinoma in situ of breast,F3,Tissue factor,13485,86,0.77 [0.38-1.54],0.4596778591106502
Chapter II Neoplasms,Carcinoma in situ of breast,F7,Coagulation factor VII,13439,89,0.95 [0.51-1.78],0.8759076731309793
Chapter II Neoplasms,Carcinoma in situ of breast,F9,Coagulation factor IX,13441,89,1.61 [0.58-4.50],0.3593247582835642
Chapter II Neoplasms,Carcinoma in situ of breast,FABP1,"Fatty acid-binding protein, liver",13445,90,0.88 [0.72-1.09],0.2347716455845259
Chapter II Neoplasms,Carcinoma in situ of breast,FABP2,"Fatty acid-binding protein, intestinal",13452,90,0.85 [0.66-1.10],0.2202110934270114
Chapter II Neoplasms,Carcinoma in situ of breast,FABP3,"Fatty acid-binding protein, heart",11652,74,0.65 [0.41-1.06],0.0824976568089145
Chapter II Neoplasms,Carcinoma in situ of breast,FABP4,"Fatty acid-binding protein, adipocyte",13609,89,0.70 [0.46-1.04],0.0782565820181315
Chapter II Neoplasms,Carcinoma in situ of breast,FABP5,Fatty acid-binding protein 5,13541,89,0.75 [0.57-0.99],0.0410402957161484
Chapter II Neoplasms,Carcinoma in situ of breast,FABP6,Gastrotropin,13203,88,1.04 [0.73-1.47],0.8276684038237757
Chapter II Neoplasms,Carcinoma in situ of breast,FABP9,Fatty acid-binding protein 9,13434,87,0.89 [0.63-1.25],0.5053199547072496
Chapter II Neoplasms,Carcinoma in situ of breast,FADD,FAS-associated death domain protein,13452,90,0.79 [0.62-1.01],0.0591932473407185
Chapter II Neoplasms,Carcinoma in situ of breast,FAM13A,Protein FAM13A,11587,77,0.63 [0.44-0.89],0.0089244812113158
Chapter II Neoplasms,Carcinoma in situ of breast,FAM171A2,Protein FAM171A2,11634,76,1.00 [0.87-1.14],0.9701272466736608
Chapter II Neoplasms,Carcinoma in situ of breast,FAM171B,Protein FAM171B,11571,75,1.53 [0.83-2.82],0.1769992423640191
Chapter II Neoplasms,Carcinoma in situ of breast,FAM172A,Cotranscriptional regulator FAM172A,11330,75,0.90 [0.63-1.29],0.5624971786862287
Chapter II Neoplasms,Carcinoma in situ of breast,FAM20A,Pseudokinase FAM20A,11652,74,1.31 [0.61-2.80],0.4884146664594827
Chapter II Neoplasms,Carcinoma in situ of breast,FAM3B,Protein FAM3B,13380,89,0.65 [0.40-1.05],0.0808969089616361
Chapter II Neoplasms,Carcinoma in situ of breast,FAM3C,Protein FAM3C,13434,90,0.52 [0.27-0.99],0.0478071840759834
Chapter II Neoplasms,Carcinoma in situ of breast,FAM3D,Protein FAM3D,11587,77,1.11 [0.85-1.43],0.4486866356564279
Chapter II Neoplasms,Carcinoma in situ of breast,FAP,Prolyl endopeptidase FAP,13609,89,1.12 [0.56-2.24],0.7498087422008839
Chapter II Neoplasms,Carcinoma in situ of breast,FARSA,Phenylalanine--tRNA ligase alpha subunit,11312,75,0.72 [0.49-1.05],0.0861126417375324
Chapter II Neoplasms,Carcinoma in situ of breast,FAS,Tumor necrosis factor receptor superfamily member 6,13559,87,1.08 [0.62-1.89],0.7841572809641206
Chapter II Neoplasms,Carcinoma in situ of breast,FASLG,Tumor necrosis factor ligand superfamily member 6,13604,89,0.55 [0.34-0.89],0.0151910206774144
Chapter II Neoplasms,Carcinoma in situ of breast,FBLN2,Fibulin-2,11632,77,1.02 [0.50-2.09],0.9595813031629988
Chapter II Neoplasms,Carcinoma in situ of breast,FBN2,Fibrillin-2,11312,75,0.90 [0.62-1.31],0.5845340700035025
Chapter II Neoplasms,Carcinoma in situ of breast,FBP1,"Fructose-1,6-bisphosphatase 1",13452,90,0.87 [0.67-1.12],0.2781002180197509
Chapter II Neoplasms,Carcinoma in situ of breast,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,11652,74,0.81 [0.59-1.11],0.1900670523879267
Chapter II Neoplasms,Carcinoma in situ of breast,FCAR,Immunoglobulin alpha Fc receptor,13434,87,1.18 [0.79-1.77],0.4140373924906128
Chapter II Neoplasms,Carcinoma in situ of breast,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,11634,76,0.80 [0.32-1.97],0.6280547253048936
Chapter II Neoplasms,Carcinoma in situ of breast,FCER2,Low affinity immunoglobulin epsilon Fc receptor,13449,89,0.86 [0.57-1.29],0.4631900953238818
Chapter II Neoplasms,Carcinoma in situ of breast,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,13354,87,0.88 [0.67-1.16],0.377819135517673
Chapter II Neoplasms,Carcinoma in situ of breast,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,13139,87,0.83 [0.59-1.17],0.2951920591294146
Chapter II Neoplasms,Carcinoma in situ of breast,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,13415,89,1.60 [1.08-2.39],0.0199616585034752
Chapter II Neoplasms,Carcinoma in situ of breast,FCN1,Ficolin-1,11629,75,0.88 [0.61-1.26],0.486332455313433
Chapter II Neoplasms,Carcinoma in situ of breast,FCN2,Ficolin-2,13353,88,1.38 [0.85-2.24],0.1919407616844282
Chapter II Neoplasms,Carcinoma in situ of breast,FCRL1,Fc receptor-like protein 1,13452,90,0.82 [0.53-1.25],0.3551065965961552
Chapter II Neoplasms,Carcinoma in situ of breast,FCRL2,Fc receptor-like protein 2,13541,89,0.80 [0.53-1.23],0.3108909364239499
Chapter II Neoplasms,Carcinoma in situ of breast,FCRL3,Fc receptor-like protein 3,13187,89,0.86 [0.60-1.23],0.4041146341361779
Chapter II Neoplasms,Carcinoma in situ of breast,FCRL5,Fc receptor-like protein 5,13449,89,0.93 [0.66-1.31],0.6860446503529651
Chapter II Neoplasms,Carcinoma in situ of breast,FCRL6,Fc receptor-like protein 6,13434,87,0.98 [0.73-1.30],0.876289933838849
Chapter II Neoplasms,Carcinoma in situ of breast,FCRLB,Fc receptor-like B,13139,87,0.83 [0.58-1.18],0.3010729444745652
Chapter II Neoplasms,Carcinoma in situ of breast,FDX1,"Adrenodoxin, mitochondrial",11293,74,0.85 [0.57-1.26],0.4130721421951154
Chapter II Neoplasms,Carcinoma in situ of breast,FDX2,"Ferredoxin-2, mitochondrial",11293,74,0.50 [0.31-0.81],0.0046403986992443
Chapter II Neoplasms,Carcinoma in situ of breast,FEN1,Flap endonuclease 1,13139,87,1.05 [0.80-1.39],0.7208782184683484
Chapter II Neoplasms,Carcinoma in situ of breast,FES,Tyrosine-protein kinase Fes/Fps,13139,87,0.63 [0.40-0.98],0.0412582425580126
Chapter II Neoplasms,Carcinoma in situ of breast,FETUB,Fetuin-B,13441,89,0.62 [0.42-0.92],0.0177022342494197
Chapter II Neoplasms,Carcinoma in situ of breast,FGA,Fibrinogen alpha chain,11381,75,1.82 [0.92-3.61],0.0864889900891647
Chapter II Neoplasms,Carcinoma in situ of breast,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",11634,76,0.78 [0.59-1.03],0.0800035905279297
Chapter II Neoplasms,Carcinoma in situ of breast,FGF12,Fibroblast growth factor 12,11319,73,0.97 [0.59-1.59],0.8961636802031794
Chapter II Neoplasms,Carcinoma in situ of breast,FGF16,Fibroblast growth factor 16,11319,73,1.12 [0.73-1.72],0.5934537762270209
Chapter II Neoplasms,Carcinoma in situ of breast,FGF19,Fibroblast growth factor 19,13507,91,0.99 [0.78-1.27],0.9493329101227632
Chapter II Neoplasms,Carcinoma in situ of breast,FGF2,Fibroblast growth factor 2,13434,87,0.73 [0.54-0.99],0.0425558470252306
Chapter II Neoplasms,Carcinoma in situ of breast,FGF20,Fibroblast growth factor 20,11319,73,0.83 [0.47-1.47],0.5252408862970324
Chapter II Neoplasms,Carcinoma in situ of breast,FGF21,Fibroblast growth factor 21,13550,87,0.96 [0.81-1.12],0.5776476242792907
Chapter II Neoplasms,Carcinoma in situ of breast,FGF23,Fibroblast growth factor 23,13552,87,0.68 [0.47-1.00],0.0495410072318901
Chapter II Neoplasms,Carcinoma in situ of breast,FGF3,Fibroblast growth factor 3,11319,73,1.52 [0.93-2.47],0.094869306625668
Chapter II Neoplasms,Carcinoma in situ of breast,FGF5,Fibroblast growth factor 5,13187,89,0.79 [0.44-1.43],0.4399743884930657
Chapter II Neoplasms,Carcinoma in situ of breast,FGF6,Fibroblast growth factor 6,11319,73,1.19 [0.79-1.78],0.4067140681494534
Chapter II Neoplasms,Carcinoma in situ of breast,FGF7,Fibroblast growth factor 7,11230,75,0.62 [0.41-0.93],0.0195764903727862
Chapter II Neoplasms,Carcinoma in situ of breast,FGF9,Fibroblast growth factor 9,11207,75,0.94 [0.54-1.63],0.8284181363410758
Chapter II Neoplasms,Carcinoma in situ of breast,FGFBP1,Fibroblast growth factor-binding protein 1,13480,90,0.96 [0.53-1.74],0.8926061806181246
Chapter II Neoplasms,Carcinoma in situ of breast,FGFBP2,Fibroblast growth factor-binding protein 2,11632,77,1.01 [0.66-1.55],0.9559146167027178
Chapter II Neoplasms,Carcinoma in situ of breast,FGFBP3,Fibroblast growth factor-binding protein 3,11617,76,0.68 [0.38-1.24],0.213520880509172
Chapter II Neoplasms,Carcinoma in situ of breast,FGFR2,Fibroblast growth factor receptor 2,13480,90,1.84 [0.77-4.38],0.1710195722417647
Chapter II Neoplasms,Carcinoma in situ of breast,FGFR4,Fibroblast growth factor receptor 4,11384,76,1.43 [0.96-2.14],0.0757167459465362
Chapter II Neoplasms,Carcinoma in situ of breast,FGL1,Fibrinogen-like protein 1,11650,75,0.84 [0.59-1.19],0.3164309545435044
Chapter II Neoplasms,Carcinoma in situ of breast,FGR,Tyrosine-protein kinase Fgr,13108,85,1.24 [0.95-1.62],0.1209051977934338
Chapter II Neoplasms,Carcinoma in situ of breast,FH,"Fumarate hydratase, mitochondrial",11311,73,1.02 [0.79-1.31],0.9044567558992116
Chapter II Neoplasms,Carcinoma in situ of breast,FHIP2A,FHF complex subunit HOOK interacting protein 2A,11293,74,1.33 [0.95-1.85],0.0985013641153683
Chapter II Neoplasms,Carcinoma in situ of breast,FHIT,Bis(5'-adenosyl)-triphosphatase,13108,85,0.80 [0.62-1.03],0.0864664996776598
Chapter II Neoplasms,Carcinoma in situ of breast,FIS1,Mitochondrial fission 1 protein,13429,89,0.83 [0.65-1.07],0.1464412304035975
Chapter II Neoplasms,Carcinoma in situ of breast,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,11634,76,0.81 [0.65-1.01],0.0587060871484415
Chapter II Neoplasms,Carcinoma in situ of breast,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,13493,88,0.83 [0.69-0.99],0.0348404722017214
Chapter II Neoplasms,Carcinoma in situ of breast,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,13363,90,0.60 [0.39-0.90],0.0132611533459122
Chapter II Neoplasms,Carcinoma in situ of breast,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,13363,90,0.81 [0.67-0.98],0.0341747421638041
Chapter II Neoplasms,Carcinoma in situ of breast,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,13079,85,0.91 [0.59-1.40],0.6624152529697047
Chapter II Neoplasms,Carcinoma in situ of breast,FKBPL,FK506-binding protein-like,11587,77,0.84 [0.58-1.22],0.3543201254202319
Chapter II Neoplasms,Carcinoma in situ of breast,FLI1,Friend leukemia integration 1 transcription factor,13139,87,0.83 [0.69-1.00],0.0537186708570119
Chapter II Neoplasms,Carcinoma in situ of breast,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,13363,90,0.70 [0.36-1.37],0.3042292023604487
Chapter II Neoplasms,Carcinoma in situ of breast,FLT1,Vascular endothelial growth factor receptor 1,13352,89,0.50 [0.20-1.30],0.1555723691226193
Chapter II Neoplasms,Carcinoma in situ of breast,FLT3,Receptor-type tyrosine-protein kinase FLT3,13139,87,0.74 [0.37-1.44],0.3724573291609898
Chapter II Neoplasms,Carcinoma in situ of breast,FLT3LG,Fms-related tyrosine kinase 3 ligand,13604,89,0.79 [0.44-1.42],0.4337272586569713
Chapter II Neoplasms,Carcinoma in situ of breast,FLT4,Vascular endothelial growth factor receptor 3,13480,90,1.56 [0.88-2.76],0.1256966890809594
Chapter II Neoplasms,Carcinoma in situ of breast,FMNL1,Formin-like protein 1,13108,85,1.19 [0.93-1.53],0.1752412659073079
Chapter II Neoplasms,Carcinoma in situ of breast,FMR1,Synaptic functional regulator FMR1,13139,87,0.67 [0.38-1.15],0.1470691009790146
Chapter II Neoplasms,Carcinoma in situ of breast,FN1,Fibronectin,11662,77,2.02 [0.92-4.44],0.0817100512739491
Chapter II Neoplasms,Carcinoma in situ of breast,FNDC1,Fibronectin type III domain-containing protein 1,11617,76,0.86 [0.54-1.38],0.5277489995503919
Chapter II Neoplasms,Carcinoma in situ of breast,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,11571,75,0.61 [0.31-1.22],0.1657165657467442
Chapter II Neoplasms,Carcinoma in situ of breast,FOLH1,Glutamate carboxypeptidase 2,11319,73,1.07 [0.90-1.27],0.4626737925497153
Chapter II Neoplasms,Carcinoma in situ of breast,FOLR1,Folate receptor alpha,13410,90,1.14 [0.57-2.28],0.7068833358964283
Chapter II Neoplasms,Carcinoma in situ of breast,FOLR2,Folate receptor beta,13577,89,0.63 [0.33-1.21],0.1686061983881216
Chapter II Neoplasms,Carcinoma in situ of breast,FOLR3,Folate receptor gamma,13436,90,0.95 [0.85-1.06],0.3644286389152212
Chapter II Neoplasms,Carcinoma in situ of breast,FOS,Proto-oncogene c-Fos,11207,75,0.93 [0.50-1.76],0.8340606771614606
Chapter II Neoplasms,Carcinoma in situ of breast,FOSB,Protein fosB,13108,85,1.15 [0.75-1.75],0.5207897673511828
Chapter II Neoplasms,Carcinoma in situ of breast,FOXJ3,Forkhead box protein J3,11319,73,0.69 [0.39-1.21],0.192871126750573
Chapter II Neoplasms,Carcinoma in situ of breast,FOXO1,Forkhead box protein O1,13434,87,0.84 [0.67-1.05],0.1299876107954705
Chapter II Neoplasms,Carcinoma in situ of breast,FOXO3,Forkhead box protein O3,13139,87,0.78 [0.63-0.96],0.0192193110556845
Chapter II Neoplasms,Carcinoma in situ of breast,FRMD4B,FERM domain-containing protein 4B,11293,74,0.60 [0.42-0.86],0.005321237980949
Chapter II Neoplasms,Carcinoma in situ of breast,FRMD7,FERM domain-containing protein 7,11312,75,0.75 [0.38-1.47],0.4022099637147528
Chapter II Neoplasms,Carcinoma in situ of breast,FRZB,Secreted frizzled-related protein 3,13319,90,1.52 [0.75-3.07],0.2487018118601662
Chapter II Neoplasms,Carcinoma in situ of breast,FSHB,Follitropin subunit beta,11330,75,1.16 [0.85-1.59],0.3579125317465697
Chapter II Neoplasms,Carcinoma in situ of breast,FST,Follistatin,13486,91,1.00 [0.70-1.41],0.9789173444427234
Chapter II Neoplasms,Carcinoma in situ of breast,FSTL1,Follistatin-related protein 1,11330,75,0.65 [0.24-1.74],0.3919817246243615
Chapter II Neoplasms,Carcinoma in situ of breast,FSTL3,Follistatin-related protein 3,13424,90,0.73 [0.38-1.40],0.3448381314121423
Chapter II Neoplasms,Carcinoma in situ of breast,FTCD,Formimidoyltransferase-cyclodeaminase,11603,76,0.91 [0.69-1.20],0.5103644264157592
Chapter II Neoplasms,Carcinoma in situ of breast,FUCA1,Tissue alpha-L-fucosidase,13523,89,1.02 [0.81-1.29],0.8665803834707042
Chapter II Neoplasms,Carcinoma in situ of breast,FUOM,Fucose mutarotase,11384,76,0.95 [0.66-1.35],0.757707829111273
Chapter II Neoplasms,Carcinoma in situ of breast,FURIN,Furin,13480,90,0.75 [0.43-1.31],0.3141078612710479
Chapter II Neoplasms,Carcinoma in situ of breast,FUS,RNA-binding protein FUS,13120,87,0.66 [0.39-1.11],0.1155917298689837
Chapter II Neoplasms,Carcinoma in situ of breast,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",11377,77,0.94 [0.67-1.33],0.7442150310463881
Chapter II Neoplasms,Carcinoma in situ of breast,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,13577,89,1.09 [0.72-1.67],0.6806756179599134
Chapter II Neoplasms,Carcinoma in situ of breast,FUT8,"Alpha-(1,6)-fucosyltransferase",13363,90,1.01 [0.74-1.39],0.9336056682259098
Chapter II Neoplasms,Carcinoma in situ of breast,FXN,"Frataxin, mitochondrial",13571,87,0.78 [0.60-1.02],0.0676059330227733
Chapter II Neoplasms,Carcinoma in situ of breast,FXYD5,FXYD domain-containing ion transport regulator 5,13187,89,0.92 [0.68-1.23],0.5747865595727417
Chapter II Neoplasms,Carcinoma in situ of breast,FYB1,FYN-binding protein 1,13428,89,0.80 [0.66-0.99],0.0362766750512907
Chapter II Neoplasms,Carcinoma in situ of breast,FZD10,Frizzled-10,11312,75,0.68 [0.41-1.11],0.1207263238319428
Chapter II Neoplasms,Carcinoma in situ of breast,FZD8,Frizzled-8,11311,73,1.14 [0.72-1.82],0.5716311787706226
Chapter II Neoplasms,Carcinoma in situ of breast,GABARAP,Gamma-aminobutyric acid receptor-associated protein,11571,75,0.72 [0.44-1.19],0.1999679210913347
Chapter II Neoplasms,Carcinoma in situ of breast,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,11399,77,1.32 [1.04-1.67],0.0218355774045839
Chapter II Neoplasms,Carcinoma in situ of breast,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,11311,73,0.75 [0.49-1.15],0.1867968088286811
Chapter II Neoplasms,Carcinoma in situ of breast,GAD1,Glutamate decarboxylase 1,11230,75,0.38 [0.16-0.90],0.0269177536820099
Chapter II Neoplasms,Carcinoma in situ of breast,GAD2,Glutamate decarboxylase 2,11319,73,0.84 [0.49-1.43],0.5137108865870932
Chapter II Neoplasms,Carcinoma in situ of breast,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,11399,77,1.17 [0.82-1.65],0.3912809329817776
Chapter II Neoplasms,Carcinoma in situ of breast,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,11330,75,0.80 [0.51-1.23],0.3083706809024962
Chapter II Neoplasms,Carcinoma in situ of breast,GAGE2A,G antigen 2A,11230,75,0.95 [0.65-1.38],0.7828671637336319
Chapter II Neoplasms,Carcinoma in situ of breast,GAL,Galanin peptides,13507,91,1.24 [0.92-1.65],0.1529833274514606
Chapter II Neoplasms,Carcinoma in situ of breast,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,13380,89,0.78 [0.40-1.53],0.47479060750529
Chapter II Neoplasms,Carcinoma in situ of breast,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,13571,87,0.63 [0.30-1.34],0.2305787562833012
Chapter II Neoplasms,Carcinoma in situ of breast,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,13187,89,0.71 [0.45-1.12],0.1406002308545855
Chapter II Neoplasms,Carcinoma in situ of breast,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,11652,74,0.95 [0.41-2.21],0.908914019554648
Chapter II Neoplasms,Carcinoma in situ of breast,GALNT7,N-acetylgalactosaminyltransferase 7,13380,89,0.54 [0.22-1.29],0.1659023249553681
Chapter II Neoplasms,Carcinoma in situ of breast,GAMT,Guanidinoacetate N-methyltransferase,11293,74,0.73 [0.36-1.48],0.3798216508426573
Chapter II Neoplasms,Carcinoma in situ of breast,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,11132,75,1.10 [0.56-2.17],0.7721331324096024
Chapter II Neoplasms,Carcinoma in situ of breast,GART,Trifunctional purine biosynthetic protein adenosine-3,11634,76,0.57 [0.22-1.47],0.2468956931855062
Chapter II Neoplasms,Carcinoma in situ of breast,GAS2,Growth arrest-specific protein 2,11399,77,0.95 [0.62-1.45],0.7959138462301465
Chapter II Neoplasms,Carcinoma in situ of breast,GAS6,Growth arrest-specific protein 6,13510,87,0.66 [0.31-1.37],0.2622170815695996
Chapter II Neoplasms,Carcinoma in situ of breast,GASK1A,Golgi-associated kinase 1A,11293,74,0.78 [0.46-1.32],0.3572900187461606
Chapter II Neoplasms,Carcinoma in situ of breast,GAST,Gastrin,11617,76,1.04 [0.87-1.24],0.6703474029862242
Chapter II Neoplasms,Carcinoma in situ of breast,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,11230,75,0.63 [0.27-1.45],0.2743874376529724
Chapter II Neoplasms,Carcinoma in situ of breast,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",11330,75,0.94 [0.70-1.25],0.6482897440950295
Chapter II Neoplasms,Carcinoma in situ of breast,GBA,Lysosomal acid glucosylceramidase,11312,75,1.25 [0.87-1.81],0.223067733501877
Chapter II Neoplasms,Carcinoma in situ of breast,GBP1,Guanylate-binding protein 1,11594,76,0.98 [0.70-1.37],0.8895485891239513
Chapter II Neoplasms,Carcinoma in situ of breast,GBP2,Guanylate-binding protein 2,13187,89,0.75 [0.55-1.03],0.0744739826633338
Chapter II Neoplasms,Carcinoma in situ of breast,GBP4,Guanylate-binding protein 4,13108,85,0.89 [0.59-1.33],0.5673029567900396
Chapter II Neoplasms,Carcinoma in situ of breast,GBP6,Guanylate-binding protein 6,11293,74,0.87 [0.51-1.49],0.6121625686119816
Chapter II Neoplasms,Carcinoma in situ of breast,GC,Vitamin D-binding protein,11662,77,0.94 [0.41-2.15],0.8894983422661544
Chapter II Neoplasms,Carcinoma in situ of breast,GCC1,GRIP and coiled-coil domain-containing protein 1,11617,76,0.82 [0.67-1.01],0.0573376589735346
Chapter II Neoplasms,Carcinoma in situ of breast,GCG,Pro-glucagon,13139,87,0.93 [0.79-1.08],0.3403384521521669
Chapter II Neoplasms,Carcinoma in situ of breast,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,11095,76,1.04 [0.68-1.60],0.8523011881908483
Chapter II Neoplasms,Carcinoma in situ of breast,GCLM,Glutamate--cysteine ligase regulatory subunit,11293,74,0.68 [0.38-1.20],0.1853529742476701
Chapter II Neoplasms,Carcinoma in situ of breast,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",13380,89,1.12 [0.65-1.93],0.6754380604199874
Chapter II Neoplasms,Carcinoma in situ of breast,GDF15,Growth/differentiation factor 15,13609,89,1.18 [0.77-1.82],0.4436076909260827
Chapter II Neoplasms,Carcinoma in situ of breast,GDF2,Growth/differentiation factor 2,13452,90,1.05 [0.62-1.77],0.8634673963596753
Chapter II Neoplasms,Carcinoma in situ of breast,GDNF,Glial cell line-derived neurotrophic factor,13108,85,0.83 [0.49-1.40],0.4901458770829678
Chapter II Neoplasms,Carcinoma in situ of breast,GET3,ATPase GET3,11652,74,0.68 [0.43-1.08],0.1029941772006029
Chapter II Neoplasms,Carcinoma in situ of breast,GFAP,Glial fibrillary acidic protein,13123,87,0.79 [0.51-1.24],0.3081878241208486
Chapter II Neoplasms,Carcinoma in situ of breast,GFER,FAD-linked sulfhydryl oxidase ALR,13139,87,0.70 [0.51-0.96],0.0258051043086549
Chapter II Neoplasms,Carcinoma in situ of breast,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,13139,87,1.08 [0.95-1.22],0.2569667696983823
Chapter II Neoplasms,Carcinoma in situ of breast,GFRA1,GDNF family receptor alpha-1,13550,87,0.94 [0.46-1.92],0.8742842630148859
Chapter II Neoplasms,Carcinoma in situ of breast,GFRA2,GDNF family receptor alpha-2,13380,89,0.53 [0.23-1.23],0.1379055957713464
Chapter II Neoplasms,Carcinoma in situ of breast,GFRA3,GDNF family receptor alpha-3,13321,89,1.10 [0.57-2.15],0.7716793802241008
Chapter II Neoplasms,Carcinoma in situ of breast,GFRAL,GDNF family receptor alpha-like,11270,75,1.05 [0.73-1.51],0.7788714181657896
Chapter II Neoplasms,Carcinoma in situ of breast,GGA1,ADP-ribosylation factor-binding protein GGA1,13108,85,1.06 [0.83-1.36],0.641464785686751
Chapter II Neoplasms,Carcinoma in situ of breast,GGACT,Gamma-glutamylaminecyclotransferase,11652,74,0.70 [0.51-0.96],0.0281208641906832
Chapter II Neoplasms,Carcinoma in situ of breast,GGCT,Gamma-glutamylcyclotransferase,11631,74,0.71 [0.44-1.14],0.1511073105614087
Chapter II Neoplasms,Carcinoma in situ of breast,GGH,Gamma-glutamyl hydrolase,13168,84,1.12 [0.64-1.95],0.700069290617825
Chapter II Neoplasms,Carcinoma in situ of breast,GGT1,Glutathione hydrolase 1 proenzyme,13426,89,0.95 [0.63-1.42],0.7885209867808037
Chapter II Neoplasms,Carcinoma in situ of breast,GGT5,Glutathione hydrolase 5 proenzyme,13363,90,1.20 [0.53-2.70],0.6563930432594882
Chapter II Neoplasms,Carcinoma in situ of breast,GH1,Somatotropin,13434,90,1.03 [0.93-1.14],0.6135678778796653
Chapter II Neoplasms,Carcinoma in situ of breast,GH2,Growth hormone variant,13139,87,0.93 [0.82-1.05],0.2356429671103151
Chapter II Neoplasms,Carcinoma in situ of breast,GHR,Growth hormone receptor,11384,76,1.16 [0.54-2.46],0.7073544792605895
Chapter II Neoplasms,Carcinoma in situ of breast,GHRHR,Growth hormone-releasing hormone receptor,13108,85,0.96 [0.69-1.35],0.834221149226884
Chapter II Neoplasms,Carcinoma in situ of breast,GHRL,Appetite-regulating hormone,13452,90,1.09 [0.85-1.40],0.4789156125902847
Chapter II Neoplasms,Carcinoma in situ of breast,GID8,Glucose-induced degradation protein 8 homolog,11634,76,1.30 [0.79-2.16],0.3056171849479133
Chapter II Neoplasms,Carcinoma in situ of breast,GIGYF2,GRB10-interacting GYF protein 2,11634,76,0.77 [0.58-1.03],0.0820219314137032
Chapter II Neoplasms,Carcinoma in situ of breast,GIMAP7,GTPase IMAP family member 7,11384,76,1.22 [0.66-2.28],0.5227315614235305
Chapter II Neoplasms,Carcinoma in situ of breast,GIMAP8,GTPase IMAP family member 8,11230,75,0.85 [0.54-1.36],0.5051566354476327
Chapter II Neoplasms,Carcinoma in situ of breast,GIP,Gastric inhibitory polypeptide,11330,75,1.31 [0.82-2.09],0.2653839546293774
Chapter II Neoplasms,Carcinoma in situ of breast,GIPC2,PDZ domain-containing protein GIPC2,11617,76,0.57 [0.26-1.26],0.1632727683943323
Chapter II Neoplasms,Carcinoma in situ of breast,GIPC3,PDZ domain-containing protein GIPC3,11587,77,0.81 [0.65-1.00],0.0499566297767572
Chapter II Neoplasms,Carcinoma in situ of breast,GIPR,Gastric inhibitory polypeptide receptor,11319,73,0.82 [0.47-1.42],0.4778303019131024
Chapter II Neoplasms,Carcinoma in situ of breast,GIT1,ARF GTPase-activating protein GIT1,11319,73,0.83 [0.66-1.06],0.1306787533332415
Chapter II Neoplasms,Carcinoma in situ of breast,GJA8,Gap junction alpha-8 protein,11230,75,1.11 [0.80-1.54],0.5464468277946383
Chapter II Neoplasms,Carcinoma in situ of breast,GKN1,Gastrokine-1,12851,82,1.74 [0.92-3.28],0.0891028019660777
Chapter II Neoplasms,Carcinoma in situ of breast,GLA,Alpha-galactosidase A,11355,76,0.73 [0.39-1.38],0.3341790276481797
Chapter II Neoplasms,Carcinoma in situ of breast,GLB1,Beta-galactosidase,13363,90,0.73 [0.46-1.17],0.1890417674029207
Chapter II Neoplasms,Carcinoma in situ of breast,GLI2,Zinc finger protein GLI2,11319,73,0.89 [0.45-1.76],0.7477924798944593
Chapter II Neoplasms,Carcinoma in situ of breast,GLO1,Lactoylglutathione lyase,13220,88,0.86 [0.62-1.19],0.360266056794762
Chapter II Neoplasms,Carcinoma in situ of breast,GLOD4,Glyoxalase domain-containing protein 4,13408,89,0.69 [0.41-1.14],0.144940915927746
Chapter II Neoplasms,Carcinoma in situ of breast,GLP1R,Glucagon-like peptide 1 receptor,11311,73,0.70 [0.35-1.38],0.3006213808440633
Chapter II Neoplasms,Carcinoma in situ of breast,GLRX,Glutaredoxin-1,13375,90,1.01 [0.73-1.39],0.9656533367046084
Chapter II Neoplasms,Carcinoma in situ of breast,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",11384,76,0.76 [0.59-0.99],0.0398392585018103
Chapter II Neoplasms,Carcinoma in situ of breast,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,13108,85,1.15 [0.83-1.60],0.4074741113004333
Chapter II Neoplasms,Carcinoma in situ of breast,GLYR1,Putative oxidoreductase GLYR1,11571,75,1.01 [0.71-1.43],0.9623707996681036
Chapter II Neoplasms,Carcinoma in situ of breast,GM2A,Ganglioside GM2 activator,11368,76,0.89 [0.47-1.68],0.7094197920866642
Chapter II Neoplasms,Carcinoma in situ of breast,GMFG,Glia maturation factor gamma,11652,74,0.76 [0.56-1.03],0.0772969313547295
Chapter II Neoplasms,Carcinoma in situ of breast,GMPR,GMP reductase 1,13604,89,0.73 [0.52-1.02],0.0632638332906973
Chapter II Neoplasms,Carcinoma in situ of breast,GMPR2,GMP reductase 2,11384,76,0.77 [0.55-1.07],0.1200773808106513
Chapter II Neoplasms,Carcinoma in situ of breast,GNAS,Neuroendocrine secretory protein 55,11634,76,0.88 [0.68-1.14],0.322379036788206
Chapter II Neoplasms,Carcinoma in situ of breast,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,13139,87,0.69 [0.50-0.94],0.0203556901446573
Chapter II Neoplasms,Carcinoma in situ of breast,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,11312,75,0.81 [0.49-1.33],0.412145392285745
Chapter II Neoplasms,Carcinoma in situ of breast,GNLY,Granulysin,13449,89,0.77 [0.54-1.09],0.143202271241647
Chapter II Neoplasms,Carcinoma in situ of breast,GNPDA1,Glucosamine-6-phosphate isomerase 1,11330,75,1.06 [0.55-2.02],0.8670082407480404
Chapter II Neoplasms,Carcinoma in situ of breast,GNPDA2,Glucosamine-6-phosphate isomerase 2,11384,76,0.67 [0.36-1.25],0.2073461014852404
Chapter II Neoplasms,Carcinoma in situ of breast,GOLGA3,Golgin subfamily A member 3,11634,76,0.77 [0.57-1.04],0.0918598591861586
Chapter II Neoplasms,Carcinoma in situ of breast,GOLM2,Protein GOLM2,13577,89,0.66 [0.28-1.55],0.3425872410369986
Chapter II Neoplasms,Carcinoma in situ of breast,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,13434,87,0.87 [0.72-1.04],0.1345001576196585
Chapter II Neoplasms,Carcinoma in situ of breast,GORASP2,Golgi reassembly-stacking protein 2,11587,77,0.73 [0.45-1.19],0.2061324432296593
Chapter II Neoplasms,Carcinoma in situ of breast,GOT1,"Aspartate aminotransferase, cytoplasmic",11632,77,0.71 [0.42-1.23],0.2228853988297937
Chapter II Neoplasms,Carcinoma in situ of breast,GP1BA,Platelet glycoprotein Ib alpha chain,13359,87,0.99 [0.55-1.78],0.9632644728732304
Chapter II Neoplasms,Carcinoma in situ of breast,GP1BB,Platelet glycoprotein Ib beta chain,11293,74,0.78 [0.56-1.10],0.1550256281473133
Chapter II Neoplasms,Carcinoma in situ of breast,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,13047,86,1.03 [0.82-1.29],0.7864302571073085
Chapter II Neoplasms,Carcinoma in situ of breast,GP5,Platelet glycoprotein V,11384,76,0.68 [0.38-1.20],0.1786127231883441
Chapter II Neoplasms,Carcinoma in situ of breast,GP6,Platelet glycoprotein VI,13428,89,0.85 [0.69-1.04],0.1143268996927852
Chapter II Neoplasms,Carcinoma in situ of breast,GPA33,Cell surface A33 antigen,13380,89,0.87 [0.76-1.00],0.04982873634292
Chapter II Neoplasms,Carcinoma in situ of breast,GPC1,Glypican-1,13571,87,0.61 [0.32-1.15],0.1273507670812506
Chapter II Neoplasms,Carcinoma in situ of breast,GPC5,Glypican-5,13363,90,0.77 [0.55-1.07],0.1219960032286406
Chapter II Neoplasms,Carcinoma in situ of breast,GPD1,Glycerol-3-phosphate dehydrogenase,11571,75,0.54 [0.33-0.87],0.0116712574619184
Chapter II Neoplasms,Carcinoma in situ of breast,GPHA2,Glycoprotein hormone alpha-2,11587,77,0.97 [0.62-1.52],0.9053575878405384
Chapter II Neoplasms,Carcinoma in situ of breast,GPI,Glucose-6-phosphate isomerase,11650,75,0.74 [0.46-1.21],0.2301696037223066
Chapter II Neoplasms,Carcinoma in situ of breast,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,11587,77,0.87 [0.66-1.15],0.3369596161160042
Chapter II Neoplasms,Carcinoma in situ of breast,GPKOW,G-patch domain and KOW motifs-containing protein,13108,85,1.09 [0.56-2.12],0.8093189512019939
Chapter II Neoplasms,Carcinoma in situ of breast,GPNMB,Transmembrane glycoprotein NMB,13093,87,1.24 [0.63-2.46],0.5353506682845774
Chapter II Neoplasms,Carcinoma in situ of breast,GPR101,Probable G-protein coupled receptor 101,11311,73,1.02 [0.73-1.43],0.8854993081026117
Chapter II Neoplasms,Carcinoma in situ of breast,GPR158,Probable G-protein coupled receptor 158,11634,76,0.75 [0.38-1.47],0.4022591329298824
Chapter II Neoplasms,Carcinoma in situ of breast,GPR15L,Protein GPR15L,11587,77,0.99 [0.70-1.41],0.963474662388302
Chapter II Neoplasms,Carcinoma in situ of breast,GPR37,Prosaposin receptor GPR37,13220,88,0.78 [0.58-1.03],0.0842151586738055
Chapter II Neoplasms,Carcinoma in situ of breast,GPRC5C,G-protein coupled receptor family C group 5 member C,11571,75,1.04 [0.71-1.52],0.8448896240848247
Chapter II Neoplasms,Carcinoma in situ of breast,GRAP2,GRB2-related adapter protein 2,13452,90,0.86 [0.75-1.00],0.0470263369477193
Chapter II Neoplasms,Carcinoma in situ of breast,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,11652,74,0.69 [0.49-0.97],0.0351132265093448
Chapter II Neoplasms,Carcinoma in situ of breast,GRIK2,"Glutamate receptor ionotropic, kainate 2",11634,76,0.53 [0.27-1.05],0.0668381740246068
Chapter II Neoplasms,Carcinoma in situ of breast,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",11311,73,0.69 [0.41-1.16],0.1634486794993266
Chapter II Neoplasms,Carcinoma in situ of breast,GRK5,G protein-coupled receptor kinase 5,13220,88,0.79 [0.52-1.20],0.2724438969680446
Chapter II Neoplasms,Carcinoma in situ of breast,GRN,Progranulin,13386,89,0.79 [0.36-1.75],0.5665402441057505
Chapter II Neoplasms,Carcinoma in situ of breast,GRP,Gastrin-releasing peptide,11330,75,0.93 [0.61-1.42],0.7458424334302203
Chapter II Neoplasms,Carcinoma in situ of breast,GRPEL1,"GrpE protein homolog 1, mitochondrial",13380,89,0.86 [0.63-1.20],0.3801295030022836
Chapter II Neoplasms,Carcinoma in situ of breast,GRSF1,G-rich sequence factor 1,11170,74,0.76 [0.56-1.03],0.0773125702757746
Chapter II Neoplasms,Carcinoma in situ of breast,GSAP,Gamma-secretase-activating protein,13139,87,1.02 [0.83-1.26],0.8333058442400527
Chapter II Neoplasms,Carcinoma in situ of breast,GSN,Gelsolin,11606,75,3.03 [0.86-10.69],0.0840847260210872
Chapter II Neoplasms,Carcinoma in situ of breast,GSR,"Glutathione reductase, mitochondrial",11576,75,0.74 [0.26-2.11],0.5783870358643997
Chapter II Neoplasms,Carcinoma in situ of breast,GSTA1,Glutathione S-transferase A1,13434,90,0.87 [0.69-1.10],0.2541658493402071
Chapter II Neoplasms,Carcinoma in situ of breast,GSTA3,Glutathione S-transferase A3,13139,87,0.97 [0.75-1.26],0.8152460626746144
Chapter II Neoplasms,Carcinoma in situ of breast,GSTM4,Glutathione S-transferase Mu 4,11293,74,1.15 [0.87-1.52],0.3241580997132338
Chapter II Neoplasms,Carcinoma in situ of breast,GSTP1,Glutathione S-transferase P,13026,84,1.12 [0.86-1.46],0.3844326742424226
Chapter II Neoplasms,Carcinoma in situ of breast,GSTT2B,Glutathione S-transferase theta-2B,11617,76,0.96 [0.88-1.05],0.4103624995760636
Chapter II Neoplasms,Carcinoma in situ of breast,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,11399,77,1.04 [0.79-1.38],0.7714917477545666
Chapter II Neoplasms,Carcinoma in situ of breast,GTPBP2,GTP-binding protein 2,11312,75,0.71 [0.53-0.95],0.0203880725833846
Chapter II Neoplasms,Carcinoma in situ of breast,GUCA2A,Guanylin,13385,89,0.85 [0.47-1.54],0.5979433216657061
Chapter II Neoplasms,Carcinoma in situ of breast,GUCY2C,Heat-stable enterotoxin receptor,11399,77,1.06 [0.84-1.34],0.6013262320741151
Chapter II Neoplasms,Carcinoma in situ of breast,GUK1,Guanylate kinase,11293,74,1.30 [0.88-1.91],0.1896554760731525
Chapter II Neoplasms,Carcinoma in situ of breast,GUSB,Beta-glucuronidase,13495,87,0.97 [0.70-1.35],0.8525774405298124
Chapter II Neoplasms,Carcinoma in situ of breast,GYS1,"Glycogen [starch] synthase, muscle",13220,88,0.85 [0.69-1.05],0.1240748316222894
Chapter II Neoplasms,Carcinoma in situ of breast,GZMA,Granzyme A,13604,89,0.60 [0.35-1.05],0.0740570534165277
Chapter II Neoplasms,Carcinoma in situ of breast,GZMB,Granzyme B,13434,87,0.79 [0.57-1.09],0.1546134552758732
Chapter II Neoplasms,Carcinoma in situ of breast,GZMH,Granzyme H,13220,88,1.00 [0.77-1.29],0.9943952257904828
Chapter II Neoplasms,Carcinoma in situ of breast,H2AP,Huntingtin-interacting protein M,11230,75,0.67 [0.36-1.23],0.1914865931529938
Chapter II Neoplasms,Carcinoma in situ of breast,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",11293,74,1.26 [0.99-1.59],0.0558741819852134
Chapter II Neoplasms,Carcinoma in situ of breast,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",13534,86,1.02 [0.79-1.31],0.8814410068125134
Chapter II Neoplasms,Carcinoma in situ of breast,HAO1,Hydroxyacid oxidase 1,13571,87,1.01 [0.88-1.16],0.9037600896448024
Chapter II Neoplasms,Carcinoma in situ of breast,HARS1,"Histidine--tRNA ligase, cytoplasmic",13449,89,0.77 [0.61-0.98],0.0353479772422693
Chapter II Neoplasms,Carcinoma in situ of breast,HAVCR1,Hepatitis A virus cellular receptor 1,13555,86,1.01 [0.73-1.41],0.9301633765494832
Chapter II Neoplasms,Carcinoma in situ of breast,HAVCR2,Hepatitis A virus cellular receptor 2,13449,89,0.64 [0.37-1.13],0.127271991054238
Chapter II Neoplasms,Carcinoma in situ of breast,HBEGF,Proheparin-binding EGF-like growth factor,13534,86,0.80 [0.62-1.04],0.0931091390690257
Chapter II Neoplasms,Carcinoma in situ of breast,HBQ1,Hemoglobin subunit theta-1,13571,87,1.13 [0.84-1.52],0.4018407016345572
Chapter II Neoplasms,Carcinoma in situ of breast,HBZ,Hemoglobin subunit zeta,11652,74,1.12 [0.92-1.37],0.2692830917534167
Chapter II Neoplasms,Carcinoma in situ of breast,HCG22,Protein PBMUCL2,11293,74,0.52 [0.27-1.00],0.0492610229014701
Chapter II Neoplasms,Carcinoma in situ of breast,HCLS1,Hematopoietic lineage cell-specific protein,13604,89,0.68 [0.49-0.95],0.0225817967521478
Chapter II Neoplasms,Carcinoma in situ of breast,HDAC8,Histone deacetylase 8,11319,73,1.16 [0.88-1.54],0.2990139745557709
Chapter II Neoplasms,Carcinoma in situ of breast,HDAC9,Histone deacetylase 9,11311,73,0.91 [0.63-1.33],0.6420972974904665
Chapter II Neoplasms,Carcinoma in situ of breast,HDDC2,5'-deoxynucleotidase HDDC2,11587,77,0.88 [0.53-1.44],0.6038218956913564
Chapter II Neoplasms,Carcinoma in situ of breast,HDGF,Hepatoma-derived growth factor,13555,87,0.86 [0.70-1.05],0.1353323125026752
Chapter II Neoplasms,Carcinoma in situ of breast,HDGFL2,Hepatoma-derived growth factor-related protein 2,11617,76,0.82 [0.57-1.18],0.2853765056636727
Chapter II Neoplasms,Carcinoma in situ of breast,HEBP1,Heme-binding protein 1,13220,88,1.15 [0.87-1.51],0.3191022348723646
Chapter II Neoplasms,Carcinoma in situ of breast,HEG1,Protein HEG homolog 1,11384,76,0.74 [0.32-1.73],0.4893889041232908
Chapter II Neoplasms,Carcinoma in situ of breast,HEPACAM2,HEPACAM family member 2,11617,76,0.63 [0.37-1.07],0.0845029437047969
Chapter II Neoplasms,Carcinoma in situ of breast,HEPH,Hephaestin,11652,74,0.87 [0.37-2.07],0.7549266030646592
Chapter II Neoplasms,Carcinoma in situ of breast,HEXIM1,Protein HEXIM1,13434,87,0.84 [0.66-1.06],0.1360568719108005
Chapter II Neoplasms,Carcinoma in situ of breast,HGF,Hepatocyte growth factor,13604,89,0.67 [0.38-1.18],0.1644242126965706
Chapter II Neoplasms,Carcinoma in situ of breast,HGFAC,Hepatocyte growth factor activator,11539,75,1.10 [0.51-2.37],0.8145118142767318
Chapter II Neoplasms,Carcinoma in situ of breast,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,13139,87,0.68 [0.52-0.89],0.0045483960910418
Chapter II Neoplasms,Carcinoma in situ of breast,HHEX,Hematopoietically-expressed homeobox protein HHEX,11617,76,0.77 [0.57-1.03],0.0784111334179145
Chapter II Neoplasms,Carcinoma in situ of breast,HIF1A,Hypoxia-inducible factor 1-alpha,11319,73,1.09 [0.82-1.44],0.5504255999554691
Chapter II Neoplasms,Carcinoma in situ of breast,HIP1,Huntingtin-interacting protein 1,11293,74,1.03 [0.55-1.91],0.927569130163154
Chapter II Neoplasms,Carcinoma in situ of breast,HIP1R,Huntingtin-interacting protein 1-related protein,11601,76,1.06 [0.64-1.75],0.8264144784812569
Chapter II Neoplasms,Carcinoma in situ of breast,HJV,Hemojuvelin,11634,76,0.63 [0.36-1.10],0.1021396424805417
Chapter II Neoplasms,Carcinoma in situ of breast,HK2,Hexokinase-2,13220,88,1.22 [0.64-2.31],0.5428314805725001
Chapter II Neoplasms,Carcinoma in situ of breast,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",11634,76,0.60 [0.31-1.17],0.1321488453102206
Chapter II Neoplasms,Carcinoma in situ of breast,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",13392,85,1.06 [0.62-1.79],0.8416730995219868
Chapter II Neoplasms,Carcinoma in situ of breast,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",13434,87,0.73 [0.36-1.50],0.3948318110684423
Chapter II Neoplasms,Carcinoma in situ of breast,HMBS,Porphobilinogen deaminase,13571,87,1.55 [1.03-2.33],0.036774115629518
Chapter II Neoplasms,Carcinoma in situ of breast,HMCN2,Hemicentin-2,11361,76,1.51 [1.02-2.25],0.0403228178828882
Chapter II Neoplasms,Carcinoma in situ of breast,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",11330,75,0.70 [0.44-1.13],0.1450860009775505
Chapter II Neoplasms,Carcinoma in situ of breast,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",11293,74,0.48 [0.27-0.87],0.015994283998375
Chapter II Neoplasms,Carcinoma in situ of breast,HMMR,Hyaluronan mediated motility receptor,11216,75,0.64 [0.36-1.12],0.1199645346560196
Chapter II Neoplasms,Carcinoma in situ of breast,HMOX1,Heme oxygenase 1,13303,88,1.31 [0.88-1.95],0.1804869501375111
Chapter II Neoplasms,Carcinoma in situ of breast,HMOX2,Heme oxygenase 2,13108,85,1.20 [0.82-1.75],0.3517348243844478
Chapter II Neoplasms,Carcinoma in situ of breast,HNF1A,Hepatocyte nuclear factor 1-alpha,11312,75,0.84 [0.58-1.22],0.3582873150309649
Chapter II Neoplasms,Carcinoma in situ of breast,HNMT,Histamine N-methyltransferase,13291,90,0.99 [0.65-1.50],0.9543926136585678
Chapter II Neoplasms,Carcinoma in situ of breast,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,13176,88,0.84 [0.65-1.08],0.1715344869343816
Chapter II Neoplasms,Carcinoma in situ of breast,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,11634,76,0.81 [0.50-1.32],0.4001212907718002
Chapter II Neoplasms,Carcinoma in situ of breast,HPCAL1,Hippocalcin-like protein 1,13604,89,0.83 [0.65-1.05],0.1253554321241776
Chapter II Neoplasms,Carcinoma in situ of breast,HPGDS,Hematopoietic prostaglandin D synthase,13139,87,0.84 [0.50-1.42],0.5258368506582077
Chapter II Neoplasms,Carcinoma in situ of breast,HPSE,Heparanase,11465,77,0.74 [0.59-0.93],0.0088021717299592
Chapter II Neoplasms,Carcinoma in situ of breast,HRAS,GTPase Hras,11383,76,0.94 [0.74-1.21],0.6447242865774867
Chapter II Neoplasms,Carcinoma in situ of breast,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,11330,75,0.62 [0.30-1.26],0.183925465494109
Chapter II Neoplasms,Carcinoma in situ of breast,HRG,Histidine-rich glycoprotein,11596,77,1.23 [0.63-2.42],0.5464620438310641
Chapter II Neoplasms,Carcinoma in situ of breast,HS1BP3,HCLS1-binding protein 3,11330,75,0.84 [0.66-1.09],0.1883028413976178
Chapter II Neoplasms,Carcinoma in situ of breast,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,13380,89,0.70 [0.43-1.14],0.1511738644504065
Chapter II Neoplasms,Carcinoma in situ of breast,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,13571,87,0.66 [0.38-1.17],0.1538379972977242
Chapter II Neoplasms,Carcinoma in situ of breast,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,11319,73,0.85 [0.39-1.84],0.6771785394718552
Chapter II Neoplasms,Carcinoma in situ of breast,HSBP1,Heat shock factor-binding protein 1,11330,75,0.93 [0.74-1.17],0.5453629725632387
Chapter II Neoplasms,Carcinoma in situ of breast,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,13434,87,1.12 [0.68-1.83],0.6506010826165226
Chapter II Neoplasms,Carcinoma in situ of breast,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,11617,76,0.99 [0.70-1.41],0.9626033059276252
Chapter II Neoplasms,Carcinoma in situ of breast,HSD17B3,Testosterone 17-beta-dehydrogenase 3,11293,74,0.57 [0.33-0.98],0.0422983298031944
Chapter II Neoplasms,Carcinoma in situ of breast,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,11330,75,0.95 [0.59-1.52],0.8307378956272539
Chapter II Neoplasms,Carcinoma in situ of breast,HSP90B1,Endoplasmin,13048,85,1.06 [0.82-1.36],0.66551726010194
Chapter II Neoplasms,Carcinoma in situ of breast,HSPA1A,Heat shock 70 kDa protein 1A,13479,91,0.83 [0.64-1.08],0.1741820643093643
Chapter II Neoplasms,Carcinoma in situ of breast,HSPA2,Heat shock-related 70 kDa protein 2,11571,75,0.77 [0.38-1.57],0.4727785812455967
Chapter II Neoplasms,Carcinoma in situ of breast,HSPB1,Heat shock protein beta-1,13220,87,0.73 [0.56-0.94],0.0134114767963918
Chapter II Neoplasms,Carcinoma in situ of breast,HSPB6,Heat shock protein beta-6,13571,87,0.91 [0.53-1.57],0.7428712577366048
Chapter II Neoplasms,Carcinoma in situ of breast,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,13301,87,1.55 [0.72-3.31],0.2589112949427929
Chapter II Neoplasms,Carcinoma in situ of breast,HTR1A,5-hydroxytryptamine receptor 1A,11311,73,0.72 [0.49-1.06],0.0949873767627705
Chapter II Neoplasms,Carcinoma in situ of breast,HTR1B,5-hydroxytryptamine receptor 1B,11311,73,0.78 [0.43-1.40],0.4000076307654893
Chapter II Neoplasms,Carcinoma in situ of breast,HTRA2,"Serine protease HTRA2, mitochondrial",13480,90,0.81 [0.59-1.09],0.1649123972861517
Chapter II Neoplasms,Carcinoma in situ of breast,HYAL1,Hyaluronidase-1,13322,89,0.87 [0.38-1.98],0.74418226203116
Chapter II Neoplasms,Carcinoma in situ of breast,HYOU1,Hypoxia up-regulated protein 1,13609,89,1.29 [0.54-3.10],0.5699003716015423
Chapter II Neoplasms,Carcinoma in situ of breast,ICA1,Islet cell autoantigen 1,13187,89,0.81 [0.64-1.04],0.0982328439917088
Chapter II Neoplasms,Carcinoma in situ of breast,ICAM1,Intercellular adhesion molecule 1,13360,86,0.75 [0.37-1.49],0.4057739319280361
Chapter II Neoplasms,Carcinoma in situ of breast,ICAM2,Intercellular adhesion molecule 2,13609,89,0.72 [0.40-1.32],0.2913093028980609
Chapter II Neoplasms,Carcinoma in situ of breast,ICAM3,Intercellular adhesion molecule 3,13609,89,0.91 [0.43-1.95],0.8106762128236082
Chapter II Neoplasms,Carcinoma in situ of breast,ICAM4,Intercellular adhesion molecule 4,13434,87,0.89 [0.62-1.26],0.4950542398289612
Chapter II Neoplasms,Carcinoma in situ of breast,ICAM5,Intercellular adhesion molecule 5,13452,90,0.61 [0.41-0.92],0.0175987764636207
Chapter II Neoplasms,Carcinoma in situ of breast,ICOSLG,ICOS ligand,13380,89,1.35 [0.51-3.58],0.5497593970453765
Chapter II Neoplasms,Carcinoma in situ of breast,ID4,DNA-binding protein inhibitor ID-4,11399,77,1.03 [0.65-1.61],0.911799647990877
Chapter II Neoplasms,Carcinoma in situ of breast,IDI2,Isopentenyl-diphosphate delta-isomerase 2,13108,85,1.03 [0.68-1.55],0.9041061820473668
Chapter II Neoplasms,Carcinoma in situ of breast,IDO1,"Indoleamine 2,3-dioxygenase 1",11330,75,0.84 [0.59-1.20],0.341279028765484
Chapter II Neoplasms,Carcinoma in situ of breast,IDS,Iduronate 2-sulfatase,13604,89,0.58 [0.07-4.53],0.6010103487602915
Chapter II Neoplasms,Carcinoma in situ of breast,IDUA,Alpha-L-iduronidase,13571,87,0.69 [0.47-1.02],0.0644782547032798
Chapter II Neoplasms,Carcinoma in situ of breast,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,11315,74,0.81 [0.44-1.49],0.5018315152072828
Chapter II Neoplasms,Carcinoma in situ of breast,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,11399,77,1.04 [0.69-1.56],0.8537377704698095
Chapter II Neoplasms,Carcinoma in situ of breast,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,11399,77,0.89 [0.48-1.65],0.7163788563783033
Chapter II Neoplasms,Carcinoma in situ of breast,IFNAR1,Interferon alpha/beta receptor 1,11587,77,1.51 [0.73-3.13],0.2693705387491329
Chapter II Neoplasms,Carcinoma in situ of breast,IFNG,Interferon gamma,13187,89,0.88 [0.76-1.03],0.1056248252763085
Chapter II Neoplasms,Carcinoma in situ of breast,IFNGR1,Interferon gamma receptor 1,13507,91,0.87 [0.34-2.22],0.765343587262729
Chapter II Neoplasms,Carcinoma in situ of breast,IFNGR2,Interferon gamma receptor 2,13363,90,0.91 [0.63-1.31],0.6079970053329349
Chapter II Neoplasms,Carcinoma in situ of breast,IFNL1,Interferon lambda-1,13108,85,0.87 [0.56-1.35],0.5388132659249841
Chapter II Neoplasms,Carcinoma in situ of breast,IFNL2,Interferon lambda-2,11311,73,0.84 [0.56-1.26],0.400961879666674
Chapter II Neoplasms,Carcinoma in situ of breast,IFNLR1,Interferon lambda receptor 1,13434,87,0.97 [0.58-1.61],0.9015722045400358
Chapter II Neoplasms,Carcinoma in situ of breast,IFNW1,Interferon omega-1,11293,74,0.72 [0.35-1.50],0.3834715129783644
Chapter II Neoplasms,Carcinoma in situ of breast,IFT20,Intraflagellar transport protein 20 homolog,11312,75,0.68 [0.39-1.18],0.1663783010052306
Chapter II Neoplasms,Carcinoma in situ of breast,IGBP1,Immunoglobulin-binding protein 1,11634,76,0.76 [0.53-1.09],0.1402011970291888
Chapter II Neoplasms,Carcinoma in situ of breast,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,11311,73,0.75 [0.42-1.34],0.336894627228021
Chapter II Neoplasms,Carcinoma in situ of breast,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,11632,77,0.97 [0.41-2.28],0.9407802742833816
Chapter II Neoplasms,Carcinoma in situ of breast,IGF1R,Insulin-like growth factor 1 receptor,13380,89,0.53 [0.28-1.02],0.0565893663884691
Chapter II Neoplasms,Carcinoma in situ of breast,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,11293,74,0.96 [0.59-1.57],0.8803021399251229
Chapter II Neoplasms,Carcinoma in situ of breast,IGF2R,Cation-independent mannose-6-phosphate receptor,13449,89,0.91 [0.40-2.05],0.8235517983144742
Chapter II Neoplasms,Carcinoma in situ of breast,IGFBP1,Insulin-like growth factor-binding protein 1,13584,88,1.00 [0.85-1.18],0.97573250329902
Chapter II Neoplasms,Carcinoma in situ of breast,IGFBP2,Insulin-like growth factor-binding protein 2,13581,89,1.06 [0.79-1.43],0.7053425533788371
Chapter II Neoplasms,Carcinoma in situ of breast,IGFBP3,Insulin-like growth factor-binding protein 3,13459,89,1.57 [0.75-3.30],0.2323044537388246
Chapter II Neoplasms,Carcinoma in situ of breast,IGFBP4,Insulin-like growth factor-binding protein 4,13260,87,0.80 [0.48-1.35],0.4044277912476438
Chapter II Neoplasms,Carcinoma in situ of breast,IGFBP6,Insulin-like growth factor-binding protein 6,13353,86,1.35 [0.67-2.70],0.399739112783587
Chapter II Neoplasms,Carcinoma in situ of breast,IGFBP7,Insulin-like growth factor-binding protein 7,13609,89,0.89 [0.46-1.71],0.7266969963548069
Chapter II Neoplasms,Carcinoma in situ of breast,IGFBPL1,Insulin-like growth factor-binding protein-like 1,13452,90,0.69 [0.39-1.24],0.2158705767266033
Chapter II Neoplasms,Carcinoma in situ of breast,IGFL4,Insulin growth factor-like family member 4,11319,73,0.99 [0.74-1.33],0.9563330294980936
Chapter II Neoplasms,Carcinoma in situ of breast,IGHMBP2,DNA-binding protein SMUBP-2,11293,74,0.68 [0.43-1.08],0.0991960401271089
Chapter II Neoplasms,Carcinoma in situ of breast,IGLC2,Immunoglobulin lambda constant 2,11643,77,1.18 [0.55-2.55],0.6736333784422731
Chapter II Neoplasms,Carcinoma in situ of breast,IGLON5,IgLON family member 5,11230,75,0.66 [0.44-0.99],0.0424072272366749
Chapter II Neoplasms,Carcinoma in situ of breast,IGSF21,Immunoglobulin superfamily member 21,11330,75,0.98 [0.56-1.72],0.945752339449292
Chapter II Neoplasms,Carcinoma in situ of breast,IGSF3,Immunoglobulin superfamily member 3,13380,89,0.59 [0.31-1.12],0.1046848995903297
Chapter II Neoplasms,Carcinoma in situ of breast,IGSF8,Immunoglobulin superfamily member 8,13452,90,0.81 [0.44-1.52],0.5207718642944981
Chapter II Neoplasms,Carcinoma in situ of breast,IGSF9,Protein turtle homolog A,11652,74,0.99 [0.75-1.32],0.9650347490099968
Chapter II Neoplasms,Carcinoma in situ of breast,IKBKG,NF-kappa-B essential modulator,13434,87,0.83 [0.67-1.02],0.0754884816982939
Chapter II Neoplasms,Carcinoma in situ of breast,IKZF2,Zinc finger protein Helios,13139,87,1.05 [0.88-1.26],0.5958925568817796
Chapter II Neoplasms,Carcinoma in situ of breast,IL10,Interleukin-10,13187,89,0.93 [0.73-1.19],0.5569495043762337
Chapter II Neoplasms,Carcinoma in situ of breast,IL10RA,Interleukin-10 receptor subunit alpha,13187,89,0.90 [0.64-1.27],0.5539938022433719
Chapter II Neoplasms,Carcinoma in situ of breast,IL10RB,Interleukin-10 receptor subunit beta,13507,91,1.05 [0.54-2.04],0.8837249266825817
Chapter II Neoplasms,Carcinoma in situ of breast,IL11,Interleukin-11,13187,89,0.83 [0.59-1.16],0.2665348253379795
Chapter II Neoplasms,Carcinoma in situ of breast,IL12A_IL12B,Interleukin-12,13380,89,0.83 [0.65-1.08],0.1666301070248743
Chapter II Neoplasms,Carcinoma in situ of breast,IL12B,Interleukin-12 subunit beta,13604,89,0.82 [0.57-1.17],0.2635846435515906
Chapter II Neoplasms,Carcinoma in situ of breast,IL12RB1,Interleukin-12 receptor subunit beta-1,13187,89,0.62 [0.37-1.03],0.0671379257025635
Chapter II Neoplasms,Carcinoma in situ of breast,IL12RB2,Interleukin-12 receptor subunit beta-2,11319,73,0.75 [0.42-1.32],0.3182322853569201
Chapter II Neoplasms,Carcinoma in situ of breast,IL13,Interleukin-13,13187,89,0.77 [0.48-1.24],0.286201940995789
Chapter II Neoplasms,Carcinoma in situ of breast,IL13RA1,Interleukin-13 receptor subunit alpha-1,13268,90,1.23 [0.50-3.02],0.6588147668840916
Chapter II Neoplasms,Carcinoma in situ of breast,IL13RA2,Interleukin-13 receptor subunit alpha-2,11311,73,0.66 [0.31-1.43],0.2927925740188494
Chapter II Neoplasms,Carcinoma in situ of breast,IL15,Interleukin-15,13434,87,0.98 [0.55-1.77],0.9519414174333048
Chapter II Neoplasms,Carcinoma in situ of breast,IL15RA,Interleukin-15 receptor subunit alpha,13187,89,0.65 [0.38-1.12],0.121039664110074
Chapter II Neoplasms,Carcinoma in situ of breast,IL16,Pro-interleukin-16,13604,89,1.21 [0.80-1.84],0.3612033426245592
Chapter II Neoplasms,Carcinoma in situ of breast,IL17A,Interleukin-17A,13172,89,1.15 [0.76-1.74],0.5009974421528569
Chapter II Neoplasms,Carcinoma in situ of breast,IL17C,Interleukin-17C,13187,89,1.13 [0.87-1.47],0.3641262815918226
Chapter II Neoplasms,Carcinoma in situ of breast,IL17D,Interleukin-17D,13187,89,0.99 [0.56-1.76],0.9678528250349434
Chapter II Neoplasms,Carcinoma in situ of breast,IL17F,Interleukin-17F,13187,89,1.08 [0.88-1.34],0.4576184864036854
Chapter II Neoplasms,Carcinoma in situ of breast,IL17RA,Interleukin-17 receptor A,13449,89,0.87 [0.57-1.32],0.508916714565915
Chapter II Neoplasms,Carcinoma in situ of breast,IL17RB,Interleukin-17 receptor B,13255,84,1.46 [1.02-2.08],0.0382581140864785
Chapter II Neoplasms,Carcinoma in situ of breast,IL18,Interleukin-18,13396,90,0.87 [0.58-1.30],0.5039280988140203
Chapter II Neoplasms,Carcinoma in situ of breast,IL18BP,Interleukin-18-binding protein,13459,89,1.06 [0.56-1.99],0.8625576466858593
Chapter II Neoplasms,Carcinoma in situ of breast,IL18R1,Interleukin-18 receptor 1,13604,89,1.35 [0.78-2.34],0.2894562846401413
Chapter II Neoplasms,Carcinoma in situ of breast,IL18RAP,Interleukin-18 receptor accessory protein,13277,89,0.91 [0.81-1.02],0.1152581911962834
Chapter II Neoplasms,Carcinoma in situ of breast,IL19,Interleukin-19,13115,89,0.95 [0.71-1.27],0.7165422648998625
Chapter II Neoplasms,Carcinoma in situ of breast,IL1A,Interleukin-1 alpha,13187,89,1.12 [0.82-1.53],0.4785147085442827
Chapter II Neoplasms,Carcinoma in situ of breast,IL1B,Interleukin-1 beta,13125,89,0.65 [0.44-0.95],0.0281203852834793
Chapter II Neoplasms,Carcinoma in situ of breast,IL1R1,Interleukin-1 receptor type 1,13426,89,1.27 [0.53-3.04],0.5903174453457813
Chapter II Neoplasms,Carcinoma in situ of breast,IL1R2,Interleukin-1 receptor type 2,13425,90,0.90 [0.34-2.39],0.8339157314290072
Chapter II Neoplasms,Carcinoma in situ of breast,IL1RAP,Interleukin-1 receptor accessory protein,13449,89,1.34 [0.88-2.05],0.1715812879591381
Chapter II Neoplasms,Carcinoma in situ of breast,IL1RL1,Interleukin-1 receptor-like 1,13559,87,0.73 [0.50-1.09],0.1252510582981154
Chapter II Neoplasms,Carcinoma in situ of breast,IL1RL2,Interleukin-1 receptor-like 2,13187,89,1.04 [0.66-1.63],0.8664832624624922
Chapter II Neoplasms,Carcinoma in situ of breast,IL1RN,Interleukin-1 receptor antagonist protein,13408,89,0.92 [0.65-1.32],0.6632512185960733
Chapter II Neoplasms,Carcinoma in situ of breast,IL2,Interleukin-2,13187,89,1.19 [0.64-2.21],0.5778737201950743
Chapter II Neoplasms,Carcinoma in situ of breast,IL20,Interleukin-20,13187,89,0.70 [0.44-1.11],0.1255094031086501
Chapter II Neoplasms,Carcinoma in situ of breast,IL20RA,Interleukin-20 receptor subunit alpha,13187,89,1.24 [0.90-1.72],0.1945426323022114
Chapter II Neoplasms,Carcinoma in situ of breast,IL20RB,Interleukin-20 receptor subunit beta,11319,73,1.05 [0.63-1.75],0.864823033649068
Chapter II Neoplasms,Carcinoma in situ of breast,IL21R,Interleukin-21 receptor,11319,73,0.88 [0.55-1.38],0.5710265647948363
Chapter II Neoplasms,Carcinoma in situ of breast,IL22,Interleukin-22,11571,75,1.17 [0.86-1.60],0.3097920212293643
Chapter II Neoplasms,Carcinoma in situ of breast,IL22RA1,Interleukin-22 receptor subunit alpha-1,13187,89,0.92 [0.59-1.43],0.7059911473237654
Chapter II Neoplasms,Carcinoma in situ of breast,IL24,Interleukin-24,13187,89,1.09 [0.76-1.58],0.636481257650718
Chapter II Neoplasms,Carcinoma in situ of breast,IL25,Interleukin-25,11189,74,0.76 [0.40-1.45],0.409956342235072
Chapter II Neoplasms,Carcinoma in situ of breast,IL2RA,Interleukin-2 receptor subunit alpha,13343,85,1.06 [0.64-1.73],0.8285821738424902
Chapter II Neoplasms,Carcinoma in situ of breast,IL2RB,Interleukin-2 receptor subunit beta,13187,89,0.89 [0.53-1.50],0.6567602859808097
Chapter II Neoplasms,Carcinoma in situ of breast,IL2RG,Cytokine receptor common subunit gamma,11571,75,0.75 [0.38-1.47],0.4010545052485988
Chapter II Neoplasms,Carcinoma in situ of breast,IL3,Interleukin-3,11230,75,0.74 [0.56-0.97],0.0308065427435482
Chapter II Neoplasms,Carcinoma in situ of breast,IL31,Interleukin-31,11319,73,0.72 [0.45-1.16],0.1818817800912814
Chapter II Neoplasms,Carcinoma in situ of breast,IL31RA,Interleukin-31 receptor subunit alpha,11278,73,0.95 [0.55-1.65],0.8519136737739428
Chapter II Neoplasms,Carcinoma in situ of breast,IL32,Interleukin-32,13434,87,0.98 [0.62-1.55],0.9359425283831644
Chapter II Neoplasms,Carcinoma in situ of breast,IL33,Interleukin-33,13187,89,0.83 [0.51-1.33],0.431230700420342
Chapter II Neoplasms,Carcinoma in situ of breast,IL34,Interleukin-34,13089,85,0.91 [0.54-1.55],0.7312661440854601
Chapter II Neoplasms,Carcinoma in situ of breast,IL36A,Interleukin-36 alpha,11319,73,1.15 [0.83-1.59],0.4131586572112586
Chapter II Neoplasms,Carcinoma in situ of breast,IL36G,Interleukin-36 gamma,11277,73,1.10 [0.81-1.48],0.5437180465710261
Chapter II Neoplasms,Carcinoma in situ of breast,IL3RA,Interleukin-3 receptor subunit alpha,13187,89,0.75 [0.41-1.39],0.3634189075196561
Chapter II Neoplasms,Carcinoma in situ of breast,IL4,Interleukin-4,13187,89,0.93 [0.77-1.12],0.4479871667698445
Chapter II Neoplasms,Carcinoma in situ of breast,IL4R,Interleukin-4 receptor subunit alpha,13434,87,1.12 [0.65-1.92],0.6827125580783078
Chapter II Neoplasms,Carcinoma in situ of breast,IL5,Interleukin-5,13187,89,0.97 [0.85-1.11],0.6957506338201316
Chapter II Neoplasms,Carcinoma in situ of breast,IL5RA,Interleukin-5 receptor subunit alpha,13434,87,0.95 [0.67-1.36],0.7912131343718127
Chapter II Neoplasms,Carcinoma in situ of breast,IL6,Interleukin-6,13380,89,0.80 [0.59-1.09],0.1536968752055347
Chapter II Neoplasms,Carcinoma in situ of breast,IL6R,Interleukin-6 receptor subunit alpha,13331,86,0.87 [0.50-1.52],0.6240438066099363
Chapter II Neoplasms,Carcinoma in situ of breast,IL6ST,Interleukin-6 receptor subunit beta,13452,90,1.25 [0.44-3.57],0.6757523685988974
Chapter II Neoplasms,Carcinoma in situ of breast,IL7,Interleukin-7,13434,87,0.82 [0.61-1.10],0.1886835885247692
Chapter II Neoplasms,Carcinoma in situ of breast,IL7R,Interleukin-7 receptor subunit alpha,13449,89,0.85 [0.60-1.21],0.3794707185780346
Chapter II Neoplasms,Carcinoma in situ of breast,IL9,Interleukin-9,11399,77,0.75 [0.46-1.20],0.2247357598085891
Chapter II Neoplasms,Carcinoma in situ of breast,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,13093,85,0.72 [0.50-1.03],0.069074799647508
Chapter II Neoplasms,Carcinoma in situ of breast,IMMT,MICOS complex subunit MIC60,11571,75,0.59 [0.33-1.06],0.0783786081653129
Chapter II Neoplasms,Carcinoma in situ of breast,IMPA1,Inositol monophosphatase 1,13363,90,0.73 [0.53-1.00],0.0480317793193936
Chapter II Neoplasms,Carcinoma in situ of breast,IMPACT,Protein IMPACT,11617,76,0.71 [0.48-1.05],0.0836595801395611
Chapter II Neoplasms,Carcinoma in situ of breast,IMPG1,Interphotoreceptor matrix proteoglycan 1,11311,73,0.68 [0.29-1.57],0.3676338884638764
Chapter II Neoplasms,Carcinoma in situ of breast,ING1,Inhibitor of growth protein 1,13079,85,0.92 [0.59-1.43],0.7048232854609273
Chapter II Neoplasms,Carcinoma in situ of breast,INHBB,Inhibin beta B chain,11384,76,1.38 [0.90-2.11],0.137045479366242
Chapter II Neoplasms,Carcinoma in situ of breast,INHBC,Inhibin beta C chain,13449,89,0.96 [0.63-1.47],0.8501316633565772
Chapter II Neoplasms,Carcinoma in situ of breast,INPP1,Inositol polyphosphate 1-phosphatase,13380,89,0.91 [0.64-1.28],0.5749280832422478
Chapter II Neoplasms,Carcinoma in situ of breast,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",11330,75,0.81 [0.54-1.22],0.3181226093910407
Chapter II Neoplasms,Carcinoma in situ of breast,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",11634,76,1.19 [0.76-1.86],0.4549023963190585
Chapter II Neoplasms,Carcinoma in situ of breast,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",13380,89,0.82 [0.67-1.00],0.0469284512135017
Chapter II Neoplasms,Carcinoma in situ of breast,INSL3,Insulin-like 3,11617,76,1.00 [0.69-1.45],0.9911055980455524
Chapter II Neoplasms,Carcinoma in situ of breast,INSL4,Early placenta insulin-like peptide,11571,75,1.00 [0.67-1.50],0.9957478848997712
Chapter II Neoplasms,Carcinoma in situ of breast,INSL5,Insulin-like peptide INSL5,11587,77,1.16 [0.93-1.44],0.1815404069088938
Chapter II Neoplasms,Carcinoma in situ of breast,INSR,Insulin receptor,11319,73,0.40 [0.10-1.57],0.187435379352101
Chapter II Neoplasms,Carcinoma in situ of breast,IPCEF1,Interactor protein for cytohesin exchange factors 1,13342,90,0.81 [0.66-1.00],0.0500733370656518
Chapter II Neoplasms,Carcinoma in situ of breast,IQGAP2,Ras GTPase-activating-like protein IQGAP2,13380,89,0.73 [0.51-1.04],0.0815506222373573
Chapter II Neoplasms,Carcinoma in situ of breast,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",13220,88,0.87 [0.70-1.09],0.2415853550372665
Chapter II Neoplasms,Carcinoma in situ of breast,IRAK1,Interleukin-1 receptor-associated kinase 1,13187,89,0.69 [0.52-0.92],0.0124167464893007
Chapter II Neoplasms,Carcinoma in situ of breast,IRAK4,Interleukin-1 receptor-associated kinase 4,13434,87,0.86 [0.72-1.03],0.0980679433936578
Chapter II Neoplasms,Carcinoma in situ of breast,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,12917,82,0.70 [0.41-1.20],0.1966213193935935
Chapter II Neoplasms,Carcinoma in situ of breast,ISM1,Isthmin-1,13434,87,0.74 [0.45-1.19],0.213231429597218
Chapter II Neoplasms,Carcinoma in situ of breast,ISM2,Isthmin-2,11632,77,1.03 [0.63-1.68],0.9077261101056632
Chapter II Neoplasms,Carcinoma in situ of breast,IST1,IST1 homolog,11510,74,0.79 [0.63-0.99],0.0382056445407142
Chapter II Neoplasms,Carcinoma in situ of breast,ITGA11,Integrin alpha-11,13434,87,0.83 [0.48-1.45],0.5199908750508402
Chapter II Neoplasms,Carcinoma in situ of breast,ITGA2,Integrin alpha-2,11384,76,1.00 [0.52-1.95],0.9956241453553292
Chapter II Neoplasms,Carcinoma in situ of breast,ITGA5,Integrin alpha-5,13449,89,0.52 [0.24-1.14],0.1009665287260094
Chapter II Neoplasms,Carcinoma in situ of breast,ITGA6,Integrin alpha-6,13434,87,0.65 [0.44-0.96],0.0305341730055139
Chapter II Neoplasms,Carcinoma in situ of breast,ITGAL,Integrin alpha-L,11319,73,0.74 [0.46-1.19],0.2193027861854203
Chapter II Neoplasms,Carcinoma in situ of breast,ITGAM,Integrin alpha-M,13449,89,0.75 [0.41-1.36],0.3427185789345265
Chapter II Neoplasms,Carcinoma in situ of breast,ITGAV,Integrin alpha-V,13571,87,0.99 [0.31-3.14],0.9864751792180836
Chapter II Neoplasms,Carcinoma in situ of breast,ITGAX,Integrin alpha-X,11399,77,1.09 [0.75-1.59],0.6463962710477744
Chapter II Neoplasms,Carcinoma in situ of breast,ITGB1,Integrin beta-1,13390,87,1.26 [0.54-2.91],0.5947120104822496
Chapter II Neoplasms,Carcinoma in situ of breast,ITGB1BP1,Integrin beta-1-binding protein 1,13139,87,0.82 [0.51-1.30],0.4000927746133994
Chapter II Neoplasms,Carcinoma in situ of breast,ITGB1BP2,Integrin beta-1-binding protein 2,13220,88,0.81 [0.69-0.96],0.0131962765170497
Chapter II Neoplasms,Carcinoma in situ of breast,ITGB2,Integrin beta-2,13352,86,0.61 [0.31-1.20],0.1552156394234138
Chapter II Neoplasms,Carcinoma in situ of breast,ITGB5,Integrin beta-5,13480,90,0.72 [0.43-1.21],0.2150327055948383
Chapter II Neoplasms,Carcinoma in situ of breast,ITGB6,Integrin beta-6,13187,89,0.89 [0.47-1.69],0.7225040433686227
Chapter II Neoplasms,Carcinoma in situ of breast,ITGB7,Integrin beta-7,13571,87,1.10 [0.74-1.65],0.6285894736670089
Chapter II Neoplasms,Carcinoma in situ of breast,ITGBL1,Integrin beta-like protein 1,11632,77,1.05 [0.55-2.01],0.8739991995136132
Chapter II Neoplasms,Carcinoma in situ of breast,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,11662,77,1.53 [0.55-4.25],0.4160261358998608
Chapter II Neoplasms,Carcinoma in situ of breast,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,13459,89,1.39 [0.84-2.30],0.2019085029401693
Chapter II Neoplasms,Carcinoma in situ of breast,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,11662,77,1.03 [0.47-2.25],0.9371761169945996
Chapter II Neoplasms,Carcinoma in situ of breast,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,11571,75,0.91 [0.56-1.49],0.7193348573588149
Chapter II Neoplasms,Carcinoma in situ of breast,ITM2A,Integral membrane protein 2A,13434,87,1.19 [0.86-1.63],0.2897219492911143
Chapter II Neoplasms,Carcinoma in situ of breast,ITPA,Inosine triphosphate pyrophosphatase,11293,74,0.76 [0.54-1.07],0.113768051837319
Chapter II Neoplasms,Carcinoma in situ of breast,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",11330,75,0.77 [0.54-1.10],0.1488929204649806
Chapter II Neoplasms,Carcinoma in situ of breast,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",11311,73,0.86 [0.52-1.42],0.5590068562674085
Chapter II Neoplasms,Carcinoma in situ of breast,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",13108,85,0.84 [0.56-1.26],0.3963194797635939
Chapter II Neoplasms,Carcinoma in situ of breast,IZUMO1,Izumo sperm-egg fusion protein 1,11230,75,0.75 [0.43-1.30],0.303755714059037
Chapter II Neoplasms,Carcinoma in situ of breast,JAM2,Junctional adhesion molecule B,13577,89,0.71 [0.33-1.53],0.3801750122689248
Chapter II Neoplasms,Carcinoma in situ of breast,JAM3,Junctional adhesion molecule C,11384,76,0.77 [0.48-1.21],0.257234990499915
Chapter II Neoplasms,Carcinoma in situ of breast,JCHAIN,Immunoglobulin J chain,13187,89,0.96 [0.70-1.32],0.8099050747802116
Chapter II Neoplasms,Carcinoma in situ of breast,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,11230,75,0.93 [0.61-1.41],0.7285966687392089
Chapter II Neoplasms,Carcinoma in situ of breast,JPT2,Jupiter microtubule associated homolog 2,11587,77,0.84 [0.66-1.08],0.1687872819419564
Chapter II Neoplasms,Carcinoma in situ of breast,JUN,Transcription factor AP-1,13187,89,1.00 [0.71-1.40],0.9802751295639892
Chapter II Neoplasms,Carcinoma in situ of breast,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,13380,89,1.16 [0.76-1.78],0.4905162805594495
Chapter II Neoplasms,Carcinoma in situ of breast,KAZN,Kazrin,11587,77,0.82 [0.67-1.01],0.0651960698035271
Chapter II Neoplasms,Carcinoma in situ of breast,KCNC4,Potassium voltage-gated channel subfamily C member 4,11311,73,0.70 [0.43-1.16],0.1671620945232888
Chapter II Neoplasms,Carcinoma in situ of breast,KCNH2,Potassium voltage-gated channel subfamily H member 2,11312,75,0.92 [0.67-1.26],0.5913376694494992
Chapter II Neoplasms,Carcinoma in situ of breast,KCNIP4,Kv channel-interacting protein 4,13108,85,0.88 [0.58-1.34],0.5599061176258917
Chapter II Neoplasms,Carcinoma in situ of breast,KCTD5,BTB/POZ domain-containing protein KCTD5,11397,76,0.95 [0.57-1.60],0.8498702566249887
Chapter II Neoplasms,Carcinoma in situ of breast,KDM3A,Lysine-specific demethylase 3A,11319,73,1.02 [0.81-1.27],0.8927124797685483
Chapter II Neoplasms,Carcinoma in situ of breast,KDR,Vascular endothelial growth factor receptor 2,13480,90,1.38 [0.66-2.88],0.3857232691804154
Chapter II Neoplasms,Carcinoma in situ of breast,KEL,Kell blood group glycoprotein,13108,85,0.66 [0.39-1.14],0.1352203591854174
Chapter II Neoplasms,Carcinoma in situ of breast,KHDC3L,KH domain-containing protein 3,11230,75,0.79 [0.52-1.18],0.2501905112421962
Chapter II Neoplasms,Carcinoma in situ of breast,KHK,Ketohexokinase,11330,75,0.83 [0.59-1.17],0.2950335963176608
Chapter II Neoplasms,Carcinoma in situ of breast,KIAA0319,Dyslexia-associated protein KIAA0319,11617,76,0.86 [0.41-1.77],0.6787899888848645
Chapter II Neoplasms,Carcinoma in situ of breast,KIAA1549,UPF0606 protein KIAA1549,11399,77,0.99 [0.72-1.35],0.9347501753050482
Chapter II Neoplasms,Carcinoma in situ of breast,KIAA1549L,UPF0606 protein KIAA1549L,11399,77,0.87 [0.40-1.91],0.7335571622825452
Chapter II Neoplasms,Carcinoma in situ of breast,KIAA2013,Uncharacterized protein KIAA2013,11571,75,1.03 [0.72-1.48],0.8636659033286839
Chapter II Neoplasms,Carcinoma in situ of breast,KIF1C,Kinesin-like protein KIF1C,11293,74,0.46 [0.20-1.05],0.0652155943896426
Chapter II Neoplasms,Carcinoma in situ of breast,KIF20B,Kinesin-like protein KIF20B,11311,73,1.02 [0.77-1.34],0.911669679433151
Chapter II Neoplasms,Carcinoma in situ of breast,KIF22,Kinesin-like protein KIF22,11293,74,0.78 [0.65-0.93],0.0067736820768687
Chapter II Neoplasms,Carcinoma in situ of breast,KIFBP,KIF-binding protein,13380,89,0.77 [0.62-0.95],0.0156752354765473
Chapter II Neoplasms,Carcinoma in situ of breast,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,11571,75,0.85 [0.65-1.10],0.21689006755634
Chapter II Neoplasms,Carcinoma in situ of breast,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,13139,87,0.86 [0.67-1.11],0.2553862777536129
Chapter II Neoplasms,Carcinoma in situ of breast,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,11587,77,0.99 [0.88-1.13],0.9157222363262848
Chapter II Neoplasms,Carcinoma in situ of breast,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,13139,87,0.84 [0.72-0.99],0.0421125735891641
Chapter II Neoplasms,Carcinoma in situ of breast,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,11230,75,0.86 [0.64-1.17],0.3491939008627501
Chapter II Neoplasms,Carcinoma in situ of breast,KIRREL1,Kin of IRRE-like protein 1,11311,73,0.67 [0.40-1.14],0.1427286976463566
Chapter II Neoplasms,Carcinoma in situ of breast,KIRREL2,Kin of IRRE-like protein 2,13108,85,0.72 [0.44-1.18],0.1958522481509322
Chapter II Neoplasms,Carcinoma in situ of breast,KIT,Mast/stem cell growth factor receptor Kit,13441,89,1.98 [1.06-3.69],0.0328212110328165
Chapter II Neoplasms,Carcinoma in situ of breast,KITLG,Kit ligand,13452,90,1.21 [0.72-2.05],0.4731923883428147
Chapter II Neoplasms,Carcinoma in situ of breast,KLB,Beta-klotho,13108,85,0.97 [0.75-1.27],0.8471371047403846
Chapter II Neoplasms,Carcinoma in situ of breast,KLF4,Krueppel-like factor 4,11311,73,0.63 [0.35-1.16],0.138209550692113
Chapter II Neoplasms,Carcinoma in situ of breast,KLHL41,Kelch-like protein 41,11634,76,0.77 [0.47-1.28],0.321231802437844
Chapter II Neoplasms,Carcinoma in situ of breast,KLK1,Kallikrein-1,13305,88,0.96 [0.83-1.12],0.646176116041761
Chapter II Neoplasms,Carcinoma in situ of breast,KLK10,Kallikrein-10,13442,90,0.73 [0.45-1.19],0.2050052438185322
Chapter II Neoplasms,Carcinoma in situ of breast,KLK11,Kallikrein-11,13343,90,0.74 [0.38-1.45],0.3804178652168659
Chapter II Neoplasms,Carcinoma in situ of breast,KLK12,Kallikrein-12,13139,87,0.86 [0.75-0.98],0.0212054807229847
Chapter II Neoplasms,Carcinoma in situ of breast,KLK13,Kallikrein-13,13147,87,0.81 [0.52-1.27],0.367375687009155
Chapter II Neoplasms,Carcinoma in situ of breast,KLK14,Kallikrein-14,13571,87,0.66 [0.43-0.99],0.0460231895920007
Chapter II Neoplasms,Carcinoma in situ of breast,KLK15,Kallikrein-15,11555,75,0.67 [0.44-1.03],0.0712239148095899
Chapter II Neoplasms,Carcinoma in situ of breast,KLK3,Prostate-specific antigen,11632,77,1.29 [0.93-1.79],0.1276760321135411
Chapter II Neoplasms,Carcinoma in situ of breast,KLK4,Kallikrein-4,13571,87,1.22 [0.91-1.63],0.177523303545992
Chapter II Neoplasms,Carcinoma in situ of breast,KLK6,Kallikrein-6,13469,90,1.07 [0.57-2.02],0.8400937576593184
Chapter II Neoplasms,Carcinoma in situ of breast,KLK7,Kallikrein-7,11054,76,1.19 [0.69-2.07],0.5274861712653498
Chapter II Neoplasms,Carcinoma in situ of breast,KLK8,Kallikrein-8,12987,88,1.13 [0.66-1.94],0.6582406374526812
Chapter II Neoplasms,Carcinoma in situ of breast,KLKB1,Plasma kallikrein,11436,76,1.92 [0.87-4.24],0.108625499459408
Chapter II Neoplasms,Carcinoma in situ of breast,KLRB1,Killer cell lectin-like receptor subfamily B member 1,13604,89,0.96 [0.57-1.62],0.8786687603743587
Chapter II Neoplasms,Carcinoma in situ of breast,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,11311,73,0.67 [0.41-1.09],0.1086470622296125
Chapter II Neoplasms,Carcinoma in situ of breast,KLRD1,Natural killer cells antigen CD94,13604,89,0.76 [0.50-1.15],0.1964326491584378
Chapter II Neoplasms,Carcinoma in situ of breast,KLRF1,Killer cell lectin-like receptor subfamily F member 1,11319,73,0.98 [0.58-1.68],0.9552090268089216
Chapter II Neoplasms,Carcinoma in situ of breast,KLRK1,NKG2-D type II integral membrane protein,11617,76,0.85 [0.52-1.37],0.5009733204282311
Chapter II Neoplasms,Carcinoma in situ of breast,KRT14,"Keratin, type I cytoskeletal 14",12680,80,1.09 [0.56-2.11],0.8051255486143527
Chapter II Neoplasms,Carcinoma in situ of breast,KRT17,"Keratin, type I cytoskeletal 17",11293,74,0.90 [0.50-1.62],0.7156167627090018
Chapter II Neoplasms,Carcinoma in situ of breast,KRT18,"Keratin, type I cytoskeletal 18",13380,89,1.01 [0.79-1.29],0.9289046388462308
Chapter II Neoplasms,Carcinoma in situ of breast,KRT19,"Keratin, type I cytoskeletal 19",13418,87,0.84 [0.62-1.15],0.2814690374641201
Chapter II Neoplasms,Carcinoma in situ of breast,KRT5,"Keratin, type II cytoskeletal 5",13108,85,0.99 [0.66-1.49],0.96886153523139
Chapter II Neoplasms,Carcinoma in situ of breast,KRT6C,"Keratin, type II cytoskeletal 6C",11293,74,0.83 [0.45-1.52],0.5466520282349058
Chapter II Neoplasms,Carcinoma in situ of breast,KRT8,"Keratin, type II cytoskeletal 8",11311,73,0.72 [0.43-1.19],0.2027495029866825
Chapter II Neoplasms,Carcinoma in situ of breast,KYAT1,Kynurenine--oxoglutarate transaminase 1,13422,88,0.78 [0.55-1.10],0.1528633303290229
Chapter II Neoplasms,Carcinoma in situ of breast,KYNU,Kynureninase,13604,89,0.68 [0.44-1.06],0.0874410727505775
Chapter II Neoplasms,Carcinoma in situ of breast,L1CAM,Neural cell adhesion molecule L1,13480,90,1.34 [0.70-2.59],0.3794581971354623
Chapter II Neoplasms,Carcinoma in situ of breast,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,11652,74,0.88 [0.68-1.12],0.2990326455295725
Chapter II Neoplasms,Carcinoma in situ of breast,LACRT,Extracellular glycoprotein lacritin,11555,75,1.09 [0.73-1.63],0.6742298967191314
Chapter II Neoplasms,Carcinoma in situ of breast,LACTB2,Endoribonuclease LACTB2,13452,90,0.80 [0.60-1.07],0.1377392011468973
Chapter II Neoplasms,Carcinoma in situ of breast,LAG3,Lymphocyte activation gene 3 protein,13380,89,0.80 [0.50-1.30],0.3705224227956847
Chapter II Neoplasms,Carcinoma in situ of breast,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,13445,90,0.76 [0.44-1.32],0.3346621676866423
Chapter II Neoplasms,Carcinoma in situ of breast,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,13363,90,1.07 [0.89-1.29],0.475102890778302
Chapter II Neoplasms,Carcinoma in situ of breast,LAMA1,Laminin subunit alpha-1,11293,74,0.67 [0.39-1.15],0.1486332763733503
Chapter II Neoplasms,Carcinoma in situ of breast,LAMA4,Laminin subunit alpha-4,13507,91,0.53 [0.30-0.96],0.0350741973285142
Chapter II Neoplasms,Carcinoma in situ of breast,LAMB1,Laminin subunit beta-1,11330,75,0.63 [0.31-1.30],0.211956469535005
Chapter II Neoplasms,Carcinoma in situ of breast,LAMP1,Lysosome-associated membrane glycoprotein 1,11324,75,1.41 [0.85-2.34],0.1859908846839436
Chapter II Neoplasms,Carcinoma in situ of breast,LAMP2,Lysosome-associated membrane glycoprotein 2,13037,86,0.39 [0.14-1.08],0.0713213040361675
Chapter II Neoplasms,Carcinoma in situ of breast,LAMP3,Lysosome-associated membrane glycoprotein 3,13577,88,0.94 [0.64-1.39],0.7572072088032763
Chapter II Neoplasms,Carcinoma in situ of breast,LAMTOR5,Ragulator complex protein LAMTOR5,11571,75,1.05 [0.63-1.75],0.8627417087195586
Chapter II Neoplasms,Carcinoma in situ of breast,LAP3,Cytosol aminopeptidase,13187,89,0.70 [0.47-1.05],0.0839421597118749
Chapter II Neoplasms,Carcinoma in situ of breast,LARP1,La-related protein 1,11571,75,0.97 [0.69-1.36],0.8749883063524418
Chapter II Neoplasms,Carcinoma in situ of breast,LAT,Linker for activation of T-cells family member 1,13604,89,0.78 [0.62-0.97],0.0293299313557756
Chapter II Neoplasms,Carcinoma in situ of breast,LAT2,Linker for activation of T-cells family member 2,13380,89,0.80 [0.68-0.94],0.0059815623006654
Chapter II Neoplasms,Carcinoma in situ of breast,LATS1,Serine/threonine-protein kinase LATS1,11319,73,0.77 [0.59-1.02],0.0660194903873809
Chapter II Neoplasms,Carcinoma in situ of breast,LAYN,Layilin,13334,90,1.14 [0.63-2.05],0.6633364168358983
Chapter II Neoplasms,Carcinoma in situ of breast,LBP,Lipopolysaccharide-binding protein,13459,89,1.11 [0.80-1.52],0.53756613859843
Chapter II Neoplasms,Carcinoma in situ of breast,LBR,Delta(14)-sterol reductase LBR,13577,89,0.93 [0.70-1.23],0.611436066454327
Chapter II Neoplasms,Carcinoma in situ of breast,LCAT,Phosphatidylcholine-sterol acyltransferase,11650,75,1.37 [0.50-3.74],0.5407044201997404
Chapter II Neoplasms,Carcinoma in situ of breast,LCN15,Lipocalin-15,11634,76,0.83 [0.56-1.23],0.344093207936388
Chapter II Neoplasms,Carcinoma in situ of breast,LCN2,Neutrophil gelatinase-associated lipocalin,12984,83,1.47 [0.89-2.43],0.1290358917354199
Chapter II Neoplasms,Carcinoma in situ of breast,LCP1,Plastin-2,11632,77,0.88 [0.55-1.40],0.57988356632161
Chapter II Neoplasms,Carcinoma in situ of breast,LDLR,Low-density lipoprotein receptor,13485,87,0.96 [0.67-1.39],0.8422132730939603
Chapter II Neoplasms,Carcinoma in situ of breast,LDLRAP1,Low density lipoprotein receptor adapter protein 1,11634,76,0.77 [0.61-0.96],0.0217174924193921
Chapter II Neoplasms,Carcinoma in situ of breast,LECT2,Leukocyte cell-derived chemotaxin-2,11652,74,0.76 [0.53-1.08],0.1256252661706661
Chapter II Neoplasms,Carcinoma in situ of breast,LEFTY2,Left-right determination factor 2,13550,87,1.06 [0.75-1.49],0.757695040943407
Chapter II Neoplasms,Carcinoma in situ of breast,LEG1,Protein LEG1 homolog,10988,73,1.15 [0.83-1.57],0.4002481991195196
Chapter II Neoplasms,Carcinoma in situ of breast,LELP1,Late cornified envelope-like proline-rich protein 1,11311,73,0.97 [0.71-1.32],0.8375336773962496
Chapter II Neoplasms,Carcinoma in situ of breast,LEO1,RNA polymerase-associated protein LEO1,11634,76,0.69 [0.29-1.66],0.4106370487350048
Chapter II Neoplasms,Carcinoma in situ of breast,LEP,Leptin,13452,90,0.92 [0.70-1.22],0.5757516938966498
Chapter II Neoplasms,Carcinoma in situ of breast,LEPR,Leptin receptor,13452,90,0.83 [0.44-1.54],0.5488108072567262
Chapter II Neoplasms,Carcinoma in situ of breast,LETM1,Mitochondrial proton/calcium exchanger protein,11634,76,0.60 [0.38-0.96],0.0322648387611498
Chapter II Neoplasms,Carcinoma in situ of breast,LGALS1,Galectin-1,13452,90,0.94 [0.53-1.66],0.8395968840553422
Chapter II Neoplasms,Carcinoma in situ of breast,LGALS3,Galectin-3,13480,87,0.71 [0.37-1.33],0.283467001776844
Chapter II Neoplasms,Carcinoma in situ of breast,LGALS3BP,Galectin-3-binding protein,11662,77,1.01 [0.50-2.06],0.9689932364854312
Chapter II Neoplasms,Carcinoma in situ of breast,LGALS4,Galectin-4,13445,90,0.81 [0.56-1.18],0.2697433353798592
Chapter II Neoplasms,Carcinoma in situ of breast,LGALS7_LGALS7B,Galectin-7,13436,86,0.80 [0.49-1.32],0.3852789419867348
Chapter II Neoplasms,Carcinoma in situ of breast,LGALS8,Galectin-8,13577,89,0.67 [0.48-0.93],0.0180269110382689
Chapter II Neoplasms,Carcinoma in situ of breast,LGALS9,Galectin-9,13436,89,0.60 [0.33-1.10],0.0985657839587825
Chapter II Neoplasms,Carcinoma in situ of breast,LGMN,Legumain,13507,91,0.61 [0.36-1.04],0.0684516464248526
Chapter II Neoplasms,Carcinoma in situ of breast,LHB,Lutropin subunit beta,13139,87,0.78 [0.60-1.01],0.0630864690973893
Chapter II Neoplasms,Carcinoma in situ of breast,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,13458,91,1.08 [0.80-1.46],0.6240581696379095
Chapter II Neoplasms,Carcinoma in situ of breast,LIF,Leukemia inhibitory factor,13108,85,0.84 [0.56-1.25],0.3811100149560575
Chapter II Neoplasms,Carcinoma in situ of breast,LIFR,Leukemia inhibitory factor receptor,13434,87,0.85 [0.39-1.87],0.6908462150393464
Chapter II Neoplasms,Carcinoma in situ of breast,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,13449,89,0.88 [0.54-1.43],0.5977027869934699
Chapter II Neoplasms,Carcinoma in situ of breast,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,11632,77,1.04 [0.88-1.24],0.6366736881921179
Chapter II Neoplasms,Carcinoma in situ of breast,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,11293,74,0.76 [0.46-1.24],0.2681805486797723
Chapter II Neoplasms,Carcinoma in situ of breast,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,13434,90,0.71 [0.39-1.27],0.2452624594650712
Chapter II Neoplasms,Carcinoma in situ of breast,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,11652,74,0.79 [0.59-1.06],0.1169391072817061
Chapter II Neoplasms,Carcinoma in situ of breast,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,13609,89,0.75 [0.38-1.49],0.4141369621090655
Chapter II Neoplasms,Carcinoma in situ of breast,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,13531,87,1.12 [0.65-1.95],0.6756648944069144
Chapter II Neoplasms,Carcinoma in situ of breast,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,13187,89,0.71 [0.45-1.13],0.1516571842991493
Chapter II Neoplasms,Carcinoma in situ of breast,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,13609,89,0.89 [0.69-1.15],0.3910051800999669
Chapter II Neoplasms,Carcinoma in situ of breast,LIPF,Gastric triacylglycerol lipase,11330,75,1.34 [0.94-1.92],0.1085852440556444
Chapter II Neoplasms,Carcinoma in situ of breast,LMNB1,Lamin-B1,11562,77,1.52 [1.18-1.96],0.0012788317575717
Chapter II Neoplasms,Carcinoma in situ of breast,LMNB2,Lamin-B2,11617,76,1.25 [0.57-2.74],0.583807243084757
Chapter II Neoplasms,Carcinoma in situ of breast,LMOD1,Leiomodin-1,11634,76,0.79 [0.40-1.55],0.4886210567238607
Chapter II Neoplasms,Carcinoma in situ of breast,LMOD2,Leiomodin-2,11311,73,0.67 [0.44-1.02],0.0605134882335914
Chapter II Neoplasms,Carcinoma in situ of breast,LONP1,"Lon protease homolog, mitochondrial",11330,75,0.87 [0.67-1.13],0.2929029808718881
Chapter II Neoplasms,Carcinoma in situ of breast,LPA,Apolipoprotein(a),11361,75,1.04 [0.92-1.18],0.5432188351815825
Chapter II Neoplasms,Carcinoma in situ of breast,LPCAT2,Lysophosphatidylcholine acyltransferase 2,13380,89,1.38 [1.02-1.86],0.0369161833652622
Chapter II Neoplasms,Carcinoma in situ of breast,LPL,Lipoprotein lipase,13452,90,1.13 [0.75-1.69],0.5694523102942735
Chapter II Neoplasms,Carcinoma in situ of breast,LPO,Lactoperoxidase,13040,88,0.89 [0.64-1.24],0.4965619194769143
Chapter II Neoplasms,Carcinoma in situ of breast,LPP,Lipoma-preferred partner,11293,74,0.69 [0.49-0.97],0.0348565808810011
Chapter II Neoplasms,Carcinoma in situ of breast,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,11293,74,0.67 [0.47-0.96],0.0300423361967716
Chapter II Neoplasms,Carcinoma in situ of breast,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,11312,75,0.62 [0.34-1.12],0.1125533703407531
Chapter II Neoplasms,Carcinoma in situ of breast,LRG1,Leucine-rich alpha-2-glycoprotein,11662,77,1.70 [0.77-3.75],0.1861059798796983
Chapter II Neoplasms,Carcinoma in situ of breast,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,13534,86,0.81 [0.47-1.42],0.4630193032073116
Chapter II Neoplasms,Carcinoma in situ of breast,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,11276,72,0.83 [0.36-1.92],0.6626452606027331
Chapter II Neoplasms,Carcinoma in situ of breast,LRP1,Prolow-density lipoprotein receptor-related protein 1,13380,89,0.65 [0.31-1.37],0.2581960874143786
Chapter II Neoplasms,Carcinoma in situ of breast,LRP11,Low-density lipoprotein receptor-related protein 11,13452,90,0.90 [0.52-1.55],0.6988070833516808
Chapter II Neoplasms,Carcinoma in situ of breast,LRP2,Low-density lipoprotein receptor-related protein 2,11312,75,0.66 [0.34-1.30],0.2295347811306975
Chapter II Neoplasms,Carcinoma in situ of breast,LRP2BP,LRP2-binding protein,11312,75,0.95 [0.72-1.25],0.701242635678063
Chapter II Neoplasms,Carcinoma in situ of breast,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,13577,89,0.72 [0.48-1.09],0.1196316016730424
Chapter II Neoplasms,Carcinoma in situ of breast,LRRC25,Leucine-rich repeat-containing protein 25,13380,89,1.06 [0.66-1.71],0.803234809301218
Chapter II Neoplasms,Carcinoma in situ of breast,LRRC37A2,Leucine-rich repeat-containing protein 37A2,11587,77,1.08 [0.64-1.80],0.7816575616631155
Chapter II Neoplasms,Carcinoma in situ of breast,LRRC38,Leucine-rich repeat-containing protein 38,11312,75,1.13 [0.74-1.71],0.5747033965101935
Chapter II Neoplasms,Carcinoma in situ of breast,LRRC59,Leucine-rich repeat-containing protein 59,11652,74,0.51 [0.29-0.90],0.0189160970387997
Chapter II Neoplasms,Carcinoma in situ of breast,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,11571,75,0.65 [0.39-1.07],0.0917775581509507
Chapter II Neoplasms,Carcinoma in situ of breast,LRRN1,Leucine-rich repeat neuronal protein 1,13187,89,1.19 [0.73-1.96],0.4859674706774463
Chapter II Neoplasms,Carcinoma in situ of breast,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,11312,75,0.52 [0.27-1.00],0.051260079236986
Chapter II Neoplasms,Carcinoma in situ of breast,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,11634,76,0.88 [0.39-2.01],0.7618059784446041
Chapter II Neoplasms,Carcinoma in situ of breast,LSM1,U6 snRNA-associated Sm-like protein LSm1,13139,87,0.81 [0.55-1.19],0.2807069983031551
Chapter II Neoplasms,Carcinoma in situ of breast,LSM8,U6 snRNA-associated Sm-like protein LSm8,11399,77,0.99 [0.78-1.26],0.9669775918514224
Chapter II Neoplasms,Carcinoma in situ of breast,LSP1,Lymphocyte-specific protein 1,13434,87,1.18 [0.75-1.85],0.4854202192095947
Chapter II Neoplasms,Carcinoma in situ of breast,LTA,Lymphotoxin-alpha,13434,87,0.81 [0.50-1.31],0.3958121554548238
Chapter II Neoplasms,Carcinoma in situ of breast,LTA4H,Leukotriene A-4 hydrolase,13571,87,0.89 [0.63-1.25],0.4942664012417989
Chapter II Neoplasms,Carcinoma in situ of breast,LTB,Lymphotoxin-beta,11571,75,0.91 [0.47-1.75],0.771592970852961
Chapter II Neoplasms,Carcinoma in situ of breast,LTBP2,Latent-transforming growth factor beta-binding protein 2,13609,89,0.81 [0.44-1.49],0.4950338852870707
Chapter II Neoplasms,Carcinoma in situ of breast,LTBP3,Latent-transforming growth factor beta-binding protein 3,13139,87,0.73 [0.48-1.10],0.1309775750969016
Chapter II Neoplasms,Carcinoma in situ of breast,LTBR,Tumor necrosis factor receptor superfamily member 3,13367,88,1.48 [0.73-3.00],0.2762033477592807
Chapter II Neoplasms,Carcinoma in situ of breast,LTO1,Protein LTO1 homolog,13187,89,0.64 [0.38-1.08],0.0941559772400306
Chapter II Neoplasms,Carcinoma in situ of breast,LUZP2,Leucine zipper protein 2,11571,75,1.02 [0.63-1.65],0.9456385566237298
Chapter II Neoplasms,Carcinoma in situ of breast,LXN,Latexin,13298,90,1.10 [0.85-1.43],0.473781211482625
Chapter II Neoplasms,Carcinoma in situ of breast,LY6D,Lymphocyte antigen 6D,13360,88,1.08 [0.63-1.84],0.7797912976515335
Chapter II Neoplasms,Carcinoma in situ of breast,LY75,Lymphocyte antigen 75,13434,87,0.70 [0.43-1.11],0.1307638089408026
Chapter II Neoplasms,Carcinoma in situ of breast,LY9,T-lymphocyte surface antigen Ly-9,13324,89,0.58 [0.29-1.14],0.1147140564373399
Chapter II Neoplasms,Carcinoma in situ of breast,LY96,Lymphocyte antigen 96,13363,90,0.66 [0.37-1.17],0.1563814516272939
Chapter II Neoplasms,Carcinoma in situ of breast,LYAR,Cell growth-regulating nucleolar protein,13139,87,0.83 [0.55-1.25],0.3751361658049702
Chapter II Neoplasms,Carcinoma in situ of breast,LYN,Tyrosine-protein kinase Lyn,13380,89,0.76 [0.61-0.95],0.0152915859541831
Chapter II Neoplasms,Carcinoma in situ of breast,LYPD1,Ly6/PLAUR domain-containing protein 1,13108,85,0.74 [0.49-1.10],0.1376955433417292
Chapter II Neoplasms,Carcinoma in situ of breast,LYPD3,Ly6/PLAUR domain-containing protein 3,13377,90,1.55 [0.94-2.55],0.087336810615521
Chapter II Neoplasms,Carcinoma in situ of breast,LYPD8,Ly6/PLAUR domain-containing protein 8,13139,87,0.97 [0.66-1.41],0.8592643627604672
Chapter II Neoplasms,Carcinoma in situ of breast,LYPLA2,Acyl-protein thioesterase 2,11311,73,1.03 [0.85-1.26],0.7368181482327376
Chapter II Neoplasms,Carcinoma in situ of breast,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,11312,75,0.81 [0.63-1.04],0.0957084971948671
Chapter II Neoplasms,Carcinoma in situ of breast,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,11662,77,0.63 [0.21-1.91],0.4101555416880311
Chapter II Neoplasms,Carcinoma in situ of breast,LYZL2,Lysozyme-like protein 2,11230,75,1.15 [0.65-2.03],0.6235829055213634
Chapter II Neoplasms,Carcinoma in situ of breast,LZTFL1,Leucine zipper transcription factor-like protein 1,11384,76,0.75 [0.54-1.03],0.07245808177648
Chapter II Neoplasms,Carcinoma in situ of breast,M6PR,Cation-dependent mannose-6-phosphate receptor,11330,75,0.99 [0.59-1.68],0.983387487784053
Chapter II Neoplasms,Carcinoma in situ of breast,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,13317,90,0.94 [0.63-1.42],0.77151379146787
Chapter II Neoplasms,Carcinoma in situ of breast,MAEA,E3 ubiquitin-protein transferase MAEA,13139,87,0.58 [0.34-0.99],0.0463815859162029
Chapter II Neoplasms,Carcinoma in situ of breast,MAG,Myelin-associated glycoprotein,11312,75,0.77 [0.48-1.23],0.2691629206251918
Chapter II Neoplasms,Carcinoma in situ of breast,MAGEA3,Melanoma-associated antigen 3,11399,77,1.20 [0.93-1.55],0.1616194136676809
Chapter II Neoplasms,Carcinoma in situ of breast,MAGED1,Melanoma-associated antigen D1,13139,87,0.76 [0.50-1.16],0.2054974049139758
Chapter II Neoplasms,Carcinoma in situ of breast,MAMDC2,MAM domain-containing protein 2,11652,74,1.02 [0.52-2.02],0.9488792497741734
Chapter II Neoplasms,Carcinoma in situ of breast,MAMDC4,Apical endosomal glycoprotein,11571,75,1.02 [0.68-1.53],0.9145457881321112
Chapter II Neoplasms,Carcinoma in situ of breast,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",11330,75,1.12 [0.47-2.65],0.7940254984754048
Chapter II Neoplasms,Carcinoma in situ of breast,MAN2B2,Epididymis-specific alpha-mannosidase,11652,74,0.92 [0.63-1.33],0.6557705375764633
Chapter II Neoplasms,Carcinoma in situ of breast,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",11230,75,0.97 [0.62-1.50],0.8800032397349618
Chapter II Neoplasms,Carcinoma in situ of breast,MANF,Mesencephalic astrocyte-derived neurotrophic factor,13507,91,0.85 [0.74-0.98],0.0278931664768374
Chapter II Neoplasms,Carcinoma in situ of breast,MANSC1,MANSC domain-containing protein 1,13480,90,1.62 [0.84-3.12],0.1495673426931157
Chapter II Neoplasms,Carcinoma in situ of breast,MANSC4,MANSC domain-containing protein 4,11293,74,0.77 [0.53-1.13],0.1874055664069387
Chapter II Neoplasms,Carcinoma in situ of breast,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,11311,73,0.90 [0.45-1.82],0.7745297462510355
Chapter II Neoplasms,Carcinoma in situ of breast,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,11293,74,1.08 [0.80-1.45],0.6366359324615569
Chapter II Neoplasms,Carcinoma in situ of breast,MAP2,Microtubule-associated protein 2,11617,76,0.49 [0.28-0.87],0.0144318189062399
Chapter II Neoplasms,Carcinoma in situ of breast,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,11587,77,0.69 [0.49-0.97],0.0306731854344255
Chapter II Neoplasms,Carcinoma in situ of breast,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,13434,87,0.84 [0.70-1.01],0.0694137085197117
Chapter II Neoplasms,Carcinoma in situ of breast,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,13139,87,0.76 [0.62-0.94],0.0122862537508422
Chapter II Neoplasms,Carcinoma in situ of breast,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,13334,90,0.82 [0.70-0.97],0.0201985172350034
Chapter II Neoplasms,Carcinoma in situ of breast,MAPK13,Mitogen-activated protein kinase 13,11230,75,1.09 [0.67-1.77],0.7176940060956569
Chapter II Neoplasms,Carcinoma in situ of breast,MAPK9,Mitogen-activated protein kinase 9,13434,87,0.79 [0.51-1.21],0.2705335645027809
Chapter II Neoplasms,Carcinoma in situ of breast,MAPKAPK2,MAP kinase-activated protein kinase 2,11399,77,0.78 [0.57-1.05],0.105637897918761
Chapter II Neoplasms,Carcinoma in situ of breast,MAPRE3,Microtubule-associated protein RP/EB family member 3,11230,75,0.92 [0.77-1.09],0.3342521654247021
Chapter II Neoplasms,Carcinoma in situ of breast,MAPT,Microtubule-associated protein tau,13108,85,0.88 [0.62-1.25],0.4812333797838747
Chapter II Neoplasms,Carcinoma in situ of breast,MARCO,Macrophage receptor MARCO,13452,90,0.86 [0.42-1.73],0.6642879903051578
Chapter II Neoplasms,Carcinoma in situ of breast,MARS1,"Methionine--tRNA ligase, cytoplasmic",11355,76,0.80 [0.62-1.04],0.1028554561193587
Chapter II Neoplasms,Carcinoma in situ of breast,MASP1,Mannan-binding lectin serine protease 1,13334,90,0.99 [0.45-2.18],0.984796521845952
Chapter II Neoplasms,Carcinoma in situ of breast,MATN2,Matrilin-2,13470,90,0.87 [0.47-1.63],0.6671573389674585
Chapter II Neoplasms,Carcinoma in situ of breast,MATN3,Matrilin-3,13342,90,1.52 [0.82-2.79],0.1802402712382231
Chapter II Neoplasms,Carcinoma in situ of breast,MAVS,Mitochondrial antiviral-signaling protein,13139,87,0.74 [0.60-0.93],0.0079533242923874
Chapter II Neoplasms,Carcinoma in situ of breast,MAX,Protein max,13108,85,0.79 [0.65-0.95],0.0128824241499835
Chapter II Neoplasms,Carcinoma in situ of breast,MB,Myoglobin,13609,89,0.98 [0.67-1.45],0.937023444472012
Chapter II Neoplasms,Carcinoma in situ of breast,MBL2,Mannose-binding protein C,11490,76,1.06 [0.86-1.30],0.6030822563384037
Chapter II Neoplasms,Carcinoma in situ of breast,MCAM,Cell surface glycoprotein MUC18,13459,89,1.24 [0.72-2.13],0.4412442482945325
Chapter II Neoplasms,Carcinoma in situ of breast,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",11634,76,0.61 [0.33-1.10],0.1011366267055682
Chapter II Neoplasms,Carcinoma in situ of breast,MCEMP1,Mast cell-expressed membrane protein 1,11319,73,0.93 [0.72-1.19],0.5536169857511402
Chapter II Neoplasms,Carcinoma in situ of breast,MCFD2,Multiple coagulation factor deficiency protein 2,13404,90,0.77 [0.50-1.19],0.2353872088108095
Chapter II Neoplasms,Carcinoma in situ of breast,MCTS1,Malignant T-cell-amplified sequence 1,11587,77,0.94 [0.39-2.23],0.8845473032620945
Chapter II Neoplasms,Carcinoma in situ of breast,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,13363,90,0.83 [0.64-1.07],0.1530018105955003
Chapter II Neoplasms,Carcinoma in situ of breast,MDH1,"Malate dehydrogenase, cytoplasmic",11576,75,0.58 [0.32-1.03],0.0632915896236009
Chapter II Neoplasms,Carcinoma in situ of breast,MDK,Midkine,13439,90,0.82 [0.56-1.21],0.3222529291981447
Chapter II Neoplasms,Carcinoma in situ of breast,MDM1,Nuclear protein MDM1,11312,75,0.33 [0.15-0.69],0.0033309709042326
Chapter II Neoplasms,Carcinoma in situ of breast,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",11330,75,0.85 [0.66-1.08],0.1868066122288351
Chapter II Neoplasms,Carcinoma in situ of breast,MED18,Mediator of RNA polymerase II transcription subunit 18,13139,87,0.76 [0.59-0.97],0.0281362012908256
Chapter II Neoplasms,Carcinoma in situ of breast,MED21,Mediator of RNA polymerase II transcription subunit 21,11293,74,0.79 [0.46-1.35],0.3859836281454265
Chapter II Neoplasms,Carcinoma in situ of breast,MEGF10,Multiple epidermal growth factor-like domains protein 10,13445,90,0.76 [0.48-1.21],0.2514881805712725
Chapter II Neoplasms,Carcinoma in situ of breast,MEGF11,Multiple epidermal growth factor-like domains protein 11,11293,74,0.46 [0.19-1.07],0.071518634442872
Chapter II Neoplasms,Carcinoma in situ of breast,MEGF9,Multiple epidermal growth factor-like domains protein 9,13559,87,0.78 [0.32-1.88],0.5817256463384264
Chapter II Neoplasms,Carcinoma in situ of breast,MELTF,Melanotransferrin,11652,74,0.37 [0.18-0.76],0.0067874631707976
Chapter II Neoplasms,Carcinoma in situ of breast,MENT,Protein MENT,11384,76,1.81 [0.64-5.16],0.2647563778891202
Chapter II Neoplasms,Carcinoma in situ of breast,MEP1A,Meprin A subunit alpha,11587,77,1.03 [0.75-1.41],0.8699200636034846
Chapter II Neoplasms,Carcinoma in situ of breast,MEP1B,Meprin A subunit beta,13452,90,1.04 [0.89-1.22],0.604736530677743
Chapter II Neoplasms,Carcinoma in situ of breast,MEPE,Matrix extracellular phosphoglycoprotein,13445,90,0.82 [0.41-1.65],0.5833170777097257
Chapter II Neoplasms,Carcinoma in situ of breast,MERTK,Tyrosine-protein kinase Mer,13604,89,0.99 [0.49-2.01],0.9735653779276464
Chapter II Neoplasms,Carcinoma in situ of breast,MESD,LRP chaperone MESD,13449,89,0.84 [0.72-0.99],0.0319087451920997
Chapter II Neoplasms,Carcinoma in situ of breast,MET,Hepatocyte growth factor receptor,13480,87,0.70 [0.27-1.82],0.4684625962320624
Chapter II Neoplasms,Carcinoma in situ of breast,METAP1,Methionine aminopeptidase 1,13108,85,1.18 [0.66-2.11],0.5778206969235138
Chapter II Neoplasms,Carcinoma in situ of breast,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",13434,87,0.87 [0.69-1.10],0.255724049719076
Chapter II Neoplasms,Carcinoma in situ of breast,METAP2,Methionine aminopeptidase 2,13550,87,0.69 [0.51-0.94],0.0171698971264657
Chapter II Neoplasms,Carcinoma in situ of breast,MFAP3,Microfibril-associated glycoprotein 3,13220,88,1.26 [0.92-1.72],0.1430910484604755
Chapter II Neoplasms,Carcinoma in situ of breast,MFAP3L,Microfibrillar-associated protein 3-like,11312,75,0.88 [0.61-1.28],0.516905653568291
Chapter II Neoplasms,Carcinoma in situ of breast,MFAP4,Microfibril-associated glycoprotein 4,11384,76,0.90 [0.44-1.84],0.7793118789910798
Chapter II Neoplasms,Carcinoma in situ of breast,MFAP5,Microfibrillar-associated protein 5,13609,89,0.86 [0.55-1.36],0.528809962996998
Chapter II Neoplasms,Carcinoma in situ of breast,MFGE8,Lactadherin,13449,89,0.79 [0.50-1.26],0.3254494840484566
Chapter II Neoplasms,Carcinoma in situ of breast,MGLL,Monoglyceride lipase,13486,91,0.82 [0.67-1.01],0.0567221500091155
Chapter II Neoplasms,Carcinoma in situ of breast,MGMT,Methylated-DNA--protein-cysteine methyltransferase,13434,87,0.91 [0.79-1.06],0.2350288947225353
Chapter II Neoplasms,Carcinoma in situ of breast,MIA,Melanoma-derived growth regulatory protein,13480,90,1.12 [0.67-1.88],0.6524766823135254
Chapter II Neoplasms,Carcinoma in situ of breast,MICALL2,MICAL-like protein 2,11312,75,0.57 [0.39-0.85],0.0056162088455313
Chapter II Neoplasms,Carcinoma in situ of breast,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,13434,87,1.00 [0.88-1.13],0.9928161484469732
Chapter II Neoplasms,Carcinoma in situ of breast,MIF,Macrophage migration inhibitory factor,13428,89,0.79 [0.61-1.04],0.0892358090126202
Chapter II Neoplasms,Carcinoma in situ of breast,MILR1,Allergin-1,13187,89,0.75 [0.51-1.12],0.1586982268258142
Chapter II Neoplasms,Carcinoma in situ of breast,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,11571,75,0.75 [0.61-0.91],0.0039538913986032
Chapter II Neoplasms,Carcinoma in situ of breast,MINK1,Misshapen-like kinase 1,11617,76,0.72 [0.58-0.91],0.005891352716196
Chapter II Neoplasms,Carcinoma in situ of breast,MITD1,MIT domain-containing protein 1,13363,90,0.80 [0.66-0.96],0.015884521200852
Chapter II Neoplasms,Carcinoma in situ of breast,MKI67,Proliferation marker protein Ki-67,11319,73,1.16 [0.70-1.92],0.5731497125650618
Chapter II Neoplasms,Carcinoma in situ of breast,MLLT1,Protein ENL,11230,75,1.27 [1.00-1.62],0.0534064943822154
Chapter II Neoplasms,Carcinoma in situ of breast,MLN,Promotilin,13434,87,1.01 [0.81-1.24],0.9566081494252208
Chapter II Neoplasms,Carcinoma in situ of breast,MME,Neprilysin,13380,89,1.02 [0.81-1.28],0.887818252004126
Chapter II Neoplasms,Carcinoma in situ of breast,MMP1,Interstitial collagenase,12936,86,0.82 [0.67-1.00],0.0454935174369358
Chapter II Neoplasms,Carcinoma in situ of breast,MMP10,Stromelysin-2,13434,90,0.88 [0.64-1.21],0.4324060442773332
Chapter II Neoplasms,Carcinoma in situ of breast,MMP12,Macrophage metalloelastase,13469,86,0.89 [0.60-1.31],0.5551910022936604
Chapter II Neoplasms,Carcinoma in situ of breast,MMP13,Collagenase 3,13108,85,0.90 [0.50-1.63],0.734075756069889
Chapter II Neoplasms,Carcinoma in situ of breast,MMP15,Matrix metalloproteinase-15,11652,74,0.82 [0.48-1.42],0.485741995447154
Chapter II Neoplasms,Carcinoma in situ of breast,MMP3,Stromelysin-1,13449,89,1.23 [0.83-1.81],0.2954717200795967
Chapter II Neoplasms,Carcinoma in situ of breast,MMP7,Matrilysin,13194,88,0.89 [0.60-1.32],0.549996134754344
Chapter II Neoplasms,Carcinoma in situ of breast,MMP8,Neutrophil collagenase,13557,89,1.14 [0.89-1.46],0.3070679579797163
Chapter II Neoplasms,Carcinoma in situ of breast,MMP9,Matrix metalloproteinase-9,13428,89,0.98 [0.72-1.33],0.8910408330821996
Chapter II Neoplasms,Carcinoma in situ of breast,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",11293,74,0.65 [0.40-1.07],0.0888762389942382
Chapter II Neoplasms,Carcinoma in situ of breast,MN1,Transcriptional activator MN1,11312,75,0.68 [0.42-1.09],0.1083549051389509
Chapter II Neoplasms,Carcinoma in situ of breast,MNAT1,CDK-activating kinase assembly factor MAT1,11399,77,1.26 [0.83-1.92],0.2792034108035185
Chapter II Neoplasms,Carcinoma in situ of breast,MNDA,Myeloid cell nuclear differentiation antigen,13434,90,1.10 [0.92-1.30],0.2911094617009469
Chapter II Neoplasms,Carcinoma in situ of breast,MOCS2,Molybdopterin synthase catalytic subunit,11384,76,0.66 [0.47-0.93],0.0179637276454651
Chapter II Neoplasms,Carcinoma in situ of breast,MOG,Myelin-oligodendrocyte glycoprotein,13571,87,0.80 [0.44-1.47],0.4745186040516274
Chapter II Neoplasms,Carcinoma in situ of breast,MORC3,MORC family CW-type zinc finger protein 3,11617,76,1.23 [0.62-2.42],0.556082672684776
Chapter II Neoplasms,Carcinoma in situ of breast,MORF4L1,Mortality factor 4-like protein 1,11399,77,0.97 [0.56-1.65],0.8969628930361144
Chapter II Neoplasms,Carcinoma in situ of breast,MORF4L2,Mortality factor 4-like protein 2,11230,75,1.02 [0.57-1.83],0.9457133395169256
Chapter II Neoplasms,Carcinoma in situ of breast,MORN4,MORN repeat-containing protein 4,11230,75,0.82 [0.59-1.14],0.236297681437268
Chapter II Neoplasms,Carcinoma in situ of breast,MPHOSPH8,M-phase phosphoprotein 8,13220,88,0.80 [0.61-1.04],0.0984005016157854
Chapter II Neoplasms,Carcinoma in situ of breast,MPI,Mannose-6-phosphate isomerase,13380,89,0.82 [0.66-1.02],0.0798669199219112
Chapter II Neoplasms,Carcinoma in situ of breast,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,13486,91,0.83 [0.66-1.04],0.0991606428065577
Chapter II Neoplasms,Carcinoma in situ of breast,MPO,Myeloperoxidase,13449,89,1.12 [0.76-1.65],0.5713373446702283
Chapter II Neoplasms,Carcinoma in situ of breast,MPRIP,Myosin phosphatase Rho-interacting protein,11549,75,0.66 [0.40-1.09],0.1034963972490634
Chapter II Neoplasms,Carcinoma in situ of breast,MRC1,Macrophage mannose receptor 1,11650,75,0.66 [0.29-1.49],0.3212587301127844
Chapter II Neoplasms,Carcinoma in situ of breast,MRI1,Methylthioribose-1-phosphate isomerase,11312,75,0.96 [0.70-1.32],0.8087334842915046
Chapter II Neoplasms,Carcinoma in situ of breast,MRPL24,"39S ribosomal protein L24, mitochondrial",11293,74,1.07 [0.64-1.79],0.7859966952623666
Chapter II Neoplasms,Carcinoma in situ of breast,MRPL28,"39S ribosomal protein L28, mitochondrial",11634,76,0.94 [0.50-1.78],0.8468484421225752
Chapter II Neoplasms,Carcinoma in situ of breast,MRPL46,"39S ribosomal protein L46, mitochondrial",13108,85,1.00 [0.50-2.02],0.9954582596106076
Chapter II Neoplasms,Carcinoma in situ of breast,MRPL52,"39S ribosomal protein L52, mitochondrial",11216,75,1.17 [0.51-2.66],0.7104282019884658
Chapter II Neoplasms,Carcinoma in situ of breast,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",11634,76,0.56 [0.36-0.86],0.00789357087502
Chapter II Neoplasms,Carcinoma in situ of breast,MRPS16,"28S ribosomal protein S16, mitochondrial",11319,73,1.84 [1.15-2.93],0.0102781051769174
Chapter II Neoplasms,Carcinoma in situ of breast,MSLN,Mesothelin,13366,89,0.89 [0.61-1.32],0.5696186625402199
Chapter II Neoplasms,Carcinoma in situ of breast,MSLNL,Mesothelin-like protein,11312,75,0.60 [0.31-1.15],0.1249945366948788
Chapter II Neoplasms,Carcinoma in situ of breast,MSMB,Beta-microseminoprotein,13397,88,1.18 [0.88-1.56],0.267852501570915
Chapter II Neoplasms,Carcinoma in situ of breast,MSR1,Macrophage scavenger receptor types I and II,13577,89,0.82 [0.56-1.22],0.3283406639714014
Chapter II Neoplasms,Carcinoma in situ of breast,MSRA,Mitochondrial peptide methionine sulfoxide reductase,13480,90,0.82 [0.64-1.06],0.1332796548691691
Chapter II Neoplasms,Carcinoma in situ of breast,MST1,Hepatocyte growth factor-like protein,11470,74,1.12 [0.74-1.68],0.5979343643779815
Chapter II Neoplasms,Carcinoma in situ of breast,MSTN,Growth/differentiation factor 8,13220,88,0.95 [0.65-1.38],0.7940349673921697
Chapter II Neoplasms,Carcinoma in situ of breast,MTDH,Protein LYRIC,11319,73,0.81 [0.63-1.04],0.1023987238056738
Chapter II Neoplasms,Carcinoma in situ of breast,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",11617,76,0.38 [0.14-1.05],0.0623945775757794
Chapter II Neoplasms,Carcinoma in situ of breast,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,11399,77,0.88 [0.72-1.07],0.1878083314561844
Chapter II Neoplasms,Carcinoma in situ of breast,MTIF3,"Translation initiation factor IF-3, mitochondrial",11587,77,0.86 [0.67-1.11],0.2393146184752684
Chapter II Neoplasms,Carcinoma in situ of breast,MTPN,Myotrophin,13220,88,1.02 [0.59-1.77],0.9376215750196496
Chapter II Neoplasms,Carcinoma in situ of breast,MTR,Methionine synthase,11293,74,0.72 [0.46-1.11],0.1356334509389835
Chapter II Neoplasms,Carcinoma in situ of breast,MTSS1,Protein MTSS 1,11587,77,0.75 [0.62-0.92],0.0053911988425338
Chapter II Neoplasms,Carcinoma in situ of breast,MTSS2,Protein MTSS 2,11571,75,0.86 [0.69-1.08],0.2051824838145693
Chapter II Neoplasms,Carcinoma in situ of breast,MTUS1,Microtubule-associated tumor suppressor 1,11399,77,0.94 [0.63-1.39],0.7520360221237258
Chapter II Neoplasms,Carcinoma in situ of breast,MUC13,Mucin-13,13108,85,0.78 [0.52-1.16],0.2137730055456158
Chapter II Neoplasms,Carcinoma in situ of breast,MUC16,Mucin-16,13380,89,1.10 [0.98-1.22],0.0973540590624619
Chapter II Neoplasms,Carcinoma in situ of breast,MUC2,Mucin-2,11632,77,1.01 [0.80-1.28],0.9205081664538826
Chapter II Neoplasms,Carcinoma in situ of breast,MUCL3,Mucin-like protein 3,11230,75,0.83 [0.48-1.45],0.5123941284065932
Chapter II Neoplasms,Carcinoma in situ of breast,MVK,Mevalonate kinase,13187,89,0.82 [0.63-1.06],0.1265710147272542
Chapter II Neoplasms,Carcinoma in situ of breast,MXRA8,Matrix remodeling-associated protein 8,11384,76,0.78 [0.39-1.58],0.4976474688068697
Chapter II Neoplasms,Carcinoma in situ of breast,MYBPC1,"Myosin-binding protein C, slow-type",11652,74,0.86 [0.59-1.25],0.4164192855054145
Chapter II Neoplasms,Carcinoma in situ of breast,MYBPC2,"Myosin-binding protein C, fast-type",11330,75,0.92 [0.69-1.23],0.578594774899936
Chapter II Neoplasms,Carcinoma in situ of breast,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,11634,76,0.77 [0.54-1.10],0.152501259119232
Chapter II Neoplasms,Carcinoma in situ of breast,MYDGF,Myeloid-derived growth factor,11652,74,0.80 [0.64-1.00],0.0470226564459009
Chapter II Neoplasms,Carcinoma in situ of breast,MYH4,Myosin-4,11293,74,0.86 [0.51-1.46],0.5762515513064379
Chapter II Neoplasms,Carcinoma in situ of breast,MYH7B,Myosin-7B,11230,75,0.91 [0.54-1.54],0.7222028789388238
Chapter II Neoplasms,Carcinoma in situ of breast,MYH9,Myosin-9,11632,77,0.88 [0.73-1.07],0.2146003732754183
Chapter II Neoplasms,Carcinoma in situ of breast,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",11293,74,0.93 [0.52-1.64],0.7956654640179361
Chapter II Neoplasms,Carcinoma in situ of breast,MYL3,Myosin light chain 3,11330,75,0.83 [0.59-1.16],0.2754864621837007
Chapter II Neoplasms,Carcinoma in situ of breast,MYL4,Myosin light chain 4,11330,75,1.09 [0.74-1.62],0.6585351385142775
Chapter II Neoplasms,Carcinoma in situ of breast,MYL6B,Myosin light chain 6B,11312,75,0.90 [0.69-1.17],0.4446795316209935
Chapter II Neoplasms,Carcinoma in situ of breast,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",11312,75,0.59 [0.29-1.18],0.1338793038647057
Chapter II Neoplasms,Carcinoma in situ of breast,MYO6,Unconventional myosin-VI,11634,76,0.43 [0.20-0.90],0.0262912022864701
Chapter II Neoplasms,Carcinoma in situ of breast,MYO9B,Unconventional myosin-IXb,13187,89,0.68 [0.49-0.94],0.0184310363489222
Chapter II Neoplasms,Carcinoma in situ of breast,MYOC,Myocilin,13449,89,0.63 [0.42-0.94],0.0233972514527606
Chapter II Neoplasms,Carcinoma in situ of breast,MYOM1,Myomesin-1,11311,73,0.98 [0.60-1.61],0.9401653817059654
Chapter II Neoplasms,Carcinoma in situ of breast,MYOM2,Myomesin-2,11293,74,0.51 [0.29-0.90],0.0205533984134389
Chapter II Neoplasms,Carcinoma in situ of breast,MYOM3,Myomesin-3,11384,76,0.96 [0.75-1.23],0.7517558739697587
Chapter II Neoplasms,Carcinoma in situ of breast,MZB1,Marginal zone B- and B1-cell-specific protein,13491,90,0.88 [0.59-1.29],0.5028751385379082
Chapter II Neoplasms,Carcinoma in situ of breast,MZT1,Mitotic-spindle organizing protein 1,13139,87,0.65 [0.43-0.98],0.0389645745150462
Chapter II Neoplasms,Carcinoma in situ of breast,NAA10,N-alpha-acetyltransferase 10,11293,74,0.61 [0.40-0.93],0.0222279900649974
Chapter II Neoplasms,Carcinoma in situ of breast,NAA80,N-alpha-acetyltransferase 80,11312,75,0.81 [0.67-0.98],0.0332541918335442
Chapter II Neoplasms,Carcinoma in situ of breast,NAAA,N-acylethanolamine-hydrolyzing acid amidase,13301,90,0.72 [0.52-1.01],0.0543100074638401
Chapter II Neoplasms,Carcinoma in situ of breast,NACC1,Nucleus accumbens-associated protein 1,11571,75,0.68 [0.44-1.06],0.0895428054958935
Chapter II Neoplasms,Carcinoma in situ of breast,NADK,NAD kinase,13452,90,1.18 [0.87-1.60],0.2947310387878955
Chapter II Neoplasms,Carcinoma in situ of breast,NAGA,Alpha-N-acetylgalactosaminidase,11299,73,0.87 [0.57-1.31],0.4904862116683371
Chapter II Neoplasms,Carcinoma in situ of breast,NAGK,N-acetyl-D-glucosamine kinase,11306,75,0.96 [0.65-1.42],0.845098720660781
Chapter II Neoplasms,Carcinoma in situ of breast,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,11384,76,0.97 [0.34-2.72],0.9488400104459276
Chapter II Neoplasms,Carcinoma in situ of breast,NAMPT,Nicotinamide phosphoribosyltransferase,13139,87,0.93 [0.64-1.35],0.7126693837479117
Chapter II Neoplasms,Carcinoma in situ of breast,NAP1L4,Nucleosome assembly protein 1-like 4,11573,77,0.72 [0.44-1.17],0.1808892948226587
Chapter II Neoplasms,Carcinoma in situ of breast,NAPRT,Nicotinate phosphoribosyltransferase,11617,76,0.82 [0.41-1.64],0.5689503762642989
Chapter II Neoplasms,Carcinoma in situ of breast,NARS1,"Asparagine--tRNA ligase, cytoplasmic",11634,76,0.74 [0.47-1.15],0.1815075199716362
Chapter II Neoplasms,Carcinoma in situ of breast,NBL1,Neuroblastoma suppressor of tumorigenicity 1,13480,90,0.98 [0.47-2.07],0.9655164570889267
Chapter II Neoplasms,Carcinoma in situ of breast,NBN,Nibrin,13187,89,0.79 [0.52-1.21],0.2848365310016176
Chapter II Neoplasms,Carcinoma in situ of breast,NCAM1,Neural cell adhesion molecule 1,13459,89,1.17 [0.60-2.29],0.6406801997238307
Chapter II Neoplasms,Carcinoma in situ of breast,NCAM2,Neural cell adhesion molecule 2,13449,89,1.38 [0.69-2.77],0.3574100887584561
Chapter II Neoplasms,Carcinoma in situ of breast,NCAN,Neurocan core protein,13577,89,0.70 [0.43-1.16],0.1669147056703313
Chapter II Neoplasms,Carcinoma in situ of breast,NCF2,Neutrophil cytosol factor 2,13418,86,1.14 [0.93-1.39],0.2125203757264914
Chapter II Neoplasms,Carcinoma in situ of breast,NCK2,Cytoplasmic protein NCK2,13507,91,0.83 [0.69-0.99],0.034677554603529
Chapter II Neoplasms,Carcinoma in situ of breast,NCLN,Nicalin,13187,89,0.92 [0.64-1.33],0.6698898308508825
Chapter II Neoplasms,Carcinoma in situ of breast,NCR1,Natural cytotoxicity triggering receptor 1,13414,87,0.97 [0.56-1.66],0.899130420688872
Chapter II Neoplasms,Carcinoma in situ of breast,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,11587,77,1.22 [0.63-2.39],0.5517518430179726
Chapter II Neoplasms,Carcinoma in situ of breast,NCS1,Neuronal calcium sensor 1,13571,87,0.64 [0.32-1.24],0.1856481662235326
Chapter II Neoplasms,Carcinoma in situ of breast,NDRG1,Protein NDRG1,13108,85,0.72 [0.49-1.04],0.0769866228653016
Chapter II Neoplasms,Carcinoma in situ of breast,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,11571,75,1.05 [0.76-1.47],0.7563984410843224
Chapter II Neoplasms,Carcinoma in situ of breast,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,11296,73,0.51 [0.27-0.98],0.0429925861885532
Chapter II Neoplasms,Carcinoma in situ of breast,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,11587,77,0.83 [0.64-1.06],0.1281534326681478
Chapter II Neoplasms,Carcinoma in situ of breast,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",13139,87,0.85 [0.65-1.12],0.2463084998175231
Chapter II Neoplasms,Carcinoma in situ of breast,NEB,Nebulin,11293,74,0.53 [0.25-1.11],0.0911138820770049
Chapter II Neoplasms,Carcinoma in situ of breast,NECAP2,Adaptin ear-binding coat-associated protein 2,11293,74,0.76 [0.53-1.11],0.154866248632589
Chapter II Neoplasms,Carcinoma in situ of breast,NECTIN1,Nectin-1,11319,73,1.27 [0.66-2.43],0.4713694006280111
Chapter II Neoplasms,Carcinoma in situ of breast,NECTIN2,Nectin-2,13434,90,0.57 [0.29-1.15],0.1147694577123987
Chapter II Neoplasms,Carcinoma in situ of breast,NECTIN4,Nectin-4,13480,90,1.40 [0.73-2.68],0.3063852514666613
Chapter II Neoplasms,Carcinoma in situ of breast,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,11319,73,0.90 [0.57-1.42],0.641393931878386
Chapter II Neoplasms,Carcinoma in situ of breast,NEDD9,Enhancer of filamentation 1,11319,73,1.17 [0.63-2.16],0.615265519022294
Chapter II Neoplasms,Carcinoma in situ of breast,NEFL,Neurofilament light polypeptide,13065,85,1.23 [0.76-1.97],0.3968859905559587
Chapter II Neoplasms,Carcinoma in situ of breast,NEK7,Serine/threonine-protein kinase Nek7,11399,77,0.86 [0.62-1.20],0.3740723306657607
Chapter II Neoplasms,Carcinoma in situ of breast,NELL1,Protein kinase C-binding protein NELL1,13480,90,0.86 [0.54-1.36],0.517810455586794
Chapter II Neoplasms,Carcinoma in situ of breast,NELL2,Protein kinase C-binding protein NELL2,13507,91,0.35 [0.18-0.69],0.0023972376678091
Chapter II Neoplasms,Carcinoma in situ of breast,NENF,Neudesin,11571,75,1.07 [0.90-1.28],0.4448606781784039
Chapter II Neoplasms,Carcinoma in situ of breast,NEO1,Neogenin,11634,76,0.76 [0.27-2.13],0.6075316162333527
Chapter II Neoplasms,Carcinoma in situ of breast,NEXN,Nexilin,11650,75,0.80 [0.57-1.11],0.1828100151449867
Chapter II Neoplasms,Carcinoma in situ of breast,NFASC,Neurofascin,13604,89,0.54 [0.26-1.10],0.0898007621154878
Chapter II Neoplasms,Carcinoma in situ of breast,NFAT5,Nuclear factor of activated T-cells 5,11319,73,0.80 [0.60-1.06],0.116748714244407
Chapter II Neoplasms,Carcinoma in situ of breast,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",13434,87,0.81 [0.66-0.99],0.042584784586829
Chapter II Neoplasms,Carcinoma in situ of breast,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",13187,89,0.75 [0.53-1.07],0.1092444351895989
Chapter II Neoplasms,Carcinoma in situ of breast,NFE2,Transcription factor NF-E2 45 kDa subunit,11330,75,0.75 [0.55-1.03],0.0738483683776103
Chapter II Neoplasms,Carcinoma in situ of breast,NFIC,Nuclear factor 1 C-type,11634,76,0.68 [0.34-1.35],0.2706221461841586
Chapter II Neoplasms,Carcinoma in situ of breast,NFKB1,Nuclear factor NF-kappa-B p105 subunit,11293,74,0.75 [0.55-1.02],0.068132261375323
Chapter II Neoplasms,Carcinoma in situ of breast,NFKB2,Nuclear factor NF-kappa-B p100 subunit,11399,77,0.74 [0.44-1.23],0.2490029577882642
Chapter II Neoplasms,Carcinoma in situ of breast,NFKBIE,NF-kappa-B inhibitor epsilon,13139,87,0.54 [0.35-0.84],0.0055131939848539
Chapter II Neoplasms,Carcinoma in situ of breast,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",11587,77,0.85 [0.69-1.05],0.1317807308221892
Chapter II Neoplasms,Carcinoma in situ of breast,NFX1,Transcriptional repressor NF-X1,11293,74,0.81 [0.57-1.16],0.2596597336677508
Chapter II Neoplasms,Carcinoma in situ of breast,NFYA,Nuclear transcription factor Y subunit alpha,11293,74,1.29 [0.79-2.10],0.3055236496212287
Chapter II Neoplasms,Carcinoma in situ of breast,NGF,Beta-nerve growth factor,13363,90,0.47 [0.10-2.08],0.3179824254972871
Chapter II Neoplasms,Carcinoma in situ of breast,NGFR,Tumor necrosis factor receptor superfamily member 16,11652,74,0.46 [0.20-1.10],0.0807571142486845
Chapter II Neoplasms,Carcinoma in situ of breast,NGRN,Neugrin,11617,76,0.59 [0.20-1.76],0.3430355574573733
Chapter II Neoplasms,Carcinoma in situ of breast,NHLRC3,NHL repeat-containing protein 3,11094,75,0.74 [0.37-1.47],0.3885042670763402
Chapter II Neoplasms,Carcinoma in situ of breast,NID1,Nidogen-1,13420,89,1.16 [0.72-1.85],0.5421676866751229
Chapter II Neoplasms,Carcinoma in situ of breast,NID2,Nidogen-2,13449,89,0.92 [0.71-1.19],0.5255504142876404
Chapter II Neoplasms,Carcinoma in situ of breast,NINJ1,Ninjurin-1,13139,87,0.91 [0.64-1.29],0.5815036896523484
Chapter II Neoplasms,Carcinoma in situ of breast,NIT1,Deaminated glutathione amidase,11330,75,0.74 [0.48-1.12],0.156233409670433
Chapter II Neoplasms,Carcinoma in situ of breast,NIT2,Omega-amidase NIT2,11617,74,0.78 [0.59-1.03],0.0782082257217168
Chapter II Neoplasms,Carcinoma in situ of breast,NLGN1,Neuroligin-1,11312,75,0.94 [0.67-1.33],0.7381684001287623
Chapter II Neoplasms,Carcinoma in situ of breast,NLGN2,Neuroligin-2,11311,73,0.91 [0.56-1.49],0.7023831337682904
Chapter II Neoplasms,Carcinoma in situ of breast,NME1,Nucleoside diphosphate kinase A,11319,73,0.90 [0.32-2.57],0.8453007998501718
Chapter II Neoplasms,Carcinoma in situ of breast,NME3,Nucleoside diphosphate kinase 3,13470,90,1.17 [0.57-2.43],0.6672116497057841
Chapter II Neoplasms,Carcinoma in situ of breast,NMI,N-myc-interactor,11529,74,0.74 [0.53-1.02],0.066109965935789
Chapter II Neoplasms,Carcinoma in situ of breast,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,13363,90,1.08 [0.86-1.37],0.5001526308350039
Chapter II Neoplasms,Carcinoma in situ of breast,NMRK2,Nicotinamide riboside kinase 2,11230,75,0.50 [0.24-1.05],0.0688600328156996
Chapter II Neoplasms,Carcinoma in situ of breast,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,11634,76,0.78 [0.53-1.14],0.2036515650670027
Chapter II Neoplasms,Carcinoma in situ of breast,NOMO1,Nodal modulator 1,13449,89,0.79 [0.36-1.73],0.5606759690890047
Chapter II Neoplasms,Carcinoma in situ of breast,NOP56,Nucleolar protein 56,11293,74,0.86 [0.67-1.09],0.2115761517684229
Chapter II Neoplasms,Carcinoma in situ of breast,NOS1,"Nitric oxide synthase, brain",13108,85,1.24 [0.85-1.80],0.2624816238686511
Chapter II Neoplasms,Carcinoma in situ of breast,NOS2,"Nitric oxide synthase, inducible",11293,74,1.02 [0.59-1.78],0.9416150868329322
Chapter II Neoplasms,Carcinoma in situ of breast,NOS3,"Nitric oxide synthase, endothelial",13108,85,0.87 [0.59-1.29],0.4893327525727892
Chapter II Neoplasms,Carcinoma in situ of breast,NOTCH1,Neurogenic locus notch homolog protein 1,13609,89,0.54 [0.16-1.82],0.3230023594104653
Chapter II Neoplasms,Carcinoma in situ of breast,NOTCH2,Neurogenic locus notch homolog protein 2,11632,77,1.30 [0.50-3.41],0.5903793700146346
Chapter II Neoplasms,Carcinoma in situ of breast,NOTCH3,Neurogenic locus notch homolog protein 3,13609,89,0.71 [0.41-1.21],0.207545825392199
Chapter II Neoplasms,Carcinoma in situ of breast,NPC2,NPC intracellular cholesterol transporter 2,11444,77,0.59 [0.28-1.25],0.1705539943024009
Chapter II Neoplasms,Carcinoma in situ of breast,NPDC1,Neural proliferation differentiation and control protein 1,13452,90,0.97 [0.50-1.88],0.929068863345417
Chapter II Neoplasms,Carcinoma in situ of breast,NPHS1,Nephrin,11319,73,0.68 [0.34-1.37],0.2786256523133054
Chapter II Neoplasms,Carcinoma in situ of breast,NPHS2,Podocin,11319,73,1.04 [0.84-1.27],0.7325850363708821
Chapter II Neoplasms,Carcinoma in situ of breast,NPL,N-acetylneuraminate lyase,11652,74,0.98 [0.58-1.66],0.9508750602136768
Chapter II Neoplasms,Carcinoma in situ of breast,NPPB,Natriuretic peptides B,13220,88,0.99 [0.85-1.15],0.8956588088308172
Chapter II Neoplasms,Carcinoma in situ of breast,NPPC,C-type natriuretic peptide,13434,87,0.92 [0.58-1.47],0.7276498828999063
Chapter II Neoplasms,Carcinoma in situ of breast,NPR1,Atrial natriuretic peptide receptor 1,11293,74,0.72 [0.38-1.36],0.3074657712041673
Chapter II Neoplasms,Carcinoma in situ of breast,NPTN,Neuroplastin,13139,87,0.98 [0.79-1.23],0.8938800325549405
Chapter II Neoplasms,Carcinoma in situ of breast,NPTX1,Neuronal pentraxin-1,13449,89,0.69 [0.43-1.13],0.1429287873589448
Chapter II Neoplasms,Carcinoma in situ of breast,NPTX2,Neuronal pentraxin-2,11632,77,1.18 [0.61-2.26],0.6239001351429238
Chapter II Neoplasms,Carcinoma in situ of breast,NPTXR,Neuronal pentraxin receptor,13452,90,1.10 [0.64-1.90],0.7288106672188828
Chapter II Neoplasms,Carcinoma in situ of breast,NPY,Pro-neuropeptide Y,13571,87,0.92 [0.70-1.22],0.5808238605904049
Chapter II Neoplasms,Carcinoma in situ of breast,NRCAM,Neuronal cell adhesion molecule,13452,90,0.66 [0.33-1.31],0.2358680643837682
Chapter II Neoplasms,Carcinoma in situ of breast,NRGN,Neurogranin,11650,75,0.85 [0.67-1.09],0.197658110410732
Chapter II Neoplasms,Carcinoma in situ of breast,NRN1,Neuritin,11634,76,0.39 [0.17-0.89],0.026421264186894
Chapter II Neoplasms,Carcinoma in situ of breast,NRP1,Neuropilin-1,13487,89,1.65 [0.86-3.18],0.1326225751207984
Chapter II Neoplasms,Carcinoma in situ of breast,NRP2,Neuropilin-2,13449,89,0.83 [0.43-1.59],0.568098028655251
Chapter II Neoplasms,Carcinoma in situ of breast,NRTN,Neurturin,13187,89,1.15 [0.81-1.64],0.4449607939125866
Chapter II Neoplasms,Carcinoma in situ of breast,NRXN3,Neurexin-3,11312,75,0.78 [0.38-1.59],0.4893089193361335
Chapter II Neoplasms,Carcinoma in situ of breast,NSFL1C,NSFL1 cofactor p47,13577,89,0.75 [0.57-1.00],0.0488815028456221
Chapter II Neoplasms,Carcinoma in situ of breast,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",11652,74,0.80 [0.60-1.08],0.1429061313798989
Chapter II Neoplasms,Carcinoma in situ of breast,NT5C1A,Cytosolic 5'-nucleotidase 1A,11617,76,0.42 [0.18-0.95],0.0372193748974599
Chapter II Neoplasms,Carcinoma in situ of breast,NT5C3A,Cytosolic 5'-nucleotidase 3A,13416,87,0.84 [0.68-1.03],0.0958550922861486
Chapter II Neoplasms,Carcinoma in situ of breast,NT5E,5'-nucleotidase,13480,90,1.11 [0.81-1.52],0.5189714256409843
Chapter II Neoplasms,Carcinoma in situ of breast,NTF3,Neurotrophin-3,13434,87,0.61 [0.35-1.07],0.084280386933729
Chapter II Neoplasms,Carcinoma in situ of breast,NTF4,Neurotrophin-4,13139,87,0.94 [0.57-1.57],0.8261088381538719
Chapter II Neoplasms,Carcinoma in situ of breast,NTRK2,BDNF/NT-3 growth factors receptor,13452,90,0.78 [0.38-1.61],0.4985707791709667
Chapter II Neoplasms,Carcinoma in situ of breast,NTRK3,NT-3 growth factor receptor,13577,89,1.11 [0.47-2.64],0.8131192038041692
Chapter II Neoplasms,Carcinoma in situ of breast,NTproBNP,N-terminal prohormone of brain natriuretic peptide,13452,90,0.92 [0.75-1.13],0.4197486311939724
Chapter II Neoplasms,Carcinoma in situ of breast,NUB1,NEDD8 ultimate buster 1,13434,87,0.85 [0.67-1.07],0.1725280323149487
Chapter II Neoplasms,Carcinoma in situ of breast,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,11571,75,0.92 [0.72-1.17],0.484373825908664
Chapter II Neoplasms,Carcinoma in situ of breast,NUCB2,Nucleobindin-2,13546,87,0.65 [0.39-1.09],0.1029183230142238
Chapter II Neoplasms,Carcinoma in situ of breast,NUDC,Nuclear migration protein nudC,13604,89,0.77 [0.58-1.02],0.0700382209673478
Chapter II Neoplasms,Carcinoma in situ of breast,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,11330,75,1.11 [0.51-2.42],0.7948241231619292
Chapter II Neoplasms,Carcinoma in situ of breast,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,11293,74,0.59 [0.34-1.03],0.0622572638485518
Chapter II Neoplasms,Carcinoma in situ of breast,NUDT16,U8 snoRNA-decapping enzyme,11568,76,0.82 [0.64-1.06],0.1283542669999513
Chapter II Neoplasms,Carcinoma in situ of breast,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],13380,89,0.96 [0.69-1.33],0.8014145788220489
Chapter II Neoplasms,Carcinoma in situ of breast,NUDT5,ADP-sugar pyrophosphatase,13449,89,0.76 [0.52-1.10],0.1406657544000631
Chapter II Neoplasms,Carcinoma in situ of breast,NUMB,Protein numb homolog,11319,73,0.77 [0.59-1.01],0.0576032167992868
Chapter II Neoplasms,Carcinoma in situ of breast,NUP50,Nuclear pore complex protein Nup50,11293,74,0.97 [0.49-1.94],0.9350078218777436
Chapter II Neoplasms,Carcinoma in situ of breast,NXPE4,NXPE family member 4,11293,74,0.72 [0.35-1.51],0.3838321261162695
Chapter II Neoplasms,Carcinoma in situ of breast,NXPH1,Neurexophilin-1,13108,85,0.79 [0.46-1.36],0.3996229776580693
Chapter II Neoplasms,Carcinoma in situ of breast,NXPH3,Neurexophilin-3,11319,73,0.78 [0.37-1.65],0.5208278344467776
Chapter II Neoplasms,Carcinoma in situ of breast,OBP2B,Odorant-binding protein 2b,13319,90,1.06 [0.80-1.41],0.6617007391099026
Chapter II Neoplasms,Carcinoma in situ of breast,OCLN,Occludin,11634,76,0.76 [0.44-1.30],0.3146950522938133
Chapter II Neoplasms,Carcinoma in situ of breast,ODAM,Odontogenic ameloblast-associated protein,13089,85,0.96 [0.66-1.41],0.838759780802988
Chapter II Neoplasms,Carcinoma in situ of breast,OFD1,Oral-facial-digital syndrome 1 protein,11399,77,1.00 [0.72-1.38],0.9952840398730912
Chapter II Neoplasms,Carcinoma in situ of breast,OGA,Protein O-GlcNAcase,11587,77,0.78 [0.57-1.08],0.13480352712004
Chapter II Neoplasms,Carcinoma in situ of breast,OGFR,Opioid growth factor receptor,13380,89,0.73 [0.41-1.30],0.2842311200032008
Chapter II Neoplasms,Carcinoma in situ of breast,OGN,Mimecan,13449,89,1.11 [0.68-1.80],0.6850227275239964
Chapter II Neoplasms,Carcinoma in situ of breast,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,11399,77,0.90 [0.62-1.31],0.5972156490977374
Chapter II Neoplasms,Carcinoma in situ of breast,OLFM4,Olfactomedin-4,10958,74,0.99 [0.82-1.19],0.9095601805550674
Chapter II Neoplasms,Carcinoma in situ of breast,OLR1,Oxidized low-density lipoprotein receptor 1,13308,87,1.24 [0.93-1.66],0.1375853831316667
Chapter II Neoplasms,Carcinoma in situ of breast,OMD,Osteomodulin,13507,91,0.93 [0.62-1.39],0.7064183670492064
Chapter II Neoplasms,Carcinoma in situ of breast,OMG,Oligodendrocyte-myelin glycoprotein,13380,89,0.80 [0.59-1.08],0.1394922163323879
Chapter II Neoplasms,Carcinoma in situ of breast,OMP,Olfactory marker protein,11311,73,0.96 [0.61-1.51],0.8627609965571945
Chapter II Neoplasms,Carcinoma in situ of breast,OPHN1,Oligophrenin-1,11617,76,0.81 [0.66-1.00],0.0452772924125866
Chapter II Neoplasms,Carcinoma in situ of breast,OPLAH,5-oxoprolinase,11330,75,0.79 [0.56-1.10],0.1604577040426883
Chapter II Neoplasms,Carcinoma in situ of breast,OPTC,Opticin,13380,89,0.82 [0.53-1.27],0.3689783816451338
Chapter II Neoplasms,Carcinoma in situ of breast,ORM1,Alpha-1-acid glycoprotein 1,11622,76,2.02 [0.72-5.64],0.1789047145353675
Chapter II Neoplasms,Carcinoma in situ of breast,OSBPL2,Oxysterol-binding protein-related protein 2,11617,76,1.41 [0.99-2.01],0.0588019047340763
Chapter II Neoplasms,Carcinoma in situ of breast,OSCAR,Osteoclast-associated immunoglobulin-like receptor,13470,90,1.08 [0.61-1.91],0.7857565060570602
Chapter II Neoplasms,Carcinoma in situ of breast,OSM,Oncostatin-M,13361,85,0.96 [0.74-1.25],0.7575864558429669
Chapter II Neoplasms,Carcinoma in situ of breast,OSMR,Oncostatin-M-specific receptor subunit beta,13487,89,1.37 [0.57-3.31],0.4774597967800434
Chapter II Neoplasms,Carcinoma in situ of breast,OSTN,Osteocrin,11312,75,0.43 [0.21-0.90],0.0239811068495688
Chapter II Neoplasms,Carcinoma in situ of breast,OTOA,Otoancorin,11311,73,0.62 [0.35-1.08],0.0930415576570559
Chapter II Neoplasms,Carcinoma in situ of breast,OTUD6B,Deubiquitinase OTUD6B,11587,77,0.67 [0.46-0.98],0.0405837232252272
Chapter II Neoplasms,Carcinoma in situ of breast,OTUD7B,OTU domain-containing protein 7B,11634,76,0.65 [0.46-0.93],0.0189823058086763
Chapter II Neoplasms,Carcinoma in situ of breast,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",11330,75,0.85 [0.61-1.18],0.3245677170122024
Chapter II Neoplasms,Carcinoma in situ of breast,OXT,Oxytocin-neurophysin 1,13577,89,0.93 [0.81-1.07],0.3185071629492018
Chapter II Neoplasms,Carcinoma in situ of breast,P4HB,Protein disulfide-isomerase,13373,90,0.84 [0.52-1.37],0.4867169992223893
Chapter II Neoplasms,Carcinoma in situ of breast,PACS2,Phosphofurin acidic cluster sorting protein 2,11293,74,0.59 [0.40-0.87],0.0072604700180343
Chapter II Neoplasms,Carcinoma in situ of breast,PADI2,Protein-arginine deiminase type-2,13187,89,0.73 [0.49-1.11],0.1410207991864363
Chapter II Neoplasms,Carcinoma in situ of breast,PADI4,Protein-arginine deiminase type-4,13089,85,1.18 [0.95-1.48],0.1428139694479596
Chapter II Neoplasms,Carcinoma in situ of breast,PAEP,Glycodelin,13363,90,1.06 [0.93-1.20],0.4010712981166828
Chapter II Neoplasms,Carcinoma in situ of breast,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,11634,76,0.97 [0.80-1.18],0.7868957596347834
Chapter II Neoplasms,Carcinoma in situ of breast,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",11399,77,0.67 [0.41-1.08],0.0968690221463324
Chapter II Neoplasms,Carcinoma in situ of breast,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,13220,88,0.89 [0.63-1.27],0.5275698204266626
Chapter II Neoplasms,Carcinoma in situ of breast,PAGR1,PAXIP1-associated glutamate-rich protein 1,11330,75,0.84 [0.50-1.43],0.5194260783903761
Chapter II Neoplasms,Carcinoma in situ of breast,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,11207,75,1.00 [0.65-1.52],0.9856541899898682
Chapter II Neoplasms,Carcinoma in situ of breast,PAK4,Serine/threonine-protein kinase PAK 4,13108,85,0.83 [0.59-1.17],0.2889947864165467
Chapter II Neoplasms,Carcinoma in situ of breast,PALLD,Palladin,11319,73,0.76 [0.40-1.44],0.4022414292443798
Chapter II Neoplasms,Carcinoma in situ of breast,PALM,Paralemmin-1,11530,76,1.09 [0.51-2.34],0.8236840459248507
Chapter II Neoplasms,Carcinoma in situ of breast,PALM2,Paralemmin-2,11617,76,0.74 [0.40-1.40],0.3574385884565287
Chapter II Neoplasms,Carcinoma in situ of breast,PALM3,Paralemmin-3,11293,74,0.99 [0.73-1.33],0.9327483888758396
Chapter II Neoplasms,Carcinoma in situ of breast,PAM,Peptidyl-glycine alpha-amidating monooxygenase,13532,89,0.58 [0.32-1.06],0.0747832732581769
Chapter II Neoplasms,Carcinoma in situ of breast,PAMR1,Inactive serine protease PAMR1,13449,89,1.15 [0.59-2.24],0.6872055738081373
Chapter II Neoplasms,Carcinoma in situ of breast,PAPPA,Pappalysin-1,13187,89,1.16 [0.78-1.73],0.4499148758305877
Chapter II Neoplasms,Carcinoma in situ of breast,PARD3,Partitioning defective 3 homolog,11399,77,0.81 [0.58-1.12],0.202811110012683
Chapter II Neoplasms,Carcinoma in situ of breast,PARK7,Parkinson disease protein 7,13449,89,0.76 [0.53-1.07],0.1167062655695631
Chapter II Neoplasms,Carcinoma in situ of breast,PARP1,Poly [ADP-ribose] polymerase 1,13434,87,0.83 [0.55-1.24],0.3630152188444799
Chapter II Neoplasms,Carcinoma in situ of breast,PAXX,Protein PAXX,11384,76,0.73 [0.45-1.17],0.1863823365112027
Chapter II Neoplasms,Carcinoma in situ of breast,PBK,Lymphokine-activated killer T-cell-originated protein kinase,11230,75,0.77 [0.37-1.60],0.4858226435371154
Chapter II Neoplasms,Carcinoma in situ of breast,PBLD,Phenazine biosynthesis-like domain-containing protein,13108,85,0.75 [0.50-1.12],0.163891753073483
Chapter II Neoplasms,Carcinoma in situ of breast,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,11587,77,0.91 [0.44-1.86],0.7876773937255935
Chapter II Neoplasms,Carcinoma in situ of breast,PCARE,Photoreceptor cilium actin regulator,11311,73,0.80 [0.58-1.12],0.190055444740993
Chapter II Neoplasms,Carcinoma in situ of breast,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,11355,76,0.88 [0.53-1.45],0.6136212685747902
Chapter II Neoplasms,Carcinoma in situ of breast,PCBP2,Poly(rC)-binding protein 2,11634,76,0.71 [0.52-0.97],0.0336491293605871
Chapter II Neoplasms,Carcinoma in situ of breast,PCDH1,Protocadherin-1,13562,88,0.75 [0.30-1.92],0.5534490693659725
Chapter II Neoplasms,Carcinoma in situ of breast,PCDH12,Protocadherin-12,11634,76,1.10 [0.47-2.60],0.8272949564616423
Chapter II Neoplasms,Carcinoma in situ of breast,PCDH17,Protocadherin-17,13452,90,0.90 [0.52-1.56],0.7003706868502171
Chapter II Neoplasms,Carcinoma in situ of breast,PCDH7,Protocadherin-7,11587,77,1.04 [0.56-1.93],0.9081750532952932
Chapter II Neoplasms,Carcinoma in situ of breast,PCDH9,Protocadherin-9,11587,77,0.96 [0.50-1.83],0.8908765605507394
Chapter II Neoplasms,Carcinoma in situ of breast,PCDHB15,Protocadherin beta-15,11571,75,1.09 [0.64-1.86],0.7457650771713933
Chapter II Neoplasms,Carcinoma in situ of breast,PCNA,Proliferating cell nuclear antigen,11230,75,1.03 [0.74-1.43],0.8789491199025397
Chapter II Neoplasms,Carcinoma in situ of breast,PCSK7,Proprotein convertase subtilisin/kexin type 7,11571,75,1.11 [0.70-1.75],0.6652325131389898
Chapter II Neoplasms,Carcinoma in situ of breast,PCSK9,Proprotein convertase subtilisin/kexin type 9,13609,89,0.87 [0.54-1.39],0.5515919960917863
Chapter II Neoplasms,Carcinoma in situ of breast,PCYT2,Ethanolamine-phosphate cytidylyltransferase,11587,77,0.77 [0.58-1.02],0.0682829946170657
Chapter II Neoplasms,Carcinoma in situ of breast,PDAP1,28 kDa heat- and acid-stable phosphoprotein,11652,74,0.83 [0.66-1.05],0.1143536912869494
Chapter II Neoplasms,Carcinoma in situ of breast,PDCD1,Programmed cell death protein 1,13554,87,0.99 [0.62-1.57],0.9580654036005224
Chapter II Neoplasms,Carcinoma in situ of breast,PDCD1LG2,Programmed cell death 1 ligand 2,13380,89,1.07 [0.58-1.95],0.8353430690080937
Chapter II Neoplasms,Carcinoma in situ of breast,PDCD5,Programmed cell death protein 5,13577,89,0.77 [0.56-1.07],0.1193777660672671
Chapter II Neoplasms,Carcinoma in situ of breast,PDCD6,Programmed cell death protein 6,13452,90,1.01 [0.77-1.32],0.9539248388136858
Chapter II Neoplasms,Carcinoma in situ of breast,PDCL2,Phosducin-like protein 2,11230,75,0.89 [0.57-1.38],0.5926511657935074
Chapter II Neoplasms,Carcinoma in situ of breast,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",11230,75,0.73 [0.43-1.21],0.219744543989059
Chapter II Neoplasms,Carcinoma in situ of breast,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",11293,74,0.88 [0.59-1.30],0.5171521138011006
Chapter II Neoplasms,Carcinoma in situ of breast,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",11384,76,0.82 [0.67-1.00],0.0541703791390957
Chapter II Neoplasms,Carcinoma in situ of breast,PDGFA,Platelet-derived growth factor subunit A,13609,89,0.91 [0.70-1.17],0.457657954450391
Chapter II Neoplasms,Carcinoma in situ of breast,PDGFB,Platelet-derived growth factor subunit B,13507,91,0.85 [0.69-1.05],0.1263037368669761
Chapter II Neoplasms,Carcinoma in situ of breast,PDGFC,Platelet-derived growth factor C,13139,87,0.72 [0.37-1.39],0.3325247237949041
Chapter II Neoplasms,Carcinoma in situ of breast,PDGFRA,Platelet-derived growth factor receptor alpha,13452,90,1.20 [0.63-2.30],0.575964565861585
Chapter II Neoplasms,Carcinoma in situ of breast,PDGFRB,Platelet-derived growth factor receptor beta,13609,89,0.71 [0.43-1.20],0.2007842703363415
Chapter II Neoplasms,Carcinoma in situ of breast,PDIA2,Protein disulfide-isomerase A2,11230,75,0.75 [0.40-1.39],0.3616997901342789
Chapter II Neoplasms,Carcinoma in situ of breast,PDIA3,Protein disulfide-isomerase A3,11384,76,0.88 [0.36-2.14],0.77761411527743
Chapter II Neoplasms,Carcinoma in situ of breast,PDIA4,Protein disulfide-isomerase A4,11632,77,0.81 [0.57-1.17],0.2687829391222504
Chapter II Neoplasms,Carcinoma in situ of breast,PDIA5,Protein disulfide-isomerase A5,11230,75,0.63 [0.41-0.97],0.0338649252686492
Chapter II Neoplasms,Carcinoma in situ of breast,PDLIM5,PDZ and LIM domain protein 5,11634,76,0.83 [0.69-0.99],0.0332982981034862
Chapter II Neoplasms,Carcinoma in situ of breast,PDLIM7,PDZ and LIM domain protein 7,13507,91,0.81 [0.70-0.94],0.0054332461357107
Chapter II Neoplasms,Carcinoma in situ of breast,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",13139,87,1.01 [0.72-1.42],0.9605507819614308
Chapter II Neoplasms,Carcinoma in situ of breast,PDRG1,p53 and DNA damage-regulated protein 1,11312,75,0.55 [0.32-0.95],0.0328563983862123
Chapter II Neoplasms,Carcinoma in situ of breast,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,11230,75,0.34 [0.16-0.73],0.0054005975169824
Chapter II Neoplasms,Carcinoma in situ of breast,PDZD2,PDZ domain-containing protein 2,11293,74,0.77 [0.51-1.15],0.2062504492419439
Chapter II Neoplasms,Carcinoma in situ of breast,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,11319,73,0.91 [0.54-1.56],0.7412878403559482
Chapter II Neoplasms,Carcinoma in situ of breast,PEAR1,Platelet endothelial aggregation receptor 1,13609,89,0.41 [0.19-0.89],0.0239938619666081
Chapter II Neoplasms,Carcinoma in situ of breast,PEBP1,Phosphatidylethanolamine-binding protein 1,13449,89,0.74 [0.54-1.03],0.0743297913064947
Chapter II Neoplasms,Carcinoma in situ of breast,PECAM1,Platelet endothelial cell adhesion molecule,13449,89,0.52 [0.27-0.99],0.048201260652175
Chapter II Neoplasms,Carcinoma in situ of breast,PECR,Peroxisomal trans-2-enoyl-CoA reductase,11330,75,0.65 [0.28-1.53],0.3289147848311122
Chapter II Neoplasms,Carcinoma in situ of breast,PENK,Proenkephalin-A,11384,76,0.71 [0.32-1.55],0.3846999750025728
Chapter II Neoplasms,Carcinoma in situ of breast,PEPD,Xaa-Pro dipeptidase,11650,75,0.65 [0.28-1.54],0.3289497572597942
Chapter II Neoplasms,Carcinoma in situ of breast,PER3,Period circadian protein homolog 3,11319,73,0.87 [0.71-1.07],0.1840980126058992
Chapter II Neoplasms,Carcinoma in situ of breast,PF4,Platelet factor 4,11574,75,0.85 [0.68-1.06],0.1503008145073119
Chapter II Neoplasms,Carcinoma in situ of breast,PFDN2,Prefoldin subunit 2,13108,85,1.18 [0.85-1.63],0.3187929620023311
Chapter II Neoplasms,Carcinoma in situ of breast,PFDN4,Prefoldin subunit 4,11230,75,0.79 [0.50-1.25],0.3174367286214067
Chapter II Neoplasms,Carcinoma in situ of breast,PFDN6,Prefoldin subunit 6,11312,75,0.89 [0.61-1.28],0.5180524491803147
Chapter II Neoplasms,Carcinoma in situ of breast,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",13361,88,0.75 [0.59-0.97],0.0250268961311601
Chapter II Neoplasms,Carcinoma in situ of breast,PGA4,Pepsin A-4,11650,75,1.86 [1.34-2.60],0.0002326931352905
Chapter II Neoplasms,Carcinoma in situ of breast,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",11652,74,0.71 [0.47-1.08],0.1132543653848286
Chapter II Neoplasms,Carcinoma in situ of breast,PGF,Placenta growth factor,13604,89,1.10 [0.53-2.30],0.7997563738978388
Chapter II Neoplasms,Carcinoma in situ of breast,PGLYRP1,Peptidoglycan recognition protein 1,13531,87,1.19 [0.78-1.84],0.4180586815773316
Chapter II Neoplasms,Carcinoma in situ of breast,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,11505,76,2.12 [1.07-4.22],0.0323186421553283
Chapter II Neoplasms,Carcinoma in situ of breast,PGLYRP4,Peptidoglycan recognition protein 4,11293,74,1.00 [0.71-1.42],0.9857528741425968
Chapter II Neoplasms,Carcinoma in situ of breast,PGM2,Phosphoglucomutase-2,11312,75,0.73 [0.45-1.17],0.1935850404798222
Chapter II Neoplasms,Carcinoma in situ of breast,PGR,Progesterone receptor,11319,73,1.05 [0.87-1.27],0.6396782001154055
Chapter II Neoplasms,Carcinoma in situ of breast,PHACTR2,Phosphatase and actin regulator 2,11634,76,0.80 [0.66-0.97],0.0232428499259081
Chapter II Neoplasms,Carcinoma in situ of breast,PHLDB1,Pleckstrin homology-like domain family B member 1,11587,77,0.89 [0.59-1.34],0.5773580837825014
Chapter II Neoplasms,Carcinoma in situ of breast,PHLDB2,Pleckstrin homology-like domain family B member 2,11230,75,0.92 [0.71-1.19],0.5425527285926184
Chapter II Neoplasms,Carcinoma in situ of breast,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,13363,90,1.02 [0.53-1.94],0.9612978994348444
Chapter II Neoplasms,Carcinoma in situ of breast,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,11384,76,0.67 [0.40-1.11],0.1169131989092587
Chapter II Neoplasms,Carcinoma in situ of breast,PI16,Peptidase inhibitor 16,11650,75,0.74 [0.30-1.82],0.506818863805039
Chapter II Neoplasms,Carcinoma in situ of breast,PI3,Elafin,13259,86,1.00 [0.69-1.45],0.9829791910074788
Chapter II Neoplasms,Carcinoma in situ of breast,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",11634,76,0.73 [0.54-0.98],0.0338186172027501
Chapter II Neoplasms,Carcinoma in situ of breast,PIGR,Polymeric immunoglobulin receptor,13281,89,1.17 [0.68-2.02],0.5653809891847679
Chapter II Neoplasms,Carcinoma in situ of breast,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,13434,87,1.02 [0.75-1.39],0.8827266312002263
Chapter II Neoplasms,Carcinoma in situ of breast,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,13449,89,0.94 [0.43-2.03],0.8745696294084297
Chapter II Neoplasms,Carcinoma in situ of breast,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,11319,73,0.69 [0.43-1.09],0.1127178342835219
Chapter II Neoplasms,Carcinoma in situ of breast,PILRA,Paired immunoglobulin-like type 2 receptor alpha,13449,89,0.79 [0.51-1.24],0.304941811594706
Chapter II Neoplasms,Carcinoma in situ of breast,PILRB,Paired immunoglobulin-like type 2 receptor beta,13452,90,0.83 [0.60-1.13],0.2287900955868629
Chapter II Neoplasms,Carcinoma in situ of breast,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,11384,76,0.90 [0.65-1.25],0.5341729624988463
Chapter II Neoplasms,Carcinoma in situ of breast,PITHD1,PITH domain-containing protein 1,11207,75,0.97 [0.74-1.28],0.8327009581870783
Chapter II Neoplasms,Carcinoma in situ of breast,PKD1,Polycystin-1,11652,74,0.73 [0.31-1.70],0.4665208777731815
Chapter II Neoplasms,Carcinoma in situ of breast,PKD2,Polycystin-2,11293,74,0.66 [0.43-1.01],0.0559271910672188
Chapter II Neoplasms,Carcinoma in situ of breast,PKLR,Pyruvate kinase PKLR,13458,91,1.06 [0.82-1.38],0.6545369244215881
Chapter II Neoplasms,Carcinoma in situ of breast,PKN3,Serine/threonine-protein kinase N3,11399,77,0.88 [0.65-1.19],0.4019097044879791
Chapter II Neoplasms,Carcinoma in situ of breast,PLA2G10,Group 10 secretory phospholipase A2,13363,90,0.92 [0.68-1.26],0.607305855086367
Chapter II Neoplasms,Carcinoma in situ of breast,PLA2G15,Phospholipase A2 group XV,13480,90,0.66 [0.31-1.39],0.2743566058392661
Chapter II Neoplasms,Carcinoma in situ of breast,PLA2G1B,Phospholipase A2,13583,89,0.97 [0.61-1.54],0.9130658297743238
Chapter II Neoplasms,Carcinoma in situ of breast,PLA2G2A,"Phospholipase A2, membrane associated",13408,88,0.83 [0.58-1.18],0.3015764638221779
Chapter II Neoplasms,Carcinoma in situ of breast,PLA2G4A,Cytosolic phospholipase A2,13507,91,0.81 [0.66-1.00],0.049171374436228
Chapter II Neoplasms,Carcinoma in situ of breast,PLA2G7,Platelet-activating factor acetylhydrolase,13449,89,1.30 [0.69-2.45],0.410603599079905
Chapter II Neoplasms,Carcinoma in situ of breast,PLAT,Tissue-type plasminogen activator,13559,87,1.16 [0.79-1.71],0.4409742577816236
Chapter II Neoplasms,Carcinoma in situ of breast,PLAU,Urokinase-type plasminogen activator,13449,89,0.73 [0.38-1.40],0.3430760981641971
Chapter II Neoplasms,Carcinoma in situ of breast,PLAUR,Urokinase plasminogen activator surface receptor,13355,88,0.87 [0.41-1.85],0.7213676462952386
Chapter II Neoplasms,Carcinoma in situ of breast,PLB1,"Phospholipase B1, membrane-associated",11617,76,1.01 [0.71-1.45],0.944848678284898
Chapter II Neoplasms,Carcinoma in situ of breast,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",11319,73,0.94 [0.58-1.53],0.8132333774088549
Chapter II Neoplasms,Carcinoma in situ of breast,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",11617,76,0.75 [0.60-0.94],0.0128646101064463
Chapter II Neoplasms,Carcinoma in situ of breast,PLEKHO1,Pleckstrin homology domain-containing family O member 1,11617,76,0.70 [0.50-0.97],0.0340224218256448
Chapter II Neoplasms,Carcinoma in situ of breast,PLG,Plasminogen,11342,74,1.75 [0.83-3.68],0.1385557481627651
Chapter II Neoplasms,Carcinoma in situ of breast,PLIN1,Perilipin-1,13108,85,0.56 [0.29-1.06],0.0735108259726228
Chapter II Neoplasms,Carcinoma in situ of breast,PLIN3,Perilipin-3,13452,90,0.78 [0.50-1.21],0.2691332891105318
Chapter II Neoplasms,Carcinoma in situ of breast,PLPBP,Pyridoxal phosphate homeostasis protein,13452,90,0.79 [0.60-1.04],0.0943714065265575
Chapter II Neoplasms,Carcinoma in situ of breast,PLSCR3,Phospholipid scramblase 3,11605,76,0.64 [0.44-0.92],0.0168900477606353
Chapter II Neoplasms,Carcinoma in situ of breast,PLTP,Phospholipid transfer protein,13552,89,1.42 [0.81-2.49],0.2212292165596263
Chapter II Neoplasms,Carcinoma in situ of breast,PLXDC1,Plexin domain-containing protein 1,13139,87,0.83 [0.46-1.50],0.5378895480781825
Chapter II Neoplasms,Carcinoma in situ of breast,PLXDC2,Plexin domain-containing protein 2,11617,76,0.60 [0.26-1.42],0.2440418356512607
Chapter II Neoplasms,Carcinoma in situ of breast,PLXNA4,Plexin-A4,13434,87,0.89 [0.71-1.12],0.316693529667588
Chapter II Neoplasms,Carcinoma in situ of breast,PLXNB2,Plexin-B2,13545,87,0.90 [0.39-2.04],0.7943175172716511
Chapter II Neoplasms,Carcinoma in situ of breast,PLXNB3,Plexin-B3,13410,90,0.78 [0.52-1.17],0.2280686452679189
Chapter II Neoplasms,Carcinoma in situ of breast,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,13395,90,0.97 [0.88-1.07],0.4985443446104601
Chapter II Neoplasms,Carcinoma in situ of breast,PMCH,Pro-MCH,11293,74,0.89 [0.65-1.21],0.4628760330192277
Chapter II Neoplasms,Carcinoma in situ of breast,PMM2,Phosphomannomutase 2,11293,74,0.63 [0.43-0.93],0.0199807346573426
Chapter II Neoplasms,Carcinoma in situ of breast,PMS1,PMS1 protein homolog 1,11312,75,0.65 [0.40-1.07],0.0891124715804008
Chapter II Neoplasms,Carcinoma in situ of breast,PMVK,Phosphomevalonate kinase,13087,85,0.83 [0.72-0.97],0.0164954984632354
Chapter II Neoplasms,Carcinoma in situ of breast,PNLIP,Pancreatic triacylglycerol lipase,11650,75,0.92 [0.63-1.34],0.657796448965871
Chapter II Neoplasms,Carcinoma in situ of breast,PNLIPRP1,Inactive pancreatic lipase-related protein 1,11617,76,0.92 [0.69-1.23],0.5642663015046352
Chapter II Neoplasms,Carcinoma in situ of breast,PNLIPRP2,Pancreatic lipase-related protein 2,13445,90,0.97 [0.91-1.03],0.2606195474952555
Chapter II Neoplasms,Carcinoma in situ of breast,PNMA1,Paraneoplastic antigen Ma1,11330,75,0.75 [0.49-1.14],0.1709570797266021
Chapter II Neoplasms,Carcinoma in situ of breast,PNMA2,Paraneoplastic antigen Ma2,11311,73,0.89 [0.53-1.51],0.6700445595765703
Chapter II Neoplasms,Carcinoma in situ of breast,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",13187,89,1.02 [0.88-1.18],0.7704854303252531
Chapter II Neoplasms,Carcinoma in situ of breast,PODXL,Podocalyxin,13380,89,0.36 [0.11-1.21],0.0976628930418987
Chapter II Neoplasms,Carcinoma in situ of breast,PODXL2,Podocalyxin-like protein 2,13480,90,0.86 [0.43-1.72],0.678971987166973
Chapter II Neoplasms,Carcinoma in situ of breast,POF1B,Protein POF1B,11319,73,1.01 [0.62-1.65],0.9656113427109906
Chapter II Neoplasms,Carcinoma in situ of breast,POLR2A,DNA-directed RNA polymerase II subunit RPB1,11319,73,0.64 [0.29-1.45],0.2877159853574436
Chapter II Neoplasms,Carcinoma in situ of breast,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",13380,89,1.12 [0.66-1.89],0.6847887008978862
Chapter II Neoplasms,Carcinoma in situ of breast,POMC,Pro-opiomelanocortin,11330,75,1.35 [0.99-1.85],0.0586056021281833
Chapter II Neoplasms,Carcinoma in situ of breast,PON1,Serum paraoxonase/arylesterase 1,11650,75,0.76 [0.35-1.69],0.5084512750496553
Chapter II Neoplasms,Carcinoma in situ of breast,PON2,Serum paraoxonase/arylesterase 2,13220,88,0.73 [0.42-1.26],0.2562348969456219
Chapter II Neoplasms,Carcinoma in situ of breast,PON3,Serum paraoxonase/lactonase 3,13507,91,0.81 [0.49-1.34],0.4064264046442235
Chapter II Neoplasms,Carcinoma in situ of breast,POSTN,Periostin,11632,77,1.69 [0.99-2.88],0.0554579337656883
Chapter II Neoplasms,Carcinoma in situ of breast,PPBP,Platelet basic protein,11569,75,0.84 [0.65-1.08],0.1679316824703153
Chapter II Neoplasms,Carcinoma in situ of breast,PPCDC,Phosphopantothenoylcysteine decarboxylase,13577,89,0.73 [0.49-1.09],0.1188341371289099
Chapter II Neoplasms,Carcinoma in situ of breast,PPIB,Peptidyl-prolyl cis-trans isomerase B,13435,87,0.81 [0.67-0.98],0.029767601905075
Chapter II Neoplasms,Carcinoma in situ of breast,PPIE,Peptidyl-prolyl cis-trans isomerase E,11399,77,1.12 [0.82-1.51],0.4775188396859178
Chapter II Neoplasms,Carcinoma in situ of breast,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",11632,77,0.78 [0.53-1.15],0.2163330390181359
Chapter II Neoplasms,Carcinoma in situ of breast,PPL,Periplakin,11319,73,0.64 [0.31-1.34],0.2374444420513863
Chapter II Neoplasms,Carcinoma in situ of breast,PPM1A,Protein phosphatase 1A,13139,87,0.72 [0.37-1.41],0.340909491281328
Chapter II Neoplasms,Carcinoma in situ of breast,PPM1B,Protein phosphatase 1B,11319,73,1.05 [0.77-1.44],0.7427884172031851
Chapter II Neoplasms,Carcinoma in situ of breast,PPM1F,Protein phosphatase 1F,11652,74,0.69 [0.45-1.06],0.0928431274838724
Chapter II Neoplasms,Carcinoma in situ of breast,PPME1,Protein phosphatase methylesterase 1,13380,89,0.75 [0.55-1.01],0.054439474882389
Chapter II Neoplasms,Carcinoma in situ of breast,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,11571,75,0.66 [0.50-0.88],0.0044190562482053
Chapter II Neoplasms,Carcinoma in situ of breast,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,13480,90,0.80 [0.66-0.98],0.0338921834877058
Chapter II Neoplasms,Carcinoma in situ of breast,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,11399,77,0.69 [0.47-1.02],0.0602237253481976
Chapter II Neoplasms,Carcinoma in situ of breast,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,11634,76,0.75 [0.56-1.01],0.0576796078731296
Chapter II Neoplasms,Carcinoma in situ of breast,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,11634,76,0.56 [0.29-1.11],0.0976942244228809
Chapter II Neoplasms,Carcinoma in situ of breast,PPP1R2,Protein phosphatase inhibitor 2,13452,90,0.81 [0.64-1.03],0.0818645865602193
Chapter II Neoplasms,Carcinoma in situ of breast,PPP1R9B,Neurabin-2,13604,89,0.77 [0.63-0.94],0.009748603700381
Chapter II Neoplasms,Carcinoma in situ of breast,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,11587,77,0.89 [0.73-1.07],0.220121946959002
Chapter II Neoplasms,Carcinoma in situ of breast,PPP3R1,Calcineurin subunit B type 1,13363,90,0.70 [0.45-1.10],0.1259789124164624
Chapter II Neoplasms,Carcinoma in situ of breast,PPT1,Palmitoyl-protein thioesterase 1,11312,75,0.69 [0.45-1.04],0.0782812598199587
Chapter II Neoplasms,Carcinoma in situ of breast,PPY,Pancreatic prohormone,13425,90,1.00 [0.83-1.20],0.9642974958805997
Chapter II Neoplasms,Carcinoma in situ of breast,PQBP1,Polyglutamine-binding protein 1,13139,87,1.09 [0.80-1.49],0.5938828950667576
Chapter II Neoplasms,Carcinoma in situ of breast,PRAME,Melanoma antigen preferentially expressed in tumors,11230,75,0.47 [0.19-1.15],0.1002876180740723
Chapter II Neoplasms,Carcinoma in situ of breast,PRAP1,Proline-rich acidic protein 1,11632,77,0.80 [0.49-1.33],0.3992519697490821
Chapter II Neoplasms,Carcinoma in situ of breast,PRC1,Protein regulator of cytokinesis 1,11571,75,1.26 [0.94-1.68],0.1211978256997561
Chapter II Neoplasms,Carcinoma in situ of breast,PRCP,Lysosomal Pro-X carboxypeptidase,13519,89,0.84 [0.45-1.54],0.5659034668297529
Chapter II Neoplasms,Carcinoma in situ of breast,PRDX1,Peroxiredoxin-1,13082,89,0.90 [0.72-1.12],0.3568277056923041
Chapter II Neoplasms,Carcinoma in situ of breast,PRDX2,Peroxiredoxin-2,11450,74,1.14 [0.81-1.59],0.4513921881474649
Chapter II Neoplasms,Carcinoma in situ of breast,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",13187,89,0.78 [0.60-1.02],0.0736387744260741
Chapter II Neoplasms,Carcinoma in situ of breast,PRDX5,"Peroxiredoxin-5, mitochondrial",13604,89,0.78 [0.61-1.00],0.0458596853566389
Chapter II Neoplasms,Carcinoma in situ of breast,PRDX6,Peroxiredoxin-6,13571,87,0.83 [0.60-1.15],0.2618172012066001
Chapter II Neoplasms,Carcinoma in situ of breast,PREB,Prolactin regulatory element-binding protein,13187,89,0.81 [0.41-1.58],0.5318635665121729
Chapter II Neoplasms,Carcinoma in situ of breast,PRELP,Prolargin,13445,90,0.70 [0.36-1.38],0.3026502088213134
Chapter II Neoplasms,Carcinoma in situ of breast,PRG2,Bone marrow proteoglycan,11632,77,1.03 [0.68-1.56],0.8817423476589694
Chapter II Neoplasms,Carcinoma in situ of breast,PRG3,Proteoglycan 3,11632,77,0.97 [0.64-1.48],0.8923166913101955
Chapter II Neoplasms,Carcinoma in situ of breast,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,13187,89,0.68 [0.46-1.00],0.0475073102545446
Chapter II Neoplasms,Carcinoma in situ of breast,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,11312,75,0.54 [0.24-1.20],0.1282035539503206
Chapter II Neoplasms,Carcinoma in situ of breast,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,13452,90,0.86 [0.69-1.07],0.1729438192268064
Chapter II Neoplasms,Carcinoma in situ of breast,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,11598,75,0.75 [0.58-0.97],0.0300571760150476
Chapter II Neoplasms,Carcinoma in situ of breast,PRKCQ,Protein kinase C theta type,13187,89,0.64 [0.39-1.07],0.0867768093036365
Chapter II Neoplasms,Carcinoma in situ of breast,PRKD2,Serine/threonine-protein kinase D2,11293,74,1.08 [0.70-1.65],0.7322667370757515
Chapter II Neoplasms,Carcinoma in situ of breast,PRKG1,cGMP-dependent protein kinase 1,11384,76,0.82 [0.69-0.97],0.0217814569179278
Chapter II Neoplasms,Carcinoma in situ of breast,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,13139,87,0.85 [0.63-1.14],0.2733352349678219
Chapter II Neoplasms,Carcinoma in situ of breast,PRL,Prolactin,13577,89,1.16 [0.92-1.47],0.1979386053073269
Chapter II Neoplasms,Carcinoma in situ of breast,PRND,Prion-like protein doppel,11617,76,0.93 [0.61-1.42],0.7326427631950069
Chapter II Neoplasms,Carcinoma in situ of breast,PROC,Vitamin K-dependent protein C,13441,89,1.48 [0.71-3.08],0.3005983033132501
Chapter II Neoplasms,Carcinoma in situ of breast,PROCR,Endothelial protein C receptor,11293,74,0.74 [0.36-1.54],0.4261348793097514
Chapter II Neoplasms,Carcinoma in situ of breast,PROK1,Prokineticin-1,13434,87,1.07 [0.83-1.38],0.6080872390086272
Chapter II Neoplasms,Carcinoma in situ of breast,PROS1,Vitamin K-dependent protein S,11662,77,1.69 [0.78-3.66],0.180821112584733
Chapter II Neoplasms,Carcinoma in situ of breast,PRR4,Proline-rich protein 4,11314,76,0.89 [0.64-1.23],0.4875030580446912
Chapter II Neoplasms,Carcinoma in situ of breast,PRR5,Proline-rich protein 5,11319,73,0.80 [0.47-1.34],0.3954421931259171
Chapter II Neoplasms,Carcinoma in situ of breast,PRRT3,Proline-rich transmembrane protein 3,11330,75,0.90 [0.49-1.66],0.731956363503312
Chapter II Neoplasms,Carcinoma in situ of breast,PRSS2,Trypsin-2,13459,89,1.00 [0.68-1.46],0.9868663747965442
Chapter II Neoplasms,Carcinoma in situ of breast,PRSS22,Brain-specific serine protease 4,11319,73,0.66 [0.31-1.38],0.2680505065341858
Chapter II Neoplasms,Carcinoma in situ of breast,PRSS27,Serine protease 27,13402,88,0.99 [0.63-1.57],0.9757743328508088
Chapter II Neoplasms,Carcinoma in situ of breast,PRSS53,Serine protease 53,11617,76,0.80 [0.44-1.44],0.4524786464008831
Chapter II Neoplasms,Carcinoma in situ of breast,PRSS8,Prostasin,13387,89,0.82 [0.50-1.33],0.4181989959999602
Chapter II Neoplasms,Carcinoma in situ of breast,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,13108,85,0.85 [0.72-1.00],0.0500460357804706
Chapter II Neoplasms,Carcinoma in situ of breast,PRTG,Protogenin,13571,87,0.68 [0.32-1.46],0.3204208104567912
Chapter II Neoplasms,Carcinoma in situ of breast,PRTN3,Myeloblastin,13091,85,1.02 [0.67-1.54],0.9435588293883546
Chapter II Neoplasms,Carcinoma in situ of breast,PRUNE2,Protein prune homolog 2,11399,77,1.19 [0.59-2.38],0.6246356314099595
Chapter II Neoplasms,Carcinoma in situ of breast,PSAP,Prosaposin,11525,77,0.88 [0.40-1.95],0.7594597887465986
Chapter II Neoplasms,Carcinoma in situ of breast,PSAPL1,Proactivator polypeptide-like 1,11587,77,1.31 [0.86-2.01],0.2089136949318765
Chapter II Neoplasms,Carcinoma in situ of breast,PSCA,Prostate stem cell antigen,11587,77,0.98 [0.90-1.06],0.5871151892527613
Chapter II Neoplasms,Carcinoma in situ of breast,PSG1,Pregnancy-specific beta-1-glycoprotein 1,13363,90,0.87 [0.75-1.00],0.0529037850519798
Chapter II Neoplasms,Carcinoma in situ of breast,PSIP1,PC4 and SFRS1-interacting protein,13434,87,0.84 [0.60-1.17],0.3081508944771631
Chapter II Neoplasms,Carcinoma in situ of breast,PSMA1,Proteasome subunit alpha type-1,13139,87,0.80 [0.51-1.24],0.3129888459667688
Chapter II Neoplasms,Carcinoma in situ of breast,PSMC3,26S proteasome regulatory subunit 6A,11230,75,0.98 [0.47-2.04],0.9645860864005064
Chapter II Neoplasms,Carcinoma in situ of breast,PSMD1,26S proteasome non-ATPase regulatory subunit 1,11634,76,1.03 [0.67-1.58],0.906022433288316
Chapter II Neoplasms,Carcinoma in situ of breast,PSMD5,26S proteasome non-ATPase regulatory subunit 5,11312,75,0.53 [0.30-0.92],0.0248279366428789
Chapter II Neoplasms,Carcinoma in situ of breast,PSMD9,26S proteasome non-ATPase regulatory subunit 9,13380,89,0.94 [0.68-1.31],0.733749528379676
Chapter II Neoplasms,Carcinoma in situ of breast,PSME1,Proteasome activator complex subunit 1,13345,90,0.77 [0.47-1.26],0.2968621290978835
Chapter II Neoplasms,Carcinoma in situ of breast,PSME2,Proteasome activator complex subunit 2,13298,88,0.82 [0.50-1.37],0.4556472469477187
Chapter II Neoplasms,Carcinoma in situ of breast,PSMG3,Proteasome assembly chaperone 3,13434,87,0.89 [0.62-1.28],0.5286413448415888
Chapter II Neoplasms,Carcinoma in situ of breast,PSMG4,Proteasome assembly chaperone 4,11319,73,0.87 [0.58-1.30],0.4963260411259484
Chapter II Neoplasms,Carcinoma in situ of breast,PSPN,Persephin,13434,87,0.99 [0.82-1.19],0.9167658852019018
Chapter II Neoplasms,Carcinoma in situ of breast,PSRC1,Proline/serine-rich coiled-coil protein 1,13139,87,0.83 [0.58-1.18],0.2927587297997659
Chapter II Neoplasms,Carcinoma in situ of breast,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,10950,73,0.80 [0.66-0.98],0.0305740457444442
Chapter II Neoplasms,Carcinoma in situ of breast,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",13108,85,0.77 [0.40-1.45],0.4104838278515851
Chapter II Neoplasms,Carcinoma in situ of breast,PTGDS,Prostaglandin-H2 D-isomerase,13310,86,1.26 [0.65-2.47],0.492395700969152
Chapter II Neoplasms,Carcinoma in situ of breast,PTGES2,Prostaglandin E synthase 2,11232,73,0.75 [0.49-1.14],0.1769654516924204
Chapter II Neoplasms,Carcinoma in situ of breast,PTGR1,Prostaglandin reductase 1,11652,74,1.01 [0.76-1.33],0.9515703495821908
Chapter II Neoplasms,Carcinoma in situ of breast,PTH,Parathyroid hormone,11312,75,0.73 [0.54-0.98],0.0354989111866453
Chapter II Neoplasms,Carcinoma in situ of breast,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,13434,87,1.15 [0.73-1.80],0.5552995210393068
Chapter II Neoplasms,Carcinoma in situ of breast,PTK7,Inactive tyrosine-protein kinase 7,13108,85,0.87 [0.52-1.45],0.5931096991338549
Chapter II Neoplasms,Carcinoma in situ of breast,PTN,Pleiotrophin,13220,88,0.69 [0.47-1.02],0.0601528530943374
Chapter II Neoplasms,Carcinoma in situ of breast,PTP4A3,Protein tyrosine phosphatase type IVA 3,11319,73,0.77 [0.48-1.24],0.2812838184040185
Chapter II Neoplasms,Carcinoma in situ of breast,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,13363,90,0.75 [0.58-0.96],0.0250850639407945
Chapter II Neoplasms,Carcinoma in situ of breast,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,13486,91,0.83 [0.68-1.01],0.0585514649904551
Chapter II Neoplasms,Carcinoma in situ of breast,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,11293,73,0.76 [0.41-1.43],0.3924341272275825
Chapter II Neoplasms,Carcinoma in situ of breast,PTPRB,Receptor-type tyrosine-protein phosphatase beta,11652,74,1.09 [0.52-2.32],0.8131093761626647
Chapter II Neoplasms,Carcinoma in situ of breast,PTPRC,Receptor-type tyrosine-protein phosphatase C,11632,77,0.72 [0.28-1.88],0.4992698966670695
Chapter II Neoplasms,Carcinoma in situ of breast,PTPRF,Receptor-type tyrosine-protein phosphatase F,13609,89,0.85 [0.44-1.62],0.6159958260513623
Chapter II Neoplasms,Carcinoma in situ of breast,PTPRH,Receptor-type tyrosine-protein phosphatase H,11587,77,1.00 [0.64-1.58],0.9938484825921364
Chapter II Neoplasms,Carcinoma in situ of breast,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,11587,77,1.70 [0.85-3.42],0.1341523174588231
Chapter II Neoplasms,Carcinoma in situ of breast,PTPRM,Receptor-type tyrosine-protein phosphatase mu,13408,87,0.40 [0.18-0.89],0.0242624887763386
Chapter II Neoplasms,Carcinoma in situ of breast,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,13311,90,0.75 [0.40-1.39],0.3604796861912344
Chapter II Neoplasms,Carcinoma in situ of breast,PTPRR,Receptor-type tyrosine-protein phosphatase R,11617,76,0.82 [0.43-1.54],0.5365233983033215
Chapter II Neoplasms,Carcinoma in situ of breast,PTPRS,Receptor-type tyrosine-protein phosphatase S,13609,89,1.83 [0.85-3.94],0.1237886204618611
Chapter II Neoplasms,Carcinoma in situ of breast,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,11652,74,0.58 [0.30-1.14],0.1159327689781841
Chapter II Neoplasms,Carcinoma in situ of breast,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,11384,76,0.75 [0.52-1.08],0.1236560272645854
Chapter II Neoplasms,Carcinoma in situ of breast,PTS,6-pyruvoyl tetrahydrobiopterin synthase,13053,85,0.90 [0.62-1.30],0.5706861024580752
Chapter II Neoplasms,Carcinoma in situ of breast,PTTG1,Securin,11399,77,1.05 [0.64-1.75],0.8362666504180671
Chapter II Neoplasms,Carcinoma in situ of breast,PTX3,Pentraxin-related protein PTX3,13434,87,1.27 [0.85-1.91],0.2403935654901504
Chapter II Neoplasms,Carcinoma in situ of breast,PVALB,Parvalbumin alpha,13515,86,0.85 [0.73-1.00],0.04684692088329
Chapter II Neoplasms,Carcinoma in situ of breast,PVR,Poliovirus receptor,13577,89,0.99 [0.60-1.65],0.976141695751752
Chapter II Neoplasms,Carcinoma in situ of breast,PXDNL,Peroxidasin-like protein,11571,75,0.85 [0.55-1.31],0.4581040375300933
Chapter II Neoplasms,Carcinoma in situ of breast,PXN,Paxillin,13108,85,1.03 [0.72-1.47],0.8635779005761117
Chapter II Neoplasms,Carcinoma in situ of breast,PYDC1,Pyrin domain-containing protein 1,11330,75,1.36 [0.91-2.03],0.1325753325536973
Chapter II Neoplasms,Carcinoma in situ of breast,PYY,Peptide YY,11293,74,0.87 [0.67-1.12],0.2889101158565
Chapter II Neoplasms,Carcinoma in situ of breast,PZP,Pregnancy zone protein,11662,77,0.76 [0.54-1.08],0.1260113441582775
Chapter II Neoplasms,Carcinoma in situ of breast,QDPR,Dihydropteridine reductase,13395,90,0.82 [0.54-1.26],0.3738719433305361
Chapter II Neoplasms,Carcinoma in situ of breast,QPCT,Glutaminyl-peptide cyclotransferase,13450,87,0.88 [0.44-1.78],0.7300548010696417
Chapter II Neoplasms,Carcinoma in situ of breast,QSOX1,Sulfhydryl oxidase 1,11413,76,0.81 [0.43-1.52],0.5130620466438985
Chapter II Neoplasms,Carcinoma in situ of breast,RAB10,Ras-related protein Rab-10,11652,74,0.62 [0.40-0.97],0.0344042990185158
Chapter II Neoplasms,Carcinoma in situ of breast,RAB11FIP3,Rab11 family-interacting protein 3,11652,74,0.81 [0.66-0.99],0.0403912821065903
Chapter II Neoplasms,Carcinoma in situ of breast,RAB27B,Ras-related protein Rab-27B,11652,74,0.77 [0.60-0.99],0.0398894335947676
Chapter II Neoplasms,Carcinoma in situ of breast,RAB2B,Ras-related protein Rab-2B,11571,75,0.63 [0.44-0.92],0.0172260970232467
Chapter II Neoplasms,Carcinoma in situ of breast,RAB33A,Ras-related protein Rab-33A,11293,74,0.69 [0.48-0.98],0.0405215305168443
Chapter II Neoplasms,Carcinoma in situ of breast,RAB37,Ras-related protein Rab-37,13187,89,0.87 [0.69-1.11],0.2770660043882127
Chapter II Neoplasms,Carcinoma in situ of breast,RAB39B,Ras-related protein Rab-39B,11293,74,0.97 [0.75-1.25],0.833022444087598
Chapter II Neoplasms,Carcinoma in situ of breast,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,11311,73,1.12 [0.80-1.56],0.5090776089744184
Chapter II Neoplasms,Carcinoma in situ of breast,RAB44,Ras-related protein Rab-44,11571,75,1.56 [1.16-2.10],0.0035059971595159
Chapter II Neoplasms,Carcinoma in situ of breast,RAB6A,Ras-related protein Rab-6A,13434,87,0.77 [0.51-1.16],0.2128637777727121
Chapter II Neoplasms,Carcinoma in situ of breast,RAB6B,Ras-related protein Rab-6B,13108,85,1.11 [0.77-1.60],0.5922661537752345
Chapter II Neoplasms,Carcinoma in situ of breast,RABEP1,Rab GTPase-binding effector protein 1,11384,76,0.76 [0.57-1.02],0.0712578789524384
Chapter II Neoplasms,Carcinoma in situ of breast,RABEPK,Rab9 effector protein with kelch motifs,13139,87,0.96 [0.70-1.31],0.807590367811446
Chapter II Neoplasms,Carcinoma in situ of breast,RABGAP1L,Rab GTPase-activating protein 1-like,13187,89,0.82 [0.59-1.13],0.2301569637365284
Chapter II Neoplasms,Carcinoma in situ of breast,RAC3,Ras-related C3 botulinum toxin substrate 3,11312,75,0.71 [0.46-1.10],0.1246169727181364
Chapter II Neoplasms,Carcinoma in situ of breast,RAD23B,UV excision repair protein RAD23 homolog B,13139,87,0.80 [0.52-1.21],0.2895069319313014
Chapter II Neoplasms,Carcinoma in situ of breast,RAD51,DNA repair protein RAD51 homolog 1,11399,77,1.11 [0.80-1.55],0.523901967310406
Chapter II Neoplasms,Carcinoma in situ of breast,RALB,Ras-related protein Ral-B,11319,73,1.14 [0.54-2.40],0.7336453352154197
Chapter II Neoplasms,Carcinoma in situ of breast,RALY,RNA-binding protein Raly,11571,75,1.08 [0.72-1.63],0.7114577210010407
Chapter II Neoplasms,Carcinoma in situ of breast,RANBP1,Ran-specific GTPase-activating protein,11330,75,0.85 [0.56-1.29],0.4524954120892297
Chapter II Neoplasms,Carcinoma in situ of breast,RANBP2,E3 SUMO-protein ligase RanBP2,11311,73,0.80 [0.40-1.59],0.5176042622514625
Chapter II Neoplasms,Carcinoma in situ of breast,RANGAP1,Ran GTPase-activating protein 1,13139,87,0.81 [0.53-1.23],0.3195764352589033
Chapter II Neoplasms,Carcinoma in situ of breast,RAP1A,Ras-related protein Rap-1A,11319,73,0.92 [0.65-1.30],0.6420496247126614
Chapter II Neoplasms,Carcinoma in situ of breast,RAPGEF2,Rap guanine nucleotide exchange factor 2,11399,77,0.70 [0.45-1.10],0.1199302802937754
Chapter II Neoplasms,Carcinoma in situ of breast,RARRES1,Retinoic acid receptor responder protein 1,13139,87,0.94 [0.54-1.66],0.8376781816673501
Chapter II Neoplasms,Carcinoma in situ of breast,RARRES2,Retinoic acid receptor responder protein 2,13487,89,0.75 [0.50-1.14],0.1782551109604027
Chapter II Neoplasms,Carcinoma in situ of breast,RASA1,Ras GTPase-activating protein 1,13108,85,0.54 [0.29-0.98],0.044110048106883
Chapter II Neoplasms,Carcinoma in situ of breast,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,11230,75,0.87 [0.51-1.48],0.596267640815134
Chapter II Neoplasms,Carcinoma in situ of breast,RASSF2,Ras association domain-containing protein 2,13139,87,1.06 [0.77-1.46],0.7281607856293637
Chapter II Neoplasms,Carcinoma in situ of breast,RBFOX3,RNA binding protein fox-1 homolog 3,11634,76,0.67 [0.35-1.31],0.2405058427494217
Chapter II Neoplasms,Carcinoma in situ of breast,RBKS,Ribokinase,13125,90,1.12 [0.78-1.61],0.5390031793321635
Chapter II Neoplasms,Carcinoma in situ of breast,RBM17,Splicing factor 45,11634,76,0.68 [0.50-0.91],0.0110094141108727
Chapter II Neoplasms,Carcinoma in situ of breast,RBM19,Probable RNA-binding protein 19,11293,74,1.31 [0.92-1.87],0.1368587263223397
Chapter II Neoplasms,Carcinoma in situ of breast,RBM25,RNA-binding protein 25,11230,75,0.69 [0.41-1.15],0.1497566882946561
Chapter II Neoplasms,Carcinoma in situ of breast,RBP1,Retinol-binding protein 1,11312,75,0.88 [0.62-1.26],0.4862023795191796
Chapter II Neoplasms,Carcinoma in situ of breast,RBP2,Retinol-binding protein 2,13380,89,0.98 [0.76-1.26],0.8666854483164651
Chapter II Neoplasms,Carcinoma in situ of breast,RBP5,Retinol-binding protein 5,13380,89,0.75 [0.51-1.08],0.1196724032738848
Chapter II Neoplasms,Carcinoma in situ of breast,RBP7,Retinoid-binding protein 7,11587,77,1.25 [0.91-1.71],0.1771446122187682
Chapter II Neoplasms,Carcinoma in situ of breast,RBPMS,RNA-binding protein with multiple splicing,11319,73,0.91 [0.62-1.31],0.6025667712985361
Chapter II Neoplasms,Carcinoma in situ of breast,RBPMS2,RNA-binding protein with multiple splicing 2,11330,75,0.80 [0.64-1.00],0.0502008447613239
Chapter II Neoplasms,Carcinoma in situ of breast,RCC1,Regulator of chromosome condensation,11571,75,1.16 [0.80-1.69],0.4303351992292193
Chapter II Neoplasms,Carcinoma in situ of breast,RCOR1,REST corepressor 1,13220,88,0.88 [0.55-1.39],0.5826672930982337
Chapter II Neoplasms,Carcinoma in situ of breast,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,11330,75,0.48 [0.16-1.45],0.1940140974752122
Chapter II Neoplasms,Carcinoma in situ of breast,REEP4,Receptor expression-enhancing protein 4,11634,76,0.68 [0.46-1.01],0.0541786005348969
Chapter II Neoplasms,Carcinoma in situ of breast,REG1A,Lithostathine-1-alpha,13344,87,1.46 [1.04-2.06],0.0303779847223725
Chapter II Neoplasms,Carcinoma in situ of breast,REG1B,Lithostathine-1-beta,13609,89,1.33 [0.99-1.78],0.0544209315880148
Chapter II Neoplasms,Carcinoma in situ of breast,REG3A,Regenerating islet-derived protein 3-alpha,13609,89,1.10 [0.81-1.50],0.5557785278843397
Chapter II Neoplasms,Carcinoma in situ of breast,REG3G,Regenerating islet-derived protein 3-gamma,11571,75,0.91 [0.52-1.60],0.7560572967472583
Chapter II Neoplasms,Carcinoma in situ of breast,REG4,Regenerating islet-derived protein 4,13470,90,0.90 [0.60-1.37],0.6287461103792182
Chapter II Neoplasms,Carcinoma in situ of breast,RELB,Transcription factor RelB,11319,73,0.77 [0.47-1.28],0.312280396949986
Chapter II Neoplasms,Carcinoma in situ of breast,RELT,Tumor necrosis factor receptor superfamily member 19L,13449,89,0.64 [0.30-1.37],0.2520435556698664
Chapter II Neoplasms,Carcinoma in situ of breast,REN,Renin,13452,90,1.08 [0.82-1.44],0.5778443877757586
Chapter II Neoplasms,Carcinoma in situ of breast,REPS1,RalBP1-associated Eps domain-containing protein 1,11319,73,0.65 [0.34-1.23],0.1861515017399948
Chapter II Neoplasms,Carcinoma in situ of breast,REST,RE1-silencing transcription factor,11230,75,0.45 [0.22-0.93],0.0312473485101989
Chapter II Neoplasms,Carcinoma in situ of breast,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,13380,89,0.83 [0.52-1.30],0.4126969685361797
Chapter II Neoplasms,Carcinoma in situ of breast,RETN,Resistin,13390,86,1.42 [0.91-2.23],0.1256069928037781
Chapter II Neoplasms,Carcinoma in situ of breast,REXO2,"Oligoribonuclease, mitochondrial",11293,74,0.73 [0.42-1.27],0.2683748363265644
Chapter II Neoplasms,Carcinoma in situ of breast,RFC4,Replication factor C subunit 4,11571,75,1.19 [0.44-3.26],0.7333507786572336
Chapter II Neoplasms,Carcinoma in situ of breast,RGCC,Regulator of cell cycle RGCC,11634,76,0.78 [0.58-1.04],0.0855821896409746
Chapter II Neoplasms,Carcinoma in situ of breast,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,11399,77,0.96 [0.68-1.35],0.8092622436399926
Chapter II Neoplasms,Carcinoma in situ of breast,RGMA,Repulsive guidance molecule A,13577,89,0.73 [0.40-1.35],0.3218946783206794
Chapter II Neoplasms,Carcinoma in situ of breast,RGMB,RGM domain family member B,13577,89,0.84 [0.39-1.81],0.6633816627968205
Chapter II Neoplasms,Carcinoma in situ of breast,RGS10,Regulator of G-protein signaling 10,11634,76,0.64 [0.43-0.95],0.0261519195501181
Chapter II Neoplasms,Carcinoma in situ of breast,RGS8,Regulator of G-protein signaling 8,13187,89,1.02 [0.77-1.35],0.8801396652930031
Chapter II Neoplasms,Carcinoma in situ of breast,RHOC,Rho-related GTP-binding protein RhoC,13266,90,0.82 [0.71-0.95],0.0096279968612856
Chapter II Neoplasms,Carcinoma in situ of breast,RICTOR,Rapamycin-insensitive companion of mTOR,11319,73,0.92 [0.57-1.50],0.7495578646477034
Chapter II Neoplasms,Carcinoma in situ of breast,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,11384,76,0.96 [0.61-1.52],0.8731302858779342
Chapter II Neoplasms,Carcinoma in situ of breast,RILP,Rab-interacting lysosomal protein,13534,86,0.83 [0.60-1.13],0.2377506945762738
Chapter II Neoplasms,Carcinoma in situ of breast,RILPL2,RILP-like protein 2,11652,74,0.80 [0.65-1.00],0.0522407614124516
Chapter II Neoplasms,Carcinoma in situ of breast,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,11293,74,0.75 [0.49-1.13],0.1688184809229913
Chapter II Neoplasms,Carcinoma in situ of breast,RLN1,Prorelaxin H1,11634,76,0.96 [0.75-1.24],0.7732182492868166
Chapter II Neoplasms,Carcinoma in situ of breast,RLN2,Prorelaxin H2,11368,76,1.00 [0.88-1.14],0.9996833363833882
Chapter II Neoplasms,Carcinoma in situ of breast,RNASE1,Ribonuclease pancreatic,11650,75,0.99 [0.37-2.63],0.9808784120881288
Chapter II Neoplasms,Carcinoma in situ of breast,RNASE10,Inactive ribonuclease-like protein 10,11330,75,1.00 [0.63-1.57],0.9914948686052713
Chapter II Neoplasms,Carcinoma in situ of breast,RNASE3,Eosinophil cationic protein,13384,88,1.04 [0.88-1.22],0.6462364782120619
Chapter II Neoplasms,Carcinoma in situ of breast,RNASE4,Ribonuclease 4,11255,74,0.83 [0.34-2.03],0.6840690642348165
Chapter II Neoplasms,Carcinoma in situ of breast,RNASE6,Ribonuclease K6,11558,74,0.60 [0.24-1.51],0.2791955237130615
Chapter II Neoplasms,Carcinoma in situ of breast,RNASEH2A,Ribonuclease H2 subunit A,11634,76,1.01 [0.66-1.54],0.9659714922638858
Chapter II Neoplasms,Carcinoma in situ of breast,RNASET2,Ribonuclease T2,13541,89,0.63 [0.30-1.35],0.2359310034796158
Chapter II Neoplasms,Carcinoma in situ of breast,RNF149,E3 ubiquitin-protein ligase RNF149,11330,75,1.62 [0.78-3.37],0.195218313888223
Chapter II Neoplasms,Carcinoma in situ of breast,RNF168,E3 ubiquitin-protein ligase RNF168,11319,73,0.78 [0.43-1.42],0.421976344077334
Chapter II Neoplasms,Carcinoma in situ of breast,RNF31,E3 ubiquitin-protein ligase RNF31,11319,73,0.85 [0.44-1.62],0.6137108162801659
Chapter II Neoplasms,Carcinoma in situ of breast,RNF4,E3 ubiquitin-protein ligase RNF4,11399,77,0.89 [0.62-1.27],0.506229154642472
Chapter II Neoplasms,Carcinoma in situ of breast,RNF41,E3 ubiquitin-protein ligase NRDP1,13139,87,0.75 [0.56-1.01],0.0613485935092127
Chapter II Neoplasms,Carcinoma in situ of breast,RNF43,E3 ubiquitin-protein ligase RNF43,11399,77,0.82 [0.53-1.28],0.3834815815145068
Chapter II Neoplasms,Carcinoma in situ of breast,RNF5,E3 ubiquitin-protein ligase RNF5,11330,75,0.82 [0.61-1.10],0.1759699288446644
Chapter II Neoplasms,Carcinoma in situ of breast,ROBO1,Roundabout homolog 1,13470,90,0.75 [0.34-1.69],0.4901773738568881
Chapter II Neoplasms,Carcinoma in situ of breast,ROBO2,Roundabout homolog 2,13577,89,1.11 [0.50-2.50],0.7933776957566201
Chapter II Neoplasms,Carcinoma in situ of breast,ROBO4,Roundabout homolog 4,11330,75,0.61 [0.17-2.15],0.4420549077494036
Chapter II Neoplasms,Carcinoma in situ of breast,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,13452,90,1.34 [0.73-2.46],0.3437806142692569
Chapter II Neoplasms,Carcinoma in situ of breast,RP2,Protein XRP2,13380,89,0.65 [0.40-1.05],0.081258135751643
Chapter II Neoplasms,Carcinoma in situ of breast,RPA2,Replication protein A 32 kDa subunit,11319,73,1.26 [0.66-2.38],0.487082988756783
Chapter II Neoplasms,Carcinoma in situ of breast,RPE,Ribulose-phosphate 3-epimerase,11399,77,0.81 [0.58-1.13],0.2079321567965554
Chapter II Neoplasms,Carcinoma in situ of breast,RPGR,X-linked retinitis pigmentosa GTPase regulator,11312,75,0.44 [0.23-0.84],0.0127649264220347
Chapter II Neoplasms,Carcinoma in situ of breast,RPL14,60S ribosomal protein L14,11330,75,0.96 [0.56-1.64],0.8807236692544769
Chapter II Neoplasms,Carcinoma in situ of breast,RPS10,40S ribosomal protein S10,11293,74,0.75 [0.41-1.37],0.3479407845572141
Chapter II Neoplasms,Carcinoma in situ of breast,RRAS,Ras-related protein R-Ras,11312,75,0.82 [0.68-0.98],0.0316203909472376
Chapter II Neoplasms,Carcinoma in situ of breast,RRM2,Ribonucleoside-diphosphate reductase subunit M2,13139,87,0.60 [0.37-0.99],0.0437120374238731
Chapter II Neoplasms,Carcinoma in situ of breast,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,13139,87,0.85 [0.64-1.14],0.2798254420875519
Chapter II Neoplasms,Carcinoma in situ of breast,RRP15,RRP15-like protein,11311,73,0.98 [0.77-1.25],0.8623110841254927
Chapter II Neoplasms,Carcinoma in situ of breast,RSPO1,R-spondin-1,13363,90,0.98 [0.58-1.65],0.9312592472879246
Chapter II Neoplasms,Carcinoma in situ of breast,RSPO3,R-spondin-3,13571,87,0.84 [0.42-1.68],0.6124180938741915
Chapter II Neoplasms,Carcinoma in situ of breast,RTBDN,Retbindin,13380,89,0.49 [0.25-0.96],0.03640411261661
Chapter II Neoplasms,Carcinoma in situ of breast,RTKN2,Rhotekin-2,11293,74,0.75 [0.45-1.24],0.256526046147658
Chapter II Neoplasms,Carcinoma in situ of breast,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",11634,76,0.79 [0.62-1.01],0.0652279015002218
Chapter II Neoplasms,Carcinoma in situ of breast,RTN4R,Reticulon-4 receptor,13571,87,0.78 [0.44-1.40],0.4042349292483759
Chapter II Neoplasms,Carcinoma in situ of breast,RUVBL1,RuvB-like 1,13139,87,1.06 [0.90-1.27],0.4763616480764584
Chapter II Neoplasms,Carcinoma in situ of breast,RWDD1,RWD domain-containing protein 1,13577,89,0.70 [0.52-0.94],0.0176068117275376
Chapter II Neoplasms,Carcinoma in situ of breast,RYR1,Ryanodine receptor 1,11293,74,0.66 [0.30-1.42],0.2870669051947129
Chapter II Neoplasms,Carcinoma in situ of breast,S100A11,Protein S100-A11,13339,90,1.18 [0.83-1.68],0.3517758878628118
Chapter II Neoplasms,Carcinoma in situ of breast,S100A12,Protein S100-A12,13264,89,1.25 [0.98-1.58],0.0692932923265601
Chapter II Neoplasms,Carcinoma in situ of breast,S100A13,Protein S100-A13,11319,73,0.92 [0.47-1.80],0.8090453499397509
Chapter II Neoplasms,Carcinoma in situ of breast,S100A14,Protein S100-A14,11634,76,0.79 [0.51-1.22],0.2927611990414471
Chapter II Neoplasms,Carcinoma in situ of breast,S100A16,Protein S100-A16,13089,85,0.66 [0.48-0.90],0.0089959457317974
Chapter II Neoplasms,Carcinoma in situ of breast,S100A3,Protein S100-A3,11571,75,0.88 [0.52-1.50],0.6424924646257465
Chapter II Neoplasms,Carcinoma in situ of breast,S100A4,Protein S100-A4,13480,90,0.87 [0.63-1.20],0.3953722679900935
Chapter II Neoplasms,Carcinoma in situ of breast,S100G,Protein S100-G,11634,76,0.76 [0.45-1.30],0.3137538636870046
Chapter II Neoplasms,Carcinoma in situ of breast,S100P,Protein S100-P,13220,88,1.08 [0.77-1.51],0.6731902208836248
Chapter II Neoplasms,Carcinoma in situ of breast,SAA4,Serum amyloid A-4 protein,11662,77,0.76 [0.30-1.92],0.5641602253841663
Chapter II Neoplasms,Carcinoma in situ of breast,SAFB2,Scaffold attachment factor B2,11634,76,0.62 [0.26-1.48],0.2807991001852709
Chapter II Neoplasms,Carcinoma in situ of breast,SAG,S-arrestin,11311,73,0.99 [0.65-1.50],0.9517211550633776
Chapter II Neoplasms,Carcinoma in situ of breast,SAMD9L,Sterile alpha motif domain-containing protein 9-like,13434,87,0.81 [0.62-1.06],0.124176602425429
Chapter II Neoplasms,Carcinoma in situ of breast,SAP18,Histone deacetylase complex subunit SAP18,11399,77,1.24 [0.99-1.55],0.0600487685222892
Chapter II Neoplasms,Carcinoma in situ of breast,SARG,Specifically androgen-regulated gene protein,11612,74,0.81 [0.66-0.98],0.0341433894191589
Chapter II Neoplasms,Carcinoma in situ of breast,SART1,U4/U6.U5 tri-snRNP-associated protein 1,11293,74,0.90 [0.46-1.75],0.7627978835948059
Chapter II Neoplasms,Carcinoma in situ of breast,SAT1,Diamine acetyltransferase 1,11293,74,1.29 [0.90-1.83],0.1627808422663129
Chapter II Neoplasms,Carcinoma in situ of breast,SAT2,Thialysine N-epsilon-acetyltransferase,11399,77,1.02 [0.75-1.38],0.9071686075482736
Chapter II Neoplasms,Carcinoma in situ of breast,SATB1,DNA-binding protein SATB1,11634,76,0.80 [0.37-1.71],0.5674209468506398
Chapter II Neoplasms,Carcinoma in situ of breast,SBSN,Suprabasin,11608,77,1.22 [0.64-2.31],0.5439617305683828
Chapter II Neoplasms,Carcinoma in situ of breast,SCAMP3,Secretory carrier-associated membrane protein 3,13380,89,0.76 [0.61-0.96],0.0199532229483163
Chapter II Neoplasms,Carcinoma in situ of breast,SCARA5,Scavenger receptor class A member 5,13577,89,0.82 [0.43-1.57],0.5444900116603202
Chapter II Neoplasms,Carcinoma in situ of breast,SCARB1,Scavenger receptor class B member 1,13108,85,1.03 [0.75-1.41],0.8457116225500427
Chapter II Neoplasms,Carcinoma in situ of breast,SCARB2,Lysosome membrane protein 2,13111,89,0.74 [0.36-1.49],0.3957337099182857
Chapter II Neoplasms,Carcinoma in situ of breast,SCARF1,Scavenger receptor class F member 1,13609,89,0.78 [0.50-1.21],0.2629856313523559
Chapter II Neoplasms,Carcinoma in situ of breast,SCARF2,Scavenger receptor class F member 2,13577,89,1.12 [0.58-2.16],0.7350869536411702
Chapter II Neoplasms,Carcinoma in situ of breast,SCG2,Secretogranin-2,13509,86,0.92 [0.50-1.72],0.802906463813724
Chapter II Neoplasms,Carcinoma in situ of breast,SCG3,Secretogranin-3,13470,90,0.76 [0.43-1.34],0.3340944006105224
Chapter II Neoplasms,Carcinoma in situ of breast,SCGB1A1,Uteroglobin,13471,91,1.20 [0.85-1.70],0.2916426502780601
Chapter II Neoplasms,Carcinoma in situ of breast,SCGB2A2,Mammaglobin-A,11293,74,0.68 [0.30-1.54],0.3538700279402972
Chapter II Neoplasms,Carcinoma in situ of breast,SCGB3A1,Secretoglobin family 3A member 1,11384,76,2.69 [1.09-6.66],0.0319784428220068
Chapter II Neoplasms,Carcinoma in situ of breast,SCGB3A2,Secretoglobin family 3A member 2,13486,91,1.06 [0.86-1.32],0.57456212103562
Chapter II Neoplasms,Carcinoma in situ of breast,SCGN,Secretagogin,13187,89,1.16 [0.77-1.77],0.4763238324228874
Chapter II Neoplasms,Carcinoma in situ of breast,SCIN,Adseverin,11311,73,0.82 [0.59-1.14],0.2397186585589021
Chapter II Neoplasms,Carcinoma in situ of breast,SCLY,Selenocysteine lyase,13534,86,0.81 [0.54-1.21],0.3041988599081989
Chapter II Neoplasms,Carcinoma in situ of breast,SCN2A,Sodium channel protein type 2 subunit alpha,11311,73,1.02 [0.65-1.61],0.9245052719580146
Chapter II Neoplasms,Carcinoma in situ of breast,SCN2B,Sodium channel subunit beta-2,11312,75,0.51 [0.21-1.22],0.1292736852400328
Chapter II Neoplasms,Carcinoma in situ of breast,SCN3A,Sodium channel protein type 3 subunit alpha,11312,75,1.03 [0.60-1.77],0.9192816468792904
Chapter II Neoplasms,Carcinoma in situ of breast,SCN3B,Sodium channel subunit beta-3,11311,73,1.00 [0.61-1.66],0.9845177989363506
Chapter II Neoplasms,Carcinoma in situ of breast,SCN4B,Sodium channel subunit beta-4,11330,75,1.32 [0.77-2.26],0.3045148413462898
Chapter II Neoplasms,Carcinoma in situ of breast,SCP2,Non-specific lipid-transfer protein,13139,87,1.00 [0.79-1.26],0.9891885656583416
Chapter II Neoplasms,Carcinoma in situ of breast,SCPEP1,Retinoid-inducible serine carboxypeptidase,11288,75,0.90 [0.57-1.42],0.6609211623879714
Chapter II Neoplasms,Carcinoma in situ of breast,SCRG1,Scrapie-responsive protein 1,11652,74,0.77 [0.33-1.80],0.5391536695699934
Chapter II Neoplasms,Carcinoma in situ of breast,SCRIB,Protein scribble homolog,11330,75,0.99 [0.78-1.25],0.9044936100151026
Chapter II Neoplasms,Carcinoma in situ of breast,SCRN1,Secernin-1,13434,87,0.78 [0.55-1.10],0.1554251856579027
Chapter II Neoplasms,Carcinoma in situ of breast,SCT,Secretin,11312,75,1.15 [0.70-1.87],0.5875632664766591
Chapter II Neoplasms,Carcinoma in situ of breast,SDC1,Syndecan-1,13452,90,0.98 [0.60-1.59],0.9284068889694568
Chapter II Neoplasms,Carcinoma in situ of breast,SDC4,Syndecan-4,13452,90,0.99 [0.66-1.49],0.9603726905754276
Chapter II Neoplasms,Carcinoma in situ of breast,SDCCAG8,Serologically defined colon cancer antigen 8,11571,75,0.81 [0.67-0.99],0.0392488385381118
Chapter II Neoplasms,Carcinoma in situ of breast,SDHB,Succinate dehydrogenase,11587,77,0.96 [0.70-1.31],0.7851252943929927
Chapter II Neoplasms,Carcinoma in situ of breast,SDK2,Protein sidekick-2,11384,76,1.04 [0.57-1.87],0.9050115839391706
Chapter II Neoplasms,Carcinoma in situ of breast,SEC31A,Protein transport protein Sec31A,11330,75,0.85 [0.64-1.13],0.2718653900581894
Chapter II Neoplasms,Carcinoma in situ of breast,SEL1L,Protein sel-1 homolog 1,11330,75,0.48 [0.19-1.22],0.124325968536889
Chapter II Neoplasms,Carcinoma in situ of breast,SELE,E-selectin,13609,89,0.77 [0.53-1.11],0.1588923056142856
Chapter II Neoplasms,Carcinoma in situ of breast,SELENOP,Selenoprotein P,11662,77,1.53 [0.62-3.77],0.3569934963336478
Chapter II Neoplasms,Carcinoma in situ of breast,SELL,L-selectin,11662,77,0.93 [0.36-2.40],0.873653825485494
Chapter II Neoplasms,Carcinoma in situ of breast,SELP,P-selectin,13459,89,0.83 [0.60-1.15],0.26343489481214
Chapter II Neoplasms,Carcinoma in situ of breast,SELPLG,P-selectin glycoprotein ligand 1,13434,87,0.64 [0.36-1.17],0.1471548000138419
Chapter II Neoplasms,Carcinoma in situ of breast,SEMA3F,Semaphorin-3F,13452,90,0.68 [0.33-1.42],0.3066831067456886
Chapter II Neoplasms,Carcinoma in situ of breast,SEMA3G,Semaphorin-3G,11384,76,0.76 [0.45-1.28],0.3025774970164386
Chapter II Neoplasms,Carcinoma in situ of breast,SEMA4C,Semaphorin-4C,13380,89,0.73 [0.35-1.50],0.3868439206594419
Chapter II Neoplasms,Carcinoma in situ of breast,SEMA4D,Semaphorin-4D,13577,89,0.50 [0.28-0.91],0.023778906372985
Chapter II Neoplasms,Carcinoma in situ of breast,SEMA6C,Semaphorin-6C,11319,73,0.61 [0.24-1.54],0.2915870618831777
Chapter II Neoplasms,Carcinoma in situ of breast,SEMA7A,Semaphorin-7A,13559,87,0.86 [0.41-1.82],0.6975178886538874
Chapter II Neoplasms,Carcinoma in situ of breast,SEPTIN3,Neuronal-specific septin-3,11634,76,0.85 [0.62-1.16],0.2991529162292743
Chapter II Neoplasms,Carcinoma in situ of breast,SEPTIN7,Septin-7,11399,77,0.76 [0.46-1.26],0.2865459979817839
Chapter II Neoplasms,Carcinoma in situ of breast,SEPTIN8,Septin-8,11589,76,0.67 [0.32-1.37],0.2680675757629827
Chapter II Neoplasms,Carcinoma in situ of breast,SEPTIN9,Septin-9,13380,89,1.27 [0.68-2.38],0.4483859587642169
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINA1,Alpha-1-antitrypsin,11434,74,3.98 [0.29-54.73],0.3015088657666158
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINA11,Serpin A11,13609,89,0.82 [0.52-1.30],0.4050168303437522
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINA12,Serpin A12,13091,89,0.95 [0.81-1.13],0.569422621307272
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINA3,Alpha-1-antichymotrypsin,11622,77,3.00 [0.82-11.03],0.0978205325460969
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINA4,Kallistatin,11435,75,1.82 [0.73-4.55],0.2021507583414777
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINA5,Plasma serine protease inhibitor,11479,76,1.35 [0.76-2.40],0.3043618967477898
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINA6,Corticosteroid-binding globulin,11662,77,2.31 [0.84-6.38],0.1062288424644102
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINA7,Thyroxine-binding globulin,11662,77,2.37 [0.79-7.15],0.1240427990816766
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINA9,Serpin A9,13301,89,0.96 [0.74-1.25],0.7691396864127221
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINB1,Leukocyte elastase inhibitor,13407,89,0.90 [0.73-1.11],0.326451096972243
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINB5,Serpin B5,13220,88,1.11 [0.75-1.64],0.5940047338242481
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINB6,Serpin B6,13535,89,0.79 [0.58-1.08],0.134800590364525
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINB8,Serpin B8,13604,89,1.27 [0.97-1.66],0.0841717388555614
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINB9,Serpin B9,13363,90,0.74 [0.43-1.28],0.2778941944086848
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINC1,Antithrombin-III,11636,77,9.22 [2.25-37.73],0.0020077369177539
Chapter II Neoplasms,Carcinoma in situ of breast,SERPIND1,Heparin cofactor 2,11636,77,1.75 [0.80-3.79],0.1583787156762287
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINE1,Plasminogen activator inhibitor 1,13609,89,0.92 [0.70-1.20],0.527139820095921
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINE2,Glia-derived nexin,11652,74,0.76 [0.54-1.09],0.1343108384930128
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINF1,Pigment epithelium-derived factor,11488,76,2.06 [0.96-4.45],0.0646823078744693
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINF2,Alpha-2-antiplasmin,11437,76,3.78 [0.87-16.44],0.0758397999245807
Chapter II Neoplasms,Carcinoma in situ of breast,SERPING1,Plasma protease C1 inhibitor,11636,77,2.90 [0.94-8.97],0.0652525266967567
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINH1,Serpin H1,11399,77,0.81 [0.68-0.96],0.0156961239889229
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINI1,Neuroserpin,11355,76,1.19 [0.62-2.29],0.6046783924938645
Chapter II Neoplasms,Carcinoma in situ of breast,SERPINI2,Serpin I2,11587,77,0.91 [0.62-1.34],0.6389950724195274
Chapter II Neoplasms,Carcinoma in situ of breast,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,13108,85,0.71 [0.52-0.97],0.0342726839232212
Chapter II Neoplasms,Carcinoma in situ of breast,SETMAR,Histone-lysine N-methyltransferase SETMAR,13327,90,1.07 [0.57-2.00],0.8275363921527765
Chapter II Neoplasms,Carcinoma in situ of breast,SEZ6,Seizure protein 6 homolog,11312,75,0.38 [0.17-0.83],0.0147135835904979
Chapter II Neoplasms,Carcinoma in situ of breast,SEZ6L,Seizure 6-like protein,13480,90,1.05 [0.52-2.10],0.896653752246527
Chapter II Neoplasms,Carcinoma in situ of breast,SEZ6L2,Seizure 6-like protein 2,13380,89,0.89 [0.40-1.94],0.7607516098044168
Chapter II Neoplasms,Carcinoma in situ of breast,SF3B4,Splicing factor 3B subunit 4,13380,89,0.80 [0.62-1.04],0.0940599735882882
Chapter II Neoplasms,Carcinoma in situ of breast,SFRP1,Secreted frizzled-related protein 1,13319,90,0.80 [0.51-1.24],0.3142480640026548
Chapter II Neoplasms,Carcinoma in situ of breast,SFRP4,Secreted frizzled-related protein 4,11384,76,0.92 [0.55-1.54],0.7502771423827032
Chapter II Neoplasms,Carcinoma in situ of breast,SFTPA1,Pulmonary surfactant-associated protein A1,13139,87,0.85 [0.59-1.23],0.3897556489747774
Chapter II Neoplasms,Carcinoma in situ of breast,SFTPA2,Pulmonary surfactant-associated protein A2,13139,87,1.09 [0.74-1.61],0.6467906626190306
Chapter II Neoplasms,Carcinoma in situ of breast,SFTPD,Pulmonary surfactant-associated protein D,13452,90,1.30 [0.98-1.73],0.0707981720872096
Chapter II Neoplasms,Carcinoma in situ of breast,SGSH,N-sulphoglucosamine sulphohydrolase,11459,71,0.87 [0.57-1.35],0.5433099055925616
Chapter II Neoplasms,Carcinoma in situ of breast,SH2B3,SH2B adapter protein 3,13139,87,0.83 [0.68-1.00],0.0555996616736979
Chapter II Neoplasms,Carcinoma in situ of breast,SH2D1A,SH2 domain-containing protein 1A,13434,87,0.69 [0.46-1.04],0.0768742567644193
Chapter II Neoplasms,Carcinoma in situ of breast,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,11311,73,0.82 [0.54-1.26],0.3687443471903192
Chapter II Neoplasms,Carcinoma in situ of breast,SH3BP1,SH3 domain-binding protein 1,11587,77,1.36 [0.96-1.92],0.0844423915178285
Chapter II Neoplasms,Carcinoma in situ of breast,SH3GL3,Endophilin-A3,11338,76,0.91 [0.71-1.18],0.4899331840838075
Chapter II Neoplasms,Carcinoma in situ of breast,SH3GLB2,Endophilin-B2,11617,76,0.74 [0.54-1.03],0.0769038372284605
Chapter II Neoplasms,Carcinoma in situ of breast,SHBG,Sex hormone-binding globulin,11650,75,0.83 [0.55-1.23],0.3497965095810563
Chapter II Neoplasms,Carcinoma in situ of breast,SHC1,SHC-transforming protein 1,11230,75,0.98 [0.80-1.19],0.8182954132282985
Chapter II Neoplasms,Carcinoma in situ of breast,SHD,SH2 domain-containing adapter protein D,11273,74,0.86 [0.63-1.18],0.3546444903886523
Chapter II Neoplasms,Carcinoma in situ of breast,SHH,Sonic hedgehog protein,11319,73,1.43 [0.94-2.19],0.0967912735347528
Chapter II Neoplasms,Carcinoma in situ of breast,SHISA5,Protein shisa-5,11632,77,1.06 [0.42-2.69],0.9065867774430924
Chapter II Neoplasms,Carcinoma in situ of breast,SHMT1,"Serine hydroxymethyltransferase, cytosolic",13486,91,0.78 [0.63-0.97],0.0236339391160432
Chapter II Neoplasms,Carcinoma in situ of breast,SHPK,Sedoheptulokinase,11399,77,0.90 [0.52-1.54],0.6914132581658317
Chapter II Neoplasms,Carcinoma in situ of breast,SIAE,Sialate O-acetylesterase,13457,89,0.73 [0.49-1.10],0.1296038225657874
Chapter II Neoplasms,Carcinoma in situ of breast,SIGLEC1,Sialoadhesin,13507,91,0.73 [0.47-1.13],0.1587085258075958
Chapter II Neoplasms,Carcinoma in situ of breast,SIGLEC10,Sialic acid-binding Ig-like lectin 10,13434,87,1.26 [0.70-2.26],0.4489349152647974
Chapter II Neoplasms,Carcinoma in situ of breast,SIGLEC15,Sialic acid-binding Ig-like lectin 15,13108,85,0.90 [0.70-1.17],0.4345677874740573
Chapter II Neoplasms,Carcinoma in situ of breast,SIGLEC5,Sialic acid-binding Ig-like lectin 5,13449,89,0.92 [0.80-1.06],0.2626610572867492
Chapter II Neoplasms,Carcinoma in situ of breast,SIGLEC6,Sialic acid-binding Ig-like lectin 6,13571,87,0.62 [0.35-1.11],0.1090098383514567
Chapter II Neoplasms,Carcinoma in situ of breast,SIGLEC7,Sialic acid-binding Ig-like lectin 7,13452,90,0.84 [0.44-1.62],0.6089118806818979
Chapter II Neoplasms,Carcinoma in situ of breast,SIGLEC8,Sialic acid-binding Ig-like lectin 8,11330,75,0.68 [0.42-1.11],0.126966765028681
Chapter II Neoplasms,Carcinoma in situ of breast,SIGLEC9,Sialic acid-binding Ig-like lectin 9,13555,86,1.00 [0.53-1.91],0.9886950665627476
Chapter II Neoplasms,Carcinoma in situ of breast,SIL1,Nucleotide exchange factor SIL1,11330,75,0.90 [0.44-1.85],0.7831466901030203
Chapter II Neoplasms,Carcinoma in situ of breast,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,13468,87,1.36 [0.95-1.95],0.0979934790311407
Chapter II Neoplasms,Carcinoma in situ of breast,SIRPB1,Signal-regulatory protein beta-1,13417,90,0.87 [0.57-1.34],0.5379979719239072
Chapter II Neoplasms,Carcinoma in situ of breast,SIRT1,NAD-dependent protein deacetylase sirtuin-1,11319,73,0.98 [0.77-1.26],0.8817494321264056
Chapter II Neoplasms,Carcinoma in situ of breast,SIRT2,NAD-dependent protein deacetylase sirtuin-2,13380,89,0.78 [0.63-0.96],0.0189913403890234
Chapter II Neoplasms,Carcinoma in situ of breast,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",13108,85,1.10 [0.81-1.51],0.5291634202304797
Chapter II Neoplasms,Carcinoma in situ of breast,SIT1,Signaling threshold-regulating transmembrane adapter 1,13187,89,1.07 [0.76-1.50],0.7026499665131952
Chapter II Neoplasms,Carcinoma in situ of breast,SKAP1,Src kinase-associated phosphoprotein 1,13334,90,0.87 [0.67-1.13],0.3011954567999798
Chapter II Neoplasms,Carcinoma in situ of breast,SKAP2,Src kinase-associated phosphoprotein 2,13507,91,0.79 [0.66-0.95],0.0097901283450574
Chapter II Neoplasms,Carcinoma in situ of breast,SKIV2L,Helicase SKI2W,11293,74,0.82 [0.45-1.48],0.5041997489480456
Chapter II Neoplasms,Carcinoma in situ of breast,SLA2,Src-like-adapter 2,11634,76,0.77 [0.62-0.95],0.0140345972413582
Chapter II Neoplasms,Carcinoma in situ of breast,SLAMF1,Signaling lymphocytic activation molecule,13187,89,0.85 [0.62-1.16],0.3085334606181174
Chapter II Neoplasms,Carcinoma in situ of breast,SLAMF6,SLAM family member 6,13139,87,0.75 [0.45-1.25],0.2658912239716131
Chapter II Neoplasms,Carcinoma in situ of breast,SLAMF7,SLAM family member 7,13434,87,0.87 [0.62-1.22],0.4228497731334198
Chapter II Neoplasms,Carcinoma in situ of breast,SLAMF8,SLAM family member 8,13139,87,0.83 [0.58-1.19],0.3153288113475652
Chapter II Neoplasms,Carcinoma in situ of breast,SLC12A2,Solute carrier family 12 member 2,11293,74,0.49 [0.20-1.23],0.1306135706201463
Chapter II Neoplasms,Carcinoma in situ of breast,SLC13A1,Solute carrier family 13 member 1,11571,75,0.84 [0.55-1.28],0.4104504468177441
Chapter II Neoplasms,Carcinoma in situ of breast,SLC16A1,Monocarboxylate transporter 1,13108,85,0.77 [0.53-1.11],0.1621636184811325
Chapter II Neoplasms,Carcinoma in situ of breast,SLC1A4,Neutral amino acid transporter A,11312,75,0.76 [0.47-1.23],0.265559745832148
Chapter II Neoplasms,Carcinoma in situ of breast,SLC27A4,Long-chain fatty acid transport protein 4,13108,85,0.70 [0.50-1.00],0.0503536245608179
Chapter II Neoplasms,Carcinoma in situ of breast,SLC28A1,Sodium/nucleoside cotransporter 1,11230,75,0.82 [0.54-1.24],0.3415964571816403
Chapter II Neoplasms,Carcinoma in situ of breast,SLC34A3,Sodium-dependent phosphate transport protein 2C,11230,75,1.13 [0.75-1.71],0.5506016417810085
Chapter II Neoplasms,Carcinoma in situ of breast,SLC39A14,Zinc transporter ZIP14,13108,85,1.79 [1.16-2.77],0.0081727217099807
Chapter II Neoplasms,Carcinoma in situ of breast,SLC39A5,Zinc transporter ZIP5,13434,87,0.98 [0.69-1.39],0.9044936680154764
Chapter II Neoplasms,Carcinoma in situ of breast,SLC44A4,Choline transporter-like protein 4,11312,75,0.70 [0.45-1.07],0.099628373057196
Chapter II Neoplasms,Carcinoma in situ of breast,SLC4A1,Band 3 anion transport protein,11632,77,0.93 [0.59-1.46],0.7371300749980805
Chapter II Neoplasms,Carcinoma in situ of breast,SLC51B,Organic solute transporter subunit beta,11293,74,0.80 [0.59-1.10],0.1782867846037657
Chapter II Neoplasms,Carcinoma in situ of breast,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,11384,76,0.77 [0.59-1.00],0.0536012522102888
Chapter II Neoplasms,Carcinoma in situ of breast,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,11587,77,1.02 [0.68-1.52],0.9262528837706208
Chapter II Neoplasms,Carcinoma in situ of breast,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",11230,75,0.62 [0.38-1.03],0.0646323993498328
Chapter II Neoplasms,Carcinoma in situ of breast,SLIT2,Slit homolog 2 protein,13108,85,0.82 [0.55-1.22],0.3335077826205229
Chapter II Neoplasms,Carcinoma in situ of breast,SLITRK1,SLIT and NTRK-like protein 1,11319,73,0.55 [0.27-1.12],0.0988311364285434
Chapter II Neoplasms,Carcinoma in situ of breast,SLITRK2,SLIT and NTRK-like protein 2,13571,87,1.02 [0.62-1.68],0.9266944458750288
Chapter II Neoplasms,Carcinoma in situ of breast,SLITRK6,SLIT and NTRK-like protein 6,13220,88,0.83 [0.47-1.45],0.5092157836333407
Chapter II Neoplasms,Carcinoma in situ of breast,SLK,STE20-like serine/threonine-protein kinase,11399,77,0.77 [0.54-1.11],0.1668216202029032
Chapter II Neoplasms,Carcinoma in situ of breast,SLMAP,Sarcolemmal membrane-associated protein,11587,77,0.80 [0.61-1.05],0.1123812068928135
Chapter II Neoplasms,Carcinoma in situ of breast,SLURP1,Secreted Ly-6/uPAR-related protein 1,11544,76,1.01 [0.56-1.80],0.9841611442264868
Chapter II Neoplasms,Carcinoma in situ of breast,SMAD1,Mothers against decapentaplegic homolog 1,13139,87,0.73 [0.57-0.94],0.0159243080006515
Chapter II Neoplasms,Carcinoma in situ of breast,SMAD2,Mothers against decapentaplegic homolog 2,11571,75,0.65 [0.46-0.93],0.0190172165729607
Chapter II Neoplasms,Carcinoma in situ of breast,SMAD3,Mothers against decapentaplegic homolog 3,11571,75,0.68 [0.43-1.08],0.1035454557370056
Chapter II Neoplasms,Carcinoma in situ of breast,SMAD5,Mothers against decapentaplegic homolog 5,13380,89,0.92 [0.38-2.24],0.853194767550986
Chapter II Neoplasms,Carcinoma in situ of breast,SMARCA2,Probable global transcription activator SNF2L2,13108,85,0.90 [0.68-1.19],0.4552950237857686
Chapter II Neoplasms,Carcinoma in situ of breast,SMC3,Structural maintenance of chromosomes protein 3,11230,75,1.11 [0.77-1.62],0.5720148751753588
Chapter II Neoplasms,Carcinoma in situ of breast,SMNDC1,Survival of motor neuron-related-splicing factor 30,11587,77,1.02 [0.72-1.45],0.925416014897062
Chapter II Neoplasms,Carcinoma in situ of breast,SMOC1,SPARC-related modular calcium-binding protein 1,13571,87,0.78 [0.44-1.38],0.3947784336852677
Chapter II Neoplasms,Carcinoma in situ of breast,SMOC2,SPARC-related modular calcium-binding protein 2,13507,91,0.72 [0.43-1.19],0.1993154947151206
Chapter II Neoplasms,Carcinoma in situ of breast,SMPD1,Sphingomyelin phosphodiesterase,13511,89,0.73 [0.49-1.09],0.122619121813197
Chapter II Neoplasms,Carcinoma in situ of breast,SMPD3,Sphingomyelin phosphodiesterase 3,11319,73,0.89 [0.59-1.33],0.5629121676334905
Chapter II Neoplasms,Carcinoma in situ of breast,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,13479,91,0.94 [0.71-1.24],0.647359958117538
Chapter II Neoplasms,Carcinoma in situ of breast,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,11571,75,0.92 [0.68-1.27],0.6234941095200423
Chapter II Neoplasms,Carcinoma in situ of breast,SMS,Spermine synthase,11311,73,0.82 [0.55-1.22],0.3307932011651849
Chapter II Neoplasms,Carcinoma in situ of breast,SMTN,Smoothelin,11591,76,0.79 [0.62-1.01],0.0597586223471582
Chapter II Neoplasms,Carcinoma in situ of breast,SNAP23,Synaptosomal-associated protein 23,13452,90,0.86 [0.70-1.05],0.1370802220391584
Chapter II Neoplasms,Carcinoma in situ of breast,SNAP25,Synaptosomal-associated protein 25,11311,73,0.58 [0.35-0.94],0.0288839357737356
Chapter II Neoplasms,Carcinoma in situ of breast,SNAP29,Synaptosomal-associated protein 29,13480,90,0.81 [0.66-1.00],0.0459442624544197
Chapter II Neoplasms,Carcinoma in situ of breast,SNAPIN,SNARE-associated protein Snapin,11634,76,0.70 [0.47-1.05],0.081991841372097
Chapter II Neoplasms,Carcinoma in situ of breast,SNCA,Alpha-synuclein,11384,76,0.86 [0.71-1.05],0.1306860435407516
Chapter II Neoplasms,Carcinoma in situ of breast,SNCG,Gamma-synuclein,13363,90,0.74 [0.56-0.98],0.0329781834470505
Chapter II Neoplasms,Carcinoma in situ of breast,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",11330,75,0.94 [0.48-1.85],0.8583737297155367
Chapter II Neoplasms,Carcinoma in situ of breast,SNRPB2,U2 small nuclear ribonucleoprotein B'',11617,76,1.18 [0.79-1.76],0.4216645878447516
Chapter II Neoplasms,Carcinoma in situ of breast,SNU13,NHP2-like protein 1,11293,74,1.16 [0.87-1.55],0.3260283926437376
Chapter II Neoplasms,Carcinoma in situ of breast,SNX15,Sorting nexin-15,11384,76,0.73 [0.49-1.10],0.1375010921267662
Chapter II Neoplasms,Carcinoma in situ of breast,SNX18,Sorting nexin-18,11587,77,1.01 [0.63-1.62],0.9552928123321062
Chapter II Neoplasms,Carcinoma in situ of breast,SNX2,Sorting nexin-2,11571,75,0.81 [0.59-1.10],0.1731488334936273
Chapter II Neoplasms,Carcinoma in situ of breast,SNX5,Sorting nexin-5,11330,75,1.04 [0.50-2.14],0.9147670945259496
Chapter II Neoplasms,Carcinoma in situ of breast,SNX9,Sorting nexin-9,13452,90,0.79 [0.60-1.04],0.0923983074807295
Chapter II Neoplasms,Carcinoma in situ of breast,SOD1,Superoxide dismutase [Cu-Zn],13123,89,0.83 [0.56-1.22],0.3445967494901109
Chapter II Neoplasms,Carcinoma in situ of breast,SOD2,"Superoxide dismutase [Mn], mitochondrial",13449,89,0.63 [0.37-1.08],0.0931524850926754
Chapter II Neoplasms,Carcinoma in situ of breast,SOD3,Extracellular superoxide dismutase,11650,75,0.97 [0.66-1.41],0.8563122679747015
Chapter II Neoplasms,Carcinoma in situ of breast,SORBS1,Sorbin and SH3 domain-containing protein 1,11634,76,0.64 [0.31-1.30],0.2174625896976985
Chapter II Neoplasms,Carcinoma in situ of breast,SORCS2,VPS10 domain-containing receptor SorCS2,13139,87,0.57 [0.33-0.98],0.0426552258185647
Chapter II Neoplasms,Carcinoma in situ of breast,SORD,Sorbitol dehydrogenase,13508,86,0.76 [0.58-0.99],0.044113437746309
Chapter II Neoplasms,Carcinoma in situ of breast,SORT1,Sortilin,13434,90,0.76 [0.45-1.29],0.3118433610994298
Chapter II Neoplasms,Carcinoma in situ of breast,SOST,Sclerostin,13434,90,0.92 [0.57-1.49],0.7453717705423627
Chapter II Neoplasms,Carcinoma in situ of breast,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,11312,75,0.46 [0.24-0.88],0.0180516937833506
Chapter II Neoplasms,Carcinoma in situ of breast,SOX2,Transcription factor SOX-2,11620,76,1.22 [0.51-2.92],0.6605631903274352
Chapter II Neoplasms,Carcinoma in situ of breast,SOX9,Transcription factor SOX-9,11312,75,0.50 [0.22-1.14],0.1008546325563677
Chapter II Neoplasms,Carcinoma in situ of breast,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,11634,76,0.56 [0.23-1.33],0.1864643325247255
Chapter II Neoplasms,Carcinoma in situ of breast,SPAG1,Sperm-associated antigen 1,11634,76,0.82 [0.54-1.23],0.3398117631651818
Chapter II Neoplasms,Carcinoma in situ of breast,SPARC,SPARC,13480,90,0.86 [0.67-1.10],0.2320488472971817
Chapter II Neoplasms,Carcinoma in situ of breast,SPARCL1,SPARC-like protein 1,13417,88,1.30 [0.67-2.50],0.4418715971122572
Chapter II Neoplasms,Carcinoma in situ of breast,SPART,Spartin,11384,76,0.76 [0.57-1.02],0.0709153566116886
Chapter II Neoplasms,Carcinoma in situ of breast,SPESP1,Sperm equatorial segment protein 1,11652,74,1.55 [0.71-3.39],0.2722627901929096
Chapter II Neoplasms,Carcinoma in situ of breast,SPINK1,Serine protease inhibitor Kazal-type 1,13449,89,0.94 [0.59-1.51],0.8106495141350636
Chapter II Neoplasms,Carcinoma in situ of breast,SPINK2,Serine protease inhibitor Kazal-type 2,11384,76,1.41 [0.82-2.44],0.2121316883724985
Chapter II Neoplasms,Carcinoma in situ of breast,SPINK4,Serine protease inhibitor Kazal-type 4,13434,87,1.15 [0.85-1.54],0.3689652540285367
Chapter II Neoplasms,Carcinoma in situ of breast,SPINK5,Serine protease inhibitor Kazal-type 5,13449,89,1.05 [0.59-1.87],0.8737850145554349
Chapter II Neoplasms,Carcinoma in situ of breast,SPINK6,Serine protease inhibitor Kazal-type 6,13571,87,0.82 [0.58-1.15],0.240094859815044
Chapter II Neoplasms,Carcinoma in situ of breast,SPINK8,Serine protease inhibitor Kazal-type 8,11293,74,1.11 [0.66-1.86],0.692450277345356
Chapter II Neoplasms,Carcinoma in situ of breast,SPINT1,Kunitz-type protease inhibitor 1,13405,89,0.80 [0.36-1.79],0.5889094109218084
Chapter II Neoplasms,Carcinoma in situ of breast,SPINT2,Kunitz-type protease inhibitor 2,13507,91,0.82 [0.54-1.26],0.3686474570205214
Chapter II Neoplasms,Carcinoma in situ of breast,SPINT3,Kunitz-type protease inhibitor 3,11587,77,1.03 [0.86-1.22],0.7676824541314279
Chapter II Neoplasms,Carcinoma in situ of breast,SPOCK1,Testican-1,13363,90,0.71 [0.33-1.53],0.3857721765378832
Chapter II Neoplasms,Carcinoma in situ of breast,SPON1,Spondin-1,13470,90,0.76 [0.42-1.37],0.3591799605787096
Chapter II Neoplasms,Carcinoma in situ of breast,SPON2,Spondin-2,13390,89,1.01 [0.58-1.78],0.9616512519475046
Chapter II Neoplasms,Carcinoma in situ of breast,SPP1,Osteopontin,13581,89,0.95 [0.64-1.41],0.7951166900560536
Chapter II Neoplasms,Carcinoma in situ of breast,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",11319,73,0.59 [0.33-1.04],0.0701364847435862
Chapter II Neoplasms,Carcinoma in situ of breast,SPRING1,SREBP regulating gene protein,11230,75,1.14 [0.82-1.58],0.4257581046788621
Chapter II Neoplasms,Carcinoma in situ of breast,SPRR1B,Cornifin-B,11399,77,0.94 [0.73-1.23],0.669439358659441
Chapter II Neoplasms,Carcinoma in situ of breast,SPRR3,Small proline-rich protein 3,11617,76,1.04 [0.76-1.42],0.8048288926714071
Chapter II Neoplasms,Carcinoma in situ of breast,SPRY2,Protein sprouty homolog 2,13187,89,0.85 [0.69-1.05],0.13064553497202
Chapter II Neoplasms,Carcinoma in situ of breast,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",11311,73,0.74 [0.35-1.57],0.4380016202618159
Chapter II Neoplasms,Carcinoma in situ of breast,SPTLC1,Serine palmitoyltransferase 1,11617,76,1.01 [0.56-1.83],0.9756285310795436
Chapter II Neoplasms,Carcinoma in situ of breast,SRC,Proto-oncogene tyrosine-protein kinase Src,13457,89,0.84 [0.73-0.98],0.0255156016980031
Chapter II Neoplasms,Carcinoma in situ of breast,SRP14,Signal recognition particle 14 kDa protein,13380,89,0.94 [0.69-1.28],0.6903091889832529
Chapter II Neoplasms,Carcinoma in situ of breast,SRPK2,SRSF protein kinase 2,13434,87,0.80 [0.62-1.02],0.0739848937374422
Chapter II Neoplasms,Carcinoma in situ of breast,SRPX,Sushi repeat-containing protein SRPX,11652,74,1.08 [0.54-2.15],0.8325317780422323
Chapter II Neoplasms,Carcinoma in situ of breast,SSB,Lupus La protein,13108,85,1.09 [0.82-1.45],0.5519530298177432
Chapter II Neoplasms,Carcinoma in situ of breast,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",11319,73,0.88 [0.46-1.69],0.7001876146558327
Chapter II Neoplasms,Carcinoma in situ of breast,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,13434,90,0.87 [0.72-1.05],0.1577771178539406
Chapter II Neoplasms,Carcinoma in situ of breast,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,13459,89,1.30 [0.84-2.02],0.2447687456162598
Chapter II Neoplasms,Carcinoma in situ of breast,SSH3,Protein phosphatase Slingshot homolog 3,11230,75,0.54 [0.24-1.22],0.1369908741696493
Chapter II Neoplasms,Carcinoma in situ of breast,SSNA1,Sjoegren syndrome nuclear autoantigen 1,11587,77,0.69 [0.43-1.08],0.106330497769253
Chapter II Neoplasms,Carcinoma in situ of breast,ST13,Hsc70-interacting protein,11384,76,0.73 [0.50-1.08],0.1200109447891559
Chapter II Neoplasms,Carcinoma in situ of breast,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",13380,89,0.80 [0.50-1.27],0.3382318651893876
Chapter II Neoplasms,Carcinoma in situ of breast,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",13609,89,0.73 [0.38-1.42],0.3581209038437434
Chapter II Neoplasms,Carcinoma in situ of breast,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",11319,73,0.83 [0.49-1.41],0.4818254738332657
Chapter II Neoplasms,Carcinoma in situ of breast,STAB2,Stabilin-2,11632,77,0.85 [0.40-1.79],0.6611880676266403
Chapter II Neoplasms,Carcinoma in situ of breast,STAM,Signal transducing adapter molecule 1,11571,75,0.65 [0.34-1.25],0.1993589240533128
Chapter II Neoplasms,Carcinoma in situ of breast,STAMBP,STAM-binding protein,13334,90,0.76 [0.57-1.02],0.0684177494846181
Chapter II Neoplasms,Carcinoma in situ of breast,STAT2,Signal transducer and activator of transcription 2,11319,73,0.71 [0.52-0.97],0.0298169168399683
Chapter II Neoplasms,Carcinoma in situ of breast,STAT5B,Signal transducer and activator of transcription 5B,13380,89,0.85 [0.74-0.98],0.0209122760221622
Chapter II Neoplasms,Carcinoma in situ of breast,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,11230,75,0.86 [0.59-1.24],0.4088305748788877
Chapter II Neoplasms,Carcinoma in situ of breast,STC1,Stanniocalcin-1,13577,89,0.67 [0.41-1.10],0.1166176218620635
Chapter II Neoplasms,Carcinoma in situ of breast,STC2,Stanniocalcin-2,13426,87,1.89 [0.91-3.93],0.0892516631215403
Chapter II Neoplasms,Carcinoma in situ of breast,STEAP4,Metalloreductase STEAP4,11311,73,0.91 [0.66-1.26],0.578563737447322
Chapter II Neoplasms,Carcinoma in situ of breast,STIP1,Stress-induced-phosphoprotein 1,13428,89,0.72 [0.53-0.96],0.0281681603086084
Chapter II Neoplasms,Carcinoma in situ of breast,STK11,Serine/threonine-protein kinase STK11,13220,88,0.83 [0.63-1.08],0.1610479496233813
Chapter II Neoplasms,Carcinoma in situ of breast,STK24,Serine/threonine-protein kinase 24,13108,85,0.70 [0.51-0.97],0.0330381402637169
Chapter II Neoplasms,Carcinoma in situ of breast,STK4,Serine/threonine-protein kinase 4,13452,90,0.80 [0.64-0.99],0.041286393380709
Chapter II Neoplasms,Carcinoma in situ of breast,STOML2,"Stomatin-like protein 2, mitochondrial",11230,75,1.01 [0.80-1.27],0.946297456928888
Chapter II Neoplasms,Carcinoma in situ of breast,STX16,Syntaxin-16,13139,87,0.64 [0.44-0.95],0.0247881945485236
Chapter II Neoplasms,Carcinoma in situ of breast,STX1B,Syntaxin-1B,11312,75,1.23 [0.83-1.83],0.3111597569522557
Chapter II Neoplasms,Carcinoma in situ of breast,STX3,Syntaxin-3,11617,76,1.08 [0.64-1.80],0.7794740798712937
Chapter II Neoplasms,Carcinoma in situ of breast,STX4,Syntaxin-4,13380,89,0.67 [0.46-0.98],0.0367982048106118
Chapter II Neoplasms,Carcinoma in situ of breast,STX5,Syntaxin-5,11319,73,0.56 [0.28-1.11],0.0955713207975948
Chapter II Neoplasms,Carcinoma in situ of breast,STX6,Syntaxin-6,13139,87,0.85 [0.64-1.15],0.2972026689677257
Chapter II Neoplasms,Carcinoma in situ of breast,STX7,Syntaxin-7,11319,73,0.71 [0.46-1.11],0.1306103993124126
Chapter II Neoplasms,Carcinoma in situ of breast,STX8,Syntaxin-8,13434,87,0.74 [0.50-1.11],0.1422530302110939
Chapter II Neoplasms,Carcinoma in situ of breast,STXBP1,Syntaxin-binding protein 1,11634,76,0.78 [0.59-1.02],0.0726533581700255
Chapter II Neoplasms,Carcinoma in situ of breast,STXBP3,Syntaxin-binding protein 3,13139,87,0.62 [0.37-1.03],0.0623732709355961
Chapter II Neoplasms,Carcinoma in situ of breast,SUGP1,SURP and G-patch domain-containing protein 1,11587,77,0.85 [0.48-1.48],0.5582297434949
Chapter II Neoplasms,Carcinoma in situ of breast,SUGT1,Protein SGT1 homolog,13139,87,0.74 [0.59-0.94],0.0130218231838053
Chapter II Neoplasms,Carcinoma in situ of breast,SULT1A1,Sulfotransferase 1A1,13577,89,0.87 [0.75-0.99],0.0406742676254851
Chapter II Neoplasms,Carcinoma in situ of breast,SULT2A1,Bile salt sulfotransferase,13434,87,0.94 [0.66-1.36],0.7582608372967569
Chapter II Neoplasms,Carcinoma in situ of breast,SUMF1,Formylglycine-generating enzyme,11319,73,1.04 [0.78-1.39],0.771993598610826
Chapter II Neoplasms,Carcinoma in situ of breast,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,13577,89,0.87 [0.62-1.23],0.4353888195306991
Chapter II Neoplasms,Carcinoma in situ of breast,SUOX,"Sulfite oxidase, mitochondrial",11634,76,0.77 [0.52-1.13],0.183367889455198
Chapter II Neoplasms,Carcinoma in situ of breast,SUSD1,Sushi domain-containing protein 1,13220,88,0.63 [0.43-0.92],0.0158492697175388
Chapter II Neoplasms,Carcinoma in situ of breast,SUSD2,Sushi domain-containing protein 2,13449,89,1.09 [0.55-2.14],0.8107460093421536
Chapter II Neoplasms,Carcinoma in situ of breast,SUSD4,Sushi domain-containing protein 4,11571,75,0.57 [0.33-0.99],0.0462961198966225
Chapter II Neoplasms,Carcinoma in situ of breast,SUSD5,Sushi domain-containing protein 5,11317,75,1.55 [0.80-3.01],0.1909770223317349
Chapter II Neoplasms,Carcinoma in situ of breast,SV2A,Synaptic vesicle glycoprotein 2A,11312,75,0.54 [0.35-0.84],0.0057986163269287
Chapter II Neoplasms,Carcinoma in situ of breast,SWAP70,Switch-associated protein 70,11587,77,1.16 [0.67-2.01],0.5969546726802849
Chapter II Neoplasms,Carcinoma in situ of breast,SYAP1,Synapse-associated protein 1,11384,76,0.69 [0.45-1.04],0.0790759882109883
Chapter II Neoplasms,Carcinoma in situ of breast,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,11311,73,0.92 [0.61-1.40],0.6983872999699882
Chapter II Neoplasms,Carcinoma in situ of breast,SYT1,Synaptotagmin-1,11617,76,0.71 [0.36-1.40],0.317070132889232
Chapter II Neoplasms,Carcinoma in situ of breast,SYTL4,Synaptotagmin-like protein 4,11652,74,0.73 [0.52-1.01],0.0582787099574085
Chapter II Neoplasms,Carcinoma in situ of breast,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,11399,77,0.81 [0.66-0.99],0.0396765156118911
Chapter II Neoplasms,Carcinoma in situ of breast,TACC3,Transforming acidic coiled-coil-containing protein 3,13380,89,0.83 [0.71-0.97],0.0188767406860955
Chapter II Neoplasms,Carcinoma in situ of breast,TACSTD2,Tumor-associated calcium signal transducer 2,11916,77,1.23 [0.61-2.47],0.5585974979309012
Chapter II Neoplasms,Carcinoma in situ of breast,TADA3,Transcriptional adapter 3,11571,75,0.83 [0.47-1.47],0.5214456797305147
Chapter II Neoplasms,Carcinoma in situ of breast,TAFA5,Chemokine-like protein TAFA-5,13380,89,0.81 [0.46-1.43],0.4644829930752455
Chapter II Neoplasms,Carcinoma in situ of breast,TAGLN3,Transgelin-3,11230,75,1.00 [0.70-1.43],0.9941619637193012
Chapter II Neoplasms,Carcinoma in situ of breast,TALDO1,Transaldolase,11591,77,0.82 [0.51-1.34],0.4387402975198853
Chapter II Neoplasms,Carcinoma in situ of breast,TANK,TRAF family member-associated NF-kappa-B activator,13187,89,0.74 [0.56-0.98],0.0387104743130368
Chapter II Neoplasms,Carcinoma in situ of breast,TAP1,Antigen peptide transporter 1,11399,77,1.04 [0.74-1.47],0.8200836542183285
Chapter II Neoplasms,Carcinoma in situ of breast,TARBP2,RISC-loading complex subunit TARBP2,13108,85,0.73 [0.56-0.93],0.0124365081262207
Chapter II Neoplasms,Carcinoma in situ of breast,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",11312,75,0.73 [0.50-1.05],0.0916852644066096
Chapter II Neoplasms,Carcinoma in situ of breast,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",11571,75,0.67 [0.36-1.25],0.2095898642601424
Chapter II Neoplasms,Carcinoma in situ of breast,TAX1BP1,Tax1-binding protein 1,11617,76,0.73 [0.50-1.05],0.0917265915123437
Chapter II Neoplasms,Carcinoma in situ of breast,TBC1D17,TBC1 domain family member 17,13108,85,0.79 [0.50-1.26],0.3241779518372446
Chapter II Neoplasms,Carcinoma in situ of breast,TBC1D23,TBC1 domain family member 23,13380,89,0.71 [0.57-0.89],0.0021695685409163
Chapter II Neoplasms,Carcinoma in situ of breast,TBC1D5,TBC1 domain family member 5,13434,87,0.86 [0.67-1.10],0.238755110176223
Chapter II Neoplasms,Carcinoma in situ of breast,TBCA,Tubulin-specific chaperone A,11384,76,0.77 [0.60-1.00],0.051033022111873
Chapter II Neoplasms,Carcinoma in situ of breast,TBCB,Tubulin-folding cofactor B,13363,90,0.80 [0.67-0.95],0.0125419311966036
Chapter II Neoplasms,Carcinoma in situ of breast,TBCC,Tubulin-specific chaperone C,13363,90,0.79 [0.63-1.00],0.047527775029365
Chapter II Neoplasms,Carcinoma in situ of breast,TBL1X,F-box-like/WD repeat-containing protein TBL1X,13139,87,0.74 [0.60-0.93],0.0091151773663963
Chapter II Neoplasms,Carcinoma in situ of breast,TBR1,T-box brain protein 1,11312,75,0.69 [0.39-1.25],0.222004283039992
Chapter II Neoplasms,Carcinoma in situ of breast,TCL1A,T-cell leukemia/lymphoma protein 1A,13336,89,0.94 [0.76-1.16],0.5604602774797733
Chapter II Neoplasms,Carcinoma in situ of breast,TCL1B,T-cell leukemia/lymphoma protein 1B,13220,88,1.02 [0.82-1.27],0.890331423669483
Chapter II Neoplasms,Carcinoma in situ of breast,TCN1,Transcobalamin-1,11411,73,1.09 [0.56-2.12],0.8072183185423425
Chapter II Neoplasms,Carcinoma in situ of breast,TCN2,Transcobalamin-2,13581,89,1.13 [0.61-2.09],0.699925780215602
Chapter II Neoplasms,Carcinoma in situ of breast,TCOF1,Treacle protein,11652,74,1.05 [0.50-2.18],0.9051655021249826
Chapter II Neoplasms,Carcinoma in situ of breast,TCP11,T-complex protein 11 homolog,11399,77,1.01 [0.71-1.45],0.9445359990555734
Chapter II Neoplasms,Carcinoma in situ of breast,TCTN3,Tectonic-3,11652,74,0.88 [0.41-1.89],0.7366703400620244
Chapter II Neoplasms,Carcinoma in situ of breast,TDGF1,Teratocarcinoma-derived growth factor 1,13108,85,0.97 [0.84-1.12],0.6691651792550617
Chapter II Neoplasms,Carcinoma in situ of breast,TDO2,"Tryptophan 2,3-dioxygenase",11312,75,0.99 [0.56-1.72],0.9600790612443294
Chapter II Neoplasms,Carcinoma in situ of breast,TDP1,Tyrosyl-DNA phosphodiesterase 1,11571,75,1.12 [0.85-1.48],0.4279629118168687
Chapter II Neoplasms,Carcinoma in situ of breast,TDRKH,Tudor and KH domain-containing protein,13108,85,0.77 [0.60-0.99],0.0384167842990235
Chapter II Neoplasms,Carcinoma in situ of breast,TEF,Thyrotroph embryonic factor,11293,74,0.93 [0.55-1.58],0.8017029770336872
Chapter II Neoplasms,Carcinoma in situ of breast,TEK,Angiopoietin-1 receptor,13480,90,0.60 [0.25-1.44],0.2549676156741333
Chapter II Neoplasms,Carcinoma in situ of breast,TERF1,Telomeric repeat-binding factor 1,11319,73,1.26 [0.61-2.57],0.5345779113239311
Chapter II Neoplasms,Carcinoma in situ of breast,TET2,Methylcytosine dioxygenase TET2,11383,76,0.96 [0.76-1.21],0.7018736258584293
Chapter II Neoplasms,Carcinoma in situ of breast,TEX101,Testis-expressed protein 101,11312,75,0.74 [0.42-1.31],0.3025321351598533
Chapter II Neoplasms,Carcinoma in situ of breast,TEX33,Testis-expressed protein 33,11399,77,1.38 [0.97-1.96],0.0724073777461142
Chapter II Neoplasms,Carcinoma in situ of breast,TF,Serotransferrin,11662,77,1.18 [0.45-3.09],0.7348733909779916
Chapter II Neoplasms,Carcinoma in situ of breast,TFAP2A,Transcription factor AP-2-alpha,11311,73,1.08 [0.76-1.53],0.6700706155910843
Chapter II Neoplasms,Carcinoma in situ of breast,TFF1,Trefoil factor 1,13382,89,0.96 [0.74-1.26],0.7883418642365652
Chapter II Neoplasms,Carcinoma in situ of breast,TFF2,Trefoil factor 2,13486,91,0.88 [0.62-1.24],0.4632886206804455
Chapter II Neoplasms,Carcinoma in situ of breast,TFF3,Trefoil factor 3,13404,88,0.94 [0.66-1.35],0.7387913112634237
Chapter II Neoplasms,Carcinoma in situ of breast,TFPI,Tissue factor pathway inhibitor,13370,87,1.64 [1.03-2.64],0.0390313869379841
Chapter II Neoplasms,Carcinoma in situ of breast,TFPI2,Tissue factor pathway inhibitor 2,13430,88,0.79 [0.46-1.38],0.410877390181525
Chapter II Neoplasms,Carcinoma in situ of breast,TFRC,Transferrin receptor protein 1,13471,89,0.87 [0.54-1.39],0.553736962133417
Chapter II Neoplasms,Carcinoma in situ of breast,TG,Thyroglobulin,11571,75,0.91 [0.74-1.11],0.3548597255362622
Chapter II Neoplasms,Carcinoma in situ of breast,TGFA,Protransforming growth factor alpha,13434,87,0.87 [0.57-1.33],0.5153628003901563
Chapter II Neoplasms,Carcinoma in situ of breast,TGFB1,Transforming growth factor beta-1 proprotein,13577,88,0.54 [0.32-0.91],0.0196428918229547
Chapter II Neoplasms,Carcinoma in situ of breast,TGFB2,Transforming growth factor beta-2 proprotein,11571,75,1.47 [1.08-1.99],0.0133224121064838
Chapter II Neoplasms,Carcinoma in situ of breast,TGFBI,Transforming growth factor-beta-induced protein ig-h3,13331,86,1.23 [0.61-2.47],0.5611304145571286
Chapter II Neoplasms,Carcinoma in situ of breast,TGFBR1,TGF-beta receptor type-1,11319,73,1.10 [0.40-3.01],0.8506393922192708
Chapter II Neoplasms,Carcinoma in situ of breast,TGFBR2,TGF-beta receptor type-2,13480,90,1.16 [0.61-2.22],0.6435598812661437
Chapter II Neoplasms,Carcinoma in situ of breast,TGFBR3,Transforming growth factor beta receptor type 3,13609,89,1.03 [0.59-1.81],0.9142765048432048
Chapter II Neoplasms,Carcinoma in situ of breast,TGM2,Protein-glutamine gamma-glutamyltransferase 2,13431,90,1.16 [0.91-1.48],0.233105821490974
Chapter II Neoplasms,Carcinoma in situ of breast,TGOLN2,Trans-Golgi network integral membrane protein 2,11650,75,1.53 [0.63-3.72],0.3518598067428049
Chapter II Neoplasms,Carcinoma in situ of breast,THAP12,52 kDa repressor of the inhibitor of the protein kinase,11207,75,1.06 [0.85-1.33],0.6133440035974335
Chapter II Neoplasms,Carcinoma in situ of breast,THBD,Thrombomodulin,13452,90,0.83 [0.41-1.67],0.5977526241947155
Chapter II Neoplasms,Carcinoma in situ of breast,THBS2,Thrombospondin-2,13449,89,0.77 [0.44-1.35],0.3612521014832214
Chapter II Neoplasms,Carcinoma in situ of breast,THBS4,Thrombospondin-4,13420,89,0.88 [0.58-1.33],0.5323612313605399
Chapter II Neoplasms,Carcinoma in situ of breast,THOP1,Thimet oligopeptidase,13402,90,0.89 [0.48-1.66],0.7209513301553576
Chapter II Neoplasms,Carcinoma in situ of breast,THPO,Thrombopoietin,13220,88,0.84 [0.51-1.40],0.5039451630222985
Chapter II Neoplasms,Carcinoma in situ of breast,THRAP3,Thyroid hormone receptor-associated protein 3,11293,74,0.92 [0.74-1.13],0.4250103886273987
Chapter II Neoplasms,Carcinoma in situ of breast,THSD1,Thrombospondin type-1 domain-containing protein 1,11237,73,1.25 [0.69-2.26],0.4592136173381812
Chapter II Neoplasms,Carcinoma in situ of breast,THTPA,Thiamine-triphosphatase,11555,74,0.78 [0.61-1.01],0.0585070872476615
Chapter II Neoplasms,Carcinoma in situ of breast,THY1,Thy-1 membrane glycoprotein,13577,89,0.85 [0.42-1.73],0.6510939789634866
Chapter II Neoplasms,Carcinoma in situ of breast,TIA1,Nucleolysin TIA-1 isoform p40,13079,87,0.84 [0.71-0.99],0.0376294532366241
Chapter II Neoplasms,Carcinoma in situ of breast,TIE1,Tyrosine-protein kinase receptor Tie-1,13609,89,0.90 [0.59-1.36],0.6099061056618367
Chapter II Neoplasms,Carcinoma in situ of breast,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",13079,85,0.98 [0.66-1.47],0.9311931584119943
Chapter II Neoplasms,Carcinoma in situ of breast,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,11399,77,0.81 [0.42-1.56],0.5306705404801226
Chapter II Neoplasms,Carcinoma in situ of breast,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,13459,89,1.09 [0.72-1.67],0.678201787869884
Chapter II Neoplasms,Carcinoma in situ of breast,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,11652,74,0.53 [0.29-0.97],0.0404095286609495
Chapter II Neoplasms,Carcinoma in situ of breast,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,11617,76,0.75 [0.58-0.97],0.0307174208160393
Chapter II Neoplasms,Carcinoma in situ of breast,TIMP1,Metalloproteinase inhibitor 1,13252,85,0.96 [0.47-1.94],0.9026973506516824
Chapter II Neoplasms,Carcinoma in situ of breast,TIMP2,Metalloproteinase inhibitor 2,11652,74,0.32 [0.11-0.93],0.0368838870476526
Chapter II Neoplasms,Carcinoma in situ of breast,TIMP3,Metalloproteinase inhibitor 3,13507,91,0.95 [0.82-1.09],0.4659973689247655
Chapter II Neoplasms,Carcinoma in situ of breast,TIMP4,Metalloproteinase inhibitor 4,13449,89,0.92 [0.57-1.48],0.7195874930872972
Chapter II Neoplasms,Carcinoma in situ of breast,TINAGL1,Tubulointerstitial nephritis antigen-like,13407,90,0.81 [0.35-1.90],0.6268952389400821
Chapter II Neoplasms,Carcinoma in situ of breast,TJAP1,Tight junction-associated protein 1,13480,90,0.82 [0.66-1.04],0.1009710332840364
Chapter II Neoplasms,Carcinoma in situ of breast,TJP3,Tight junction protein ZO-3,11311,73,0.42 [0.21-0.81],0.0095827856263556
Chapter II Neoplasms,Carcinoma in situ of breast,TK1,"Thymidine kinase, cytosolic",11399,77,1.28 [0.84-1.93],0.2466770442792639
Chapter II Neoplasms,Carcinoma in situ of breast,TLR1,Toll-like receptor 1,11319,73,0.66 [0.27-1.62],0.3612063012910667
Chapter II Neoplasms,Carcinoma in situ of breast,TLR2,Toll-like receptor 2,11399,77,1.59 [0.64-3.96],0.317836574809989
Chapter II Neoplasms,Carcinoma in situ of breast,TLR3,Toll-like receptor 3,13604,89,0.94 [0.70-1.26],0.6713947918541137
Chapter II Neoplasms,Carcinoma in situ of breast,TLR4,Toll-like receptor 4,11319,73,0.40 [0.17-0.90],0.0277980385341775
Chapter II Neoplasms,Carcinoma in situ of breast,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,11312,75,0.76 [0.49-1.20],0.2420064149071031
Chapter II Neoplasms,Carcinoma in situ of breast,TMED1,Transmembrane emp24 domain-containing protein 1,11399,77,0.96 [0.64-1.44],0.8429641603395059
Chapter II Neoplasms,Carcinoma in situ of breast,TMED10,Transmembrane emp24 domain-containing protein 10,11293,74,0.89 [0.55-1.46],0.6543057486394721
Chapter II Neoplasms,Carcinoma in situ of breast,TMED4,Transmembrane emp24 domain-containing protein 4,11293,74,1.37 [1.04-1.80],0.0249478120178147
Chapter II Neoplasms,Carcinoma in situ of breast,TMED8,Protein TMED8,11587,77,0.80 [0.65-0.99],0.037336599885513
Chapter II Neoplasms,Carcinoma in situ of breast,TMEM106A,Transmembrane protein 106A,11571,75,0.78 [0.56-1.09],0.1458688285250041
Chapter II Neoplasms,Carcinoma in situ of breast,TMEM132A,Transmembrane protein 132A,11330,75,1.16 [0.83-1.63],0.3755553379813267
Chapter II Neoplasms,Carcinoma in situ of breast,TMEM25,Transmembrane protein 25,11634,76,0.98 [0.60-1.61],0.9393783835366404
Chapter II Neoplasms,Carcinoma in situ of breast,TMOD4,Tropomodulin-4,11230,75,1.02 [0.60-1.75],0.934634187208581
Chapter II Neoplasms,Carcinoma in situ of breast,TMPRSS11B,Transmembrane protease serine 11B,11311,73,1.18 [0.93-1.50],0.1787223798408123
Chapter II Neoplasms,Carcinoma in situ of breast,TMPRSS11D,Transmembrane protease serine 11D,11589,76,0.86 [0.47-1.56],0.6133396668872022
Chapter II Neoplasms,Carcinoma in situ of breast,TMPRSS15,Enteropeptidase,13380,89,0.94 [0.77-1.16],0.5792648530760671
Chapter II Neoplasms,Carcinoma in situ of breast,TMPRSS5,Transmembrane protease serine 5,13295,89,0.96 [0.59-1.57],0.8742024331825538
Chapter II Neoplasms,Carcinoma in situ of breast,TMSB10,Thymosin beta-10,13449,89,0.87 [0.68-1.11],0.2646578098002733
Chapter II Neoplasms,Carcinoma in situ of breast,TNC,Tenascin,13459,89,1.16 [0.78-1.72],0.4697882311914042
Chapter II Neoplasms,Carcinoma in situ of breast,TNF,Tumor necrosis factor,13200,88,0.87 [0.51-1.49],0.6044174691208448
Chapter II Neoplasms,Carcinoma in situ of breast,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,11587,77,1.03 [0.65-1.62],0.9093503867882632
Chapter II Neoplasms,Carcinoma in situ of breast,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,13187,89,0.97 [0.57-1.64],0.9093742257137756
Chapter II Neoplasms,Carcinoma in situ of breast,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,11384,76,0.79 [0.55-1.13],0.1937552451163924
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,13363,90,0.82 [0.45-1.51],0.5211411559005366
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,13363,90,0.64 [0.32-1.28],0.2087587735986319
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,13455,87,1.00 [0.68-1.47],0.9877054416472324
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,13604,89,0.78 [0.46-1.34],0.3677925347363292
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,13445,90,0.85 [0.45-1.62],0.6287093970914697
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,13480,90,1.31 [0.76-2.25],0.3377631580238664
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,13470,90,0.93 [0.49-1.74],0.8097469151680853
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,13187,89,0.87 [0.54-1.40],0.5701470973326124
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,13470,90,0.70 [0.36-1.36],0.2911812478396618
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,11384,76,1.03 [0.58-1.82],0.925719071277703
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,13571,87,1.12 [0.58-2.16],0.7411738161091144
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,13449,89,1.09 [0.54-2.19],0.8171227122488571
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,13449,89,0.85 [0.47-1.52],0.5764632808551902
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,13577,89,1.12 [0.55-2.25],0.760287238907588
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,13577,88,0.70 [0.40-1.21],0.2038364462911184
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,13363,90,0.80 [0.55-1.16],0.2330334633504265
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,13577,89,0.95 [0.62-1.46],0.8201929637490302
Chapter II Neoplasms,Carcinoma in situ of breast,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,13363,90,0.79 [0.47-1.32],0.3630192197125195
Chapter II Neoplasms,Carcinoma in situ of breast,TNFSF10,Tumor necrosis factor ligand superfamily member 10,13604,89,1.43 [0.70-2.92],0.32474461698509
Chapter II Neoplasms,Carcinoma in situ of breast,TNFSF11,Tumor necrosis factor ligand superfamily member 11,13434,87,0.86 [0.63-1.16],0.3187958307804995
Chapter II Neoplasms,Carcinoma in situ of breast,TNFSF12,Tumor necrosis factor ligand superfamily member 12,13604,89,0.77 [0.41-1.46],0.4244713668056358
Chapter II Neoplasms,Carcinoma in situ of breast,TNFSF13,Tumor necrosis factor ligand superfamily member 13,13507,91,0.72 [0.36-1.47],0.3715797041493605
Chapter II Neoplasms,Carcinoma in situ of breast,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,13579,87,0.71 [0.33-1.52],0.3755278425542603
Chapter II Neoplasms,Carcinoma in situ of breast,TNFSF14,Tumor necrosis factor ligand superfamily member 14,13363,90,0.89 [0.65-1.24],0.4981559529107735
Chapter II Neoplasms,Carcinoma in situ of breast,TNFSF8,Tumor necrosis factor ligand superfamily member 8,11632,77,1.05 [0.57-1.91],0.8797563961801776
Chapter II Neoplasms,Carcinoma in situ of breast,TNIP1,TNFAIP3-interacting protein 1,11617,76,0.85 [0.66-1.09],0.2011874867369135
Chapter II Neoplasms,Carcinoma in situ of breast,TNN,Tenascin-N,11632,77,1.13 [0.70-1.82],0.6294257864219595
Chapter II Neoplasms,Carcinoma in situ of breast,TNNI3,"Troponin I, cardiac muscle",13220,88,1.17 [0.91-1.49],0.2148078446426415
Chapter II Neoplasms,Carcinoma in situ of breast,TNPO1,Transportin-1,11399,77,0.87 [0.46-1.62],0.6543600864609317
Chapter II Neoplasms,Carcinoma in situ of breast,TNR,Tenascin-R,13363,90,0.83 [0.53-1.28],0.3895712286727048
Chapter II Neoplasms,Carcinoma in situ of breast,TNXB,Tenascin-X,13449,89,1.02 [0.49-2.11],0.957359637093805
Chapter II Neoplasms,Carcinoma in situ of breast,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,11652,74,0.82 [0.61-1.11],0.198269735595373
Chapter II Neoplasms,Carcinoma in situ of breast,TOP1,DNA topoisomerase 1,11587,77,0.94 [0.77-1.15],0.5391466516436596
Chapter II Neoplasms,Carcinoma in situ of breast,TOP1MT,"DNA topoisomerase I, mitochondrial",11230,75,0.97 [0.61-1.53],0.8827531558473595
Chapter II Neoplasms,Carcinoma in situ of breast,TOP2B,DNA topoisomerase 2-beta,11319,73,0.82 [0.61-1.11],0.207366851572554
Chapter II Neoplasms,Carcinoma in situ of breast,TOR1AIP1,Torsin-1A-interacting protein 1,11330,75,1.29 [0.90-1.85],0.166861221207708
Chapter II Neoplasms,Carcinoma in situ of breast,TP53,Cellular tumor antigen p53,13139,87,0.75 [0.48-1.17],0.2035951064830903
Chapter II Neoplasms,Carcinoma in situ of breast,TP53BP1,TP53-binding protein 1,11319,73,0.84 [0.65-1.09],0.193496574701815
Chapter II Neoplasms,Carcinoma in situ of breast,TP53I3,Quinone oxidoreductase PIG3,11127,76,0.73 [0.48-1.12],0.1515900085745088
Chapter II Neoplasms,Carcinoma in situ of breast,TP53INP1,Tumor protein p53-inducible nuclear protein 1,13220,88,0.66 [0.32-1.37],0.2704019857116912
Chapter II Neoplasms,Carcinoma in situ of breast,TP73,Tumor protein p73,11312,75,0.62 [0.33-1.19],0.1507417985335868
Chapter II Neoplasms,Carcinoma in situ of breast,TPBGL,Trophoblast glycoprotein-like,11312,75,0.70 [0.38-1.29],0.2520537783227656
Chapter II Neoplasms,Carcinoma in situ of breast,TPD52L2,Tumor protein D54,11384,76,0.80 [0.66-0.98],0.0277273012020481
Chapter II Neoplasms,Carcinoma in situ of breast,TPK1,Thiamin pyrophosphokinase 1,11652,74,0.67 [0.31-1.48],0.324244558605242
Chapter II Neoplasms,Carcinoma in situ of breast,TPM3,Tropomyosin alpha-3 chain,11293,74,0.64 [0.35-1.17],0.1444580254684307
Chapter II Neoplasms,Carcinoma in situ of breast,TPMT,Thiopurine S-methyltransferase,13139,87,0.63 [0.48-0.83],0.0010858471848894
Chapter II Neoplasms,Carcinoma in situ of breast,TPP1,Tripeptidyl-peptidase 1,13365,90,0.78 [0.50-1.22],0.2799355720952673
Chapter II Neoplasms,Carcinoma in situ of breast,TPPP2,Tubulin polymerization-promoting protein family member 2,11399,77,1.12 [0.88-1.42],0.3706770608475747
Chapter II Neoplasms,Carcinoma in situ of breast,TPPP3,Tubulin polymerization-promoting protein family member 3,13108,85,0.98 [0.60-1.59],0.9354357514873008
Chapter II Neoplasms,Carcinoma in situ of breast,TPR,Nucleoprotein TPR,11293,74,1.04 [0.67-1.62],0.8610478553246389
Chapter II Neoplasms,Carcinoma in situ of breast,TPRKB,EKC/KEOPS complex subunit TPRKB,11230,75,0.52 [0.32-0.84],0.0079340569939839
Chapter II Neoplasms,Carcinoma in situ of breast,TPSAB1,Tryptase alpha/beta-1,13580,89,0.90 [0.63-1.27],0.5363114004047647
Chapter II Neoplasms,Carcinoma in situ of breast,TPSD1,Tryptase delta,11634,76,1.15 [0.68-1.93],0.6001885302839884
Chapter II Neoplasms,Carcinoma in situ of breast,TPSG1,Tryptase gamma,11319,73,0.59 [0.24-1.48],0.264771210052889
Chapter II Neoplasms,Carcinoma in situ of breast,TPT1,Translationally-controlled tumor protein,13187,89,1.14 [0.90-1.44],0.2917191507999572
Chapter II Neoplasms,Carcinoma in situ of breast,TRAF2,TNF receptor-associated factor 2,13434,87,0.88 [0.67-1.15],0.3444560737237234
Chapter II Neoplasms,Carcinoma in situ of breast,TRAF3,"TNF receptor-associated factor 3, Isoform 2",11319,73,1.01 [0.56-1.81],0.982089051982938
Chapter II Neoplasms,Carcinoma in situ of breast,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,11293,74,0.56 [0.30-1.05],0.0729242482464128
Chapter II Neoplasms,Carcinoma in situ of breast,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,11399,77,0.90 [0.68-1.20],0.4797427057484589
Chapter II Neoplasms,Carcinoma in situ of breast,TREH,Trehalase,11632,77,0.97 [0.72-1.29],0.8224870298258358
Chapter II Neoplasms,Carcinoma in situ of breast,TREM2,Triggering receptor expressed on myeloid cells 2,13445,90,1.08 [0.74-1.57],0.6831011660030691
Chapter II Neoplasms,Carcinoma in situ of breast,TREML1,Trem-like transcript 1 protein,11650,75,0.82 [0.54-1.26],0.3729048696261546
Chapter II Neoplasms,Carcinoma in situ of breast,TREML2,Trem-like transcript 2 protein,13449,89,0.95 [0.54-1.69],0.8736841702395642
Chapter II Neoplasms,Carcinoma in situ of breast,TRIAP1,TP53-regulated inhibitor of apoptosis 1,13571,87,0.75 [0.55-1.01],0.062175430595502
Chapter II Neoplasms,Carcinoma in situ of breast,TRIM21,E3 ubiquitin-protein ligase TRIM21,13434,87,0.86 [0.68-1.08],0.2002234229328298
Chapter II Neoplasms,Carcinoma in situ of breast,TRIM24,Transcription intermediary factor 1-alpha,11373,77,0.91 [0.65-1.28],0.5880112175587956
Chapter II Neoplasms,Carcinoma in situ of breast,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,11587,77,0.81 [0.66-1.00],0.0446566495152463
Chapter II Neoplasms,Carcinoma in situ of breast,TRIM26,Tripartite motif-containing protein 26,11230,75,1.01 [0.69-1.48],0.9475572943432674
Chapter II Neoplasms,Carcinoma in situ of breast,TRIM40,E3 ubiquitin ligase TRIM40,11312,75,0.87 [0.63-1.19],0.3779736755476324
Chapter II Neoplasms,Carcinoma in situ of breast,TRIM5,Tripartite motif-containing protein 5,13434,87,0.86 [0.69-1.08],0.1930563330346675
Chapter II Neoplasms,Carcinoma in situ of breast,TRIM58,E3 ubiquitin-protein ligase TRIM58,11571,75,0.81 [0.63-1.06],0.1221359032262157
Chapter II Neoplasms,Carcinoma in situ of breast,TRPV3,Transient receptor potential cation channel subfamily V member 3,11293,74,0.55 [0.31-0.97],0.0389775988865228
Chapter II Neoplasms,Carcinoma in situ of breast,TSC1,Hamartin,11319,73,0.98 [0.73-1.31],0.8913854349323702
Chapter II Neoplasms,Carcinoma in situ of breast,TSC22D1,TSC22 domain family protein 1,11634,76,0.61 [0.42-0.88],0.0086973571910692
Chapter II Neoplasms,Carcinoma in situ of breast,TSHB,Thyrotropin subunit beta,13452,90,0.97 [0.77-1.21],0.7835978955223301
Chapter II Neoplasms,Carcinoma in situ of breast,TSLP,Thymic stromal lymphopoietin,13220,88,1.07 [0.80-1.42],0.664720933123246
Chapter II Neoplasms,Carcinoma in situ of breast,TSNAX,Translin-associated protein X,11293,74,0.57 [0.32-1.04],0.0652503965844266
Chapter II Neoplasms,Carcinoma in situ of breast,TSPAN1,Tetraspanin-1,13220,88,0.68 [0.34-1.36],0.2791053761456589
Chapter II Neoplasms,Carcinoma in situ of breast,TSPAN15,Tetraspanin-15,11293,74,1.02 [0.67-1.56],0.9233117803707488
Chapter II Neoplasms,Carcinoma in situ of breast,TSPAN7,Tetraspanin-7,11311,73,0.86 [0.65-1.14],0.2903850370566758
Chapter II Neoplasms,Carcinoma in situ of breast,TSPAN8,Tetraspanin-8,11587,77,0.90 [0.73-1.12],0.3502905615042905
Chapter II Neoplasms,Carcinoma in situ of breast,TSPYL1,Testis-specific Y-encoded-like protein 1,11319,73,0.66 [0.36-1.20],0.1734609289080211
Chapter II Neoplasms,Carcinoma in situ of breast,TST,Thiosulfate sulfurtransferase,13092,83,0.72 [0.55-0.95],0.0189018003499455
Chapter II Neoplasms,Carcinoma in situ of breast,TTF2,Transcription termination factor 2,11312,75,0.57 [0.35-0.93],0.0234404361978689
Chapter II Neoplasms,Carcinoma in situ of breast,TTN,Titin,11293,74,0.86 [0.59-1.24],0.4154225926009766
Chapter II Neoplasms,Carcinoma in situ of breast,TTR,Transthyretin,11528,75,1.48 [0.62-3.54],0.3754974690663686
Chapter II Neoplasms,Carcinoma in situ of breast,TUBB3,Tubulin beta-3 chain,11311,73,0.52 [0.23-1.19],0.1216489681909481
Chapter II Neoplasms,Carcinoma in situ of breast,TWF2,Twinfilin-2,11632,77,0.78 [0.60-1.02],0.0646139490120324
Chapter II Neoplasms,Carcinoma in situ of breast,TXK,Tyrosine-protein kinase TXK,11399,77,0.89 [0.65-1.22],0.4714622818961056
Chapter II Neoplasms,Carcinoma in situ of breast,TXLNA,Alpha-taxilin,13363,90,0.82 [0.67-1.01],0.0680661872075769
Chapter II Neoplasms,Carcinoma in situ of breast,TXN,Thioredoxin,11439,74,0.84 [0.49-1.44],0.5232138290644524
Chapter II Neoplasms,Carcinoma in situ of breast,TXNDC15,Thioredoxin domain-containing protein 15,13480,90,1.08 [0.55-2.13],0.8204422609078916
Chapter II Neoplasms,Carcinoma in situ of breast,TXNDC5,Thioredoxin domain-containing protein 5,13577,89,0.72 [0.54-0.97],0.0287138987980869
Chapter II Neoplasms,Carcinoma in situ of breast,TXNDC9,Thioredoxin domain-containing protein 9,11617,76,0.66 [0.42-1.05],0.077339931496941
Chapter II Neoplasms,Carcinoma in situ of breast,TXNL1,Thioredoxin-like protein 1,11290,73,1.01 [0.80-1.26],0.9654767504511724
Chapter II Neoplasms,Carcinoma in situ of breast,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",13449,89,0.69 [0.45-1.05],0.0835316963540628
Chapter II Neoplasms,Carcinoma in situ of breast,TYMP,Thymidine phosphorylase,13373,90,0.76 [0.57-1.00],0.0518138085147354
Chapter II Neoplasms,Carcinoma in situ of breast,TYRO3,Tyrosine-protein kinase receptor TYRO3,13452,90,1.22 [0.64-2.36],0.5456137305195294
Chapter II Neoplasms,Carcinoma in situ of breast,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",11319,73,1.04 [0.71-1.51],0.8405378737812123
Chapter II Neoplasms,Carcinoma in situ of breast,UBAC1,Ubiquitin-associated domain-containing protein 1,13380,89,0.91 [0.54-1.53],0.7209215172202592
Chapter II Neoplasms,Carcinoma in situ of breast,UBE2B,Ubiquitin-conjugating enzyme E2 B,11571,75,0.62 [0.28-1.38],0.2369649136585072
Chapter II Neoplasms,Carcinoma in situ of breast,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,11652,74,0.63 [0.44-0.92],0.0159476015566305
Chapter II Neoplasms,Carcinoma in situ of breast,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,11319,73,0.79 [0.52-1.21],0.2864586794556774
Chapter II Neoplasms,Carcinoma in situ of breast,UBQLN3,Ubiquilin-3,11293,74,0.83 [0.47-1.46],0.51515597187011
Chapter II Neoplasms,Carcinoma in situ of breast,UBXN1,UBX domain-containing protein 1,11384,76,0.71 [0.51-0.99],0.0434864213032214
Chapter II Neoplasms,Carcinoma in situ of breast,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,11587,77,0.86 [0.73-1.00],0.0487072421324618
Chapter II Neoplasms,Carcinoma in situ of breast,UGDH,UDP-glucose 6-dehydrogenase,11293,74,0.95 [0.75-1.20],0.6652582053573612
Chapter II Neoplasms,Carcinoma in situ of breast,UHRF2,E3 ubiquitin-protein ligase UHRF2,11293,74,0.69 [0.33-1.45],0.3245566599876611
Chapter II Neoplasms,Carcinoma in situ of breast,ULBP2,UL16-binding protein 2,13363,90,0.98 [0.59-1.65],0.9516482058870888
Chapter II Neoplasms,Carcinoma in situ of breast,UMOD,Uromodulin,13567,89,1.10 [0.77-1.58],0.5943837004237371
Chapter II Neoplasms,Carcinoma in situ of breast,UNC5D,Netrin receptor UNC5D,11319,73,0.83 [0.36-1.94],0.6701534508715314
Chapter II Neoplasms,Carcinoma in situ of breast,UNC79,Protein unc-79 homolog,11230,75,0.82 [0.54-1.25],0.3667679434964466
Chapter II Neoplasms,Carcinoma in situ of breast,UNG,Uracil-DNA glycosylase,11571,75,0.84 [0.43-1.63],0.6054944950035916
Chapter II Neoplasms,Carcinoma in situ of breast,UPB1,Beta-ureidopropionase,11652,74,0.99 [0.78-1.26],0.95721350531355
Chapter II Neoplasms,Carcinoma in situ of breast,UPK3A,Uroplakin-3a,11311,73,0.95 [0.60-1.51],0.8336628148860575
Chapter II Neoplasms,Carcinoma in situ of breast,UPK3BL1,Uroplakin-3b-like protein 1,11385,77,1.08 [0.76-1.53],0.6630440353679005
Chapter II Neoplasms,Carcinoma in situ of breast,UROD,Uroporphyrinogen decarboxylase,11384,76,0.76 [0.55-1.04],0.0840422752598663
Chapter II Neoplasms,Carcinoma in situ of breast,UROS,Uroporphyrinogen-III synthase,11312,75,1.15 [0.87-1.53],0.3210748903766221
Chapter II Neoplasms,Carcinoma in situ of breast,USO1,General vesicular transport factor p115,13380,89,0.79 [0.64-0.97],0.0220630831807915
Chapter II Neoplasms,Carcinoma in situ of breast,USP25,Ubiquitin carboxyl-terminal hydrolase 25,11571,75,0.66 [0.48-0.91],0.0100971975938487
Chapter II Neoplasms,Carcinoma in situ of breast,USP28,Ubiquitin carboxyl-terminal hydrolase 28,11617,76,0.80 [0.43-1.51],0.4904754146653872
Chapter II Neoplasms,Carcinoma in situ of breast,USP47,Ubiquitin carboxyl-terminal hydrolase 47,11293,74,0.86 [0.65-1.15],0.3211877170317467
Chapter II Neoplasms,Carcinoma in situ of breast,USP8,Ubiquitin carboxyl-terminal hydrolase 8,13220,88,0.82 [0.67-1.00],0.054101847999163
Chapter II Neoplasms,Carcinoma in situ of breast,UXS1,UDP-glucuronic acid decarboxylase 1,13139,87,0.96 [0.67-1.36],0.7991178833385504
Chapter II Neoplasms,Carcinoma in situ of breast,VAMP5,Vesicle-associated membrane protein 5,13220,88,0.85 [0.58-1.25],0.4134147615025833
Chapter II Neoplasms,Carcinoma in situ of breast,VAMP8,Vesicle-associated membrane protein 8,11319,73,0.80 [0.62-1.04],0.0934886879916659
Chapter II Neoplasms,Carcinoma in situ of breast,VASH1,Tubulinyl-Tyr carboxypeptidase 1,13434,87,0.83 [0.65-1.05],0.1241166484354382
Chapter II Neoplasms,Carcinoma in situ of breast,VASN,Vasorin,13196,85,1.76 [0.91-3.38],0.0909534966273232
Chapter II Neoplasms,Carcinoma in situ of breast,VASP,Vasodilator-stimulated phosphoprotein,11650,75,0.75 [0.55-1.03],0.0754144704795517
Chapter II Neoplasms,Carcinoma in situ of breast,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,13380,89,1.31 [0.52-3.29],0.5676842357080374
Chapter II Neoplasms,Carcinoma in situ of breast,VAV3,Guanine nucleotide exchange factor VAV3,11311,73,0.73 [0.58-0.92],0.0076117099874907
Chapter II Neoplasms,Carcinoma in situ of breast,VCAM1,Vascular cell adhesion protein 1,13441,89,0.93 [0.45-1.89],0.8377148058651791
Chapter II Neoplasms,Carcinoma in situ of breast,VCAN,Versican core protein,13577,89,0.84 [0.45-1.58],0.5977214339857162
Chapter II Neoplasms,Carcinoma in situ of breast,VCPKMT,Protein-lysine methyltransferase METTL21D,11230,75,0.93 [0.71-1.21],0.5816156441184417
Chapter II Neoplasms,Carcinoma in situ of breast,VEGFA,Vascular endothelial growth factor A,13563,89,0.83 [0.59-1.15],0.2608636343836209
Chapter II Neoplasms,Carcinoma in situ of breast,VEGFB,Vascular endothelial growth factor B,11319,73,0.52 [0.24-1.15],0.1062903056754004
Chapter II Neoplasms,Carcinoma in situ of breast,VEGFC,Vascular endothelial growth factor C,13480,90,0.77 [0.55-1.07],0.1244577041566671
Chapter II Neoplasms,Carcinoma in situ of breast,VEGFD,Vascular endothelial growth factor D,13583,89,1.37 [0.78-2.41],0.2727060480966422
Chapter II Neoplasms,Carcinoma in situ of breast,VGF,Neurosecretory protein VGF,11634,76,0.76 [0.36-1.61],0.4743988989602425
Chapter II Neoplasms,Carcinoma in situ of breast,VIM,Vimentin,13220,88,1.12 [0.94-1.33],0.2170383467021991
Chapter II Neoplasms,Carcinoma in situ of breast,VIPR1,Vasoactive intestinal polypeptide receptor 1,11330,75,1.11 [0.50-2.46],0.7888850251536287
Chapter II Neoplasms,Carcinoma in situ of breast,VIT,Vitrin,11652,74,0.87 [0.47-1.58],0.6376835976846994
Chapter II Neoplasms,Carcinoma in situ of breast,VMO1,Vitelline membrane outer layer protein 1 homolog,13380,89,1.03 [0.77-1.37],0.8440853487552777
Chapter II Neoplasms,Carcinoma in situ of breast,VNN1,Pantetheinase,11650,75,1.22 [0.89-1.67],0.2226878275935912
Chapter II Neoplasms,Carcinoma in situ of breast,VNN2,Vascular non-inflammatory molecule 2,13380,89,0.80 [0.54-1.18],0.2563686705310521
Chapter II Neoplasms,Carcinoma in situ of breast,VPS28,Vacuolar protein sorting-associated protein 28 homolog,11399,77,0.84 [0.59-1.18],0.308722380987718
Chapter II Neoplasms,Carcinoma in situ of breast,VPS37A,Vacuolar protein sorting-associated protein 37A,13380,89,0.74 [0.58-0.95],0.0164679223483113
Chapter II Neoplasms,Carcinoma in situ of breast,VPS4B,Vacuolar protein sorting-associated protein 4B,11571,75,0.83 [0.66-1.06],0.1346972166901795
Chapter II Neoplasms,Carcinoma in situ of breast,VPS53,Vacuolar protein sorting-associated protein 53 homolog,13380,89,0.69 [0.53-0.90],0.0066861598711844
Chapter II Neoplasms,Carcinoma in situ of breast,VSIG10,V-set and immunoglobulin domain-containing protein 10,11571,75,1.10 [0.64-1.87],0.7381135862734477
Chapter II Neoplasms,Carcinoma in situ of breast,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,11293,74,1.06 [0.56-2.01],0.8521049925466133
Chapter II Neoplasms,Carcinoma in situ of breast,VSIG2,V-set and immunoglobulin domain-containing protein 2,11571,75,1.04 [0.68-1.58],0.8505739829683467
Chapter II Neoplasms,Carcinoma in situ of breast,VSIG4,V-set and immunoglobulin domain-containing protein 4,13426,87,0.79 [0.46-1.34],0.3781063869250736
Chapter II Neoplasms,Carcinoma in situ of breast,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,13434,90,0.74 [0.53-1.03],0.0741994964370765
Chapter II Neoplasms,Carcinoma in situ of breast,VSNL1,Visinin-like protein 1,11617,76,1.11 [0.62-1.99],0.7335338925222035
Chapter II Neoplasms,Carcinoma in situ of breast,VSTM1,V-set and transmembrane domain-containing protein 1,13108,85,1.26 [0.86-1.84],0.2433985023911703
Chapter II Neoplasms,Carcinoma in situ of breast,VSTM2B,V-set and transmembrane domain-containing protein 2B,11399,77,0.98 [0.59-1.64],0.933411921237546
Chapter II Neoplasms,Carcinoma in situ of breast,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,13220,88,0.86 [0.61-1.22],0.4040143589877412
Chapter II Neoplasms,Carcinoma in situ of breast,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,13577,89,0.80 [0.62-1.05],0.1033519634635694
Chapter II Neoplasms,Carcinoma in situ of breast,VTCN1,V-set domain-containing T-cell activation inhibitor 1,13139,87,0.55 [0.30-1.02],0.0584834870945361
Chapter II Neoplasms,Carcinoma in situ of breast,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,11384,76,0.80 [0.54-1.18],0.2553559954109627
Chapter II Neoplasms,Carcinoma in situ of breast,VWA1,von Willebrand factor A domain-containing protein 1,13550,87,0.70 [0.45-1.10],0.1266954088419425
Chapter II Neoplasms,Carcinoma in situ of breast,VWA5A,von Willebrand factor A domain-containing protein 5A,11230,75,0.88 [0.64-1.21],0.4411566521869371
Chapter II Neoplasms,Carcinoma in situ of breast,VWC2,Brorin,13313,90,0.93 [0.57-1.53],0.7706793064082487
Chapter II Neoplasms,Carcinoma in situ of breast,VWC2L,von Willebrand factor C domain-containing protein 2-like,11634,76,0.73 [0.41-1.32],0.2987840245343222
Chapter II Neoplasms,Carcinoma in situ of breast,VWF,von Willebrand factor,13609,89,1.06 [0.82-1.36],0.6793429087802286
Chapter II Neoplasms,Carcinoma in situ of breast,WARS,"Tryptophan--tRNA ligase, cytoplasmic",13449,89,0.63 [0.38-1.03],0.0629152850292159
Chapter II Neoplasms,Carcinoma in situ of breast,WAS,Wiskott-Aldrich syndrome protein,13187,89,0.67 [0.50-0.91],0.0091900133256517
Chapter II Neoplasms,Carcinoma in situ of breast,WASF1,Wiskott-Aldrich syndrome protein family member 1,13220,88,0.77 [0.62-0.96],0.0201664417144934
Chapter II Neoplasms,Carcinoma in situ of breast,WASF3,Wiskott-Aldrich syndrome protein family member 3,13108,85,0.74 [0.61-0.90],0.0025496869365319
Chapter II Neoplasms,Carcinoma in situ of breast,WASHC3,WASH complex subunit 3,11617,76,0.76 [0.56-1.04],0.090498810988801
Chapter II Neoplasms,Carcinoma in situ of breast,WASL,Neural Wiskott-Aldrich syndrome protein,11319,73,0.93 [0.64-1.37],0.7236779738685483
Chapter II Neoplasms,Carcinoma in situ of breast,WDR46,WD repeat-containing protein 46,11571,75,0.44 [0.22-0.90],0.0235289848605222
Chapter II Neoplasms,Carcinoma in situ of breast,WFDC1,WAP four-disulfide core domain protein 1,11360,72,1.24 [0.88-1.74],0.2162346536935706
Chapter II Neoplasms,Carcinoma in situ of breast,WFDC12,WAP four-disulfide core domain protein 12,13552,87,1.08 [0.81-1.44],0.598412013994287
Chapter II Neoplasms,Carcinoma in situ of breast,WFDC2,WAP four-disulfide core domain protein 2,12727,83,0.84 [0.45-1.57],0.5840261772676678
Chapter II Neoplasms,Carcinoma in situ of breast,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",13327,90,0.89 [0.56-1.43],0.6420178425176917
Chapter II Neoplasms,Carcinoma in situ of breast,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",13470,90,0.80 [0.46-1.39],0.4305230200413975
Chapter II Neoplasms,Carcinoma in situ of breast,WIF1,Wnt inhibitory factor 1,13571,87,0.65 [0.37-1.13],0.1280897845048541
Chapter II Neoplasms,Carcinoma in situ of breast,WNT9A,Protein Wnt-9a,13187,89,0.54 [0.27-1.09],0.0852055190569622
Chapter II Neoplasms,Carcinoma in situ of breast,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,13363,90,0.70 [0.49-1.00],0.0492054722068282
Chapter II Neoplasms,Carcinoma in situ of breast,XCL1,Lymphotactin,13571,87,0.80 [0.55-1.17],0.2506513415371327
Chapter II Neoplasms,Carcinoma in situ of breast,XG,Glycoprotein Xg,13537,87,0.86 [0.43-1.69],0.6514311002037578
Chapter II Neoplasms,Carcinoma in situ of breast,XIAP,E3 ubiquitin-protein ligase XIAP,11319,73,0.68 [0.45-1.03],0.0669194252714357
Chapter II Neoplasms,Carcinoma in situ of breast,XPNPEP2,Xaa-Pro aminopeptidase 2,13480,90,1.05 [0.85-1.30],0.6330250144026776
Chapter II Neoplasms,Carcinoma in situ of breast,XRCC4,DNA repair protein XRCC4,13108,85,0.79 [0.46-1.36],0.3920483608358779
Chapter II Neoplasms,Carcinoma in situ of breast,YAP1,Transcriptional coactivator YAP1,11617,76,0.87 [0.36-2.10],0.7636703988790872
Chapter II Neoplasms,Carcinoma in situ of breast,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",11587,77,0.89 [0.77-1.02],0.095043888641635
Chapter II Neoplasms,Carcinoma in situ of breast,YES1,Tyrosine-protein kinase Yes,13380,89,0.78 [0.66-0.92],0.0034198942584366
Chapter II Neoplasms,Carcinoma in situ of breast,YJU2,Splicing factor YJU2,11571,75,0.65 [0.32-1.35],0.2519630112758469
Chapter II Neoplasms,Carcinoma in situ of breast,YOD1,Ubiquitin thioesterase OTU1,11293,74,0.79 [0.55-1.13],0.1985661056307778
Chapter II Neoplasms,Carcinoma in situ of breast,YTHDF3,YTH domain-containing family protein 3,13187,89,0.82 [0.65-1.03],0.08200443312377
Chapter II Neoplasms,Carcinoma in situ of breast,YWHAQ,14-3-3 protein theta,11384,76,0.72 [0.52-0.98],0.0361733496752564
Chapter II Neoplasms,Carcinoma in situ of breast,YY1,Transcriptional repressor protein YY1,11319,73,1.20 [0.54-2.65],0.6584742537646857
Chapter II Neoplasms,Carcinoma in situ of breast,ZBP1,Z-DNA-binding protein 1,11319,73,0.92 [0.52-1.63],0.7864799826119236
Chapter II Neoplasms,Carcinoma in situ of breast,ZBTB16,Zinc finger and BTB domain-containing protein 16,13139,87,0.68 [0.50-0.92],0.0134048944018483
Chapter II Neoplasms,Carcinoma in situ of breast,ZBTB17,Zinc finger and BTB domain-containing protein 17,13220,88,0.86 [0.52-1.41],0.546789925526364
Chapter II Neoplasms,Carcinoma in situ of breast,ZCCHC8,Zinc finger CCHC domain-containing protein 8,11293,74,1.05 [0.74-1.49],0.7844665216647463
Chapter II Neoplasms,Carcinoma in situ of breast,ZFYVE19,Abscission/NoCut checkpoint regulator,11587,77,0.81 [0.64-1.04],0.0969170457021374
Chapter II Neoplasms,Carcinoma in situ of breast,ZHX2,Zinc fingers and homeoboxes protein 2,11617,76,1.35 [0.83-2.20],0.2266221214079721
Chapter II Neoplasms,Carcinoma in situ of breast,ZNF174,Zinc finger protein 174,11319,73,0.71 [0.35-1.46],0.3494566397849085
Chapter II Neoplasms,Carcinoma in situ of breast,ZNF75D,Zinc finger protein 75D,11399,77,0.81 [0.54-1.22],0.3155911827645969
Chapter II Neoplasms,Carcinoma in situ of breast,ZNF830,Zinc finger protein 830,11571,75,1.12 [0.88-1.42],0.3478382264955941
Chapter II Neoplasms,Carcinoma in situ of breast,ZNRD2,Protein ZNRD2,11587,77,1.03 [0.74-1.41],0.8734058008223724
Chapter II Neoplasms,Carcinoma in situ of breast,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,11571,75,0.79 [0.52-1.22],0.2893780634577991
Chapter II Neoplasms,Carcinoma in situ of breast,ZP3,Zona pellucida sperm-binding protein 3,11330,75,1.01 [0.93-1.10],0.7840712458486312
Chapter II Neoplasms,Carcinoma in situ of breast,ZP4,Zona pellucida sperm-binding protein 4,11230,75,0.62 [0.27-1.43],0.2593977710435274
Chapter II Neoplasms,Carcinoma in situ of breast,ZPR1,Zinc finger protein ZPR1,11311,73,0.98 [0.77-1.24],0.869045534781971
